pyrazinamide has been researched along with ethambutol in 972 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 198 (20.37) | 18.7374 |
| 1990's | 129 (13.27) | 18.2507 |
| 2000's | 197 (20.27) | 29.6817 |
| 2010's | 366 (37.65) | 24.3611 |
| 2020's | 82 (8.44) | 2.80 |
| Authors | Studies |
|---|---|
| Bansal, NP; Dick, JD; Houston, TA; Jones, PB; Parrish, NM; Stapon, A; Townsend, CA | 1 |
| Hashizume, H; Kawasaki, M; Komatsu, M; Matsumoto, M; Sasaki, H; Shimokawa, Y; Tomishige, T; Tsubouchi, H | 1 |
| Cho, SH; Franzblau, SG; Hwang, CH; Pauli, GF; Wan, B; Warit, S | 1 |
| Aarnoutse, RE; Alisjahbana, B; Nijland, HM; Parwati, I; Ruslami, R; van Crevel, R | 1 |
| Chung, WJ; Jacobs, WR; Ngo, SC; Sayahi, H; Welch, JT; Zimhony, O | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Connell, TG; Curtis, N; Ritz, N; Robins-Browne, R; Sievers, A; Tebruegge, M | 1 |
| Karthikeyan, SV; Perumal, S; Shetty, KA; Sriram, D; Yogeeswari, P | 1 |
| Perumal, S; Ranjith Kumar, R; Senthilkumar, P; Sriram, D; Yogeeswari, P | 1 |
| Gaillard, JL; Jackson, M; McDonnell, G; Niederweis, M; Skovierová, H; Svetlíková, Z | 1 |
| Rieder, RJ; Zavizion, B; Zhao, Z | 1 |
| Banerjee, D; Indumathi, S; Perumal, S; Sriram, D; Yogeeswari, P | 1 |
| Banerjee, D; Kumar, RS; Perumal, S; Rajesh, SM; Sriram, D; Yogeeswari, P | 1 |
| Bala, BD; Karthikeyan, SV; Perumal, S; Raja, VP; Sriram, D; Yogeeswari, P | 1 |
| Aarnoutse, RE; Adhiarta, IG; Alisjahbana, B; Kariadi, SH; Nijland, HM; Ruslami, R; van Crevel, R | 1 |
| Angulo-Barturen, I; Beltrán, M; Cáceres, N; Cardona, PJ; García, JI; García-Bustos, JF; Rullas, J | 1 |
| Manikannan, R; Muthusubramanian, S; Sriram, D; Yogeeswari, P | 1 |
| Khanna, A; Pareek, PK; Raj, VS; Rattan, A; Saini, KS; Sharma, P; Singh, H; Sood, R; Tarai, B; Upadhyay, DJ | 1 |
| Manikannan, R; Muthusubramanian, S; Sriram, D; Venkatesan, R; Yogeeswari, P | 1 |
| Kantevari, S; Patpi, SR; Sridhar, B; Sriram, D; Yogeeswari, P | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Perumal, S; Raja, VP; Sriram, D; Yogeeswari, P | 1 |
| Kantevari, S; Sridhar, B; Sriram, D; Yempala, T; Yogeeswari, P | 1 |
| Jacobs, WR; Sayahi, H; Shekhtman, A; Welch, JT; Zimhony, O | 1 |
| Murugavel, M; Muthusubramanian, S; Paul, N; Sriram, D | 1 |
| Bocanegra-García, V; García, A; Palma-Nicolás, JP; Rivera, G | 1 |
| Anjana Devi, T; Jain, N; Kalivendi, SV; Kantevari, S; Murthy, R; Patpi, SR; Pulipati, L; Sridhar, B; Sriram, D; Yogeeswari, P | 1 |
| Chikhalia, KH; Kumari, P; Patel, PK; Patel, RV; Rajani, DP | 1 |
| Chakrapani, H; Malwal, SR; Sriram, D; Yogeeswari, P | 1 |
| Jeyachandran, M; Ramesh, P; Senthilkumar, P; Sriram, D; Yogeeswari, P | 1 |
| Alexandrova, L; Andreevskaya, S; Chernousova, L; Chizhov, A; Karpenko, I; Khandazhinskaya, A; Kochetkov, S; Matyugina, E; Smirnova, T | 1 |
| Kantevari, S; Sriram, D; Yempala, T; Yogeeswari, P | 1 |
| Alexandrova, LA; Andreevskaya, SN; Chernousova, LN; Chizhov, AO; Efremenkova, OV; Karpenko, IL; Kochetkov, SN; Shmalenyuk, ER; Smirnova, TG | 1 |
| Barry, CE; Dartois, V | 1 |
| Kantevari, S; Sridevi, JP; Sriram, D; Yempala, T; Yogeeswari, P | 1 |
| Avupati, VR; Boddeda, B; Cheepurupalli, P; Gavalapu, VR; Killari, KN; Papasani, VM; Parala, VR; Yejella, RP | 1 |
| Addla, D; Gurram, D; Jallapally, A; Kantevari, S; Sriram, D; Yogeeswari, P | 2 |
| Chikhalia, KH; Kumari, P; Patel, AB | 1 |
| Chaturvedi, V; Chauhan, K; Chauhan, PM; Sharma, M; Trivedi, P | 1 |
| Achur, R; Dalimba, U; Kumar, HS; Nayak, N; Peethambar, SK; Ramprasad, J; Sriram, D; Yogeeswari, P | 1 |
| Bera, S; Chaturvedi, V; Jana, AK; Kumar M, SL; Manna, SK; Mishra, P; Mondal, S; Panda, G; Parai, MK; Saha, T; Singh, P; Singh, S; Sinha, S; Trivedi, P | 1 |
| Askri, M; Boudriga, S; Golz, C; Knorr, M; Mhiri, C; Nana, F; Sriram, D; Strohmann, C; Yogeeswari, P | 1 |
| Dalimba, U; Nayak, N; Ramprasad, J; Sriram, D; Yogeeswari, P | 1 |
| Dalimba, U; Nayak, N; Ramprasad, J | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Chakraborti, AK; Dhameliya, TM; Jadhavar, PS; Pancholia, S; Shah, P; Sridevi, JP; Sriram, D; Yogeshwari, P | 1 |
| Chakraborti, AK; Dhameliya, TM; Jadhavar, PS; Kumar, D; Sridevi, JP; Sriram, D; Vaja, MD; Yogeeswari, P | 1 |
| Kantevari, S; Pulipati, L; Sriram, D; Yogeeswari, P | 1 |
| Kantevari, S; Pulipati, L; Sridevi, JP; Sriram, D; Yogeeswari, P | 1 |
| Kantevari, S; Sriram, D; Surineni, G; Yogeeswari, P | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Beuerman, RW; Cao, D; Corkran, HM; Dick, T; Koh, JJ; Lakshminarayanan, R; Lim, F; Lin, S; Liu, S; Mukherjee, D; Stocker, BL; Tan, DTH; Tan, DZ; Tan, JK; Timmer, MSM; Zou, H | 1 |
| Chakraborti, AK; Kumar, A; Sriram, D; Tanwar, B; Yogeeswari, P | 1 |
| Balaji, NV; Hari Babu, B; Murali Krishna Kumar, M; Purna Nagasree, K; Subbaraju, GV | 1 |
| Feng, LS; Gao, C; Hu, YQ; Lv, ZS; Wu, X; Xu, Z; Zhang, S; Zhao, F | 1 |
| Chang, L; Feng, LS; Gao, C; Lv, ZS; Ren, QC; Xu, Z; Zhang, S | 1 |
| Feng, LS; Gao, C; Lv, ZS; Ren, QC; Song, XF; Xu, Z | 1 |
| Aiub, CAF; Araujo-Lima, CF; Boechat, N; Castelo-Branco, FS; Costa, TEMM; Costa-Lima, MM; de Lima, EC; Domingos, JLO; Felzenszwalb, I; Gomes, KM; Henriques, MG; Lourenço, MCS; Penido, C; Pinto, AC | 1 |
| Kantevari, S; Marvadi, SK; Sriram, D; Surineni, G; Yogeeswari, P | 1 |
| Banerjee, A; Chakraborti, AK; Dhameliya, TM; Pancholia, S; Panda, D; Sriram, D; Tiwari, R | 1 |
| Ashok, D; Goud, GL; Manga, V; Ramesh, S; Reddy, VP; Saikrishna, B; Sriram, D; Yogeeswari, P | 1 |
| Bera, S; Mondal, D | 1 |
| Mabhula, A; Singh, V | 1 |
| Jayathirtha Rao, V; Kishore, G; Kumar, SB; Ravinder, M; Sriram, D; Yogeeswari, P | 1 |
| Cordeiro, R; Kachroo, M | 1 |
| Dhawan, S; Girase, PS; Karpoormath, R; Kumar, V; Palkar, MB; Shinde, SR | 1 |
| Trotsko, N | 1 |
| Ahmad, I; Alshahrani, MY; Jain, R; Pradeep Kumar, CB; Prashanth, MK; Raghu, MS; Yogesh Kumar, K | 1 |
| Agrahari, AK; Rajkhowa, S; Sharma, A; Tiwari, VK | 1 |
| Martin, PD | 1 |
| Bates, JH | 1 |
| Newton, RW | 1 |
| Rossouw, JE; Saunders, SJ | 1 |
| Springett, VH | 1 |
| Burjanová, B; Dornetzhuber, V | 1 |
| Clarke, PD | 1 |
| Pearson, JO | 1 |
| Mitchison, DA | 4 |
| Víznerová, A | 1 |
| Vieritz, HD | 1 |
| Chan, SL | 1 |
| Girling, DJ | 2 |
| Aquinas, M | 1 |
| Grosset, J; Perdrizet, S; Pretet, S | 1 |
| Aber, VR; Dickinson, JM; Mitchison, DA | 1 |
| Morgan, EJ | 1 |
| Anastasatu, C; Plopeanu, D | 1 |
| Eule, H | 1 |
| Gow, JG | 1 |
| Johnston, RF; Promisloff, RA | 1 |
| Balogh, F; Borthwick, WM; Mallo, N; Mazurek, L; Trnka, L; Victorov, J | 1 |
| Fallon, RJ | 1 |
| Korotaev, GA; Kozulitsyna, TM | 1 |
| Utkin, VV | 1 |
| Ait Khaled, N; Benachenhou, A; Chaulet, P; Fekar, A; Virot, JP | 1 |
| Hinshaw, HC | 1 |
| Iatsozhinskiĭ, IuD; Kulik, NM; Molotkov, VN | 1 |
| Boman, G; Dahlström, G; Hanngren, A; Stavenow, S; Wiman, LG | 1 |
| Kelley, WN | 1 |
| Kislitsyna, NA; Kotova, NI | 1 |
| Kumar, L | 1 |
| Schmidt, M | 1 |
| Nolan, CM | 1 |
| Chotpitayasunonah, T; Jacobs, RF; Kelleher, K; Pope, S; Sunakorn, P | 1 |
| Kovaleva, SI | 1 |
| Pust, RE | 1 |
| Malaviya, AN; Singh, S; Singh, YN | 1 |
| Lalwani, AK; Lee, KC; Schecter, G; Tami, TA | 1 |
| Adrados, M; Díaz, F; García Aguado, C; González Lahoz, JM; Laguna, F; Martínez, R; Puente, S | 1 |
| Cramer, G; Hamel, U; Roth, G; Wiesner, B | 1 |
| Alexander, M; Held, T; Mielke, M; Reichelt, A; Rössler, W | 1 |
| Geiter, LJ | 1 |
| Chaisson, RE; Goodman, PC; Hopewell, PC; Sande, MA; Schecter, GF; Small, PM | 1 |
| Scott, JT | 1 |
| Croughan, M; Harris, G; Rayner, A; Watt, B | 1 |
| Combs, DL; Geiter, LJ; O'Brien, RJ | 1 |
| Lode, H; Schaberg, T | 1 |
| Holdiness, MR | 2 |
| Mitchison, DA; Nunn, AJ | 1 |
| Daramas, M; Jittinandana, A; Kecharanandana, P; Payanandana, W | 1 |
| Aziz, A; Aziz, K; Ishaq, M; Siddiqi, SH | 1 |
| Domingo, Z; Peter, JC | 1 |
| Baumann, HR; Bohn, W; Brändli, O; Haegi, V; Villiger, B; Zäch, R | 1 |
| Bellon, G; Gallet, S | 1 |
| Felten, MK | 1 |
| Fischer, P; Merkel, S; Weinecke, W | 1 |
| Zeis, BM | 1 |
| Aeberhardt, G; Bernheim, J; Dautzenberg, B; Gallinari, C; Grosset, J; Lévy, A; Sors, C | 1 |
| Ellis, ME; Tayoub, F | 1 |
| Aluoch, JA; Babu Swai, O; Darbyshire, JH; Edwards, EA; Githui, WA; Nunn, AJ; Thiong'o, R | 1 |
| Chang, SC; Hong, YP; Jin, BW; Kim, SC; Kim, SJ; Park, CD | 1 |
| Ashtekar, DR; Fernandes, F; Khadse, BG; Shirodkar, MV | 1 |
| Collins, CH; Uttley, AH | 1 |
| Grosset, JH; Lecoeur, H; Truffot-Pernot, C | 1 |
| Ormerod, LP | 1 |
| Goldberger, MJ | 1 |
| Bek, E; Farer, LS; Graczyk, J; Snider, DE; Zierski, M | 1 |
| Des Prez, RM; Sheller, JR | 1 |
| Davidson, PT; Hanh, LQ | 1 |
| Dong, SQ | 1 |
| Corsello, BF | 1 |
| Knoester, H; Knol, K; van Aalderen, WM | 1 |
| Horsfield, N; Ormerod, LP | 1 |
| Van Scoy, RE; Wilkowske, CJ | 2 |
| Duraipandian, M; Nagarajan, M; Prabhakar, R; Ramachandran, P; Ramakrishnan, CV; Tripathy, SP | 1 |
| Berkani, M; Chaulet, P; Darbyshire, JH; Fox, W; Nunn, A | 1 |
| Engelhard, M; Layer, P | 1 |
| McKenzie, DK; Mukerjee, CM | 1 |
| Huchon, G; Marin, I; Sandron, D | 1 |
| Bezel, R; Brändli, O; Häcki, M; Karrer, W; Röthlisberger, K; Rubin, S | 1 |
| Blanco Quirós, A | 1 |
| Boulahbal, F; Chaulet, P; Mazouni, L; Tazir, M | 1 |
| Geiseler, PJ; Maddux, MS; Manis, RD | 1 |
| Berfelo, WF; Greve, LH; Hupperts, RM; Janevski, B; Vreeling, FW; Willebrand, D; Wouters, EF | 1 |
| Cowie, RL; Escreet, BC; Langton, ME | 1 |
| Acharya, VN; Kudva, BT; Mehta, PJ; Retnam, VJ | 1 |
| Pines, A | 1 |
| Jancik, E | 1 |
| Krivinka, R; Tousek, J | 1 |
| Wilson, TM | 1 |
| Bartmann, K; Radenbach, KL; Schütz, I | 1 |
| Flemming, J; Virchow, C | 1 |
| Fox, W | 1 |
| Almeyda, J; Levantine, A | 1 |
| Mühlberger, F | 1 |
| Pätiälä, J; Tani, P | 1 |
| Zierski, M | 2 |
| Jentgens, H | 1 |
| Tousek, J; Trnka, L | 1 |
| Pierson, DJ; Sahn, SA | 1 |
| Dingley, HB | 1 |
| Rees, RJ | 1 |
| Dickinson, JM; Mitchison, DA | 1 |
| Dickinson, JM | 1 |
| Johnston, RF; Wildrick, KH | 1 |
| Berg, G; Kazemi, H; Stottmeier, K; Zack, MB | 1 |
| Deshayes, P; Desseauve, P; Houdent, G; Lemercier, JP; Morere, P; Simonin, JL | 1 |
| Steiner, M | 1 |
| Ovreberg, K | 1 |
| Berktin, K | 1 |
| Grumbach, F | 1 |
| Gartmann, J | 1 |
| Steininger, WJ | 1 |
| Bernard, E | 1 |
| Lucchesi, M; Mancini, P; Matzeu, M | 1 |
| Jesiotr, M | 1 |
| Crofton, J | 1 |
| Lester, W | 2 |
| Suzuki, T | 1 |
| Bethge, H | 1 |
| Ota, Y | 2 |
| Blaha, H; Heise, A; Reimann, B | 1 |
| Neumann, G | 1 |
| Burgher, LW; Kass, I | 1 |
| Wolinsky, E | 1 |
| Koĭfman, SG; Man'kovetskiĭ, EF; Sirota, DS; Vatsyk, MZ | 1 |
| Protivinsky, R | 1 |
| Aoyagi, T; Gomi, J | 1 |
| Doster, B; Murray, FJ; Newman, R; Woolpert, SF | 1 |
| Dölle, W | 1 |
| Rocklin, RE; Whitcomb, ME | 1 |
| Rasmussen, KN | 1 |
| Bartel, AG; Kelley, WN; Postlethwaite, AE | 1 |
| Barwick, DD; Thrush, DC | 1 |
| Kerby, G; Rauscher, CR; Ruth, WE | 1 |
| Ellorhaoui, M; Storch, W; Tauchnitz, C | 1 |
| Krebs, A | 1 |
| De March Ayuela, P; Turell Gumá, J | 1 |
| Grunert, M; Iwainsky, H; Reutgen, H; Sehrt, I | 1 |
| Eulenberger, J; Mordasini, ER | 1 |
| Hopewell, PC; Johnston, RF | 1 |
| Schaich, W | 1 |
| Sunahara, S | 1 |
| Marr, JJ | 1 |
| Selkon, JB; Somner, AR; Walton, M; White, AB | 1 |
| Drabkina, RO; Ginzburg, TS | 1 |
| Perfeito, JB | 1 |
| Hokama, S | 2 |
| Opl, G; Sighart, H | 1 |
| Allan, GW; Lees, AW; Smith, J; Tyrrell, WF | 1 |
| König, K | 1 |
| Böszörményi, M | 2 |
| Urbancik, B | 1 |
| Fegiz, G | 1 |
| Organick, AB; Wilson, EM | 1 |
| Lind, A; Rist, N | 1 |
| Freerksen, E | 1 |
| Begg, KJ | 1 |
| Avant, ME; Carpenter, JL; Covelli, HD; Higbee, JW; McAllister, CK; Ognibene, AJ | 1 |
| Bollinelli, R | 1 |
| Pretet, S | 1 |
| Flenley, DC | 1 |
| Nagasawa, S | 1 |
| Kozlova, NV; Tynystanova, RI | 1 |
| Boman, G; Löfdahl, CG; Sjögren, I; Skoogh, BE | 1 |
| Chan, SL; Fan, ST; Ho, KK; Lau, WY; Wong, SH; Yiu, TF | 1 |
| Ait Khaled, N; Boulahbal, F; Chaulet, P; El Awadi, Z; Tazir, M | 1 |
| Brändli, O; Fiala, W; Häcki, MA | 1 |
| Chan, SL; Fan, ST; Ho, KK; Lau, WY; Poon, GP; Wong, SH; Yiu, TF | 1 |
| Boulahbal, F; Chaulet, P; el Awadi, Z; Khaled, S; Tazir, M | 1 |
| Dutt, AK; Stead, WW | 2 |
| Bek, E; Zierski, M | 2 |
| Sbarbaro, JA | 1 |
| Angel, JH | 1 |
| Jain, VK; Mathur, KC | 1 |
| Andrew, OT; Hopewell, PC; Humphreys, MH; Schoenfeld, PY | 1 |
| Nelson, SD; Nolan, CM; Sandblom, RE; Slattery, JT; Thummel, KE | 1 |
| de Villiers, CL; Macnab, MF | 1 |
| Choi, HY; Wong, CF; Wong, PC; Yew, WW | 1 |
| Elufimova, VF; Iavorskiĭ, KM; Iukhimenko, NV; Mitinskaia, LA; Pogodaeva, NP | 1 |
| Bohmer, PD; Macnab, MF; Seager, JR | 1 |
| Angarano, G; Carbonara, D; Costa, D | 1 |
| Kroegel, C; Schrappe, M; Wassermann, K | 1 |
| Hill, AR; Hudak, A; Mateo, F | 1 |
| Macnab, MF; Seager, JR | 1 |
| Nakasono, T; Ogata, H; Sugie, T; Sugita, H; Wada, M; Yosikawa, M; Yosiyama, T | 1 |
| Anglaret, X; Lacassin, F; Leport, C; Longuet, P; Perronne, C; Saba, J; Vildé, JL | 1 |
| Devred, P; Dubus, JC; Faure, F; Garnier, JM; Panuel, M; Piarroux, R; Unal, D | 1 |
| Antoniskis, D; Barnes, PF; Davidson, PT; Jones, BE; Mercado, A; Otaya, M; Sian, S; Wang, F | 1 |
| Greten, T; Hautmann, H; Huber, RM; Trauner, A | 1 |
| Ahn, CH; Brown, BA; Dunbar, D; Dunlap, R; Murphy, DT; Onyi, G; Wallace, RJ | 1 |
| Altman, C; Biour, M; Grangé, JD | 1 |
| Fox, R; Gillespie, SH; Kennedy, N; Kisyombe, GM; Ngowi, FI; Ramsay, AR; Saruni, AO; Uiso, LO | 1 |
| Dickinson, JM; Guy, A; Mitchison, DA | 1 |
| Campbell, IA; Friend, JA; Jenkins, PA; Ormerod, LP; Prescott, RJ | 1 |
| Elistratova, NA; Khalbaeva, IV; Koriakin, VA; Sokolova, GB; Ziia, AV | 1 |
| Ellard, GA | 2 |
| Herbert, D; Paramasivan, CN; Prabhakar, R | 1 |
| Carroll, CP; Kim, JY; Opremcak, EM | 1 |
| Develioğlu, O; Gürgan, T; Urman, B; Yarali, H; Zeyneloğlu, H | 1 |
| Delaney, V; Hong, JH; Sommer, B; Sumrani, N | 1 |
| Chugh, KS; Jha, V; Joshi, K; Sakhuja, V; Varma, PP | 1 |
| Fahn, HJ; Hsu, HS; Huang, MH; Wang, LS; Wu, YC | 1 |
| McColloster, P; Neff, NE | 1 |
| Davey, JR; Kreder, HJ | 1 |
| Matthews, TJ; Peto, RJ | 1 |
| Berger, L; Curram, J; Fox, R; Gillespie, SH; Gutmann, J; Kennedy, N; Kisyombe, GM; Ngowi, FI; Ramsay, AR; Sam, N; Saruni, AO; Tillotson, G; Uiso, LO; Yates, M | 1 |
| Birnbaum, J; Chan, SP; Rao, M; Steiner, P | 1 |
| Morris, CD | 1 |
| Begić-Janeva, A; Boricić, I; Brmbolić, BJ; Jevtović, DL; Ranin, JT; Salemović, DR | 1 |
| Coker, RJ; Fisher, M; Tomlinson, DR | 1 |
| Rao, TP; Schmitt, JK | 1 |
| Kuijper, EJ; Prins, JM; Schultsz, C; van Soolingen, D | 1 |
| Paul, CR; Rabah, R; Rao, RB | 1 |
| Belt, EL; Durrheim, DN | 1 |
| Alvarez, L; Diliz, HS; Hernandez, A; Treviño, M; Zaragoza, RM | 1 |
| Sarela, AI; Supe, AN | 1 |
| Diezi, J; Guisan, B; Roch-Ramel, F | 1 |
| Ohgimi, T; Ohtake, M; Okuno, M; Saito, H; Yamamoto, S | 1 |
| Chang, SY; Changchien, CC; Hsu, TY; Lin, JW; Ma, YY | 1 |
| Bozóky, G; Góhér, I; Mohos, A; Ruby, E; Tóth, J | 1 |
| Cohen, LB; Knowles, SR; Liu, BA; Shear, NH; Werb, MR | 1 |
| Cameron, DW; Gallicano, K; Garber, G; Oliveras, L; Rachlis, A; Sahai, J; Seguin, I; Swick, L; Tailor, S; Walker, S | 1 |
| Siribaddana, SH; Wijesundera, A | 1 |
| Chirgwin, K; El Sadr, WM; Hafner, R; Heifets, LB; Klein, O; Kreiswirth, BN; Matts, JP; Musser, JM; Nelson, ET; Perlman, DC; Salomon, N; Telzak, EE | 1 |
| Akhtar, F; Akhtar, S; Askari, H; Bhatti, S; Lal, M; Naqvi, A; Naqvi, R; Rizvi, A; Shahzad, A; Soomro, S | 1 |
| Lin, S; Yan, S; Ye, H | 1 |
| Jiang, M; Wang, S; Yang, T | 1 |
| Barry, CE | 1 |
| Balambal, R; Balasubramanian, R; Nagarajan, M; Paramasivam, CN; Prabhakar, R; Rajasambandam, P; Rangabashyam, N; Sundararaman, R; Tripathy, SP; Venkatesan, P | 1 |
| Bilgiç, H; Ciftçi, F; Köylü, R; Pabuşçu, Y; Seber, O; Tozkoparan, E | 1 |
| Kuś, J; Michałowska-Mitczuk, D | 2 |
| Fujihara, K; Itoyama, Y; Jin, K; Kinpara, T; Nagai, M; Sakuma, R; Shiga, Y | 1 |
| Dautzenberg, B; Jouveshomme, S | 1 |
| Devoto, FM; González, C; González, CD; Iannantuono, R; Sáenz, C; Serra, HA | 1 |
| Beji, M; Ben Rhomdane, N; Daghfous, J; Louzir, B; Mtimet, B; Zouari, M | 1 |
| Choi, BW; Hue, SH; Park, IW | 1 |
| Rieder, HL; Trébucq, A | 1 |
| Ali, SA; Amanullah, S; Arif, K; Khan, JA; Nayani, P; Siddiqui, I | 1 |
| Kul'chavenia, EV; Kuznetsov, PV | 1 |
| Finelli, L; Liu, Z; Shilkret, KL | 1 |
| Bai, KJ; Chiang, CY; Chiang, IH; Lin, TP; Luh, KT; Suo, J; Yu, MC | 1 |
| Chirgwin, KD; Cohn, DL; el-Sadr, WM; Hafner, R; Heifets, L; Jones, BE; Klein, O; Matts, JP; Medard, F; Mildvan, D; Nelson, ET; Olibrice, M; Perlman, DC; Salomon, N; Telzak, EE | 1 |
| Gallemore, GH; Mehta, JB; Mejia, E; Ramsey, GF | 1 |
| Autret, E; Carré, P; Jonville-Bera, AP; Lemarié, E; Radal, M; Van-Egroo, C | 1 |
| Barrera, L; de Kantor, IN; Latini, O | 1 |
| Ivanyi, J; Moreno, C; Pasvol, G; Sjölund, A; Vordermeier, HM; Wilkinson, KA; Wilkinson, RJ | 1 |
| Chow, SK; Tong, FM | 1 |
| Antia, NH; Dholakia, Y; Harboe, M; Mistry, NF; Sethna, KB | 1 |
| Koriakin, VA; Kunichan, AD; Lazareva, IaV; Sokolova, GB | 1 |
| Eladari, D; Klotz, F; Mbaye, PS; Sane, M; Talarmin, F | 1 |
| Dass, A; Goyal, A; Mohan, H; Nagarkar, NM; Uppal, KS | 1 |
| Bancel, B; Biron, F; Boibieux, A; Bouhour, D; Chidiac, C; Peyramond, D; Rode, A; Sève, P | 1 |
| Araki, J; Asai, S; Futsuki, Y; Tomari, S | 1 |
| Childs, JM; Fish, DN; Malone, RS; Peloquin, CA; Spiegel, DM | 1 |
| Aljada, IS; Amsterdam, D; Corriere, N; Crane, JK; Wagle, DG | 1 |
| Autret, E; Jonville-Béra, AP; Martel, C; Mazaud, S; Olivier, C; Radal, M | 1 |
| Ito, K; Mizutani, S; Ogata, H; Sugita, H; Wada, M; Yoshiyama, T | 1 |
| Connolly, C; Davies, GR; McAdam, KP; Sturm, AW; Wilkinson, D | 1 |
| Baello, BQ; Balagtas, ED; Cardano, RC; Co, VM; Mantala, MJ; Pascual, LG; Quelapio, ID; Rivera, AB; Tupasi, TE; Villa, LA | 1 |
| Duchin, JS; Goldberg, SV; Nolan, CM; Shields, T | 1 |
| Chinchilla, D; Martorano, A; Rodriguez, E; Villanueva, C | 1 |
| Long, R; Scalcini, M | 1 |
| Alwood, K; Bishai, WR; Blazes, D; Chaisson, RE; Coggin, W; Gachuhi, R; Sterling, TR | 1 |
| Asai, S; Endou, T; Iwamoto, A; Nakamura, T; Takahashi, T; Yoshikawa, K | 1 |
| Drobniewski, FA; Eltringham, IJ; Wilson, SM | 1 |
| Barrière, V; Blétry, O; Bricaire, F; Caumes, E; Gepner, P | 1 |
| Bartsch, P; Corhay, JL; Gach, O; Lousberg, L | 1 |
| Akçay, S; Arslan, H; Demirag, A; Gürdogan, K; Haberal, M; Kalpaklioglu, F; Oner-Eyüboglu, F | 1 |
| Haberal, M; Kalpaklioglu, AF; Moray, G; Oner-Eyüboglu, AF | 1 |
| Musser, JM; Ramaswamy, S | 1 |
| Barker, J; Makatini, Z; Millard, J | 1 |
| Baruchin, AM; Nelly, P; Oren, S; Weiler, Z | 1 |
| Daniel, N; Geiter, LJ; Grosset, J; Hejblum, G; Ji, B; Lounis, N; O'Brien, RJ; Szpytma, M; Truffot-Pernot, C; Vernon, A | 1 |
| Gerber, F; Herrmann, JL; Lagrange, PH; Lavergne, F; Poinsignon, Y; Simonney, N; Sousa, AO; Wargnier, A | 1 |
| Horvath, JA; Talwani, R | 1 |
| Aral, Y; Cakir, B; Demirbaş, B; Güler, S; Gürsoy, G; Odabaşi, E; Yönem, A | 1 |
| Taniguchi, H | 1 |
| Nakae, K; Nishiyama, M; Roosihermiatie, B | 1 |
| Bartolini, L; Beer, J; Mattei, R; Savarino, A; Tortoli, E | 1 |
| Chase, SE; Cynamon, MH; Lenaerts, AM | 1 |
| Dokouhaki, P; Heidary, A; Masjedi, MR; Mohammadi, F; Velayati, AA | 1 |
| Chang, IT; Tsai, BL; Yang, WC | 1 |
| Choi, IS; Huh, WS; Joh, JW; Kim, MK; Kim, SJ; Kim, SM; Ko, YH; Lee, BB; Lee, SK; Oh, HY; Park, JB; Peck, KR; Song, JH | 1 |
| Gupta, HP; Gupta, R; Rathi, GL; Sharma, AK; Tolani, SL | 1 |
| Asakuma, J; Asano, T; Hayakawa, M; Kawamoto, H; Kobayashi, H; Tanimoto, T | 1 |
| Akalin, E; Chandrakantan, A; Hamburger, RJ; Keane, J | 1 |
| Assengone-Zeh, Y; Kengue-Lechiombeka, PR; Loembe, PM; Mwanyombet-Ompounga, L | 1 |
| Wada, M | 1 |
| Cheon, SH; Dietze, R; Ellner, JJ; Hise, AG; Landen, K; Palaci, M; Phillips, M; Ribeiro, FC; Song, HY; Vinhas, S; Wallis, RS | 1 |
| Arnadottir, T; Enarson, DA; Rieder, HL; Trébucq, A | 1 |
| Block, JA; Co, H; Sequeira, W | 1 |
| Khan, MY; Kinsara, AJ; Memish, Z; Osoba, AO; Samman, Y; Wali, S | 1 |
| Turgut, M | 1 |
| Bowersox, J | 1 |
| Bakare, NA; Ige, OM; Onadeko, BO | 1 |
| Ellard, GA; Fourie, PB; Pillai, G; Smith, PJ | 1 |
| Kirtane, MV; Muranjan, SN | 1 |
| Gawkrodger, DJ; Green, ST; Strauss, RM | 1 |
| Long, R; Ollé-Goig, J; Scalcini, M | 1 |
| Hira, SK; Kura, MM | 1 |
| Bhardwaj, M; Gautam, RK; Kar, HK; Sharma, PK | 1 |
| Spedini, P | 1 |
| Arjratanakul, W; Chaiprasert, A; Chierakul, N; Pattanakitsakul, SN; Tingtoy, N | 1 |
| Arnold, SM; Els, T; Kassubek, J; Lücking, CH; Oehm, E; Serr, A; Zucker, B | 1 |
| Dosumu, EA | 1 |
| Flaherty, JP; Gupta, SN; Shaw, JC | 1 |
| Carnelio, S; Rodrigues, G | 1 |
| Ghebremichael, S; Hoffner, SE; Koivula, T; Krüüner, A; Mikelsaar, M; Pehme, L | 1 |
| Bambery, P; Bhatnagar, A; Khullar, M; Singh, S; Sud, A; Wanchu, A | 1 |
| Bajaj, M; Bhutani, H; Kaur, H; Mariappan, TT; Pakhale, S; Singh, S | 1 |
| Rodrigues, VS; Rossetti, ML; Silva, MS; Valim, AR | 1 |
| Danilova, ID; Espinal, M; Grzemska, M; Migliori, GB; Punga, VV; Raviglione, MC | 1 |
| Agrawal, S; Bhade, SR; Kaul, CL; Kaur, KJ; Panchagnula, R; Singh, I | 1 |
| Bogadel'nikova, IV; Elistratova, NA; Kunichan, AD; Semenova, OV; Sokolova, GB; Zeliger, LR | 1 |
| Aguilar, R; Auclair, B; Maslow, JN; Mikota, SK; Peloquin, CA | 1 |
| Goldberg, SV; Nolan, CM | 1 |
| Doré, CJ; Jindani, A; Mitchison, DA | 1 |
| Chang, SC; Hung, CC; Luh, KT; Sheng, WH; Wang, JT; Wang, JY | 1 |
| Martínez-Rossier, LA; Pérez-Guzmán, C; Torres-Cruz, A; Vargas, MH; Villarreal-Velarde, H | 1 |
| Menzies, D; Parisien, I; Pelletier, M; Rocher, I; Valiquette, C; Yee, D | 1 |
| Bardarov, E; Miteva, L | 1 |
| Bjorvatn, B; Grewal, HM; Hmun, T; Htun, A; Jureen, R; Myint, H; Phyu, S; Ti, T | 1 |
| Mohan, B; Sharda, N; Singh, S | 1 |
| Chen, TP; Chen, YH; Hwang, KP; Lee, YW; Lu, PL; Peng, CF; Tsai, JJ | 1 |
| Beena, S; Pai, MR; Rao, KN | 1 |
| Kumar, A; Malik, P; Mathur, MB; Prakash, G; Sharma, PM; Singh, RP | 1 |
| Dekker, TG; Lötter, AP | 1 |
| Danckwerts, MP; Ebrahim, S; Pillay, V | 1 |
| Mohan, B; Singh, S | 1 |
| Ahn, HC; Lee, YC | 1 |
| Brown, RS; Farquharson, AA; Nasseri, S | 1 |
| Agrawal, S; Kaul, CL; Panchagnula, R; Rungta, S; Sancheti, P | 1 |
| CHAVES, AD | 1 |
| SUTINEN, S; TUOVINEN, PI | 1 |
| BLALOCK, FA; CORPE, RF; GOLDHAMMER, EJ; GROSS, JH | 1 |
| KASS, I | 1 |
| Castro, A; Frisch, IB; Krastel, H; Kunze, AK; Meinck, HM | 1 |
| Semenova, OV | 1 |
| Chandrasekaran, V; Gurumurthy, P; Immanuel, C; Prabhakar, R; Ramachandran, G; Venkatesan, P | 1 |
| Arevalo, J; Campos, PE; Holmes, KK; Hooton, TM; Nolan, CM; Sanchez, J; Suarez, PG; Ticona, E; Zavala, D | 1 |
| Schuh, A; Zeiler, G | 1 |
| Chaudhary, H; Raghavendran, M; Srivastava, A | 1 |
| Mitchison, DA; Prabhaker, R; Reetha, AM; Rehman, F; Santha, T; Sarma, GR | 1 |
| Ahmed, I; Obaideen, AM; Rahman, NU; Shahat, AH; Zahman Au, Au | 1 |
| Maartens, G; Texeira-Swiegelaar, C; Visser, ME | 1 |
| Chimzizi, R; Gausi, F; Harries, AD; Salaniponi, FM | 1 |
| Asencios-Solis, L; Bayona, J; Becerra, MC; Leo-Hurtado, E; Quispe-Torres, N; Salazar-Lindo, E; Vásquez-Campos, L | 1 |
| Gausi, F; Harries, AD; Salaniponi, FM | 1 |
| Ditto, AM; Story, RE | 1 |
| Janulionis, E; Sofer, C; Song, HY; Wallis, RS | 1 |
| Bhagavathy, S; Gayathri, TN; Gurumurthy, P; Venkatesan, P | 1 |
| Ahmedani, MY; Islam, N | 1 |
| Karachunskiĭ, MA; Uvarova, TE | 1 |
| Pinto, A; Sullivan, J; Yepes, JF | 1 |
| Aydin, G; Keleş, I; Kendi, TK; Orkun, S | 1 |
| Agarwal, S; Jain, UK | 1 |
| Johansen, IS; Lundgren, B; Marjamäki, M; Sosnovskaja, A; Thomsen, VØ | 1 |
| Gelmanova, IE; Golubchikova, VT; Pavlova, VE; Peremitin, GG; Seung, KJ; Sirotkina, OB; Strelis, AK; Yanova, GV | 1 |
| Carbonell, D; Fernández-Olivera, N; García-García, I; López-Saura, PA; Machado-Molina, D; Milanés-Virelles, MT; Suárez-Méndez, R; Valdés-Quintana, M; Valenzuela-Silva, CM | 1 |
| Bhagavathy, S; Gurumurthy, P; Hemanth Kumar, AK; Mahilmaran, A; Padmapriyadarsini, C; Paramesh, P; Rajasekaran, S; Ramachandran, G; Ravichandran, N; Sekar, L; Swaminathan, S; Venkatesan, P | 1 |
| Chacko, AG; Chandy, MJ; Moorthy, RK | 1 |
| Leung, KT; Siu, YP; Tong, MK; Yung, CY | 1 |
| Delgado, R; Lambert, ML; Michaux, G; Van der Stuyft, P; Volz, A | 1 |
| Moritaka, T; Nakanishi, N; Ueda, N | 1 |
| Bjune, G; Brantsaeter, AB; Farah, MG; Heldal, E; Steen, TW; Tverdal, A | 1 |
| Almasio, PL; Barbiera, F; Craxì, A; Licata, A; Runza, G; Venezia, G | 1 |
| Hoeppner, VH; Jones, W; Marciniuk, DD; Ward, HA | 1 |
| Shah, BA; Splain, S | 1 |
| Ige, OM; Odaibo, GN; Olaleye, OD; Sogaolu, OM | 1 |
| Choi, MS; Chung, MP; Kim, H; Koh, WJ; Kwon, OJ; Lee, BH; Suh, GY | 1 |
| Bhutani, H; Chakraborti, AK; Jindal, KC; Singh, S | 1 |
| Avramopoulos, I; Falagas, ME; Rafailidis, PI; Sapkas, G | 1 |
| Agerton, TB; Bradford, WZ; Hopewell, P; Kenyon, TA; Lockman, S; Moeti, TL; Moffat, HJ; Oyewo, A; Peloquin, CA; Reingold, AL; Talbot, EA; Tappero, JW | 1 |
| Göpel, B; Götte, K | 1 |
| Janssens, JP; Ketterer, JP; Rochat, T; Wacker, J; Younossian, AB | 1 |
| Holm, JP; Schram, AJ; van Altena, R | 1 |
| Alosi, MM; Ruggeri, C; Scibilia, G; Valenzise, M; Wasniewska, M | 1 |
| Curry, K; Yoon, Y | 1 |
| Ader, F; Bernard, L; Carlier, R; Perronne, C; Salomon, J; Toubiana, J | 1 |
| Esteban, J; Jiménez, MS; Ortiz, A | 1 |
| Currie, GP; Devereux, G; Emmanuel, FX; Ford, D | 1 |
| Listernick, R | 1 |
| Bhutani, H; Jindal, KC; Singh, S | 1 |
| Bell, DJ; Graham, SM; Hartkoorn, R; Molyneux, EM; Nyirongo, S; Ward, SA | 1 |
| Chakravarty, B; Chaudhury, K; Dam, P; Ganesh, A; Ghosh, S; Goswami, SK; Shirazee, HH | 1 |
| Aggarwal, N; Aggarwaln, JK; Dhingra, VK; Jain, SK; Rajpal, S; Shadab, K | 1 |
| Burger, A; Folb, PI; McIlleron, H; Norman, J; Smith, P; Wash, P | 1 |
| Ahmad, Z; Khuller, GK; Pandey, R; Sharma, S | 1 |
| Boutemy, M; Bruniau, A; Devauchelle, B; Gbaguidi, C; Jounieaux, V; Mbuyamba, S; Moure, C; Testelin, S | 1 |
| Abraham, S; Cope, A; Mitchell, A | 1 |
| Bauer, TW; Fraser, TG; Hall, GS; Joyce, MJ; Kobayashi, N; Procop, GW; Tuohy, MJ | 1 |
| Ano, H; Danno, K; Han, Y; Kawahara, K; Matsumoto, T; Nagai, T; Takashima, T; Tamura, Y; Tsuyuguchi, I; Yoshida, H | 1 |
| Almeida, D; Bishai, WR; Grosset, JH; Nuermberger, E; Peloquin, CA; Rosenthal, I; Tyagi, S; Williams, KN | 1 |
| Elwood, RK; FitzGerald, JM; Moniruzzaman, A; Schulzer, M | 1 |
| Barr, G; Grimard, F; Jacquet, V; Menzies, D; Morose, W; Oxlade, O; Schwartzman, K | 1 |
| Baquero-Artigao, F; del Castillo, F; García-Consuegra, J; Garcia-Miguel, MJ; Merino, R | 1 |
| Babu, RB; Biswas, J; Kumarasamy, N; Sudharshan, S; Therese, L | 1 |
| Chang, HC; Chen, J; Chen, SC; Hsieh, JT; Wu, WC | 1 |
| Aufschild, J; Boehm, BO; Zenz, T | 1 |
| Asimakis, P; Bilous, M; Jennings, A; Maloof, AJ | 1 |
| Folb, PI; Fourie, PB; Gabriels, GA; McIlleron, H; Smith, PJ | 1 |
| Izumi, S; Taniguchi, H | 1 |
| Aydin, O; Bakir Ozbey, S; Helvaci, S; Kasapoğlu, F | 1 |
| Bai, GH; Bai, JI; Chang, CL; Choi, YW; Kim, HJ; Kim, SJ; Lee, JK; Park, YK | 1 |
| Ikeda, T; Ishikawa, S; Kobayashi, K; Takeyama, H; Tokuda, Y; Touge, H; Yano, S | 1 |
| Hinrichs, R; Maetzke, J; Scharffetter-Kochanek, K; Sigge, A | 1 |
| Gursoy, B; Ozturk, A; Sirmatel, F; Sirmatel, O; Yazgan, P; Zeyrek, FY | 1 |
| Kwon, SY; Lee, CT; Lee, JH; Lee, SW; Park, KU; Song, J; Um, SW; Yoon, HI | 1 |
| Bant, A; Markov, M; Nadir, A; Patel, K; Raeesy, A; Van Thiel, DH | 1 |
| Harada, Y; Kawakami, K; Kimura, Y; Koyama, K; Yamaryo, T | 1 |
| Kibadi, K | 1 |
| Gonda, H; Ida, N; Kinoshita, K; Oishi, T; Suganuma, N; Suzuki, R; Yamaguchi, I; Yamamoto, K | 1 |
| Chung, MP; Kim, H; Kim, YH; Koh, WJ; Kwon, OJ; Lim, SY; Suh, GY | 1 |
| Gomathy, P; Iliayas, S; Kumar, SR; Mathew, M; Narayanan, PR; Padmapriyadarsini, C; Sukumar, B; Swaminathan, S; Thomas, B; Triveni, C | 1 |
| Diémé, C; Fall, I; Ndoye, M; Ngom, G | 1 |
| Dhingra, VK; Hanif, M; Mittal, A; Rajpal, S | 1 |
| Chaudhry, A; Jamshaid, M; Zaka-Ur-Rehman, Z | 1 |
| Ahmad, MN; Hussain, R; Khan, GM; Khan, KA; Mirza, MK; uz-Zaman, M | 1 |
| Awan, S; Dar, NR; Raza, N; Zafar, O | 1 |
| Dhanlaklshmi, M; Ethirajan, N; Padmavathy, L; Rao, LL | 1 |
| Hoshino, H; Mitarai, S; Ogata, H; Ohmori, M; Okumura, M; Uchimura, K; Wada, M; Yoshiyama, T | 1 |
| Hussain, SJ; Irfan, M; Rao, NA | 1 |
| Apisarnthanarak, A; Apisarnthanarak, P; Khawcharoenporn, T; Kiratisin, P; Mundy, LM; Rakskul, P; Warnnissorn, N | 1 |
| Opondo, EA | 1 |
| El Nazir, B; Mahesh, B; McShane, D; Molloy, J; Shandilya, M | 1 |
| Chida, K; Fujita, K; Hayakawa, H; Miwa, S; Murakami, M; Nakamura, H; Ohba, H; Shirai, M; Suda, T; Suzuki, Y | 1 |
| Adhvaryu, MR; Reddy, N; Vakharia, BC | 1 |
| Inge, LD; Wilson, JW | 1 |
| Chang, W; Moon, S; Son, J | 1 |
| Kant, S; Mahajan, V; Natu, NK | 1 |
| Gupta, A; Kumar, V; Sabat, D | 1 |
| Acharya, PR; Baliga, P; Sahoo, R | 1 |
| Gönlügür, T; Gönlügür, U; Hasbek, M; Katrancioğlu, O; Sapmaz, F | 1 |
| Ho, YJ; Lee, CH; Lee, CL; Wei, YS | 1 |
| Kanagaraj, A; Marthandam, LR; Meenakumari, P; Rajesh, A; Sriramakrishnan, V | 1 |
| Ambroggi, M; Ambrosioni, J; Brezzo, C; Cecchini, D; Corti, M; Perez, M; Poggi, S; Rybko, A | 1 |
| Azeeza, S; Kamal, A; Malik, MS; Rao, MV; Shaik, AA | 1 |
| Ariél', BM; Belkova, OV; Bellendir, EN; Chuzhov, AL | 1 |
| de Reina, L; Duca, A; Ramos, A; Saucedo, G | 1 |
| Martínez, E; Nam-Cha, S; Puerta, A; Salinas, A | 1 |
| Dovgaliuk, IF; Ovchinnikova, IuE; Starshinova, AA | 1 |
| Biscopink, RJ; Davis, TL; Naidu, VG; Tammineni, AK; Veerabagu, MP | 1 |
| Bishai, WR; Cezar, MC; Chaisson, RE; Chaudhary, MA; Conde, MB; De Souza, GR; Efron, A; Graça, NP; Kritski, AL; Loredo, C; Ram, M | 1 |
| Garg, R; Mehra, S; Prasad, R | 1 |
| Alvarez-Espejo, T; Daza, R; Guzmán, MF; Ramos, A | 1 |
| Basir, Y; Chu, D; Gong, Z; McCort-Tipton, M | 1 |
| Bradford, WZ; Chideya, S; Hopewell, PC; Kenyon, TA; Moeti, TL; Peloquin, CA; Reingold, AL; Tappero, JW; Wells, CD; Winston, CA | 1 |
| Bartacek, A; Borek, M; Panosch, B; Schütt, D | 1 |
| Deftereos, S; Kantartzi, K; Kriki, P; Mourvati, E; Panagoutsos, S; Passadakis, P; Prassopoulos, P; Theodoridis, M; Thodis, E; Vargemezis, V | 1 |
| Brilhante, RS; Cordeiro, Rde A; de Camargo, ZP; de Lima, RA; Medrano, DJ; Monteiro, AJ; Rocha, MF; Sidrim, JJ; Tavares, JL | 1 |
| Alcaneses, MR; Boom, WH; Debanne, SM; Dietze, R; Eisenach, KD; Gitta, P; Hadad, DJ; Horter, L; Johnson, JL; Maciel, EL; Mugerwa, RD; Okwera, A; Quelapio, MI; Sewali, B; Tupasi, TE | 1 |
| Abughali, N; Auletta, J; Esper, F; LaBeaud, AD; Lancioni, C | 1 |
| Fisher, M; Hemingway, C; Innes, J; Scott, G; Solomon, T; Thwaites, G | 1 |
| Chien, YJ; Lee, LN; Wang, JY; Yang, PC; Yu, CJ | 1 |
| Byeon, JS; Choe, JW; Kim, JH; Kim, KJ; Myung, SJ; Park, SH; Yang, DH; Yang, SK; Ye, BD; Yoon, SM | 1 |
| Hanna, LE; Narayanan, PR; Nayak, K; Subramanyam, S; Swaminathan, S; Venkatesan, P | 1 |
| Chinnaiyan, P; Iliayas, S; Menon, PA; Narayanan, PR; Narendran, G; Padmapriyadarsini, C; Ramachandran, R; Sakthivel, R; Santhanakrishnan, R; Suhadev, M; Swaminathan, S; Venkatesan, P | 1 |
| Baraka, A; Cobelens, F; Egwaga, S; Grewal, P; Haag-Arbenz, V; Lwilla, F; Mkopi, A; Mshinda, H; Range, N; van Leth, F | 1 |
| Bame, R; Djella, S; Kuaban, C; Mouangue, L; Yomgni, C | 1 |
| Gumbo, T | 1 |
| Baseke, J; Boom, WH; Charlebois, E; Chervenak, KA; Havlir, DV; Johnson, DF; Lancioni, C; Mahan, CS; Mayanja-Kizza, H; Mugerwa, RD; Walusimbi, M; Whalen, CC | 1 |
| Gey van Pittius, NC; Hoek, KG; Schaaf, HS; van Helden, PD; Warren, RM | 1 |
| Cansü, E; Erdogan, F; Ulusam, AO | 1 |
| Ascenzi, P; Bevilacqua, N; Gullotta, F; Lauria, FN; Mancone, C; Notari, S; Pucillo, LP; Sergi, M; Tempestilli, M; Tripodi, M; Urso, R | 1 |
| Baquero, F; Buitrago, LA; Burgos Revilla, J; Gómez García, I; Gómez Mampaso, E; Gómez Rodríguez, A; Molina, MR; Sampietro Crespo, A | 1 |
| Guleria, K; Gupta, B; Vaid, N | 1 |
| Irfan, M; Mehfooz, Z; Rao, NA; Soomro, MM | 1 |
| Jablenska, L; Lo, S; Toma, A; Uddin, J | 1 |
| Debjani, B; Dharmarajan, S; Perumal, Y; Raju, SK; Stephen, MR; Subbu, P | 1 |
| Baniasadi, S; Eftekhari, P; Fahimi, F; Masjedi, MR; Raoufy, MR; Tabarsi, P; Velayati, AA | 1 |
| Agarwal, A; Arora, A; Kumar, S | 1 |
| Allton, DR; Ballard, EA; Folio, L; Jesinger, RA; Lane, JW | 1 |
| Chiu, YC; Feng, JY; Huang, SF; Lee, YC; Su, WJ | 1 |
| Ermertcan, AT; Gençoğlan, G; İnanir, I; Özkütük, N; Öztürk, F; Temiz, P | 1 |
| Arquinio, L; García-Gasalla, M; Losada, I; Sarasibar, H | 1 |
| Elwood, RK; Fitzgerald, JM; Guo, N; Marra, CA; Marra, F | 1 |
| Helbling, CA; Iizuka, T; Kuttenberger, J; Lieger, O; Smolka, W | 1 |
| Aloui, N; Bousnina, S; Boussetta, K; Brini, I; Ghaffari, H; Jaubert, F; Tinsa, F | 1 |
| Caminero, JA; Migliori, GB; Sotgiu, G; Zumla, A | 1 |
| Azevedo, F; Bettencourt, H; Ferreira, O; Morais, P; Nogueira, A | 1 |
| Kafle, P; Kolade, V | 1 |
| Aida, S; Nakano, Y; Nishio, K; Okabayashi, K; Shimada, H | 1 |
| Delarbre, JM; Gravet, A; Habermacher, J; Lohmann, C; Moser, A; Schmitt, F; Souillard, N | 1 |
| Martín, JM; Pérez, J; Renau, A; Ricart, JM | 1 |
| Altintas, AK; Beyazyildiz, E; Ozdal, PC; Ozdamar, Y; Ozkan, SS; Teberik, K | 1 |
| Higashimoto, I; Kawabata, T; Matsuyama, T; Momi, H; Sadamura, Y | 1 |
| Gulati, K; Ray, A; Vijayan, VK | 1 |
| Alvarado, M; Morales, S; Pérez, J; Ramos, W; Vílchez, R | 1 |
| Fujita, M; Ikegame, S; Kajiki, A; Nakanishi, Y; Wakamatsu, K | 1 |
| Diop, SA; Nichols, S; Salou, M; Tidjani, O; Wateba, MI; Womitso, K | 1 |
| Costard-Jäckle, A; Meyer, S; Sattinger, E | 1 |
| Campbell, PJ; Cowan, LS; Dalton, TL; Hooks, DP; Metchock, B; Morlock, GP; Plikaytis, BB; Posey, JE; Sikes, RD; Starks, AM | 1 |
| Khajotia, R; Manthari, K | 1 |
| Fortes-Alen, J; Gómez-Escolar, PF; Gómez-Seco, J; Presa-Abos, T; Rodríguez-Guzmán, MJ; Rodríguez-Nieto, MJ | 1 |
| Agarwal, N; Kriplani, A; Kulshrestha, V; Rana, T; Singh, UB | 1 |
| Anyo, G; Burgos, M; Cook, SV; Enarson, DA; Jindani, A; Kim, SJ; Lienhardt, C; Nunn, AJ; Rigouts, L; Yorke-Edwards, V | 2 |
| Ambrose, PG; Bhavnani, SM; Caws, M; Chau, TT; Dung, NT; Farrar, J; Hammel, JP; Hien, TT; Kulawy, R; Mai, PP; Reynolds, DK; Thwaites, GE; Török, ME; Van Wart, SA | 1 |
| Thakur, BK; Verma, S | 1 |
| Alegre de Miquel, V; Martínez Casimiro, L; Vilata Corell, JJ | 1 |
| Abes, FL; Abes, GT; Jamir, JC | 1 |
| Enarson, DA; Jindani, A; Nunn, AJ | 1 |
| Anand, A; Datye, AS; Inamdar, V; Iyer, R; Kale, V; Kanoj, DM; Khillare, KM; Manoj, MM; Pereira, M; Risbud, AR; Thakar, M; Tripathy, S | 1 |
| Desai, VB; Fredrick, JS; Joseph, P; Mohan, NS; Ramachandran, R; Raman, B; Thomas, A; Wares, F | 1 |
| Baek, SH; Li, AH; Sassetti, CM | 1 |
| da Silva Junior, GB; Daher, Ede F; de Oliveira, JL | 1 |
| Amarti, A; Baybay, H; Bounouar, M; Chraibi, M; Gallouj, S; Harmouch, T; Mernissi, F; Meziane, M; Mikou, O | 1 |
| Achawal, S; Anderson, G; Lee, WY; Ling, M; Thaker, HK | 1 |
| Brilhante, RS; Caetano, EP; Castelo-Branco, Dde S; Cordeiro, Rde A; de Lima, RA; Fechine, MA; Marques, FJ; Mesquita, JR; Monteiro, AJ; Mourão, CI; Ribeiro, JF; Rocha de Castro E Silva, K; Rocha, FA; Rocha, MF; Sidrim, JJ | 1 |
| Choi, WC; Hong, JH; Jeon, TJ; Kim, SY; Oh, TH; Seo, DD; Seo, JY; Shin, WC | 1 |
| Gallo, A; Hurwitz, M; Hwang, C; Mojtahed, A; Whitney, J | 1 |
| Bouhasan, L; Consunji-Araneta, R; Higgins, R; Qing, G | 1 |
| Colucci, G; Silzle, T; Solenthaler, M | 1 |
| Kuwabara, K | 1 |
| Aïssi, E; Ettahar, N; Huleux, T; Massongo, M; Melliez, H; Pasquet, A; Yazdanpanah, Y | 1 |
| Liu, Y; Zhang, J; Zhang, M | 1 |
| da Costa, FS; de Lima, KM; de Morais, SC; de Oliveira Neves, AC; Porto, DL; Soares, GM | 1 |
| Eide, GE; Kielland, LG; Naess, A; Sørnes, S; Vage, RA | 1 |
| Malhotra, A; Manchanda, Y; Mittal, R; Ramam, M; Ramesh, V; Sharma, S; Tejasvi, T | 1 |
| Bonkoungou, V; Carvalho, AC; Comelli, M; Cusato, M; Dembélé, SM; Kouanda, S; Matteelli, A; Nacanabo, R; Regazzi, M; Saleri, N; Villani, P | 1 |
| Imanishi, H; Ishii, M; Mizuno, N; Nakagawa, K; Oshimo, T; Sowa, J; Tsuruta, D | 1 |
| Cifuentes, C; García, M; Losada, I; Martín, C | 1 |
| Aarnoutse, R; Boeree, M; Ijdema, D; Magis-Escurra, C; van den Boogaard, J | 1 |
| Adali, G; Çolak, Y; Enç, F; Kiziltaş, Ş; Öztürk, O; Tuncer, İ; Ulaşoğlu, C; Yorulmaz, E | 1 |
| Angheben, A; Boriani, L; Gasbarrini, A; Luzi, CA; Marocco, S; Rigotti, S; Zorzi, C | 1 |
| Arévalo Gómez, A; Llinares Modejar, P; Sánchez Vidal, E; Servia Dopazo, M | 1 |
| Becker, P; Dawson, R; Diacon, AH; Donald, PR; du Bois, J; Erondu, N; Ginsberg, AM; Narunsky, K; Spigelman, MK; van Niekerk, C; Venter, A | 1 |
| Opremcak, EM | 1 |
| Friedrich, C; Grundmann, K | 1 |
| Cohen, T; Furin, J; Gegia, M; Kalandadze, I; Vashakidze, L | 1 |
| Sarkar, D; Sarkar, S | 1 |
| Hassan, G; Kant, S; Parengal, J; Saheer, S | 1 |
| Behera, D; Gupta, R; Jaiswal, A; Kumar, L; Murar, A; Puri, MM | 1 |
| Gönlügür, U; Koşar, S; Mirici, A | 1 |
| Almeida, D; Grosset, JH; Karakousis, PC; Mdluli, KE; Nuermberger, EL; Peloquin, CA; Rosenthal, IM; Tasneen, R; Zhang, M | 1 |
| Peña-Santos, G; Ruiz-Moreno, JL | 1 |
| Chandran, PA; Ismail, R; Jalalonmuhali, M; Lee, CK; Lee, YY | 1 |
| Kano, T; Matsushima, M; Sasaki, H; Sato, K; Takahashi, I; Yabe, I; Yamada, M | 1 |
| Dejaegher, B; Kaale, E; Risha, PG; Shewiyo, DH; Smeyers-Verbeke, J; Vander Heyden, Y | 1 |
| Balne, PK; Basu, S; Mittal, R; Sharma, S | 1 |
| Adán, A; González-Martin, J; Keller, J; Llorenç, V; Mesquida, M; Pelegrín, L; Rey, A | 1 |
| Aarnoutse, RE; Boeree, MJ; Burger, DM; Fillekes, Q; Kibiki, GS; Kisanga, ER; Kisonga, RM; Mleoh, L; Mtabho, CM; Ndaro, A; Semvua, HH; van den Boogaard, J; van der Ven, A | 1 |
| Aggarwal, T; Sharma, C; Sharma, M; Sharma, V; Shekhar, S | 1 |
| González, C; Herrmann, E; Jajati, M; Kaplan, P; Monzón, D; Sáenz, C | 1 |
| Aarnoutse, RE; de Groot, R; de Waard, JH; García, JF; Hermans, PW; López, D; Verhagen, LM; Warris, A | 1 |
| Elson, I; Friedland, G; Gandhi, NR; Kreiswirth, BN; Mathema, B; Moll, AP; Moodley, P; Ramathal, M; Rothenberg, R; Shah, NS; Shashkina, E; Sturm, AW; Weissman, D | 1 |
| Chigutsa, E; Denti, P; Karlsson, MO; Kirkpatrick, CM; Maartens, G; McIlleron, H; Patel, K; Visser, M | 1 |
| Bonovas, S; Lytras, T; Panagiotopoulos, T; Spala, G | 1 |
| Akçalı, A; Akman, T; Değirmenci, Y; Karatağ, O; Koşar, S; Sener, A | 1 |
| Lueangniyomkul, A; Mankatitham, W; Manosuthi, S; Manosuthi, W; Nilkamhang, S; Sukasem, C; Sungkanuparph, S; Thongyen, S | 1 |
| Gao, HY; Lai, YX; Li, WP; Lian, ZQ; Wang, Q; Xu, J; Yang, JM; Yu, HJ; Zhang, AQ; Zhu, CX | 1 |
| Garg, K; Mohapatra, PR | 1 |
| Agrela Rojas, E; Cuesta Hernández, M; Díaz Pérez, JÁ; Gómez Hoyos, E; Téllez Molina, MJ | 1 |
| Chen, M; Fu, L; Jin, H; Liu, C; Lu, Y; Wang, B; Xu, J; Zhao, W; Zheng, M; Zhou, L; Zhu, H | 1 |
| Hara, M; Hatta, T; Ohtani, M; Sawada, K; Segawa, H; Ueno, R | 1 |
| Hishiki, H; Ichimoto, K; Ishiwada, N; Kinoshita, K; Kohno, Y; Nagasawa, K; Tokunaga, O | 1 |
| Ali Aitbenasser, M; Benjelloun, A; Bouaity, B; Bouchentouf, R; Touati, M | 1 |
| Achour, A; El Barni, R; Lahkim, M | 1 |
| Choe, KH; Chung, GT; Hwang, SC; Jnawali, HN; Kim, H; Lee, YS; Park, YK; Ryoo, S | 1 |
| Braga, JU; da Conceição, DA; Trajman, A | 1 |
| Horsburgh, CR; Kvasnovsky, C; Master, I; O'Donnell, MR; Padayatchi, N; Werner, L | 1 |
| Aarnoutse, RE; Boeree, MJ; Kibiki, GS; Mtabho, CM; Semvua, HH; Tostmann, A; van den Boogaard, J | 1 |
| Liu, P; Liu, Y; Ma, A; Wei, Q; Wu, X; Zhou, Z; Zou, F | 1 |
| Benson, SM; Narasimhamurthy, R | 1 |
| Boerrigter, BG; van den Berk, GE; van Sandwijk, MS | 1 |
| Camara, C; Furtado, A; Gerstoft, J; Katzenstein, TL; Lüneborg-Nielsen, M; Sodemann, M; Wejse, C | 1 |
| Chandrasekaran, V; Dewan, P; Hemanth Kumar, AK; Ramachandran, G; Swaminathan, S; Thomas, A | 1 |
| Bhadauria, M; Jaswal, A; Shrivastava, S; Shukla, S; Sinha, N | 1 |
| Arpag, H; Babalik, A; Bakirci, N; Capaner, E; Dagyildizi, L; Kuyucu, T; Ulus, IH | 1 |
| Cardone, M; Colasanti, P; Cordedda, M; Grande, A; Mozzillo, R; Zanchini, R | 1 |
| Benzekri, A; Benzekri, L; El Amrani, F; Hassam, B; Khalil, F; Raffas, W; Tbatou, F | 1 |
| Arpag, H; Babalık, A; Bakirci, N; Çarpaner, E; Dagyildiz, L; Kuyucu, T; Ulus, IH | 1 |
| Bark, CM; Boom, WH; Eisenach, KD; Gitta, P; Johnson, JL; Joloba, ML; Nsereko, M; Ogwang, S; Thiel, BA | 1 |
| Głowacki, J; Głowacki, M; Jagodziński, PP; Lehmann, TP; Misterska, E; Walczak, M | 1 |
| Ando, H; Hang, NT; Hung, NV; Keicho, N; Kuwahara, T; Lien, LT; Sakurada, S; Thuong, PH; Thuy, TT | 1 |
| Crownover, P; Jafri, I; Naqvi, A; O'Gorman, M; Wang, HF; Wang, R | 1 |
| Chen, TC; Chou, LT; Huang, CC; Lai, AB; Wang, JH | 1 |
| Chanez, P; Gouitaa, M; Neino Mourtala Mohamed, A; Tummino, C | 1 |
| Casal, M; Gutiérrez-Aroca, JB; Ruiz, P | 1 |
| Cao, M; Gu, J; Li, Y; Liu, W; Ma, J; Ma, L; Mao, Y; Merle, C; Milligan, P; Wang, Q; Wu, W; Wubuli, A; Xiang, Y; Xin, X; Yang, L; Yao, X; Zhu, X | 1 |
| Heysell, SK; Reynolds, J | 1 |
| Aritomo, Y; Fujihara, S; Kamada, H; Kanaji, N; Katou, K; Kobara, H; Masaki, T; Mori, H; Nishiyama, N; Ono, M; Oryu, M; Rafiq, K | 1 |
| Bourkadi, JE; Iraqi, G; Nejjari, S; Oualil, H | 1 |
| Egelund, EF; Hunter, RP; Isaza, R; P Brock, A; Peloquin, CA | 1 |
| Blyth, CC; Colby, S; Fagan, JM; Francis, JR; Waring, J | 1 |
| Bhoi, SK; Kalita, J; Misra, UK; Prasad, S | 1 |
| Pal, P; Patra, SK; Ray, S | 1 |
| Almutairi, FE; Bourgea, J; Court, MH; Greenblatt, DJ; Hazarika, S; Klein, K; Kwara, A; Patten, CJ; Sheng, H; Zanger, UM | 1 |
| Bhattacharya, S; Choudhury, S; Das, A; Das, SK; Pandit, S | 1 |
| Cheng, S; Du, X; Gao, T; Goel, S; Harries, AD; Lin, Y; Wang, L; Xia, Y; Zhang, Z | 1 |
| Bock, N; Bozeman, L; Goldberg, SV; Hamilton, CD; Heilig, CM; Hershfield, E; Kyle, RP; Narita, M; Reves, R; Tapy, JM; Wing, D | 1 |
| Kedarisetty, CK; Khillan, V; Kumar, N; Kumar, S; Sarin, SK | 1 |
| de Melo Guedes de Oliveira, HM; de Oliveira, MM; Delogo, KN; Dos Anjos, MJ; Kritski, AL; Mesquita, ED; Miranda, PF; Moraes, ML; Netto, AR; Ramalho, DM | 1 |
| Fu, EQ; Jin, FG | 1 |
| Akçay, A; Arslan, K; Dündar, M; İşcan, KM; Kanbur, M; Karabacak, M; Sarıca, ZS; Taşçıoğlu, N | 1 |
| Patsche, CB; Svensson, E; Wejse, C | 1 |
| Crook, AM; Gillespie, SH; McHugh, TD; Mendel, CM; Meredith, SK; Murray, SR; Nunn, AJ; Pappas, F; Phillips, PP | 1 |
| Chiang, CY; Madan, J; Meredith, SK; Nunn, AJ; Phillips, PP; Rusen, ID; Squire, SB; Torrea, G; Van Deun, A | 1 |
| Boukary, I; Daouda, M; Hanki, Y; Harouna, SH; Morou, S; Piubello, A; Souleymane, MB; Van Deun, A | 1 |
| de Droogh, E; Groenen, G; Mathys, V; Soetaert, K; van de Vyvere, M | 1 |
| Biadglegne, F; Rodloff, AC; Sack, U; Tessema, B | 1 |
| Chigutsa, E; Gumbo, T; McIlleron, H; Pasipanodya, JG; Sirgel, FA; Smith, PJ; van Helden, PD; Visser, ME | 1 |
| Bhatnagar, S; Faurholt-Jepsen, D; Friis, H; Grewal, HM; Kabra, SK; Lodha, R; Mukherjee, A; Saini, S; Singh, S; Singh, V | 1 |
| Amukoye, E; Bah, B; de Jong, BC; Fielding, K; Gninafon, M; Horton, J; Kassa, F; Lapujade, O; Lienhardt, C; Lo, MB; Merle, CS; Mthiyane, T; N'Diaye, A; Odhiambo, J; Olliaro, PL; Perronne, C; Rustomjee, R; Sismanidis, C; Sow, OB | 1 |
| Bateson, AL; Butcher, PD; Charalambous, S; Churchyard, GJ; Clouting, HE; Coleman, D; Geldenhuys, H; Harrison, TS; Hatherill, M; Jindani, A; Magweta, L; McHugh, TD; McIlleron, HM; Mitchison, DA; Mungofa, S; Nunn, AJ; Nyirenda, S; Phillips, PP; Shah, NA; Shepherd, J; van Dijk, JH; Zizhou, S; Zvada, SP | 1 |
| Alobu, I; Oshi, DC; Oshi, SN; Ukwaja, KN | 2 |
| Juneja, R; Kalakoti, P; Sahu, S; Sharma, K; Singh, V; Subramanian, PS | 1 |
| Garcia-Rodriguez, F; Martinez-Longoria, CA; Rios-Solis, JE; Rubio-Perez, NE | 1 |
| Fushimi, K; Matsui, H; Yamana, H; Yasunaga, H | 1 |
| Adelakun, A; Bhatnagar, V; Chen, Q; Emadi, A; Farshidpour, M; Holtzman, N; Kendall, T; Stevenson, B | 1 |
| Bekele, D; Bekuretsion, Y | 1 |
| Cho, YJ; Jeong, I; Lee, CT; Lee, JH; Park, JS; Song, J; Yoon, HI | 1 |
| Aarnoutse, RE; Boeree, MJ; Burger, D; Dawson, R; Diacon, AH; du Bois, J; Gillespie, SH; Heinrich, N; Hoelscher, M; Magis-Escurra, C; McHugh, TD; Narunsky, K; Phillips, PP; Plemper van Balen, G; Rehal, S; van Ingen, J; van Soolingen, D; Venter, A | 1 |
| Archuleta, S; Huggan, PJ; Molton, JS | 1 |
| Bharti, H; Bhushan, B; Chander, R; Gupta, A; Kajal, NC; Ranga, V | 1 |
| Hershow, RC; Huo, D; Jimenez, A; Johnson, W; Paul, W; Prachand, N; Rahimian, A; Ricks, PM; Wiebel, W | 1 |
| Eckold, C; Evangelopoulos, D; Gillespie, SH; Honeyborne, I; Lipman, MC; McHugh, TD; Pym, A | 1 |
| Arai, M | 1 |
| Dereli, T; Kandıloglu, G; Turk, BG; Turkmen, M | 1 |
| Ardrey, A; Davies, GR; Dzinjalamala, F; Mlotha, R; Molyneux, E; Ward, S; Waterhouse, D | 1 |
| Burger, DA; Conradie, A; Dawson, R; Diacon, AH; Donald, PR; Eisenach, K; Everitt, D; Ive, P; Mendel, CM; Ntinginya, NE; Page-Shipp, L; Pym, A; Reither, K; Schall, R; Spigelman, M; van Niekerk, C; Variava, E; Venter, A; von Groote-Bidlingmaier, F | 1 |
| Aniked, S; Bakouh, O; Bourkadi, JE | 1 |
| Lipman, MC; Phillips, PP | 1 |
| Reves, RR | 1 |
| Abena Foe, JL; Aït-Khaled, N; Kuaban, C; Noeske, J; Rieder, HL; Trébucq, A | 1 |
| Chakraborty, S; Rhee, KY | 1 |
| Braga, JU; Trajman, A | 1 |
| Kabra, SK; Kanhiya, K; Lodha, R; Mukherjee, A; Singla, M; Velpandian, T | 2 |
| Acuña-Villaorduña, C; Ayakaka, I; Dryden-Peterson, S; Fennelly, KP; Hosford, J; Jones-López, EC; Nakubulwa, S; Okwera, A; Reilly, N; Worodria, W | 1 |
| Aprile, V; Centis, R; Costa, D; D'Ambrosio, L; Donateo, L; Fedele, A; Gillini, L; Migliori, GB; Pasanisi, G; Tundo, P | 1 |
| Igari, H; Imasawa, T; Ishikawa, S; Kadomura, M; Mizuno, S; Nagayoshi, M; Nishimura, M; Noguchi, N; Yamagishi, F | 1 |
| Barnes, GL; Carman, D; Chaisson, RE; Dawson, R; Dorman, SE; Efron, A; Gupte, N; Hoffman, J; McIlleron, H; Narunsky, K; Whitelaw, A | 1 |
| Chi, X; Gao, C; Hu, YW; Huang, Z; Wang, Q; Zeng, T; Zheng, L | 1 |
| Hasan, R; Kadavigere, R; Kumar, S; Mathew, M | 1 |
| Shi, G; Zhang, L | 1 |
| Davies, G; Dimba, A; Dzinjalamala, FK; Molyneux, EM; Molyneux, ME; van Oosterhout, JJ; Ward, S; Waterhouse, D; Zijlstra, EE | 1 |
| Gao, T; Huang, X; Tan, QC; Tian, CL; Yang, M; Yao, Y; Yu, SY; Zhang, JT | 1 |
| Barrie, J; Long, R; Peloquin, CA | 1 |
| Azami, R; Bawa, T; Haroon, N; Khan, S | 1 |
| Abuaku, BK; Chen, M; Deng, J; Li, W; Li, X; Su, C; Tan, H; Wang, M; Wen, SW; Xia, Y | 1 |
| Demiroz, AS; Dulgar, O; Ersen, E; Eskazan, AE; Oz, B; Turna, A; Tuzuner, N | 1 |
| Cho, YJ; Kim, SJ; Lee, CT; Lee, JH; Lee, JY; Lee, YJ; Park, JS; Song, J; Yoon, HI | 1 |
| Egan, D; Hennig, S; Kellerman, T; McIlleron, H; Naiker, S; Owen, A; Pym, A; Reddy, T; Wiesner, L | 1 |
| Andersen, AB; Castel, S; Changalucha, J; Chigutsa, E; Christiansen, M; Denti, P; Faurholt-Jepsen, D; Friis, H; Hagen, CM; Jeremiah, K; McIlleron, H; PrayGod, G; Range, N; Wiesner, L | 1 |
| Hatakeyama, N; Kagawa, K; Machida, H; Naito, N; Ogushi, F; Ohno, A; Okano, Y; Shinohara, T; Takahashi, N; Wada, T; Yoshida, S | 1 |
| Gie, RP; Graham, SM; Grzemska, M | 1 |
| Altet, N; Dedicoat, M; Duarte, R; Gualano, G; Günther, G; Kunst, H; Lange, C; Muylle, I; Spinu, V; Tiberi, S; van Leth, F; Viiklepp, P | 1 |
| Akkus, E; Avcu, G; Duyu, M; Karapinar, B; Sahbudak Bal, Z; Vardar, F | 1 |
| Betoudji, F; Lanoix, JP; Nuermberger, E | 1 |
| Lim, JI; Thomas, M | 1 |
| Bekker, A; Donald, PR; Draper, HR; Hesseling, AC; McIlleron, HM; Murray, S; Schaaf, HS; van der Laan, L; Wiesner, L | 1 |
| Chidiac, R; Dobler, CC; Jelfs, PJ; Williamson, JP | 1 |
| Gotoh, H; Kurasima, A; Matsuda, S; Morimoto, K; Ogata, H; Okumura, M; Osawa, T; Sasaki, Y; Yanai, H; Yoshiyama, T | 1 |
| Arya, R; Bishwal, SC; Das, A; Das, MK; Debnath, R; Debnath, S; Lodh, A; Nanda, RK | 1 |
| Du, J; Fu, Y; Gao, J; Hu, D; Li, L; Li, Q; Li, X; Liu, F; Ma, L; Ma, Y; Tan, S; Zhang, L; Zhang, Y; Zhu, G | 1 |
| Adamson, J; Almeida, DV; Ammerman, NC; Bester, LA; Dorasamy, A; Grosset, JH; Mgaga, Z; Moodley, C; Moodley, S; Ngcobo, B; Singh, SD; Swanson, RV | 1 |
| Alonso, E; Batlle, M; Marcos, P; Martínez de Lagrán, I; Plana, A; Tomasa, T | 1 |
| Adaramoye, OA; Adefisan, A; Adeyemi, O; Akanni, OO; Kehinde, AO; Oyinlola, I | 1 |
| Al-Efraij, K; Campbell, JR; Cook, VJ; Johnston, J; Marra, F; Mota, L | 1 |
| Hamilton, CD; Holland, DP; Stout, JE | 1 |
| Atwine, D; Bonnet, M; Borgulya, G; Burgos, M; Checkley, AM; de Fernandes, RA; de Patiño, IW; Dubash, F; Gonzales, T; Harrison, TS; Jindani, A; Mitchison, D; Patel, N; Shrestha, B | 1 |
| Betai, S; Bhoi, SK; Kalita, J; Misra, UK | 1 |
| Dai, F; Luo, F; Sun, D; Xu, J; Zhang, Z; Zhou, Q | 1 |
| Chang, MC; Chou, PH; Lin, CP; Liu, CL; Ma, HL; Wang, ST; Yu, WK | 1 |
| Günther, G; Hunter, C; Kibuule, D; Rennie, TW; Verbeeck, RK | 1 |
| Aderaye, G; Aguwa, EN; Aseffa, A; Bedru, A; Chukwu, JN; Connolly, C; Ezechi, OC; Mebrahtu, T; Medhin, G; Onyebujoh, PC; Rida, W; Vahedi, M; Yamuah, LK; Yimer, G; Zumla, AI | 1 |
| Hosmane, GB; Jain, A; Kushwaha, RA; Prasad, R; Singh, A; Srivastava, R | 1 |
| Geiter, L; Mallikaarjun, S; Paccaly, A; Patil, S; Petersen, C; Shoaf, SE; Wells, C | 1 |
| Alameda, L; Chen, C; Ferrer, S; Ortega, F; Simonsson, US | 1 |
| Alland, D; Barry, CE; Dodd, LE; Kriel, M; Malherbe, S; Peppard, T; Ronacher, K; Shenai, S; Stanley, K; Via, LE; Walzl, G; Wang, J; Winter, J | 1 |
| Andersen, ÅB; Bahl, JM; Cohen, AS; Frimodt-Møller, N; Johansen, IS; Lundqvist, M; Prahl, JB | 1 |
| Akbas, G; Akkoc, G; Atici, S; Bakir, M; Karaaslan, A; Kepenekli Kadayifci, E; Ocal Demir, S; Soysal, A; Yakut, N; Zeliha Cinel, L | 1 |
| Becerra, MC; Calderon, RI; Contreras, CC; Galea, JT; Huang, CC; Lecca, LW; Mitnick, CD; Murray, MB; Velásquez, GE; Yataco, RM; Zhang, Z | 1 |
| Blackmore, T; McNaughton, A; McNaughton, H | 1 |
| He, JQ; Ji, GY; Liu, QQ; Sandford, AJ; Wang, Y; Wu, JC; Wu, SQ; Zhang, MM | 1 |
| Dookie, N; Moodley, P; Sturm, AW | 1 |
| Ahuja, V; Jain, S; Jullien, S; Ryan, H | 1 |
| Patel, K; Patel, S; Vora, A | 1 |
| Centis, R; D'Ambrosio, L; Fuentes, Z; Migliori, GB; Sotgiu, G; Tiberi, S; Zumla, A | 1 |
| Bright-Thomas, RJ; Gondker, AR; Morris, J; Ormerod, LP | 1 |
| Allen, SJ; Carlson, SL; Furukawa, NW; Haider, MZ; Lindquist, SW | 1 |
| Balin, SO; Denk, A; Dogdu, O; Kara, SS; Kobat, MA | 1 |
| Ahmad, N; Javaid, A; Khan, AH; Shaheen, Z | 1 |
| Aarnoutse, R; Boeree, MJ; Charalambous, S; Churchyard, G; Colbers, A; Dawson, R; Diacon, AH; Gillespie, SH; Hanekom, M; Heinrich, N; Henne, S; Hoelscher, M; Hunt, RD; Kibiki, GS; Manyama, C; Mekota, A; Minja, LT; Mpagama, SG; Mtafya, B; Narunsky, K; Ntinginya, NE; Phillips, PPJ; Rehal, S; Reither, K; Sanne, I; Semvua, HH; van Balen, GP; Venter, A; Wallis, RS | 1 |
| Al-Shaer, MH; Elewa, H; Iqbal, F; Mansour, H; Salameh, P | 1 |
| Mebrahtu, T; Weldegebreal, S | 1 |
| Mendel, C; Murray, S; Spigelman, M | 1 |
| Marks, SM; Mase, SR; Morris, SB | 1 |
| Filipe, P; Machado, AP; Marcos-Pinto, A; Marques, T; Soares-de-Almeida, L | 1 |
| Chen, G; He, JQ; Sandford, AJ; Wang, FJ; Wang, MG; Wang, Y; Wu, SQ; Xiang, X; Zhang, MM | 1 |
| Ahn, Y; Eun, BW; Kim, HJ; Ryoo, S; Yoon, HH | 1 |
| Kubo, M; Omonge, E; Otieno, F; Shiruli, B | 1 |
| Chirehwa, MT; Denti, P; McIlleron, H; Mthiyane, T; Onyebujoh, P; Rustomjee, R; Smith, P | 1 |
| Bakker-Woudenberg, IAJM; Davies, GR; de Knegt, GJ; de Steenwinkel, JEM; Dickinson, L; Evangelopoulos, D; McHugh, TD; Pertinez, H | 1 |
| Cao, L; Greenblatt, DJ; Kwara, A | 1 |
| Chen, YH; Huang, CH; Kuo, CY; Lu, PL; Wang, WH | 1 |
| Arora, S; Ghosh, B; Goel, N; Kumar, V | 1 |
| Indumati, V; Krishnaswamy, D; Rajeshwari, V; Ramesh, A; Shantala, D; Shilpa, A; Vijay, V | 1 |
| Chellini, PR; Franco, PHC; Oliveira, MAL; Pianetti, GA | 1 |
| Gleeson, F; Larson, A; Rajan, E | 1 |
| Bax, HI; de Knegt, GJ; de Steenwinkel, JEM; Mourik, BC; Mouton, JW; Verbon, A | 1 |
| Czapka, M; Shukla, S; Slosar-Cheah, M | 1 |
| Andreou, A; Gerhardy, B; Nagel, RA; Sellars, R | 1 |
| Aarnoutse, RE; Boeree, MJ; Colbers, A; Gillespie, SH; Haraka, F; Hoelscher, M; Kibiki, GS; Logger, JGM; Magis-Escurra, C; Mpagama, SG; Mtabho, CM; Phillips, PPJ; Plemper van Balen, G; Reither, K; Semvua, HH; Sumari-de Boer, IM; Te Brake, LHM; van den Boogaard, J; Wattenberg, M | 1 |
| Bay, ML; Besedovsky, H; Bongiovanni, B; Bottasso, O; Brandan, N; D'Attilio, L; Del Rey, A; Díaz, A; Dídoli, G; Fernández, RDV; Gardeñez, W; Kovalevski, L; Lioi, S; Nannini, LJ; Santucci, N | 1 |
| Buzibye, A; Castelnuovo, B; Corti, N; Fehr, J; Gutteck, U; Henning, L; Kambugu, A; Lamorde, M; Ledergerber, B; Muller, D; Musaazi, J; Sekaggya-Wiltshire, C; von Braun, A | 1 |
| Chen, G; Feng, M; He, JQ; Ji, GY; Liu, QQ; Wang, Y; Wu, JC; Wu, SQ; Zhang, MM | 1 |
| Jo, KW; Kim, WS; Lee, SD; Park, S; Shim, TS | 1 |
| Duckett, SB; Green, GGR; Norcott, P; Rayner, PJ | 1 |
| Baillie, T; Cho, D; Lee, CK; Moses, J; Sivasubramaniam, R; Tjokrowidjaja, A | 1 |
| Chen, J; Chiang, CY; Innes, AL; Li, L; Xu, L | 1 |
| Barbero, S; Davis, JL; Haynesworth, K; Jacobs, J; Jarlsberg, L; Lewinsohn, DM; Mathew, A; Nahid, P; Schorey, J; Segal, MR; Sigal, GB; Small, N; Wang, M; Weiner, M; Whitworth, WC | 1 |
| Anukool, U; Butr-Indr, B; Gamngoen, R; Intorasoot, S; Jaresitthikunchai, J; Kasinrerk, W; Phaonakrop, N; Phunpae, P; Putim, C; Roytrakul, S; Tayapiwatana, C; Tharincharoen, CS; Tragoolpua, K | 1 |
| de Kock, M; Denti, P; Garcia-Prats, AJ; Hesseling, AC; McIlleron, H; Norman, J; Schaaf, HS; Tikiso, T; van der Laan, LE; Wiesner, L; Winckler, J | 1 |
| Huh, HJ; Jeon, K; Jeong, BH; Kim, S; Lee, H; Lee, NY; Park, HY | 1 |
| Charfi, S; Ghorbel, A; Mnejja, M; Sellami, M | 1 |
| Ameni, G; Medihn, G; Mersha, W; Tamirat, M; Teklu, T; Wondale, B | 1 |
| Clifton, DA; Crook, DW; Iqbal, Z; Niehaus, KE; Peto, TEA; Smith, EG; Walker, AS; Walker, TM; Wilson, DJ; Yang, Y; Zhu, T | 1 |
| Hsia, YC; Naseri, A; Schallhorn, JM | 1 |
| Ahmad, S; Al-Mutairi, NM; Mokaddas, E | 1 |
| Ahmed, AE; Al Ammari, M; Al Essa, M; Al Turaiki, A; Eltigani, SA; Kashkary, AM | 1 |
| Caminero Luna, JA; Cerezo Lajas, A; de Miguel Díez, J; Rodríguez Guzmán, MDC | 1 |
| Bian, Y; Cao, J; Huang, C; Liu, L; Mi, Y; Miao, L; Shi, C; Ye, Z | 1 |
| Battini, S; Mannava, MKC; Nangia, A | 1 |
| Adane, K; Dinant, GJ; Spigt, M | 1 |
| Alvarez-Uria, G; Midde, M | 1 |
| Chen, W; Gao, S; Wang, Z; Xi, Y; Xie, X; Yang, Y; You, C | 1 |
| Ahuja, SD; Akkerman, OW; Arakaki-Sanchez, D; Ayakaka, I; Baghaei, P; Bang, D; Banurekha, VV; Bastos, M; Benedetti, A; Bonnet, M; Cattamanchi, A; Cegielski, P; Chien, JY; Cox, H; Dedicoat, M; Erkens, C; Escalante, P; Falzon, D; Fregonese, F; Galliez, RM; Garcia-Prats, AJ; Gegia, M; Gillespie, SH; Glynn, JR; Goldberg, S; Griffith, D; Jacobson, KR; Johnston, JC; Jones-López, EC; Khan, A; Koh, WJ; Kritski, A; Lan, ZY; Lee, JH; Li, PZ; Maciel, EL; Menzies, D; Merle, CSC; Munang, M; Narendran, G; Nguyen, VN; Nunn, A; Ohkado, A; Park, JS; Phillips, PPJ; Ponnuraja, C; Reves, R; Romanowski, K; Schaaf, HS; Seung, K; Skrahina, A; Soolingen, DV; Tabarsi, P; Trajman, A; Trieu, L; Viiklepp, P; Wang, JY; Yoshiyama, T | 1 |
| Leong, BCS; Lightman, S; McCluskey, PJ; Tomkins-Netzer, O; Zhang, X | 1 |
| Bax, HI; de Knegt, GJ; de Steenwinkel, JEM; Mourik, BC; Simonsson, USH; Svensson, RJ; Verbon, A | 1 |
| Carrera-Pineda, R; Garcia-Luna, RC; Soto-Cabrera, E; Villamil-Osorio, LV | 1 |
| Al-Shaer, MH; Alghamdi, WA; Peloquin, CA | 1 |
| Aarnoutse, RE; Aguirre, S; Alffenaar, JW; Chaparro, G; Coronel, R; Gomez, R; Gonzalez, F; Huisman, J; Jongedijk, E; Kerkhoff, J; Magis-Escurra, C; Martial, LC; Martinez, N; Molinas, G; Pérez, D; Rodríguez, M; Roman, M; Touw, DJ | 1 |
| Das, A; Das, SK | 1 |
| Chen, H; Song, X; Wang, W; Wu, S; Xiong, W; Yu, X | 1 |
| Addise, D; Admasu, A; Amare, M; Beyene, D; Dagne, B; Mesfin, EA; Tesfaye, A; Tesfaye, E; Tessema, B; Yaregal, Z | 1 |
| Abrahem, R; Cao, R; Gyurjian, K; Islamoglu, H; Munjal, S; Teskey, G; Venketaraman, V; Zhong, L | 1 |
| Boulle, A; Fox, T; Khomo, N; Kock, Y; Leslie, J; Manning, K; Meintjes, G; Mudaly, V; Stewart, A; Tiffin, N; Wasserman, S; Zhao, Y | 1 |
| Cao, P; Doan, TN; Emeto, TI; McBryde, ES; McCaw, JM | 1 |
| Allix-Béguec, C; Arandjelovic, I; Beckert, P; Bi, L; Bonnet, M; Bradley, P; Cabibbe, AM; Cancino-Muñoz, I; Caulfield, MJ; Chaiprasert, A; Cirillo, DM; Clifton, DA; Comas, I; Crook, DW; De Filippo, MR; de Neeling, H; Diel, R; Drobniewski, FA; Faksri, K; Farhat, MR; Fleming, J; Fowler, P; Fowler, TA; Gao, Q; Gardy, J; Gascoyne-Binzi, D; Gibertoni-Cruz, AL; Gil-Brusola, A; Golubchik, T; Gonzalo, X; Grandjean, L; Guthrie, JL; He, G; Hoosdally, S; Hunt, M; Iqbal, Z; Ismail, N; Johnston, J; Khanzada, FM; Khor, CC; Kohl, TA; Kong, C; Lipworth, S; Liu, Q; Maphalala, G; Martinez, E; Mathys, V; Merker, M; Miotto, P; Mistry, N; Moore, DAJ; Murray, M; Niemann, S; Omar, SV; Ong, RT; Peto, TEA; Posey, JE; Prammananan, T; Pym, A; Rodrigues, C; Rodrigues, M; Rodwell, T; Rossolini, GM; Sánchez Padilla, E; Schito, M; Shen, X; Shendure, J; Sintchenko, V; Sloutsky, A; Smith, EG; Snyder, M; Soetaert, K; Starks, AM; Supply, P; Suriyapol, P; Tahseen, S; Tang, P; Teo, YY; Thuong, TNT; Thwaites, G; Tortoli, E; van Soolingen, D; Walker, AS; Walker, TM; Wilcox, M; Wilson, DJ; Wyllie, D; Yang, Y; Zhang, H; Zhao, Y; Zhu, B | 1 |
| Augustino, D; Gratz, J; Heysell, SK; Houpt, ER; Justine, M; Kibiki, GS; Kivuyo, S; Mduma, E; Mfinanga, S; Mmbaga, B; Nicodemu, I; Peloquin, CA; Thomas, TA; Yeconia, A; Zagurski, T | 1 |
| Andres, S; Gröschel, MI; Hillemann, D; Kranzer, K; Merker, M; Niemann, S | 1 |
| Ahn, H; Cho, YJ; Choi, HS; Choi, SM; Hahn, S; Han, J; Heo, EY; Hwang, YR; Jeong, I; Jo, YS; Joh, JS; Ki, J; Kim, DK; Kim, H; Kim, HS; Kim, J; Kim, SJ; Kwak, N; Lee, CH; Lee, J; Lee, JH; Lee, JK; Lee, JY; Lee, M; Lee, SH; Lee, SM; Lee, YJ; Lim, JN; Park, JH; Park, JS; Park, SS; Park, YS; Song, T; Yim, JJ; Yoon, HI | 1 |
| Alarcón Guizado, VA; Alarcon, E; Cornejo Garcia, JG; Heldal, E; Mendoza Ticona, A; Moore, DAJ | 1 |
| Tadele, H | 1 |
| Bang, H; Delva, S; Joissaint, G; Koenig, SP; Pape, JW; Peeples, M; Pry, J; Royal, G; Souroutzidis, A; Vilbrun, SC; Walsh, KF; Widmann, P | 1 |
| Ahmad, S; Al-Mutairi, NM; Eldeen, HS; Joseph, S; Mokaddas, E | 1 |
| Aragón Fernández, C; Gomez-Pastrana, D; Morales Pérez, C; Pérez Escolano, E | 1 |
| Ban, GY; Jeong, YJ; Kim, SH; Lee, SH; Park, HS; Shin, SS; Shin, YS; Ye, YM | 1 |
| Ronald, BSM; Senthil Kumar, TMA; Sweetline Anne, N; Thangavelu, A | 1 |
| Ding, X; Fan, G; Ho, CM; Jiang, J; Lan, L; Lou, Y; Wu, S | 1 |
| Abd-Ellatief, RB; Hasanain, AFA; Nafee, AMA; Zayed, AAH | 1 |
| Nair, SG; Patel, DB; Patel, HD; Rathwa, SK; Vasava, MS | 1 |
| Ali, M; Mertaniasih, NM; Novita, BD; Pranoto, A; Soediono, EI | 1 |
| Balganesh, T; Bhavani, PK; Gomathy, SN; Guleria, R; Jawahar, SM; Kumar, H; Natrajan, M; Padmapriyadarsini, C; Ponnuraja, C; Singh, M; Swaminathan, S | 1 |
| Kabra, SK; Lodha, R; Mukherjee, A | 1 |
| Fattorini, L; Giannoni, F; Iacobino, A; Pardini, M; Piccaro, G | 1 |
| Prasad, K; Vibha, D | 1 |
| Aucamp, M; Geldenhuys, M; Liebenberg, W; Okaecwe, T; Stieger, N | 1 |
| Andriescu, EC; Khetan, NG; Mazur, L; Smith, KC | 1 |
| Bunte, A; Fätkenheuer, G; Jaspers, N; Jung, N; Lehmann, C; Maria Fünger, S; Mehrkens, D; Plum, G; Reimer, RP; Rybniker, J; Schmidt, M; Suárez, I | 1 |
| Altmann, D; Brodhun, B; Glasauer, S; Haas, W; Hauer, B; Perumal, N | 1 |
| Asaoka, M; Baba, T; Hagiwara, E; Katano, T; Kitamura, H; Komatsu, S; Ogura, T; Okuda, R; Sekine, A; Suido, Y | 1 |
| Muntean, PE | 1 |
| Akkerman, OW; Alffenaar, JC; Hak, E; Pradipta, IS; Van't Boveneind-Vrubleuskaya, N | 1 |
| Bhatt, N; Davies, G; Gillespie, SH; Kibiki, GS; Ntinginya, NE; Sabiiti, W; Simonsson, USH; Svensson, RJ | 1 |
| Abbara, A; Abubakar, I; Alexander, E; Booth, H; Bothamley, GH; Creer, DD; Davidson, JA; Harris, RJ; Kon, OM; Kunst, H; Lalor, MK; Lipman, MC; Loebinger, MR; Loutet, MG; Lozewicz, S; McHugh, TD; Milburn, HJ; Mohiyuddin, T; Palchaudhuri, P; Phillips, PPJ; Schmok, E; Stagg, HR; Taylor, L | 1 |
| Crook, AM; Dawson, R; Diacon, AH; Gillespie, SH; McHugh, TD; Mendel, CM; Meredith, SK; Mohapi, L; Murphy, ME; Nunn, AJ; Phillips, PPJ; Singh, KP; Spigelman, M; Tweed, CD | 1 |
| Esmail, H; Lipman, MC; Nunn, A; Walker, TM | 1 |
| Dang, L; Lei, Q; Lv, X; Wang, H; Zhao, Y; Zhou, J; Zhu, C | 1 |
| Heyckendorf, J; Kalsdorf, B; Lange, C; Maurer, FP | 1 |
| Bai, H; Jiao, L; Liu, T; Lu, X; Lv, Y; Song, J; Wu, Q; Wu, T; Ying, B; Zhao, Z | 1 |
| Andrade, BB; Arriaga, MB; Calvacante, S; Cordeiro-Santos, M; Durovni, B; Figueiredo, MC; Kritski, A; Peetluk, LS; Rebeiro, PF; Rolla, VC; Sterling, TR; Turner, MM | 1 |
| Adiga, SK; Kalthur, G; Kalthur, SG; Kumari, S; Mutalik, S; Mutalik, SP; Nayak, G; Rao, A | 1 |
| Costales-Álvarez, C; Fernández-García, M; Macías-Franco, S; Mayordomo-Colunga, J; Rozas-Reyes, P | 1 |
| Chu, N; Guo, H; Lin, J; Liu, H; Liu, X; Wu, L; Ye, Z; Zheng, L | 1 |
| Mishra, DK; Murthy, SI; Pappuru, RR; Rathi, VM; Tyagi, M | 1 |
| Burger, DA; Dawson, R; De Jager, VR; Diacon, AH; Everitt, D; Mendel, CM; Narunsky, K; Nedelman, J; Pappas, F; Vanker, N | 1 |
| Ader, F; Berland, JL; Bryant, JE; Dumitrescu, O; Genestet, C; Ginevra, C; Hodille, E; Lina, G | 1 |
| Beraldi-Magalhães, F; Boger, B; Cordeiro-Santos, M; de Fátima Cobre, A; de Liz, MV; Domingos, EL; Dos Santos, JMMF; Fachi, MM; Junkert, AM; Momade, DRO; Pontarolo, R; Vilhena, RO | 1 |
| Dolgushin, MV | 1 |
| Kasinathan, A; Palanisamy, S; Serane, VK | 1 |
| Ahmadi, Q; Hayat, MS; Rahimi, BA; Rahimy, N; Wasiq, AW | 1 |
| Choi, J; Dawson, R; de Jager, VR; Diacon, AH; Hutchings, J; Kim, J; Nam, K; van der Merwe, L; van Niekerk, C; Vanker, N | 1 |
| Banerji, JS | 1 |
| Huynh, J; Marais, BJ; Schaaf, HS; Thwaites, G | 1 |
| De Sessions, PF; Hibberd, ML; Kwan, PKW; Lin, W; Naim, ANM; Paton, NI; Periaswamy, B | 1 |
| Danna, BJ; Harvey, AW; Woc-Colburn, LE | 1 |
| Chesdachai, S; Katz, B; Sapkota, S | 1 |
| Bongomin, F; Khan, SA; Oravec, T | 1 |
| Blumberg, HM; Fekadu, A; Holland, DP; Manyazewal, T; Marconi, VC; Woldeamanuel, Y | 1 |
| Kalita, J; Misra, UK; Pandey, PC; Singh, VK; Thomas, J | 1 |
| Eller, P; Hackl, G; Hermann, J; Reisinger, AC; Vagena, FR | 1 |
| Balakrishnan, S; Das, M; Manu, MS; Mehta, K; Neena, PS; Rakesh, PS; Satyanarayana, S; Sindhu, MP; Sunil Kumar, M; Valamparampil, MJ | 1 |
| Desai, U; Doshi, K; Joshi, JM | 1 |
| Berger, T; Dean, P; Matt, M; Riney, L; Schlaudecker, E | 1 |
| Xiao, K; Zhong, L | 1 |
| Ahn, DJ; Kang, S; Kim, MK; Kim, SG; Kwon, JG; Lee, IH; Yang, CS | 1 |
| Alva-Diaz, C; Esteban-Arias, D; López-Saavedra, A; Metcalf, T; Orellana-Tovar, I; Pacheco-Barrios, K; Rodriguez-López, E; Velásquez-Rimachi, V | 1 |
| Aung, KJM; de Jong, BC; Decroo, T; Hossain, MA; Lempens, P; Meehan, CJ; Rigouts, L; Van Deun, A | 1 |
| Chasweka, M; Chirambo, AP; Chitani, A; Davies, GR; Dilly-Penchala, S; Else, LJ; Gordon, SB; Khoo, SH; Malamba, RD; McCallum, AD; Meghji, JZ; Mwandumba, HC; Pertinez, HE; Sheha, I; Sloan, DJ | 1 |
| Eather, G; Matigian, N; O'Connor, B; Wilson, M | 1 |
| Alffenaar, JC; Bruchfeld, J; Davies Forsman, L; Hu, Y; Jongedijk, EM; Kuhlin, J; Niward, K; Paues, J; Schön, T; Xu, B; Zheng, R; Zheng, X | 1 |
| Chu, N; Du, Y; Guo, R; Han, X; Pang, Y; Wang, J; Wang, Q | 1 |
| Bang, ND; Day, JN; Hoglund, RM; Ngo, VN; Nosoongnoen, W; Panjasawatwong, N; Pouplin, T; Tarning, J; Wattanakul, T | 1 |
| Anton, C; Bernardi, RM; Freitas, AA; Lemos, CX; Machado, FD; Silva, DR | 1 |
| Einbeck, CO; Hunter, CJ; Yasukawa, K | 1 |
| Antonio, M; Maggio, RM; Raffaghelli, M | 1 |
| Alameer, R; Almaghrabi, RS; Almohaizeie, A; Alrajhi, AA; Alshehri, N; Nizami, I; Omrani, AS | 1 |
| Ahmad, N; Atif, M; Ghafoor, A; Iqbal, Q; Khan, S; Latif, A; Saleem, F; Wahid, A | 1 |
| Bishai, W; Dawson, R; De Jager, V; Diacon, A; Donahue, K; Fletcher, CV; Hafner, R; Hogg, E; Miyahara, S; Sun, X; Swindells, S; Urbanowski, M | 1 |
| Aarnoutse, R; Chabala, C; Chirehwa, M; Choo, L; Gibb, D; Hesseling, AC; Hissar, S; Kapasa, M; Kinikar, A; LeBeau, K; Mave, V; McIlleron, H; Mulenga, V; Palmer, M; Turkova, A; van der Zalm, M; Wiesner, L; Wobudeya, E; Zimba, KM | 1 |
| Bajaj, A; Dasgupta, U; Jain, D; Jha, SK; Kar, R; Kumar, S; Medatwal, N; Mehta, D; Nandicoori, VK; Pal, S; Patil, VS; Rana, K; Sharma, P; Soni, V; Srivastava, A; Yadav, P | 1 |
| Mistry, N; Oswal, V; Rao, S; Shaikh, A; Sriraman, K; Vaswani, S | 1 |
| Karthikeyan, K; Premjith, R; Vijayasankar, P | 1 |
| Bekker, A; Davies, G; Denti, P; Gonzalez-Martinez, C; Hesseling, AC; McIlleron, HM; Rabie, H; Svensson, EM; van der Laan, LE; van Rie, A; Wasmann, RE; Wiesner, L; Winckler, J; Zar, HJ | 1 |
| Bollela, VR; Della Pasqua, O; Lanchote, VL; Nardotto, GHB; Rocha, A | 1 |
| Bandere, D; Cirule, A; Grinberga, S; Igumnova, V; Kivrane, A; Krams, A; Pole, I; Pugovics, O; Ranka, R; Sevostjanovs, E; Viksna, A | 1 |
| Kumari, D; Perveen, S; Sharma, R; Singh, K | 1 |
| Della Pasqua, O; Ferrer, S; Muliaditan, M; Ortega-Muro, F; Teutonico, D | 1 |
| Chasweka, M; Chirambo, AP; Chitani, A; Corbett, EL; Davies, GR; Ghany, JF; Gordon, SB; Khoo, SH; Malamba, R; Mallewa, JE; McCallum, AD; Meghji, JZ; Mwandumba, HC; Pertinez, HE; Shani, D; Sheha, I; Sloan, DJ | 1 |
| Anderson, R; Cholo, MC; Mashele, SA; Matjokotja, MT; Rasehlo, SSM; Steel, HC | 1 |
| Abulfathi, AA; Carter, CL; Dartois, V; Decloedt, EH; Demers, AM; Deventer, AV; Garcia-Prats, AJ; Goussard, P; Hesseling, AC; Janson, J; Lopez-Varela, E; Morrison, J; Reuter, H; Savic, RM; Seddon, JA; Strydom, N; Svensson, EM; van der Merwe, J; van Wyk, AC; Warren, R; Zimmerman, M | 1 |
| Byeon, SJ; Choi, JH; Chung, SJ | 1 |
| Jiang, H; Li, X; Niu, Q; Xing, Z; Xu, J | 1 |
| Anderson, G; Vinnard, C | 1 |
| Alshaer, MH; Gratz, J; Heysell, SK; Houpt, ER; Justine, M; Kosek, M; Liu, J; Maro, A; Mduma, E; Mpagama, SG; Mujaga, B; Peloquin, CA; Rogawski McQuade, ET; Thomas, TA; Van Aartsen, D | 1 |
| Chimbetete, T; Choshi, P; Lehloenya, R; Meintjes, G; Pedretti, S; Peter, J; Phillips, E; Porter, M; Smith, R | 1 |
| Wen, Y; Wu, X; Zhang, G | 1 |
| Addise, D; Beyene, D; Merker, M; Mesfin, EA; Niemann, S; Shuaib, YA; Tesfaye, A; Tessema, B | 1 |
| Bennie, M; Godman, B; Kruger, D; Kurdi, A; Meyer, JC; Schellack, N; Skosana, PP | 1 |
| Kang, JY; Kim, HW; Kim, JS; Kim, JW; Kim, SK; Kim, YH; Lee, SH; Min, J; Yoon, HK | 1 |
| George, S; Gerbo, RM; Hartman-Adams, H | 1 |
| Kilonzo, K; Lyamuya, F; Mremi, A; Sadiq, A; Temba, B; Urassa, D; Vara, P | 1 |
| Chen, KH; Chen, YL; Hung, CC; Lin, SW; Liu, WD; Wang, JT; Wang, YC | 1 |
| Kamoshita, F; Karaushi, H; Mitsutake, K; Miyawaki, Y; Seki, M; Watanabe, N | 1 |
| Castel, S; Court, R; Joubert, A; Loveday, M; Norman, J; van der Merwe, M; Waitt, C; Wiesner, L; Zuma, P | 1 |
| Di Palma, M; Francis, JR; Globan, M; Hall, C; Hersch, N; Horan, K; Lopes, C; Meumann, EM; Pereira, HM; Ralph, AP; Sarmento, N | 1 |
| Cáceres-Pérez, AR; Fariña, JB; Oliva, A; Santoveña-Estévez, A; Suárez-González, J | 1 |
| Aarnoutse, RE; Agarwal, D; Alffenaar, JC; Antwi, S; Bang, ND; Bekker, A; Bell, DJ; Chabala, C; Choo, L; Davies, GR; Day, JN; Dayal, R; Denti, P; Donald, PR; Engidawork, E; Gafar, F; Garcia-Prats, AJ; Gibb, D; Graham, SM; Hesseling, AC; Heysell, SK; Idris, MI; Kabra, SK; Kinikar, A; Kumar, AKH; Kwara, A; Lodha, R; Magis-Escurra, C; Marais, BJ; Martinez, N; Mathew, BS; Mave, V; McIlleron, HM; Mduma, E; Mlotha-Mitole, R; Mpagama, SG; Mukherjee, A; Nataprawira, HM; Peloquin, CA; Pouplin, T; Ramachandran, G; Ranjalkar, J; Roy, V; Ruslami, R; Schaaf, HS; Shah, I; Singh, Y; Stevens, J; Sturkenboom, MGG; Svensson, EM; Swaminathan, S; Taxis, K; Thatte, U; Thee, S; Thomas, TA; Tikiso, T; Touw, DJ; Turkova, A; Velpandian, T; Verhagen, LM; Wasmann, RE; Winckler, JL; Yang, H; Yunivita, V | 1 |
| Kertys, M; Mokrý, J; Porvazník, I; Pršo, K; Solovič, I; Žideková, N | 1 |
| Bhadauria, M; Nirala, SK; Rakshit, S; Sahu, N | 1 |
| Béranger, A; Gegia, M; Linh, NN; Mirzayev, F; Mohamed, A; Nahid, P; Radtke, K; Savic, RM; Schumacher, SG; Solans, BP | 1 |
| Avihingsanon, A; Balanag, VM; Burhan, E; Chew, KL; Cousins, C; Crook, AM; Dalay, VB; Djaharuddin, I; Kusmiati, T; Lee, SL; Lu, Q; Nunn, AJ; Papineni, P; Paton, NI; Pokharkar, Y; Ruslami, R; Sarin, R; Sekaggya-Wiltshire, C; Sugiri, JJR; Suresh, C; Veto, RS | 1 |
| Gadgil, CJ; Ramachandran, A | 1 |
| Aalhoul, F; Cotton, F; Fage, D | 1 |
| Choudhary, S; Joshi, D; Sahni, M; Srivastava, A | 1 |
86 review(s) available for pyrazinamide and ethambutol
| Article | Year |
|---|---|
Recent advances in antitubercular natural products.
Topics: Animals; Antitubercular Agents; Biological Products; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Humans; Mycobacterium tuberculosis; Tuberculosis | 2012 |
A medicinal chemists' guide to the unique difficulties of lead optimization for tuberculosis.
Topics: Animals; Antitubercular Agents; Drug Discovery; Humans; Lung; Mycobacterium tuberculosis; Tuberculosis | 2013 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Isoniazid derivatives and their anti-tubercular activity.
Topics: Animals; Antitubercular Agents; Drug Discovery; Humans; Isoniazid; Mycobacterium tuberculosis; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2017 |
Triazole derivatives and their anti-tubercular activity.
Topics: Antitubercular Agents; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship; Triazoles; Tuberculosis | 2017 |
Recent advances of pyrazole-containing derivatives as anti-tubercular agents.
Topics: Antitubercular Agents; Dose-Response Relationship, Drug; Humans; Molecular Structure; Mycobacterium tuberculosis; Pyrazoles; Structure-Activity Relationship; Tuberculosis | 2017 |
Insights of synthetic analogues of anti-leprosy agents.
Topics: Humans; Leprostatic Agents; Leprosy; Structure-Activity Relationship | 2019 |
Drug-resistance in
Topics: | 2019 |
An appraisal of anti-mycobacterial activity with structure-activity relationship of piperazine and its analogues: A review.
Topics: Animals; Antitubercular Agents; Drug Design; Drug Discovery; Humans; Mycobacterium tuberculosis; Piperazine; Structure-Activity Relationship; Tuberculosis | 2021 |
Antitubercular properties of thiazolidin-4-ones - A review.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium; Structure-Activity Relationship; Thiazolidines; THP-1 Cells; Vero Cells | 2021 |
Emerging impact of triazoles as anti-tubercular agent.
Topics: Antitubercular Agents; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Structure-Activity Relationship; Triazoles; Tuberculosis | 2022 |
Treatment of tuberculosis.
Topics: Adult; Aminosalicylic Acids; Capreomycin; Child; Cycloserine; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Time Factors; Tuberculosis; Viomycin | 1975 |
Advances in the treatment of tuberculosis.
Topics: Aminosalicylic Acids; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Thioacetazone; Tuberculosis; Tuberculosis, Lymph Node; Tuberculosis, Meningeal; Tuberculosis, Miliary; Tuberculosis, Osteoarticular; Tuberculosis, Pulmonary; Tuberculosis, Urogenital | 1976 |
The hepatic toxicity of antituberculosis regimens containing isoniazid, rifampicin and pyrazinamide.
Topics: Acetylation; Adolescent; Adult; Aged; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Liver Function Tests; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1978 |
Effects of drugs on uric acid in man.
Topics: Antineoplastic Agents; Depression, Chemical; Diuretics; Ethambutol; Ethanol; Fructose; Humans; Levodopa; Nicotinic Acids; Pyrazinamide; Salicylates; Thiadiazoles; Uric Acid; Uricosuric Agents | 1975 |
Failure of therapy for tuberculosis in human immunodeficiency virus infection.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Drug Therapy, Combination; Ethambutol; Female; HIV Seropositivity; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Pyrazinamide; Pyridoxine; Rifampin; Tuberculosis | 1992 |
[Chemoprophylaxis of tuberculosis (lecture)].
Topics: Adolescent; Adult; Age Factors; Antitubercular Agents; BCG Vaccine; Child; Ethambutol; Humans; Infant, Newborn; Isoniazid; Pyrazinamide; Rifampin; Time Factors; Tuberculosis | 1992 |
Drug-induced gout.
Topics: Cyclosporins; Cytotoxins; Diuretics; Drug-Related Side Effects and Adverse Reactions; Ethambutol; Ethanol; Fructose; Gout; Humans; Niacin; Pyrazinamide; Salicylates; Uric Acid | 1991 |
[Therapy of tuberculosis].
Topics: Antitubercular Agents; Contraindications; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Prothionamide; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis | 1990 |
Adverse cutaneous reactions to antituberculosis drugs.
Topics: Acne Vulgaris; Adult; Amikacin; Antitubercular Agents; Drug Hypersensitivity; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Male; Middle Aged; Pellagra; Pigmentation Disorders; Prothionamide; Pyrazinamide; Rifampin; Skin Diseases; Streptomycin; Thioacetazone | 1985 |
Chromatographic analysis of antituberculosis drugs in biological samples.
Topics: Aminosalicylic Acids; Antitubercular Agents; Capreomycin; Chromatography; Cycloserine; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Kinetics; Monitoring, Physiologic; Pyrazinamide; Rifampin; Streptomycin; Thioacetazone; Viomycin | 1985 |
[Which treatment for primary tuberculosis?].
Topics: Acquired Immunodeficiency Syndrome; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis | 1989 |
Antituberculosis agents.
Topics: Antitubercular Agents; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1988 |
CNS tuberculosis.
Topics: Biopsy; Cerebral Ventricles; Cerebrospinal Fluid; Ethambutol; Humans; Hyaluronoglucosaminidase; Isoniazid; Nervous System Diseases; Prognosis; Pyrazinamide; Rifampin; Streptomycin; Tomography, X-Ray Computed; Tuberculoma; Tuberculosis, Meningeal | 1986 |
Respiratory pharmacology. Antituberculosis drugs.
Topics: Aminosalicylic Acids; Antitubercular Agents; Cyclosporins; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis | 1986 |
[Treatment of pleuropulmonary tuberculosis in 1985].
Topics: Aminoglycosides; Antitubercular Agents; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Thioamides; Tuberculosis, Pleural; Tuberculosis, Pulmonary | 1985 |
[Results of chemotherapy in tuberculosis].
Topics: Ambulatory Care; Anti-Bacterial Agents; Antitubercular Agents; Drug Synergism; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Peptides; Pyrazinamide; Thioacetazone; Tuberculosis; Tuberculosis, Pulmonary; Tuberculosis, Urogenital; Viomycin | 1971 |
General considerations in intermittent drug therapy of pulmonary tuberculosis.
Topics: Aminosalicylic Acids; Antitubercular Agents; Clinical Trials as Topic; Ethambutol; Ethionamide; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Thioacetazone; Time Factors; Tuberculosis, Pulmonary | 1971 |
Drug reactions. 18. Cutaneous reactions to antituberculous drugs.
Topics: Aminosalicylic Acids; Antitubercular Agents; Capreomycin; Cycloserine; Drug Eruptions; Ethambutol; Ethionamide; Humans; Isoniazid; Isonicotinic Acids; Kanamycin; Pyrazinamide; Rifampin; Skin; Stomatitis; Streptomycin; Thioacetazone; Viomycin | 1972 |
New trends in the chemotherapy of tuberculosis--current aspects.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Ethionamide; Follow-Up Studies; Humans; Isoniazid; Pyrazinamide; Rifampin; Sputum; Streptomycin; Thioacetazone; Time Factors; Tuberculosis | 1974 |
Leprosy. A preliminary review of the experimental evaluation of drugs for the treatment of leprosy.
Topics: Aminosalicylic Acids; Animals; Anti-Bacterial Agents; Antitubercular Agents; Cycloserine; Ethambutol; Humans; Isoniazid; Leprosy; Mice; Mycobacterium leprae; Phenazines; Pyrazinamide; Streptomycin; Sulfadimethoxine; Sulfides; Thioacetazone; Urea | 1967 |
The impact of chemotherapy on the care of patients with tuberculosis.
Topics: Antitubercular Agents; Aspirin; Bacteriological Techniques; BCG Vaccine; Drug Therapy, Combination; Ethambutol; Hospitalization; Humans; Isoniazid; Length of Stay; Mycobacterium tuberculosis; Outpatient Clinics, Hospital; Pyrazinamide; Rifampin; Streptomycin; Time Factors; Tuberculin Test; Tuberculosis, Pulmonary | 1974 |
Newer and second-line drugs in the treatment of drug-resistant tuberculosis in children.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Child, Preschool; Cycloserine; Drug Resistance, Microbial; Ethambutol; Ethionamide; Humans; Kanamycin; Mycobacterium tuberculosis; Pyrazinamide; Tuberculosis, Pulmonary; Viomycin | 1967 |
[Chemotherapeutic studies on advanced tuberculosis in mice].
Topics: Aminosalicylic Acids; Animals; Antitubercular Agents; Drug Resistance, Microbial; Drug Synergism; Ethambutol; Ethionamide; Isoniazid; Kanamycin; Mice; Models, Biological; Phenazines; Pyrazinamide; Streptomycin; Tuberculosis, Pulmonary; Viomycin | 1965 |
Chemotherapeutics with tuberculostatic action.
Topics: Aminosalicylic Acids; Antitubercular Agents; Catalase; Ethambutol; Ethionamide; Hemin; Humans; Hydrogen Peroxide; Isoniazid; Isonicotinic Acids; Metals; NAD; Pyrazinamide; Structure-Activity Relationship; Thiosemicarbazones | 1971 |
[Experimental chemotherapy of tuberculosis].
Topics: Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Drug Synergism; Ethambutol; Ethionamide; Humans; Isoniazid; Phenylthiourea; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis | 1969 |
[Results of 2 or 3 secondary drug combinations in the retreatment of chronic pulmonary tuberculosis].
Topics: Adolescent; Antitubercular Agents; Child; Child, Preschool; Cycloserine; Drug Synergism; Ethambutol; Ethionamide; Female; Humans; Male; Psychoses, Substance-Induced; Pyrazinamide; Tuberculosis, Pulmonary | 1968 |
[Identification and determination of antitubercular compounds].
Topics: Aminosalicylic Acids; Antitubercular Agents; Chromatography, Ion Exchange; Chromatography, Paper; Chromatography, Thin Layer; Countercurrent Distribution; Cycloserine; Electrophoresis; Ethambutol; Ethionamide; Isoniazid; Methods; Pyrazinamide; Streptomycin | 1970 |
[Antitubercular agents. 2. Specific chemotherapeutic agents].
Topics: Aminosalicylic Acids; Antitubercular Agents; Ethambutol; Ethionamide; Isoniazid; Isonicotinic Acids; Phenylthiourea; Pyrazinamide; Sulfones; Thiosemicarbazones | 1971 |
Chemotherapy of pulmonary tuberculosis.
Topics: Aminosalicylic Acids; Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Hospitalization; Humans; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Streptomycin; Tuberculosis, Pulmonary | 1969 |
New drugs in respiratory disorders: II.
Topics: Adult; Aged; Amantadine; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Cephalosporins; Cyclophosphamide; Drug Combinations; Erythromycin; Ethambutol; Humans; Metronidazole; Pyrazinamide; Respiratory Tract Diseases; Respiratory Tract Infections; Rifampin; Trimethoprim; Tuberculosis, Pulmonary | 1983 |
Treatment of tuberculosis. The Mitchell lecture 1979.
Topics: Animals; Antitubercular Agents; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1980 |
Tuberculosis.
Topics: Alcohol Drinking; Carrier State; Chemical and Drug Induced Liver Injury; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tuberculin Test; Tuberculosis, Pulmonary | 1980 |
[Esophagomediastinal fistulae as a rare complication of tuberculosis in an HIV-infected patient].
Topics: AIDS-Related Opportunistic Infections; Ciprofloxacin; Drug Therapy, Combination; Esophageal Fistula; Ethambutol; Fistula; HIV-1; Humans; Male; Mediastinal Diseases; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis, Lymph Node | 1994 |
Outpatient management of tuberculosis.
Topics: Algorithms; Ambulatory Care; Antitubercular Agents; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Mass Screening; Population Surveillance; Pyrazinamide; Rifampin; Sensitivity and Specificity; Streptomycin; Tuberculin Test; Tuberculosis, Pulmonary; United States | 1996 |
New horizons in the treatment of tuberculosis.
Topics: Animals; Drug Design; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Mycolic Acids; Pyrazinamide; Rifampin; Tuberculosis | 1997 |
[Antitubercular chemotherapy].
Topics: Aged; AIDS-Related Opportunistic Infections; Antitubercular Agents; Child; Clinical Protocols; Drug Combinations; Ethambutol; Follow-Up Studies; HIV Seronegativity; Humans; Isoniazid; Patient Compliance; Patient Education as Topic; Pyrazinamide; Rifampin; Treatment Failure; Tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1997 |
[Short-course chemotherapy of tuberculosis with pyrazinamide].
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Drug Administration Schedule; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1998 |
Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Cycloserine; Drug Resistance, Multiple; Ethambutol; Ethionamide; Fluoroquinolones; Genes, Bacterial; Isoniazid; Mutation; Mycobacterium tuberculosis; Polymorphism, Genetic; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Virulence | 1998 |
Tuberculous peritonitis in patients undergoing continuous ambulatory peritoneal dialysis: case report and review.
Topics: Adult; Antitubercular Agents; Ethambutol; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis, Tuberculous; Pyrazinamide; Rifampin | 2000 |
[Molecular mechanisms of multidrug resistance in Mycobacterium tuberculosis].
Topics: Antitubercular Agents; Drug Resistance, Multiple; Ethambutol; Humans; Isoniazid; Mutation; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant | 2000 |
[Effectiveness and problems of PZA-containing 6-month regimen for the treatment of new pulmonary tuberculosis patients].
Topics: Animals; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Risk Factors; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 2001 |
Tubercular laryngeal abscess.
Topics: Abscess; Adult; Antitubercular Agents; Cefotaxime; Diclofenac; Drainage; Ethambutol; Humans; Hydrocortisone; Isoniazid; Laryngoscopy; Male; Pyrazinamide; Rifampin; Tomography, X-Ray Computed; Tuberculosis, Laryngeal | 2001 |
Primary lingual tuberculosis: a case report with review of literature.
Topics: Adult; Antibiotics, Antitubercular; Antitubercular Agents; Diagnosis, Differential; Ethambutol; Follow-Up Studies; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Tongue Diseases; Tongue Neoplasms; Tuberculosis, Oral | 2002 |
[Resistant tuberculosis: a molecular review].
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant | 2002 |
Management of spinal tuberculosis--current concepts.
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Pyrazinamide; Tuberculosis, Spinal | 2004 |
[Procedure in case of suspected mycobacterial infection of lymph nodes of the neck. 2. Therapy].
Topics: Adult; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Disease Notification; Drug Therapy, Combination; Ethambutol; Female; Germany; Humans; Immunocompromised Host; Isoniazid; Male; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Patient Isolation; Pyrazinamide; Rifampin; Streptomycin; Time Factors; Tuberculosis, Lymph Node | 2005 |
Diffuse pachymeningitis due to Mycobacterium tuberculosis: a case report and review of the literature.
Topics: Adrenal Cortex Hormones; Aged; Antibiotics, Antitubercular; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Meningitis; Mycobacterium tuberculosis; Prednisone; Pyrazinamide; Rifampin; Tuberculosis, Meningeal | 2008 |
Efforts towards the development of new antitubercular agents: potential for thiolactomycin based compounds.
Topics: Animals; Antitubercular Agents; Drug Design; Ethambutol; Isoniazid; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Physiological Phenomena; Pyrazinamide; Rifamycins; Streptomycin; Thiophenes; Tuberculosis; Tuberculosis, Pulmonary | 2008 |
Tuberculous orchiepididymitis during 1978-2003 period: review of 34 cases and role of 16S rRNA amplification.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Combined Modality Therapy; Comorbidity; Epididymitis; Ethambutol; Exudates and Transudates; HIV Infections; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Orchitis; Prostatitis; Pyrazinamide; Retrospective Studies; Ribotyping; Rifampin; RNA, Ribosomal, 16S; Scrotum; Spain; Tuberculosis, Male Genital; Tuberculosis, Renal; Urine | 2010 |
Bronchiectatic air bronchograms in pulmonary tuberculosis: a case report and literature review.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Bronchiectasis; Bronchoalveolar Lavage; Bronchoscopy; Diagnosis, Differential; Ethambutol; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Radiography; Rifampin; Tuberculosis, Pulmonary | 2010 |
Primary tuberculosis of the TMJ: presentation of a case and literature review.
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Temporomandibular Joint; Temporomandibular Joint Disorders; Treatment Outcome; Tuberculosis, Osteoarticular; Young Adult | 2010 |
Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis.
Topics: Amikacin; Antitubercular Agents; Capreomycin; Drug Resistance, Multiple; Ethambutol; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Humans; Isoniazid; Kanamycin; Levofloxacin; Ofloxacin; Pyrazinamide; Tuberculosis | 2010 |
[Not just a success story. On the history of tuberculosis treatment].
Topics: Antitubercular Agents; Ethambutol; History, 17th Century; History, 18th Century; History, 19th Century; History, 20th Century; History, Medieval; Humans; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Tuberculin; Tuberculosis | 2012 |
Unilateral and painless development of isoniazid induced gynecomastia during re-treatment of pulmonary tuberculosis.
Topics: Adolescent; Anti-Bacterial Agents; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Gynecomastia; Humans; Isoniazid; Male; Pyrazinamide; Retreatment; Rifampin; Sputum; Streptomycin; Treatment Outcome; Tuberculosis, Pulmonary | 2011 |
[Tubercular abscess of the chest wall in the child].
Topics: Abscess; Adolescent; Antitubercular Agents; Biopsy; Combined Modality Therapy; Diagnosis, Differential; Drainage; Drug Therapy, Combination; Ethambutol; Female; Humans; Immunocompetence; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Sternum; Thoracic Neoplasms; Thoracic Wall; Tomography, X-Ray Computed; Tuberculosis, Cutaneous; Tuberculosis, Osteoarticular | 2013 |
Isolated tuberculous liver abscess in an immunocompetent adult patient: A case report and literature review.
Topics: Aged; Antitubercular Agents; Biopsy; Blood Chemical Analysis; Drug Combinations; Ethambutol; Humans; Isoniazid; Laparotomy; Liver; Liver Abscess; Male; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis | 2016 |
Understanding pharmacokinetics to improve tuberculosis treatment outcome.
Topics: Antitubercular Agents; Diabetes Mellitus; Drug Monitoring; Ethambutol; HIV Infections; Humans; Isoniazid; Microbial Sensitivity Tests; Pyrazinamide; Rifamycins; Treatment Outcome; Tuberculosis; Tuberculosis, Pulmonary | 2014 |
Antitubercular therapy in patients with cirrhosis: challenges and options.
Topics: Antitubercular Agents; Ethambutol; Humans; Immune System Diseases; Isoniazid; Latent Tuberculosis; Liver; Liver Cirrhosis; Liver Diseases; Liver Failure; Liver Function Tests; Liver Transplantation; Prevalence; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2014 |
Tuberculosis Drug Development: History and Evolution of the Mechanism-Based Paradigm.
Topics: Antitubercular Agents; Diarylquinolines; Drug Design; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Evolution, Chemical; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2015 |
Therapeutic drug monitoring in anti-tuberculosis treatment: a systematic review and meta-analysis.
Topics: Antitubercular Agents; Databases, Factual; Dose-Response Relationship, Drug; Drug Monitoring; Ethambutol; Humans; Isoniazid; Pyrazinamide; Randomized Controlled Trials as Topic; Rifampin; Treatment Outcome; Tuberculosis | 2016 |
Optimizing treatment outcome of first-line anti-tuberculosis drugs: the role of therapeutic drug monitoring.
Topics: Antitubercular Agents; Drug Monitoring; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis | 2016 |
Six-month therapy for abdominal tuberculosis.
Topics: Abdomen; Antitubercular Agents; Drug Administration Schedule; Ethambutol; Humans; Isoniazid; Pyrazinamide; Randomized Controlled Trials as Topic; Recurrence; Rifampin; Time Factors; Tuberculosis, Gastrointestinal | 2016 |
Anti-tuberculosis drug resistance in Ethiopia: systematic review.
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Ethambutol; Ethiopia; Humans; Isoniazid; Prevalence; Public Health; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant | 2017 |
Systematic Review, Meta-analysis, and Cost-effectiveness of Treatment of Latent Tuberculosis to Reduce Progression to Multidrug-Resistant Tuberculosis.
Topics: Antitubercular Agents; Cost-Benefit Analysis; Disease Progression; Drug Resistance, Multiple, Bacterial; Ethambutol; Fluoroquinolones; Humans; Latent Tuberculosis; Pyrazinamide; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2017 |
Comparison of different treatments for isoniazid-resistant tuberculosis: an individual patient data meta-analysis.
Topics: Antibiotics, Antitubercular; Cohort Studies; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Fluoroquinolones; Humans; Observational Studies as Topic; Outcome Assessment, Health Care; Pyrazinamide; Randomized Controlled Trials as Topic; Review Literature as Topic; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant | 2018 |
Development of new drug-regimens against multidrug-resistant tuberculosis.
Topics: Adamantane; Antitubercular Agents; Diarylquinolines; Drug Development; Drug Therapy, Combination; Duration of Therapy; Ethambutol; Ethylenediamines; Humans; Isoniazid; Macrolides; Medication Adherence; Nitroimidazoles; Oxazolidinones; Pyrazinamide; Rifampin; Tuberculosis, Multidrug-Resistant | 2019 |
Pharmacokinetics of First-Line Anti-Tubercular Drugs.
Topics: Age Factors; Antitubercular Agents; Child; Drug Overdose; Ethambutol; Food; Genotype; HIV Infections; Humans; Isoniazid; Malnutrition; Nutritional Status; Polymorphism, Genetic; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis | 2019 |
Severe disseminated tuberculosis in HIV-negative refugees.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Ethambutol; Fluorine Radioisotopes; HIV Infections; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Positron Emission Tomography Computed Tomography; Pyrazinamide; Refugees; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult | 2019 |
Tuberculosis treatment in children: The changing landscape.
Topics: Antitubercular Agents; Child; Drug Therapy, Combination; Duration of Therapy; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis; Tuberculosis, Central Nervous System; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2020 |
Diagnostic Challenges and Dilemmas in Tuberculous Meningitis.
Topics: Adult; Antitubercular Agents; Asthma; Ethambutol; Female; Headache; Hospitalization; Humans; Hydrocephalus; Isoniazid; Leukocytosis; Magnetic Resonance Imaging; Polymerase Chain Reaction; Pyrazinamide; Rifampin; Somalia; Spinal Puncture; Tuberculosis, Meningeal; United States; Vision Disorders | 2020 |
Tuberculosis in 2019.
Topics: Antitubercular Agents; Ethambutol; Health Policy; Humans; India; Isoniazid; Molecular Diagnostic Techniques; Nucleic Acid Amplification Techniques; Polymerase Chain Reaction; Practice Guidelines as Topic; Pulmonologists; Pyrazinamide; Rifampin; Surveys and Questionnaires; Tuberculosis; Tuberculosis, Multidrug-Resistant; World Health Organization | 2020 |
Multiple tuberculomas in an immunocompetent patient and their diagnostic challenge in a high prevalence country: Case report and literature review.
Topics: Antitubercular Agents; Blindness; Brain; Brain Diseases; Cerebellar Ataxia; Dexamethasone; Drug Therapy, Combination; Endemic Diseases; Ethambutol; Female; Glucocorticoids; Humans; Immunocompetence; Isoniazid; Magnetic Resonance Imaging; Nausea; Nystagmus, Pathologic; Peru; Pyrazinamide; Quadriplegia; Rifampin; Tomography, X-Ray Computed; Tuberculoma, Intracranial; Tuberculosis, Pulmonary; Vomiting; Young Adult | 2020 |
Tuberculosis drug discovery: Progression and future interventions in the wake of emerging resistance.
Topics: Antitubercular Agents; Diarylquinolines; Drug Therapy, Combination; Ethambutol; Extensively Drug-Resistant Tuberculosis; Humans; Isoniazid; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Pyrazinamide; Rifampin | 2022 |
Global estimates and determinants of antituberculosis drug pharmacokinetics in children and adolescents: a systematic review and individual patient data meta-analysis.
Topics: Adolescent; Antitubercular Agents; Child; Child, Preschool; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin | 2023 |
Effectiveness and Pharmacokinetic Exposures of First-Line Drugs Used to Treat Drug-Susceptible Tuberculosis in Children: A Systematic Review and Meta-Analysis.
Topics: Adolescent; Adult; Antitubercular Agents; Child; Ethambutol; HIV; HIV Infections; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis | 2023 |
133 trial(s) available for pyrazinamide and ethambutol
| Article | Year |
|---|---|
Pharmacokinetics and tolerability of a higher rifampin dose versus the standard dose in pulmonary tuberculosis patients.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Antitubercular Agents; Area Under Curve; Biological Availability; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Drug Tolerance; Ethambutol; Female; Half-Life; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Radiography, Thoracic; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary | 2007 |
Controlled trial of 6-month and 8-month regimens in the treatment of pulmonary tuberculosis. First report.
Topics: Adolescent; Adult; Antitubercular Agents; Clinical Trials as Topic; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Ethambutol; Humans; Infant, Newborn; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Random Allocation; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1978 |
The hepatic toxicity of antituberculosis regimens containing isoniazid, rifampicin and pyrazinamide.
Topics: Acetylation; Adolescent; Adult; Aged; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Liver Function Tests; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1978 |
[Controlled trial of 6 to 8 month chemotherapeutic regimens in the treatment of pulmonary tuberculosis. A study of Hong Kong Chest Service/British Medical Research Council/].
Topics: Antitubercular Agents; Clinical Trials as Topic; Drug Therapy, Combination; Ethambutol; Hong Kong; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1978 |
[Short term chemotherapy of tuberculosis. Evaluation of an 18-week-long treatment including pyrazinamide (preliminary results)].
Topics: Antitubercular Agents; Clinical Trials as Topic; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1978 |
A controlled trial of daily and intermittent rifampicin plus ethambutol in the retreatment of patients with pulmonary tuberculosis: results up to 30 months.
Topics: Antibody Formation; Body Weight; Clinical Trials as Topic; Cycloserine; Drug Combinations; Drug Resistance; Ethambutol; Ethionamide; Fever; Follow-Up Studies; Humans; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1975 |
Investigations of allergic status and blood counts in Chinese patients receiving daily or intermittent rifampicin in Hong Kong.
Topics: ABO Blood-Group System; Blood Cell Count; China; Clinical Trials as Topic; Cycloserine; Drug Hypersensitivity; Drug Therapy, Combination; Ethambutol; Ethionamide; Hematocrit; Hemoglobins; Hong Kong; Humans; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1975 |
Six-months versus nine-months chemotherapy for tuberculosis of lymph nodes: preliminary results. British Thoracic Society Research Committee.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Drug Administration Schedule; Ethambutol; Humans; Isoniazid; Middle Aged; Pyrazinamide; Rifampin; Time Factors; Tuberculosis, Lymph Node | 1992 |
USPHS Tuberculosis Short-Course Chemotherapy Trial 21: effectiveness, toxicity, and acceptability. The report of final results.
Topics: Adult; Antitubercular Agents; Centers for Disease Control and Prevention, U.S.; Data Interpretation, Statistical; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Multicenter Studies as Topic; Patient Compliance; Proportional Hazards Models; Pyrazinamide; Randomized Controlled Trials as Topic; Recurrence; Rifampin; Sputum; Survival Rate; Tuberculosis, Pulmonary; United States | 1990 |
Intracranial tuberculomas. An assessment of a therapeutic 4-drug trial in 35 children.
Topics: Adolescent; Antitubercular Agents; Brain Diseases; Child; Child, Preschool; Combined Modality Therapy; Ethambutol; Female; Humans; Infant; Isoniazid; Male; Pyrazinamide; Retrospective Studies; Rifampin; Tomography, X-Ray Computed; Tuberculoma | 1989 |
[Short-term therapy of lung tuberculosis using a fixed combination of isoniazid, rifampicin and pyrazinamide. Results after 2 years].
Topics: Adult; Antitubercular Agents; Drug Combinations; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Multicenter Studies as Topic; Patient Compliance; Prospective Studies; Pyrazinamide; Recurrence; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1989 |
Adrenal function in tuberculosis.
Topics: Acute Disease; Adolescent; Adrenal Glands; Adrenocorticotropic Hormone; Adult; Aged; Child; Child, Preschool; Ethambutol; Female; Humans; Hydrocortisone; Infant; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1986 |
Controlled clinical trial of a regimen of two durations for the treatment of isoniazid resistant pulmonary tuberculosis.
Topics: Adolescent; Adult; Clinical Trials as Topic; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Pyrazinamide; Random Allocation; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1988 |
Comparison of a daily and three intermittent retreatment regimens for pulmonary tuberculosis administered under programme conditions.
Topics: Adolescent; Adult; Antitubercular Agents; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Prothionamide; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1988 |
Short-course tuberculosis chemotherapy studies conducted in Poland during the past decade.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Recurrence; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1986 |
Three chemotherapy studies of tuberculous meningitis in children.
Topics: Antitubercular Agents; Child; Child, Preschool; Drug Therapy, Combination; Ethambutol; Female; Humans; India; Infant; Isoniazid; Male; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Meningeal | 1986 |
[Which is the best drug combination for the short-term therapy of tuberculosis? A prospective randomized study with 190 patients].
Topics: Adult; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Patient Compliance; Prospective Studies; Pyrazinamide; Random Allocation; Rifampin; Tuberculosis, Pulmonary | 1985 |
[Controlled study comparing 3 daily chemotherapy regimens for six months in pulmonary tuberculosis in routine practice in Algiers. Results at 30 months].
Topics: Antitubercular Agents; Clinical Trials as Topic; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1985 |
The combination of ethambutol, capreomycin and a third drug in chronic pulmonary tuberculosis with bacterial polyresistance.
Topics: Administration, Oral; Aminosalicylic Acids; Antitubercular Agents; Capreomycin; Chronic Disease; Clinical Trials as Topic; Cycloserine; Drug Combinations; Ethambutol; Evaluation Studies as Topic; Female; Humans; Middle Aged; Penicillin Resistance; Penicillins; Pyrazinamide; Radiography; Tetracycline; Time Factors; Tuberculosis, Pulmonary | 1970 |
General considerations in intermittent drug therapy of pulmonary tuberculosis.
Topics: Aminosalicylic Acids; Antitubercular Agents; Clinical Trials as Topic; Ethambutol; Ethionamide; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Thioacetazone; Time Factors; Tuberculosis, Pulmonary | 1971 |
Interaction aspects of antimycobacterial drugs in the chemotherapy of tuberculosis. I. Role of individual antituberculous drugs in drug regimens used in the chemotherapy of human tuberculosis.
Topics: Aminosalicylic Acids; Antitubercular Agents; Clinical Trials as Topic; Cycloserine; Drug Evaluation; Drug Therapy, Combination; Ethambutol; Ethionamide; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Thioacetazone; Tuberculosis, Pulmonary | 1974 |
Evaluation of results of chemotherapy in tuberculosis with special consideration of ethambutol.
Topics: Aminosalicylic Acids; Clinical Trials as Topic; Cycloserine; Drug Combinations; Electronic Data Processing; Ethambutol; Ethionamide; Evaluation Studies as Topic; Humans; Isoniazid; Phenylthiourea; Pyrazinamide; Streptomycin; Thiosemicarbazones; Tuberculosis, Pulmonary; Viomycin | 1970 |
Ethambutol in the initial treatment of pulmonary tuberculosis. U.S. Public Health Service tuberculosis therapy trials.
Topics: Adolescent; Adult; Aminosalicylic Acids; Clinical Trials as Topic; Ethambutol; Evaluation Studies as Topic; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Radiography; Sputum; Tuberculosis, Pulmonary; Visual Acuity | 1973 |
A Hong Kong Tuberculosis Treatment Services/Brompton Hospital/British Medical Research Council Investigation.
Topics: Adult; Antitubercular Agents; Clinical Trials as Topic; Cycloserine; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Ethionamide; Female; Hong Kong; Humans; Male; Microbial Sensitivity Tests; Pyrazinamide; Radiography; Rifampin; Sputum; Tuberculosis, Pulmonary | 1974 |
A controlled clinical trial of small daily doses of rifampicin in the prevention of adverse reactions to the drug in a once-weekly regimen of chemotherapy in Hong Kong: second report:-the results at 12 months.
Topics: Adolescent; Adult; Clinical Trials as Topic; Drug Administration Schedule; Drug Hypersensitivity; Drug Therapy, Combination; Ethambutol; Female; Hong Kong; Humans; Male; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1974 |
A controlled clinical trial of small daily doses of rifampicin in the prevention of adverse reactions to the drug in a once-weekly regimen of chemotherapy. A Hong Kong Tuberculosis Treatment Services-British Medical Research Council Investigation.
Topics: Adult; Alanine Transaminase; Antibodies; Ethambutol; Female; Fever; Humans; Jaundice; Male; Middle Aged; Nausea; Pain; Placebos; Pyrazinamide; Respiratory Tract Diseases; Rifampin; Skin Manifestations; Tuberculosis, Pulmonary | 1974 |
[Short-term chemotherapy of tuberculosis. Cooperative French trial].
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Clinical Trials as Topic; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1983 |
Controlled clinical trial comparing a 6-month and a 12-month regimen in the treatment of pulmonary tuberculosis in the Algerian Sahara. Algerian working group/British Medical Research Council cooperative study.
Topics: Adolescent; Adult; Algeria; Antitubercular Agents; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Hospitalization; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Rural Population; Streptomycin; Tuberculosis, Pulmonary | 1984 |
A controlled trial of 6 months' chemotherapy in pulmonary tuberculosis. Final report: results during the 36 months after the end of chemotherapy and beyond. British Thoracic Society.
Topics: Antitubercular Agents; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Follow-Up Studies; Humans; Isoniazid; Pyrazinamide; Recurrence; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1984 |
[A comparison of PZA and EB in short course chemotherapy. Report of the 22nd series of controlled trial of chemotherapy].
Topics: Adult; Aged; Clinical Trials as Topic; Drug Therapy, Combination; Ethambutol; Humans; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Tuberculosis, Pulmonary | 1984 |
[Pyrazinamide versus ethambutol in short-term therapy of lung tuberculosis. A randomized study].
Topics: Adult; Aged; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Middle Aged; Pyrazinamide; Random Allocation; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1983 |
A controlled trial of six months chemotherapy in pulmonary tuberculosis. Second report: results during the 24 months after the end of chemotherapy. British Thoracic Association.
Topics: Antitubercular Agents; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Follow-Up Studies; Humans; Isoniazid; Pyrazinamide; Recurrence; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1982 |
[Short-term chemotherapy of pulmonary tuberculosis. Bacteriologic results].
Topics: Adolescent; Adult; Clinical Trials as Topic; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Sputum; Time Factors; Tuberculosis, Pulmonary | 1980 |
[Controlled trial of isoniazid.rifampicin.ethambutol regimen and isoniazid.rifampicin.pyrazinamide regimen in the primary chemotherapy for pulmonary tuberculosis (author's transl)].
Topics: Adult; Antitubercular Agents; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1980 |
Side-effects of drug regimens used in short-course chemotherapy for pulmonary tuberculosis. A controlled clinical study.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Middle Aged; Pyrazinamide; Random Allocation; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1980 |
A controlled trial of six months chemotherapy in pulmonary tuberculosis. First Report: results during chemotherapy. British Thoracic Association.
Topics: Adolescent; Adult; Clinical Trials as Topic; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1981 |
BTA short-course chemotherapy studies.
Topics: Clinical Trials as Topic; Ethambutol; Female; Hepatitis; Humans; Isoniazid; Liver Function Tests; Male; Pyrazinamide; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary; United Kingdom | 1981 |
Chemotherapy for tuberculosis today.
Topics: Antitubercular Agents; Clinical Trials as Topic; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1982 |
[Contemporary methods in the diagnosis and treatment of intrathoracic tuberculosis in children].
Topics: Administration, Oral; Child; Child, Preschool; Drug Therapy, Combination; Ethambutol; Follow-Up Studies; Humans; Injections, Intramuscular; Isoniazid; Pyrazinamide; Rifampin; Time Factors; Treatment Outcome; Tuberculosis, Pulmonary | 1994 |
Evaluation of the 3-drug combination, Rifater, versus 4-drug therapy in the ambulatory treatment of tuberculosis in Cape Town.
Topics: Antitubercular Agents; Drug Combinations; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Patient Compliance; Prospective Studies; Pyrazinamide; Rifampin; Sputum; Streptomycin; Tuberculosis | 1994 |
[Six-month short course chemotherapy containing pyrazinamide for initial treatment of pulmonary tuberculosis].
Topics: Adolescent; Adult; Aged; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1994 |
A prospective evaluation of antituberculosis therapy in patients with human immunodeficiency virus infection.
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; HIV-1; Humans; Isoniazid; Los Angeles; Male; Mycobacterium tuberculosis; Patient Compliance; Prospective Studies; Pyrazinamide; Remission Induction; Rifampin; Time Factors; Treatment Outcome; Tuberculosis, Pulmonary | 1994 |
Early bactericidal and sterilizing activities of ciprofloxacin in pulmonary tuberculosis.
Topics: Adult; Aged; Ciprofloxacin; Drug Therapy, Combination; Ethambutol; Female; HIV Seropositivity; HIV-1; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Prospective Studies; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1993 |
Six months versus nine months chemotherapy for tuberculosis of lymph nodes: final results.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Follow-Up Studies; Humans; Isoniazid; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis, Lymph Node | 1993 |
[Combined chemotherapy of patients with tuberculosis - new regimens and dosage forms].
Topics: Antitubercular Agents; Dosage Forms; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1993 |
Randomized controlled trial of a drug regimen that includes ciprofloxacin for the treatment of pulmonary tuberculosis.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antitubercular Agents; Ciprofloxacin; Ethambutol; Female; HIV-1; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1996 |
Susceptibility to levofloxacin of Myocobacterium tuberculosis isolates from patients with HIV-related tuberculosis and characterization of a strain with levofloxacin monoresistance. Community Programs for Clinical Research on AIDS 019 and the AIDS Clinica
Topics: AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Humans; In Vitro Techniques; Isoniazid; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Pyrazinamide; Rifampin; Sputum; Tuberculosis | 1997 |
Randomised controlled clinical trial of short course chemotherapy in abdominal tuberculosis: a five-year report.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Child; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Prognosis; Pyrazinamide; Rifampin; Streptomycin; Time Factors; Tuberculosis, Gastrointestinal | 1997 |
A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antitubercular Agents; Child; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Recurrence; Rifampin; Sputum; Tuberculosis, Pulmonary | 1997 |
Prospective study of corticosteroid as an adjunct in the treatment of endobronchial tuberculosis in adults.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Bronchoscopy; Chi-Square Distribution; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Glucocorticoids; Humans; Isoniazid; Lung; Male; Middle Aged; Prednisolone; Prospective Studies; Pyrazinamide; Radiography; Respiratory Function Tests; Rifampin; Streptomycin; Treatment Outcome; Tuberculosis, Pulmonary | 1997 |
Evaluation of an intensive intermittent-induction regimen and duration of short-course treatment for human immunodeficiency virus-related pulmonary tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) and the AIDS Clinical Tr
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Levofloxacin; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Pyrazinamide; Recurrence; Rifampin; Sputum; Treatment Outcome; Tuberculosis, Pulmonary | 1998 |
[Lomefloxacin in complex treatment of acute progressive form of pulmonary tuberculosis].
Topics: Acute Disease; Adolescent; Adult; Animals; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Colony Count, Microbial; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Ethambutol; Fluoroquinolones; Humans; Isoniazid; Mice; Middle Aged; Pyrazinamide; Quinolones; Streptomycin; Treatment Outcome; Tuberculosis, Pulmonary | 1998 |
[Long-term efficacy of full course intermittent short-course chemotherapy on new smear positive tuberculosis patients].
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Follow-Up Studies; Humans; Isoniazid; Pyrazinamide; Recurrence; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1997 |
Modified short-course chemotherapy of pulmonary tuberculosis in Ibadan, Nigeria--a preliminary report.
Topics: Adolescent; Adult; Antitubercular Agents; Developing Countries; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Male; Middle Aged; Nigeria; Pyrazinamide; Rifampin; Sputum; Streptomycin; Thioacetazone; Time Factors; Treatment Outcome; Tuberculosis, Pulmonary; Urban Health; World Health Organization | 2000 |
The potential use of urinary excretion data for assessing the relative bioavailability of rifampicin in fixed dose combination anti-tuberculosis formulations.
Topics: Antibiotics, Antitubercular; Area Under Curve; Biological Availability; Chromatography, High Pressure Liquid; Colorimetry; Cross-Over Studies; Drug Combinations; Ethambutol; Humans; Isoniazid; Male; Pyrazinamide; Quality Control; Reference Values; Rifampin; Therapeutic Equivalency; Tuberculosis; Urinalysis | 2001 |
Reintroducing antituberculosis therapy after Stevens-Johnson syndrome in human immunodeficiency virus-infected patients with tuberculosis: role of desensitization.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Desensitization, Immunologic; Dose-Response Relationship, Drug; Ethambutol; Female; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Stevens-Johnson Syndrome; Treatment Outcome; Tuberculosis | 2001 |
Side-effects of drugs used in directly observed treatment short-course in newly diagnosed pulmonary tuberculosis subjects in Nigerians: a controlled clinical study.
Topics: Adolescent; Adult; Antitubercular Agents; Clinical Protocols; Directly Observed Therapy; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Nigeria; Pyrazinamide; Rifampin; Time Factors; Tuberculosis, Pulmonary | 2002 |
Bioequivalence assessment of rifampicin, isoniazid and pyrazinamide in a fixed dose combination of rifampicin, isoniazid, pyrazinamide and ethambutol vs. separate formulations.
Topics: Analysis of Variance; Antibiotics, Antitubercular; Cross-Over Studies; Drug Combinations; Ethambutol; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Therapeutic Equivalency; Time Factors; Tuberculosis | 2002 |
Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Antitubercular Agents; Drug Administration Schedule; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Outcome Assessment, Health Care; Prospective Studies; Pyrazinamide; Rifampin; Streptomycin; Time Factors; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2002 |
Comparative evaluation of efficacy and safety profile of three anti-tuberculous regimens in Mangalore.
Topics: Adult; Antitubercular Agents; Dizziness; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Gastritis; Humans; Hypesthesia; Isoniazid; Male; Nausea; Pyrazinamide; Rifampin; Streptomycin; Treatment Outcome; Tuberculosis, Pulmonary | 2002 |
The clearance of theophylline is increased during the initial period of tuberculosis treatment.
Topics: Adult; Aged; Antitubercular Agents; Bronchodilator Agents; Drug Interactions; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Prospective Studies; Pyrazinamide; Rifampin; Theophylline; Time Factors; Tuberculosis, Pulmonary | 2003 |
Evaluation of bioequivalence of isoniazid and pyrazinamide in three and four drugs fixed dose combinations using WHO simplified protocol.
Topics: Administration, Oral; Adult; Analysis of Variance; Antitubercular Agents; Area Under Curve; Chemistry, Pharmaceutical; Clinical Protocols; Cross-Over Studies; Dosage Forms; Drug Administration Schedule; Drug Combinations; Drug Evaluation; Ethambutol; Half-Life; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Therapeutic Equivalency; World Health Organization | 2003 |
[Assessment of the use of a multicomponent drug in the treatment of new cases of pulmonary tuberculosis].
Topics: Adolescent; Adult; Drug Combinations; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Radiography; Rifampin; Sputum; Time Factors; Tuberculosis, Pulmonary | 2003 |
Split-drug regimens for the treatment of patients with sputum smear-positive pulmonary tuberculosis--a unique approach.
Topics: Adult; Antitubercular Agents; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Risk Factors; Survival Analysis; Treatment Outcome; Tuberculosis, Pulmonary | 2004 |
The short-term effects of anti-tuberculosis therapy on plasma pyridoxine levels in patients with pulmonary tuberculosis.
Topics: Adult; Antitubercular Agents; Ethambutol; Female; Follow-Up Studies; HIV Infections; Humans; Isoniazid; Male; Pyrazinamide; Pyridoxine; Rifampin; Time Factors; Tuberculosis, Pulmonary | 2004 |
Adjuvant interferon gamma in patients with drug - resistant pulmonary tuberculosis: a pilot study.
Topics: Adjuvants, Immunologic; Adult; Amikacin; Antitubercular Agents; Ciprofloxacin; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Ethionamide; Female; Follow-Up Studies; Humans; Interferon-gamma; Kanamycin; Male; Middle Aged; Mycobacterium tuberculosis; Pilot Projects; Pyrazinamide; Radiography; Recombinant Proteins; Rifampin; Sputum; Treatment Outcome; Tuberculosis, Pulmonary | 2004 |
Decreased bioavailability of rifampin and other antituberculosis drugs in patients with advanced human immunodeficiency virus disease.
Topics: Acetylation; Adult; Antibiotics, Antitubercular; Antitubercular Agents; Biological Availability; Ethambutol; Feces; Female; HIV Infections; Humans; Intestinal Absorption; Isoniazid; Male; Middle Aged; Phenotype; Pyrazinamide; Rifampin; Tuberculosis | 2004 |
Evaluation of modified short course chemotherapy in active pulmonary tuberculosis patients with human immunodeficiency virus infection in University College Hospital, Ibadan, Nigeria--a preliminary report.
Topics: Acne Vulgaris; Adolescent; Adult; Age Distribution; Aged; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Male; Middle Aged; Nigeria; Pyrazinamide; Radiography; Rifampin; Tuberculosis, Pulmonary | 2004 |
Evaluation of a non-rifampicin continuation phase (6HE) following thrice-weekly intensive phase for the treatment of new sputum positive pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Sputum; Treatment Outcome; Tuberculosis, Pulmonary | 2007 |
Low serum concentrations of anti-tuberculosis drugs and determinants of their serum levels.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Chromatography, Liquid; Drug Monitoring; Ethambutol; Female; Humans; Isoniazid; Linear Models; Male; Mass Spectrometry; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis | 2007 |
Nutritional status of persons with HIV infection, persons with HIV infection and tuberculosis, and HIV-negative individuals from southern India.
Topics: Adult; AIDS-Related Opportunistic Infections; Anemia; Antitubercular Agents; Body Composition; Drug Therapy, Combination; Ethambutol; HIV Infections; HIV Seronegativity; Humans; Hypoalbuminemia; India; Isoniazid; Malnutrition; Nutritional Status; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary | 2008 |
Clinical evaluation and monitoring of adverse effects for fixed multidose combination against single drug therapy in pulmonary tuberculosis patients.
Topics: Adolescent; Adult; Antitubercular Agents; Dose-Response Relationship, Drug; Drug Monitoring; Drug Therapy, Combination; Educational Status; Employment; Ethambutol; Humans; Isoniazid; Middle Aged; Pakistan; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 2008 |
[Relapse rate of pulmonary tuberculosis within two years following completion of twice weekly intermittent chemotherapy].
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Directly Observed Therapy; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Recurrence; Rifampin; Self Administration; Tuberculosis, Pulmonary | 2008 |
Prevention of hepatotoxicity due to anti tuberculosis treatment: a novel integrative approach.
Topics: Adult; Antitubercular Agents; Blood Sedimentation; Body Weight; Chemical and Drug Induced Liver Injury; Curcuma; Drug Therapy, Combination; Ethambutol; Female; Hemoglobins; Humans; Isoniazid; Liver Diseases; Male; Middle Aged; Patient Compliance; Plant Preparations; Pyrazinamide; Rifampin; Tinospora; Treatment Outcome; Tuberculosis | 2008 |
Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial.
Topics: Adult; Antitubercular Agents; Aza Compounds; Brazil; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Fluoroquinolones; Humans; Isoniazid; Kaplan-Meier Estimate; Logistic Models; Male; Moxifloxacin; Multivariate Analysis; Pyrazinamide; Quinolines; Rifampin; Sputum; Time Factors; Treatment Outcome; Tuberculosis, Pulmonary | 2009 |
Comparison of a four-drug fixed-dose combination regimen with a single tablet regimen in smear-positive pulmonary tuberculosis.
Topics: Adult; Antitubercular Agents; Drug Combinations; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Patient Satisfaction; Pyrazinamide; Rifampin; Sputum; Treatment Outcome; Tuberculosis, Pulmonary | 2009 |
Shortening treatment in adults with noncavitary tuberculosis and 2-month culture conversion.
Topics: Adult; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Kaplan-Meier Estimate; Male; Mycobacterium tuberculosis; Proportional Hazards Models; Pyrazinamide; Rifampin; Sputum; Treatment Outcome; Tuberculosis, Pulmonary | 2009 |
Prospective randomized trial of six-month versus nine-month therapy for intestinal tuberculosis.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Gastrointestinal; Young Adult | 2009 |
Efficacy of a 6-month versus 9-month intermittent treatment regimen in HIV-infected patients with tuberculosis: a randomized clinical trial.
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; CD4 Lymphocyte Count; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Kaplan-Meier Estimate; Logistic Models; Male; Medication Adherence; Pyrazinamide; Rifampin; Tuberculosis; Viral Load | 2010 |
Patient-centred tuberculosis treatment delivery under programmatic conditions in Tanzania: a cohort study.
Topics: Adult; Antitubercular Agents; Cohort Studies; Directly Observed Therapy; Ethambutol; Humans; Isoniazid; Middle Aged; Pyrazinamide; Rifampin; Tanzania; Treatment Outcome; Tuberculosis; Young Adult | 2009 |
Tuberculosis treatment in HIV infected Ugandans with CD4 counts>350 cells/mm reduces immune activation with no effect on HIV load or CD4 count.
Topics: Adult; Antitubercular Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cohort Studies; Ethambutol; Female; Flow Cytometry; HIV Infections; HIV-1; Humans; Isoniazid; Male; Middle Aged; Prospective Studies; Pyrazinamide; Rifampin; Tuberculosis; Uganda; Viral Load; Young Adult | 2010 |
Protective effect of N-acetylcysteine on antituberculosis drug-induced hepatotoxicity.
Topics: Acetylcysteine; Aged; Aged, 80 and over; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Drug Interactions; Drug Therapy, Combination; Ethambutol; Female; Free Radical Scavengers; Humans; Isoniazid; Liver; Male; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 2010 |
Assessment of protective role of polyherbal preparation, Livina, against anti-tubercular drug induced liver dysfunction.
Topics: Adolescent; Adult; Alanine Transaminase; Antitubercular Agents; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Drug Combinations; Ethambutol; Follow-Up Studies; Humans; Liver Diseases; Liver Function Tests; Middle Aged; Phytotherapy; Plant Preparations; Plants, Medicinal; Prospective Studies; Pyrazinamide; Rifampin; Single-Blind Method; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult | 2010 |
Genital tuberculosis among infertile women and fertility outcome after antitubercular therapy.
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Fertilization; Humans; Infertility, Female; Isoniazid; Laparoscopy; Polymerase Chain Reaction; Pregnancy; Prospective Studies; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Female Genital | 2011 |
Efficacy and safety of a 4-drug fixed-dose combination regimen compared with separate drugs for treatment of pulmonary tuberculosis: the Study C randomized controlled trial.
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult | 2011 |
Randomized pharmacokinetic and pharmacodynamic comparison of fluoroquinolones for tuberculous meningitis.
Topics: Administration, Oral; Adolescent; Adult; Aged; Ciprofloxacin; Ethambutol; Female; Fluoroquinolones; Gatifloxacin; Humans; Injections, Intramuscular; Isoniazid; Levofloxacin; Male; Middle Aged; Multivariate Analysis; Ofloxacin; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Meningeal; Young Adult | 2011 |
Results at 30 months of a randomised trial of two 8-month regimens for the treatment of tuberculosis.
Topics: Adolescent; Adult; Aged; Antibiotics, Antitubercular; Antitubercular Agents; Drug Combinations; Drug Therapy, Combination; Ethambutol; Female; Humans; Intention to Treat Analysis; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Sputum; Treatment Failure; Tuberculosis, Pulmonary; World Health Organization; Young Adult | 2011 |
Outcome of standardized treatment for patients with MDR-TB from Tamil Nadu, India.
Topics: Adult; Antibiotics, Antitubercular; Communicable Disease Control; Cycloserine; Directly Observed Therapy; Drug-Related Side Effects and Adverse Reactions; Ethambutol; Ethionamide; Female; Humans; India; Kanamycin; Male; Middle Aged; Ofloxacin; Prospective Studies; Pyrazinamide; Sputum; Time Factors; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2011 |
Phase II dose-ranging trial of the early bactericidal activity of PA-824.
Topics: Adolescent; Adult; Antitubercular Agents; Drug Administration Schedule; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Nitroimidazoles; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary; Young Adult | 2012 |
Efavirenz, tenofovir and emtricitabine combined with first-line tuberculosis treatment in tuberculosis-HIV-coinfected Tanzanian patients: a pharmacokinetic and safety study.
Topics: Adenine; Adult; Alkynes; Anti-HIV Agents; Antitubercular Agents; Benzoxazines; Cyclopropanes; Deoxycytidine; Drug Combinations; Drug Therapy, Combination; Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Male; Organophosphonates; Oxazines; Pyrazinamide; Reverse Transcriptase Inhibitors; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary | 2013 |
A time-to-event pharmacodynamic model describing treatment response in patients with pulmonary tuberculosis using days to positivity in automated liquid mycobacterial culture.
Topics: Antimalarials; Bacterial Load; Bacteriological Techniques; Diagnostic Techniques, Respiratory System; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Sputum; Treatment Outcome; Tuberculosis, Pulmonary | 2013 |
Oral bioavailability of rifampicin, isoniazid, ethambutol, and pyrazinamide in a 4-drug fixed-dose combination compared with the separate formulations in healthy Chinese male volunteers.
Topics: Adult; Antitubercular Agents; Area Under Curve; China; Chromatography, High Pressure Liquid; Cross-Over Studies; Drug Combinations; Ethambutol; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Tandem Mass Spectrometry; Therapeutic Equivalency | 2013 |
Impact of tuberculosis treatment on CD4 cell count, HIV RNA, and p24 antigen in patients with HIV and tuberculosis.
Topics: Adult; Antitubercular Agents; Biomarkers; CD4 Lymphocyte Count; Coinfection; Dietary Supplements; Drug Therapy, Combination; Ethambutol; Female; Guinea-Bissau; HIV Core Protein p24; HIV Infections; HIV-1; HIV-2; Humans; Isoniazid; Kaplan-Meier Estimate; Male; Middle Aged; Pyrazinamide; Rifampin; RNA, Viral; Tuberculosis, Pulmonary; Vitamin D; Young Adult | 2013 |
Bioequivalence of fixed-dose combination Myrin®-P Forte and reference drugs in loose combination.
Topics: Adult; Antitubercular Agents; Area Under Curve; Cross-Over Studies; Drug Combinations; Drug Therapy, Combination; Ethambutol; Fasting; Female; Healthy Volunteers; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Singapore; Therapeutic Equivalency; Young Adult | 2013 |
The pharmacokinetics of a single oral or rectal dose of concurrently administered isoniazid, rifampin, pyrazinamide, and ethambutol in Asian elephants (Elephas maximus).
Topics: Administration, Oral; Administration, Rectal; Animals; Antitubercular Agents; Area Under Curve; Cross-Over Studies; Drug Combinations; Elephants; Ethambutol; Female; Isoniazid; Male; Pyrazinamide; Rifampin | 2014 |
Safety and efficacy of levofloxacin versus rifampicin in tuberculous meningitis: an open-label randomized controlled trial.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Aspirin; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Levofloxacin; Male; Middle Aged; Prednisolone; Pyrazinamide; Radiography; Rifampin; Treatment Outcome; Tuberculosis, Meningeal; Young Adult | 2014 |
Intermittent tuberculosis treatment for patients with isoniazid intolerance or drug resistance.
Topics: Adult; Ambulatory Care Facilities; Antitubercular Agents; Canada; Directly Observed Therapy; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Prospective Studies; Pyrazinamide; Rifampin; Time Factors; Treatment Outcome; Tuberculosis; United States | 2014 |
Four-month moxifloxacin-based regimens for drug-sensitive tuberculosis.
Topics: Adult; Antitubercular Agents; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Fluoroquinolones; HIV Seropositivity; Humans; Isoniazid; Kaplan-Meier Estimate; Male; Moxifloxacin; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary; Young Adult | 2014 |
Evaluation of a standardized treatment regimen of anti-tuberculosis drugs for patients with multi-drug-resistant tuberculosis (STREAM): study protocol for a randomized controlled trial.
Topics: Antitubercular Agents; Bangladesh; Clinical Protocols; Clofazimine; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Fluoroquinolones; Humans; Isoniazid; Kanamycin; Moxifloxacin; Prothionamide; Pyrazinamide; Research Design; Time Factors; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2014 |
Results at 30 months of a randomised trial of FDCs and separate drugs for the treatment of tuberculosis.
Topics: Africa; Antitubercular Agents; Asia; Dose-Response Relationship, Drug; Drug Combinations; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Latin America; Male; Pyrazinamide; Recurrence; Rifampin; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2014 |
Impact of nonlinear interactions of pharmacokinetics and MICs on sputum bacillary kill rates as a marker of sterilizing effect in tuberculosis.
Topics: Adolescent; Adult; Antitubercular Agents; Area Under Curve; Disinfection; Drug Antagonism; Drug Synergism; Drug Therapy, Combination; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Sputum; Sterilization; Treatment Outcome; Tuberculosis; Young Adult | 2015 |
Effect of micronutrient supplementation on treatment outcomes in children with intrathoracic tuberculosis: a randomized controlled trial.
Topics: Adolescent; Antitubercular Agents; Body Height; Body Mass Index; Body Weight; Child; Child, Preschool; Dietary Supplements; Double-Blind Method; Ethambutol; Female; Humans; India; Infant; Isoniazid; Male; Micronutrients; Patient Compliance; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis; Zinc | 2014 |
A four-month gatifloxacin-containing regimen for treating tuberculosis.
Topics: Adult; Antitubercular Agents; Blood Glucose; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Fluoroquinolones; Gatifloxacin; Humans; Intention to Treat Analysis; Isoniazid; Male; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 2014 |
High-dose rifapentine with moxifloxacin for pulmonary tuberculosis.
Topics: Adolescent; Adult; Antitubercular Agents; Coinfection; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Fluoroquinolones; HIV Seropositivity; Humans; Isoniazid; Kaplan-Meier Estimate; Male; Middle Aged; Moxifloxacin; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary; Young Adult | 2014 |
A dose-ranging trial to optimize the dose of rifampin in the treatment of tuberculosis.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Bacterial Load; Drug Dosage Calculations; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary; Young Adult | 2015 |
A randomized trial comparing standard outcomes in two treatment models for substance users with tuberculosis.
Topics: Adult; Antitubercular Agents; Directly Observed Therapy; Drug Users; Ethambutol; Ethnicity; Female; Humans; Isoniazid; Male; Patient Compliance; Pyrazinamide; Rifampin; Socioeconomic Factors; Substance-Related Disorders; Treatment Outcome; Tuberculosis | 2015 |
Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pul
Topics: Adolescent; Adult; Antitubercular Agents; Colony Count, Microbial; Drug Therapy, Combination; Ethambutol; Female; Fluoroquinolones; Humans; Isoniazid; Male; Moxifloxacin; Nitroimidazoles; Pyrazinamide; Rifampin; South Africa; Sputum; Tanzania; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2015 |
Two-stage activity-safety study of daily rifapentine during intensive phase treatment of pulmonary tuberculosis.
Topics: Adult; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; South Africa; Sputum; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult | 2015 |
Effects on type 2 diabetes complicated with pulmonary tuberculosis: regiment of insulin, isoniazid, rifampicin, pyrazinamide and ethambutol versus the regiment plus Qi-boosting and Yin-nourishing decoction of Traditional Chinese Medicine.
Topics: Adult; Aged; Antitubercular Agents; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Drugs, Chinese Herbal; Ethambutol; Female; Humans; Hypoglycemic Agents; Insulin; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 2015 |
Pharmacokinetics of Antituberculosis Drugs in HIV-Positive and HIV-Negative Adults in Malawi.
Topics: Adolescent; Adult; Antitubercular Agents; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Malawi; Male; Middle Aged; Pyrazinamide; Rifampin; Young Adult | 2015 |
Effect of SLCO1B1 Polymorphisms on Rifabutin Pharmacokinetics in African HIV-Infected Patients with Tuberculosis.
Topics: Adult; Antitubercular Agents; Area Under Curve; CD4 Lymphocyte Count; Coinfection; Ethambutol; Female; Gene Expression; HIV Infections; Humans; Isoniazid; Liver-Specific Organic Anion Transporter 1; Male; Monte Carlo Method; Organic Anion Transporters; Polymorphism, Single Nucleotide; Pyrazinamide; Rifabutin; Rifampin; Sex Factors; Tuberculosis, Pulmonary | 2016 |
Pharmacokinetics of Isoniazid, Pyrazinamide, and Ethambutol in Newly Diagnosed Pulmonary TB Patients in Tanzania.
Topics: Adult; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Male; Pyrazinamide; Tanzania; Tuberculosis, Pulmonary | 2015 |
Pharmacokinetics of Rifampin, Isoniazid, Pyrazinamide, and Ethambutol in Infants Dosed According to Revised WHO-Recommended Treatment Guidelines.
Topics: Anti-Bacterial Agents; Area Under Curve; Coinfection; Drug Dosage Calculations; Ethambutol; Female; HIV; HIV Infections; Humans; Infant; Infant, Newborn; Isoniazid; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Practice Guidelines as Topic; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 2016 |
Tackling the unknowns of short-course rifapentine-based treatment for active tuberculosis: a decision analysis.
Topics: Antitubercular Agents; Decision Support Techniques; Ethambutol; Humans; Isoniazid; Markov Chains; Pyrazinamide; Recurrence; Rifampin; Treatment Outcome; Tuberculosis | 2016 |
A randomised Phase II trial to evaluate the toxicity of high-dose rifampicin to treat pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Dose-Response Relationship, Drug; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Patient Compliance; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult | 2016 |
Safety and efficacy of additional levofloxacin in tuberculous meningitis: A randomized controlled pilot study.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Disability Evaluation; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Levofloxacin; Male; Middle Aged; Pilot Projects; Proportional Hazards Models; Pyrazinamide; Rifampin; Seizures; Time Factors; Treatment Outcome; Tuberculosis, Meningeal; Young Adult | 2016 |
Efficacy and Safety of 'Fixed Dose' versus 'Loose' Drug Regimens for Treatment of Pulmonary Tuberculosis in Two High TB-Burden African Countries: A Randomized Controlled Trial.
Topics: Adult; Africa; Aged; Antitubercular Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Sputum; Treatment Outcome; Tuberculosis, Pulmonary | 2016 |
Delamanid Coadministered with Antiretroviral Drugs or Antituberculosis Drugs Shows No Clinically Relevant Drug-Drug Interactions in Healthy Subjects.
Topics: Adult; Alkynes; Anti-HIV Agents; Antitubercular Agents; Benzoxazines; Cyclopropanes; Drug Combinations; Drug Interactions; Ethambutol; Female; Healthy Volunteers; Humans; Isoniazid; Male; Nitroimidazoles; Oxazoles; Pyrazinamide; Rifampin | 2016 |
High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial.
Topics: Adamantane; Adult; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Ethylenediamines; Female; Fluoroquinolones; Humans; Isoniazid; Male; Moxifloxacin; Pyrazinamide; Rifampin; South Africa; Tanzania; Tuberculosis, Pulmonary | 2017 |
Pharmacokinetics, Tolerability, and Bacteriological Response of Rifampin Administered at 600, 900, and 1,200 Milligrams Daily in Patients with Pulmonary Tuberculosis.
Topics: Adult; Antibiotics, Antitubercular; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary | 2017 |
Association of UGT2B7 polymorphisms with risk of induced liver injury by anti-tuberculosis drugs in Chinese Han.
Topics: Adult; Antitubercular Agents; Asian People; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Ethambutol; Female; Genetic Predisposition to Disease; Glucuronosyltransferase; Humans; Isoniazid; Male; Middle Aged; Polymorphism, Single Nucleotide; Pyrazinamide; Rifampin; Risk; Tuberculosis, Pulmonary; Young Adult | 2017 |
Biomarkers of Tuberculosis Severity and Treatment Effect: A Directed Screen of 70 Host Markers in a Randomized Clinical Trial.
Topics: Adult; Aged; Antitubercular Agents; Biomarkers; Drug Combinations; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Severity of Illness Index; Treatment Outcome; Tuberculosis, Pulmonary | 2017 |
Substitution of ethambutol with linezolid during the intensive phase of treatment of pulmonary tuberculosis: a prospective, multicentre, randomised, open-label, phase 2 trial.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Drug Substitution; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Linezolid; Male; Middle Aged; Prospective Studies; Pyrazinamide; Rifampin; Sputum; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2019 |
Treatment outcomes for isoniazid-monoresistant tuberculosis in Peru, 2012-2014.
Topics: Adolescent; Adult; Child; Child, Preschool; Cross-Sectional Studies; Drug Therapy, Combination; Ethambutol; Female; Humans; Infant; Infant, Newborn; Isoniazid; Levofloxacin; Male; Middle Aged; Peru; Pyrazinamide; Retrospective Studies; Rifampin; Sex Factors; Time Factors; Tuberculosis, Multidrug-Resistant | 2018 |
Efficacy and safety of cholecalciferol-augmented anti-tuberculosis therapy for treatment of naïve patients with pulmonary tuberculosis: A randomized, controlled, clinical study.
Topics: Adult; Antitubercular Agents; Cholecalciferol; Drug Therapy, Combination; Egypt; Ethambutol; Female; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Treatment Failure; Treatment Outcome; Tuberculosis, Pulmonary; Vitamins; Young Adult | 2019 |
Evaluation of metformin in combination with rifampicin containing antituberculosis therapy in patients with new, smear-positive pulmonary tuberculosis (METRIF): study protocol for a randomised clinical trial.
Topics: Adult; Antibiotics, Antitubercular; Drug Combinations; Drug Therapy, Combination; Ethambutol; Humans; India; Isoniazid; Metformin; Multicenter Studies as Topic; Mycobacterium tuberculosis; Pyrazinamide; Randomized Controlled Trials as Topic; Rifampin; Tuberculosis, Pulmonary | 2019 |
Safety of pyrazinamide-including regimen in late elderly patients with pulmonary tuberculosis: A prospective randomized open-label study.
Topics: Age Factors; Aged, 80 and over; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Ethambutol; Female; Humans; Incidence; Isoniazid; Male; Mycobacterium tuberculosis; Prospective Studies; Pyrazinamide; Rifampin; Time Factors; Treatment Outcome; Tuberculosis, Pulmonary | 2019 |
Toxicity related to standard TB therapy for pulmonary tuberculosis and treatment outcomes in the REMoxTB study according to HIV status.
Topics: Adult; Antitubercular Agents; Ethambutol; Female; HIV Seropositivity; Humans; Incidence; Isoniazid; Linear Models; Male; Multivariate Analysis; Prospective Studies; Pyrazinamide; Rifampin; Risk Factors; Treatment Outcome; Tuberculosis, Pulmonary; United Kingdom | 2019 |
Fourteen-Day Bactericidal Activity, Safety, and Pharmacokinetics of Linezolid in Adults with Drug-Sensitive Pulmonary Tuberculosis.
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Linezolid; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; South Africa; Sputum; Tuberculosis, Pulmonary | 2020 |
Telacebec (Q203), a New Antituberculosis Agent.
Topics: Administration, Oral; Antitubercular Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ethambutol; Humans; Imidazoles; Isoniazid; Mycobacterium tuberculosis; Piperidines; Pyrazinamide; Pyridines; Rifampin; Tuberculosis, Pulmonary | 2020 |
Electronic pillbox-enabled self-administered therapy versus standard directly observed therapy for tuberculosis medication adherence and treatment outcomes in Ethiopia (SELFTB): protocol for a multicenter randomized controlled trial.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Cost-Benefit Analysis; Directly Observed Therapy; Electrical Equipment and Supplies; Equivalence Trials as Topic; Ethambutol; Ethiopia; Female; Follow-Up Studies; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Multicenter Studies as Topic; Mycobacterium tuberculosis; Patient Acceptance of Health Care; Prospective Studies; Pyrazinamide; Randomized Controlled Trials as Topic; Rifampin; Self Administration; Sputum; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult | 2020 |
Assessing whether isoniazid is essential during the first 14 days of tuberculosis therapy: a phase 2a, open-label, randomised controlled trial.
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Moxifloxacin; Pyrazinamide; Rifampin; Tuberculosis | 2020 |
Treatment Strategy for Rifampin-Susceptible Tuberculosis.
Topics: Antitubercular Agents; Diarylquinolines; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Linezolid; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2023 |
755 other study(ies) available for pyrazinamide and ethambutol
| Article | Year |
|---|---|
A new class of antituberculosis agents.
Topics: Amides; Antitubercular Agents; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Structure-Activity Relationship; Sulfones | 2000 |
OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice.
Topics: Animals; Antitubercular Agents; Blood; Cell Line; Humans; In Vitro Techniques; Intracellular Membranes; Macrophages; Mammals; Mice; Microbial Sensitivity Tests; Microsomes, Liver; Mycobacterium; Mycobacterium bovis; Mycolic Acids; Nitroimidazoles; Oxazoles; Treatment Outcome; Tuberculosis | 2006 |
Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Antitubercular Agents; DNA, Bacterial; Drug Evaluation, Preclinical; Mycobacterium tuberculosis; Oxygen | 2007 |
Inhibition of isolated Mycobacterium tuberculosis fatty acid synthase I by pyrazinamide analogs.
Topics: Bacterial Proteins; Cell-Free System; Fatty Acid Synthases; Humans; Inhibitory Concentration 50; Kinetics; Mass Spectrometry; Molecular Structure; Mycobacterium tuberculosis; NADP; Oxidation-Reduction; Pyrazinamide; Reproducibility of Results; Substrate Specificity | 2007 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Susceptibility of Mycobacterium bovis BCG vaccine strains to antituberculous antibiotics.
Topics: Antitubercular Agents; BCG Vaccine; Microbial Sensitivity Tests; Mycobacterium bovis | 2009 |
A microwave-assisted facile regioselective Fischer indole synthesis and antitubercular evaluation of novel 2-aryl-3,4-dihydro-2H-thieno[3,2-b]indoles.
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Indoles; Microwaves; Mycobacterium tuberculosis; Stereoisomerism; Structure-Activity Relationship | 2009 |
A facile synthesis and antimycobacterial evaluation of novel spiro-pyrido-pyrrolizines and pyrrolidines.
Topics: Anti-Bacterial Agents; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Mycobacterium Infections, Nontuberculous; Mycobacterium smegmatis; Mycobacterium tuberculosis; Piperidones; Pyrrolidines; Spiro Compounds; Tuberculosis | 2009 |
Role of porins in the susceptibility of Mycobacterium smegmatis and Mycobacterium chelonae to aldehyde-based disinfectants and drugs.
Topics: Antitubercular Agents; Disinfectants; Drug Resistance, Bacterial; Glutaral; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Mycobacterium chelonae; Mycobacterium smegmatis; o-Phthalaldehyde; Porins | 2009 |
New approach for drug susceptibility testing: monitoring the stress response of mycobacteria.
Topics: Electric Impedance; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Stress, Physiological | 2009 |
L-proline-catalysed facile green protocol for the synthesis and antimycobacterial evaluation of [1,4]-thiazines.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Catalysis; Drug Resistance, Multiple, Bacterial; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium smegmatis; Mycobacterium tuberculosis; Proline; Thiazines | 2009 |
Novel three-component domino reactions of ketones, isatin and amino acids: synthesis and discovery of antimycobacterial activity of highly functionalised novel dispiropyrrolidines.
Topics: Amino Acids; Anti-Bacterial Agents; Isatin; Ketones; Microbial Sensitivity Tests; Models, Molecular; Molecular Conformation; Mycobacterium tuberculosis; Pyrrolidines | 2010 |
A highly atom economic, chemo-, regio- and stereoselective synthesis and evaluation of spiro-pyrrolothiazoles as antitubercular agents.
Topics: Antitubercular Agents; Crystallography, X-Ray; Drug Resistance, Multiple, Bacterial; Molecular Conformation; Mycobacterium tuberculosis; Pyrroles; Spiro Compounds; Stereoisomerism; Thiazoles | 2010 |
Pharmacokinetics of antituberculosis drugs in pulmonary tuberculosis patients with type 2 diabetes.
Topics: Adult; Antitubercular Agents; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Drug Administration Schedule; Ethambutol; Female; Humans; Male; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary | 2010 |
Fast standardized therapeutic-efficacy assay for drug discovery against tuberculosis.
Topics: Acetamides; Animals; Antitubercular Agents; Aza Compounds; Disease Models, Animal; Drug Discovery; Ethambutol; Fluoroquinolones; Immunocompetence; Inhalation Exposure; Isoniazid; Linezolid; Mice; Mice, Inbred C57BL; Moxifloxacin; Oxazolidinones; Pyrazinamide; Quinolines; Reproducibility of Results; Rifampin; Tuberculosis, Pulmonary | 2010 |
Selective one-pot multicomponent synthesis and anti-tubercular evaluation of 5-(aryl/cyclohexylsulfanyl)-2-alkoxy-4,6-diarylnicotinonitriles.
Topics: Antitubercular Agents; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nicotine | 2010 |
Emergence and molecular characterization of extensively drug-resistant Mycobacterium tuberculosis clinical isolates from the Delhi Region in India.
Topics: Amikacin; Antitubercular Agents; Bacterial Proteins; Capreomycin; DNA Gyrase; DNA Mutational Analysis; DNA-Directed RNA Polymerases; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; India; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Point Mutation; Polymerase Chain Reaction; Rifampin | 2010 |
Pyrazole derivatives from azines of substituted phenacyl aryl/cyclohexyl sulfides and their antimycobacterial activity.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Dimethylformamide; Formamides; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazoles; Sulfides | 2010 |
Synthesis and antitubercular evaluation of novel substituted aryl and thiophenyl tethered dihydro-6H-quinolin-5-ones.
Topics: Antitubercular Agents; Catalysis; Cesium; Chlorides; Crystallography, X-Ray; Microbial Sensitivity Tests; Molecular Conformation; Mycobacterium tuberculosis; Quinolones; Structure-Activity Relationship | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Synthesis and antimycobacterial activity of highly functionalized tetrahydro-4(1H)-pyridinones.
Topics: Anti-Bacterial Agents; Crystallography, X-Ray; Microbial Sensitivity Tests; Models, Molecular; Mycobacterium tuberculosis; Pyridones | 2011 |
Synthesis and antitubercular evaluation of amidoalkyl dibenzofuranols and 1H-benzo[2,3]benzofuro[4,5-e][1,3]oxazin-3(2H)-ones.
Topics: Antitubercular Agents; Benzofurans; Catalysis; Cyclization; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazines; Phosphoric Acids; Polymers; Silicon Dioxide; Temperature; Urea | 2011 |
Pyrazinamide, but not pyrazinoic acid, is a competitive inhibitor of NADPH binding to Mycobacterium tuberculosis fatty acid synthase I.
Topics: Bacterial Proteins; Binding Sites; Binding, Competitive; Crystallography, X-Ray; Enzyme Inhibitors; Fatty Acid Synthases; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Structure; Mycobacterium tuberculosis; NADP; Pyrazinamide; Stereoisomerism; Structure-Activity Relationship | 2011 |
Camphorsulfonic acid catalysed facile tandem double Friedlander annulation protocol for the synthesis of phenoxy linked bisquinoline derivatives and discovery of antitubercular agents.
Topics: Animals; Antitubercular Agents; Camphor; Catalysis; Chemistry Techniques, Synthetic; Mice; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Phenols; Quinolines; Structure-Activity Relationship | 2012 |
Design, synthesis, and structure-activity correlations of novel dibenzo[b,d]furan, dibenzo[b,d]thiophene, and N-methylcarbazole clubbed 1,2,3-triazoles as potent inhibitors of Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Benzofurans; Carbazoles; Cell Line, Tumor; Click Chemistry; Cytostatic Agents; Drug Design; Humans; Mycobacterium tuberculosis; Thiophenes; Triazoles | 2012 |
Synthesis of benzimidazolyl-1,3,4-oxadiazol-2ylthio-N-phenyl (benzothiazolyl) acetamides as antibacterial, antifungal and antituberculosis agents.
Topics: Antifungal Agents; Antitubercular Agents; Bacteria; Benzothiazoles; Chemistry Techniques, Synthetic; Fungi; Microbial Sensitivity Tests; Mycobacterium tuberculosis | 2012 |
Synthesis and antimycobacterial activity of prodrugs of sulfur dioxide (SO2).
Topics: Animals; Antitubercular Agents; Hydrogen-Ion Concentration; Kinetics; Mycobacterium tuberculosis; Prodrugs; Rats; Structure-Activity Relationship; Sulfonamides; Sulfur Dioxide | 2012 |
Synthesis and in vitro antitubercular activity of 4-aryl/alkylsulfonylmethylcoumarins as inhibitors of Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship | 2012 |
The synthesis and antituberculosis activity of 5'-nor carbocyclic uracil derivatives.
Topics: Animals; Antitubercular Agents; Cell Survival; Chlorocebus aethiops; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Stereoisomerism; Uracil; Vero Cells | 2012 |
Molecular hybridization of bioactives: synthesis and antitubercular evaluation of novel dibenzofuran embodied homoisoflavonoids via Baylis-Hillman reaction.
Topics: Antitubercular Agents; Biological Products; Chromones; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship | 2012 |
Inhibition of Mycobacterium tuberculosis strains H37Rv and MDR MS-115 by a new set of C5 modified pyrimidine nucleosides.
Topics: Animals; Antitubercular Agents; Cell Line, Tumor; Cell Survival; Chlorocebus aethiops; Humans; Jurkat Cells; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrimidine Nucleosides; Structure-Activity Relationship; Vero Cells | 2013 |
Design, synthesis and antitubercular evaluation of novel 2-substituted-3H-benzofuro benzofurans via palladium-copper catalysed Sonagashira coupling reaction.
Topics: Animals; Antitubercular Agents; Benzofurans; Catalysis; Copper; Drug Design; Heterocyclic Compounds, 4 or More Rings; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Palladium; Structure-Activity Relationship | 2013 |
Synthesis, characterization and in vitro biological evaluation of some novel 1,3,5-triazine-Schiff base conjugates as potential antimycobacterial agents.
Topics: Anti-Bacterial Agents; Humans; Mycobacterium tuberculosis; Schiff Bases; Triazines; Tuberculosis | 2013 |
Rational design, synthesis and antitubercular evaluation of novel 2-(trifluoromethyl)phenothiazine-[1,2,3]triazole hybrids.
Topics: Antitubercular Agents; Click Chemistry; Dose-Response Relationship, Drug; Drug Design; HEK293 Cells; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship; Thiazines; Triazoles | 2014 |
Design, synthesis and evaluation of 1,2,3-triazole-adamantylacetamide hybrids as potent inhibitors of Mycobacterium tuberculosis.
Topics: Acetamides; Adamantane; Antitubercular Agents; Click Chemistry; Drug Design; HEK293 Cells; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Structure-Activity Relationship; Triazoles | 2014 |
Facile synthesis of benzonitrile/nicotinonitrile based s-triazines as new potential antimycobacterial agents.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nicotinic Acids; Nitriles; Structure-Activity Relationship; Triazines | 2014 |
New class of methyl tetrazole based hybrid of (Z)-5-benzylidene-2-(piperazin-1-yl)thiazol-4(%H)-one as potent antitubercular agents.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship; Tetrazoles; Thiazoles; Vero Cells | 2014 |
Synthesis and biological evaluation of new imidazo[2,1-b][1,3,4]thiadiazole-benzimidazole derivatives.
Topics: Animals; Antifungal Agents; Antioxidants; Antitubercular Agents; Benzimidazoles; Cell Survival; Chlorocebus aethiops; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Structure-Activity Relationship; Thiadiazoles; Tuberculosis; Vero Cells | 2015 |
Thiophene containing trisubstituted methanes [TRSMs] as identified lead against Mycobacterium tuberculosis.
Topics: Animals; Anti-Bacterial Agents; Chlorocebus aethiops; Drug Design; Drug Resistance, Bacterial; Drug Resistance, Multiple; Humans; Methane; Mice; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rats; Thiophenes; Vero Cells | 2015 |
Design of novel dispirooxindolopyrrolidine and dispirooxindolopyrrolothiazole derivatives as potential antitubercular agents.
Topics: Animals; Antitubercular Agents; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Drug Design; Mice; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Pyrrolidines; Spiro Compounds; Structure-Activity Relationship; Thiazoles | 2015 |
One-pot synthesis of new triazole--Imidazo[2,1-b][1,3,4]thiadiazole hybrids via click chemistry and evaluation of their antitubercular activity.
Topics: Antitubercular Agents; Click Chemistry; Crystallography, X-Ray; Dose-Response Relationship, Drug; Imidazoles; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship; Thiadiazoles; Triazoles | 2015 |
New INH-pyrazole analogs: Design, synthesis and evaluation of antitubercular and antibacterial activity.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Bacteria; Binding Sites; Drug Design; Inhibitory Concentration 50; Isoniazid; Microbial Sensitivity Tests; Models, Molecular; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Pyrazoles | 2015 |
Benzo[d]thiazol-2-yl(piperazin-1-yl)methanones as new anti-mycobacterial chemotypes: Design, synthesis, biological evaluation and 3D-QSAR studies.
Topics: Animals; Antitubercular Agents; Chemistry Techniques, Synthetic; Drug Design; Mice; Microbial Sensitivity Tests; Models, Molecular; Molecular Conformation; Mycobacterium tuberculosis; Piperazine; Piperazines; Quantitative Structure-Activity Relationship; RAW 264.7 Cells | 2016 |
Synthesis, biological evaluation and structure-activity relationship of 2-styrylquinazolones as anti-tubercular agents.
Topics: Antitubercular Agents; Cell Survival; Dose-Response Relationship, Drug; HEK293 Cells; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Quinazolines; Structure-Activity Relationship | 2016 |
Click-based synthesis and antitubercular evaluation of novel dibenzo[b,d]thiophene-1,2,3-triazoles with piperidine, piperazine, morpholine and thiomorpholine appendages.
Topics: Antitubercular Agents; Cell Survival; Click Chemistry; Dose-Response Relationship, Drug; HEK293 Cells; Humans; Molecular Structure; Morpholines; Mycobacterium tuberculosis; Piperazine; Piperazines; Piperidines; Structure-Activity Relationship; Thiophenes; Triazoles | 2016 |
Synthesis and antitubercular evaluation of novel dibenzo[b,d]thiophene tethered imidazo[1,2-a]pyridine-3-carboxamides.
Topics: Antitubercular Agents; Cell Proliferation; Dose-Response Relationship, Drug; HEK293 Cells; Humans; Imidazoles; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Pyridines; Structure-Activity Relationship; Thiophenes | 2016 |
Click-based synthesis and antitubercular evaluation of dibenzofuran tethered thiazolyl-1,2,3-triazolyl acetamides.
Topics: Acetamides; Animals; Antitubercular Agents; Benzofurans; Cell Proliferation; Click Chemistry; Dose-Response Relationship, Drug; Mice; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; RAW 264.7 Cells; Structure-Activity Relationship | 2016 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Amphiphilic xanthones as a potent chemical entity of anti-mycobacterial agents with membrane-targeting properties.
Topics: Adenosine Triphosphate; Animals; Antitubercular Agents; Biological Availability; Cell Membrane; Cytochrome P-450 Enzyme Inhibitors; Drug Design; Hydrophobic and Hydrophilic Interactions; Kinetics; Mycobacterium tuberculosis; Rats; Xanthones | 2016 |
Design, development of new synthetic methodology, and biological evaluation of substituted quinolines as new anti-tubercular leads.
Topics: Antitubercular Agents; Dose-Response Relationship, Drug; Drug Design; HEK293 Cells; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Quinolines; Structure-Activity Relationship; Tuberculosis | 2016 |
Synthesis, screening and docking analysis of hispolon analogs as potential antitubercular agents.
Topics: Antitubercular Agents; Catechols; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship | 2017 |
New hydrazides derivatives of isoniazid against Mycobacterium tuberculosis: Higher potency and lower hepatocytotoxicity.
Topics: Animals; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Hep G2 Cells; Humans; Hydrazines; Isoniazid; Macrophages; Mice; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship | 2018 |
Dibenzofuran, dibenzothiophene and N-methyl carbazole tethered 2-aminothiazoles and their cinnamamides as potent inhibitors of Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Benzofurans; Carbazoles; Cell Survival; Cinnamates; Dose-Response Relationship, Drug; HEK293 Cells; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship; Thiazoles; Thiophenes | 2018 |
Benzo[d]thiazole-2-carbanilides as new anti-TB chemotypes: Design, synthesis, biological evaluation, and structure-activity relationship.
Topics: Animals; Antitubercular Agents; Carbanilides; Cell Survival; Dose-Response Relationship, Drug; Drug Design; Mice; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; RAW 264.7 Cells; Structure-Activity Relationship; Thiazoles | 2018 |
Design, synthesis, molecular-docking and antimycobacterial evaluation of some novel 1,2,3-triazolyl xanthenones.
Topics: | 2017 |
Synthesis, antitubercular and anticancer activity of new Baylis-Hillman adduct-derived
Topics: | 2014 |
Synthesis and biological evaluation of anti-tubercular activity of Schiff bases of 2-Amino thiazoles.
Topics: Amination; Antitubercular Agents; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Schiff Bases; Thiazoles; Tuberculosis | 2020 |
Design, synthesis and molecular docking studies of imidazole and benzimidazole linked ethionamide derivatives as inhibitors of InhA and antituberculosis agents.
Topics: Antitubercular Agents; Benzimidazoles; Dose-Response Relationship, Drug; Drug Design; Ethionamide; Humans; Imidazoles; Inhibins; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship | 2022 |
Tuberculosis in the 1980s: a case for short-course chemotherapy.
Topics: Animals; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Humans; Hydrogen-Ion Concentration; Isoniazid; Mice; New Zealand; Pyrazinamide; Rifampin; Tuberculosis | 1979 |
Side effects of drugs used to treat tuberculosis.
Topics: Aminosalicylic Acids; Animals; Antitubercular Agents; Capreomycin; Chemical and Drug Induced Liver Injury; Cycloserine; Deafness; Drug Hypersensitivity; Ethambutol; Ethionamide; Gastrointestinal Diseases; Goiter; Humans; Isoniazid; Kanamycin; Liver; Mental Disorders; Mice; Nervous System Diseases; Pyrazinamide; Rifampin; Streptomycin; Thioacetazone; Tuberculosis; Viomycin | 1975 |
Hepatic complications of antituberculous therapy.
Topics: Aminosalicylic Acids; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Drug Hypersensitivity; Ethambutol; Ethionamide; Female; Gastrointestinal Diseases; Humans; Isoniazid; Jaundice; Lymphatic Diseases; Male; Pyrazinamide; Skin Diseases; Streptomycin; Thioacetazone; Tuberculosis, Pulmonary | 1975 |
The treatment of tuberculosis.
Topics: Aminosalicylic Acids; Capreomycin; Ethambutol; Ethionamide; Humans; Isoniazid; Prothionamide; Pyrazinamide; Rifampin; Streptomycin; Thioacetazone; Tuberculosis | 1975 |
Editorial: Treatment of tuberculous meningitis.
Topics: Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Meningeal | 1976 |
[Sensitivity of m. kansasii strains to various antibiotics and chemotherapeutics in vitro and in vivo (author's transl)].
Topics: Animals; Anti-Bacterial Agents; Antitubercular Agents; Capreomycin; Drug Resistance, Microbial; Ethambutol; Gentamicins; Mice; Mycobacterium; Oleandomycin; Phenazines; Pyrazinamide; Rifampin; Species Specificity | 1975 |
Short-term chemotherapy of pulmonary tuberculosis. A controlled trial. The Research Committee of the Tuberculosis Association of India.
Topics: Drug Therapy, Combination; Ethambutol; Humans; India; Isoniazid; Pyrazinamide; Streptomycin; Thioacetazone; Tuberculosis, Pulmonary | 1976 |
Short-course chemotherapy for tuberculosis.
Topics: Adult; Ambulatory Care; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; South Africa; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1979 |
Basic mechanisms of chemotherapy.
Topics: Aminosalicylic Acid; Animals; Antitubercular Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Guinea Pigs; Humans; In Vitro Techniques; Isoniazid; Mice; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Thioacetazone; Tuberculosis, Pulmonary | 1979 |
[Criteria of resistance of some antibiotics and chemotherapeutics for strains of Mycobacterium tuberculosis isolated in Czechoslovakia. Cycloserin, ethionamide, pyrazinamide, rifampicin, and ethambutol (author's transl)].
Topics: Anti-Bacterial Agents; Cycloserine; Drug Resistance, Microbial; Ethambutol; Ethionamide; Mycobacterium tuberculosis; Pyrazinamide; Rifampin | 1979 |
[The abdominal tuberculoses].
Topics: Aftercare; Cycloserine; Ethambutol; Ethionamide; Gastrointestinal Diseases; Humans; Mesentery; Peritoneum; Pyrazinamide; Tuberculosis; Tuberculosis, Gastrointestinal; Tuberculosis, Hepatic; Tuberculosis, Lymph Node | 1978 |
Recent advances in antituberculosis chemotherapy.
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1979 |
Bactericidal activity of streptomycin, isoniazid, rifampin, ethambutol, and pyrazinamide alone and in combination against Mycobacterium Tuberculosis.
Topics: Drug Interactions; Drug Therapy, Combination; Ethambutol; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin | 1977 |
Silicosis and tuberculosis.
Topics: Adult; Aminosalicylic Acid; Antitubercular Agents; Ethambutol; Ethionamide; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Radiography; Recurrence; Silicotuberculosis; Streptomycin; Time Factors | 1979 |
[Tuberculosis in Romania (author's transl)].
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Ethambutol; Female; Humans; Infant; Infant, Newborn; Male; Middle Aged; Pyrazinamide; Recurrence; Rifampin; Romania; Statistics as Topic; Tuberculosis | 1979 |
[Therapy of tuberculosis].
Topics: Alanine Transaminase; Aspartate Aminotransferases; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1979 |
Genitourinary tuberculosis: a 7-year review.
Topics: Adolescent; Adult; Aged; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Forecasting; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Time Factors; Tuberculosis, Urogenital | 1979 |
Modern management of tuberculosis.
Topics: Adolescent; Adult; Aminosalicylic Acid; Child; Cycloserine; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Ethionamide; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1979 |
Principles of the chemotherapy of tuberculosis.
Topics: Aminosalicylic Acid; Ethambutol; Female; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Urogenital | 1977 |
The treatment of tuberculous meningitis.
Topics: Aminosalicylic Acid; Antitubercular Agents; Drug Evaluation; Drug Therapy, Combination; Ethambutol; Ethionamide; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Meningeal | 1978 |
[Interactions of reserve antitubercular agents in combined administration].
Topics: Amides; Drug Therapy, Combination; Ethambutol; Humans; Pyrazinamide; Rifampin; Thioamides; Tuberculosis, Pulmonary | 1978 |
[Intermittent chemotherapy of pulmonary tuberculosis (review of the literature)].
Topics: Aminosalicylic Acid; Antitubercular Agents; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1978 |
[Results of a cooperative international questionnaire on the cost of antitubercular drugs].
Topics: Antitubercular Agents; Costs and Cost Analysis; Ethambutol; Ethionamide; Isoniazid; Pyrazinamide; Rifampin; Streptomycin | 1978 |
Management of tuberculosis: altered role of the primary care physician.
Topics: Adolescent; Adult; Aminosalicylic Acid; Antitubercular Agents; Child; Cycloserine; Ethambutol; Ethionamide; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tuberculin Test; Tuberculosis, Pulmonary | 1977 |
[Chemotherapy of lung tuberculosis].
Topics: Cyclacillin; Ethambutol; Ethionamide; Humans; Isoniazid; Pyrazinamide; Streptomycin; Tuberculosis, Pulmonary | 1977 |
[Treatment of tuberculosis. A care program carried out by a working group in the Swedish Pulmonary Medical Society].
Topics: Ambulatory Care; Antitubercular Agents; Drug Interactions; Ethambutol; Eye Diseases; Female; Follow-Up Studies; Hospitalization; Humans; Kidney Failure, Chronic; Pregnancy; Pregnancy Complications, Infectious; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1976 |
[Concentration of ethambutol and pyrazinamide in the blood and the resected lungs of patients with tuberculosis].
Topics: Ethambutol; Humans; Lung; Lymph Nodes; Pyrazinamide; Tuberculoma; Tuberculosis, Pulmonary | 1976 |
Rationale for chemotherapy of tuberculosis and current recommendations.
Topics: Antitubercular Agents; Child; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Time Factors; Tuberculosis | 1992 |
[Therapy of pulmonary tuberculosis].
Topics: Adult; Antitubercular Agents; Ethambutol; Female; Follow-Up Studies; Humans; Inpatients; Isoniazid; Male; Outpatients; Pregnancy; Prothionamide; Pyrazinamide; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1992 |
Intensive short course chemotherapy for tuberculous meningitis.
Topics: Antitubercular Agents; Child; Child, Preschool; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; Infant; Isoniazid; Male; Prospective Studies; Pyrazinamide; Rifampin; Streptomycin; Treatment Outcome; Tuberculosis, Meningeal | 1992 |
Tuberculosis in the 1990's: resurgence, regimens, and resources.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Child; Drug Administration Schedule; Drug Interactions; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; False Negative Reactions; Humans; Isoniazid; Pyrazinamide; Radiography, Thoracic; Rifampin; Risk Factors; Streptomycin; Tuberculosis; United States | 1992 |
Tubercular colitis in a patient with systemic lupus erythematosus: diagnosis by stool examination.
Topics: Adrenal Cortex Hormones; Adult; Colitis; Drug Therapy, Combination; Ethambutol; Feces; Female; Humans; Lupus Erythematosus, Systemic; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis, Gastrointestinal | 1992 |
Transmission of multidrug-resistant tuberculosis among immunocompromised persons in a correctional system--New York, 1991.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Ethionamide; HIV Seropositivity; Humans; Immunocompromised Host; Isoniazid; Kanamycin; Mycobacterium tuberculosis; New York; Prisons; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis | 1992 |
From the Centers for Disease Control. Transmission of multidrug-resistant tuberculosis among immunocompromised persons, correctional system--New York, 1991.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Ethionamide; HIV Seropositivity; Humans; Immunocompromised Host; Isoniazid; Kanamycin; Mycobacterium tuberculosis; New York; Prisons; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis | 1992 |
Contemporary management of cervical tuberculosis.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Biopsy, Needle; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Neck; Pyrazinamide; Recurrence; Retrospective Studies; Rifampin; Sputum; Streptomycin; Tuberculin Test; Tuberculosis, Lymph Node | 1992 |
AIDS and tuberculosis in Spain. A report of 140 cases.
Topics: Acquired Immunodeficiency Syndrome; Drug Therapy, Combination; Ethambutol; Female; Humans; Incidence; Isoniazid; Male; Prospective Studies; Pyrazinamide; Retrospective Studies; Rifampin; Risk Factors; Spain; Streptomycin; Substance Abuse, Intravenous; Tuberculosis; Tuberculosis, Pulmonary | 1991 |
[Standardized controlled antitubercular therapy and results in 755 patients].
Topics: Adult; Aged; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Recurrence; Rifampin; Sputum; Streptomycin; Tuberculosis, Pulmonary | 1991 |
[Tuberculosis of the larynx, oral cavity and pharynx].
Topics: Adult; Diagnosis, Differential; Drug Therapy, Combination; Endoscopy; Ethambutol; Humans; Isoniazid; Male; Pharyngeal Diseases; Pharyngeal Neoplasms; Pyrazinamide; Rifampin; Tuberculosis; Tuberculosis, Laryngeal; Tuberculosis, Oral | 1991 |
Contribution of pyrazinamide to antituberculosis chemotherapy.
Topics: Drug Resistance, Microbial; Ethambutol; Humans; Pyrazinamide; Tuberculosis | 1991 |
Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection.
Topics: Acquired Immunodeficiency Syndrome; Adult; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Pyrazinamide; Retrospective Studies; Rifampin; Sputum; Tuberculosis; Tuberculosis, Pulmonary | 1991 |
Use of a radiometric technique for rapid sensitivity testing of mycobacteria in Scotland: the first year's experience.
Topics: Carbon Radioisotopes; Culture Media; Drug Resistance, Microbial; Egg Proteins; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Radiometry; Rifampin; Scotland | 1990 |
Influence of initial drug resistance on the response to short-course chemotherapy of pulmonary tuberculosis.
Topics: Antitubercular Agents; Drug Evaluation; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Thioacetazone; Tuberculosis, Pulmonary | 1986 |
180 doses in 26 weeks vs 56 doses in 24 weeks of chemotherapy in pulmonary tuberculosis: a preliminary report.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Drug Administration Schedule; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Thioacetazone; Tuberculosis, Pulmonary | 1988 |
Drug resistance of Mycobacterium tuberculosis isolated from treated patients in Pakistan.
Topics: Adolescent; Adult; Aminosalicylic Acid; Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Pakistan; Pyrazinamide; Rifampin; Sputum; Streptomycin; Thioacetazone; Tuberculosis | 1989 |
Importance of rifampicin in combined daily/intermittent chemotherapy for tuberculosis.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Dapsone; Drug Combinations; Drug Evaluation; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Prothionamide; Pyrazinamide; Rifampin; Sputum; Tuberculosis, Pulmonary | 1989 |
[Recommendations for the therapy of tuberculosis. (Position: December, 1988)].
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis | 1989 |
Antimycobacterial drugs and the production of reactive oxidants by polymorphonuclear leucocytes in vitro.
Topics: Antitubercular Agents; Ethambutol; In Vitro Techniques; Isoniazid; Luminescent Measurements; Neutrophils; Oxidation-Reduction; Peroxidase; Pyrazinamide; Rifampin; Streptomycin | 1988 |
[Routine use of 6-month antitubercular treatment in 300 patients].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Drug Therapy, Combination; Drug Tolerance; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Patient Compliance; Pyrazinamide; Retrospective Studies; Rifampin; Time Factors; Tuberculosis | 1986 |
A rapid method for the evaluation of new antituberculous agents.
Topics: Antitubercular Agents; Carbon Dioxide; Ethambutol; Guanidines; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Scintillation Counting; Streptomycin; Succinimides; Thiazoles; Time Factors | 1987 |
In vitro activity of ciprofloxacin in combination with standard antituberculous drugs against mycobacterium tuberculosis.
Topics: Antitubercular Agents; Ciprofloxacin; Ethambutol; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin | 1988 |
[New and future drugs in pulmonary tuberculosis].
Topics: Antitubercular Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1988 |
Management and outcome of pulmonary tuberculosis in adults notified in England and Wales in 1983. Medical Research Council Tuberculosis and Chest Diseases Unit.
Topics: Adolescent; Adult; Antitubercular Agents; Bangladesh; Drug Administration Schedule; England; Ethambutol; Female; Follow-Up Studies; Hospitalization; Humans; India; Isoniazid; Male; Pakistan; Patient Acceptance of Health Care; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary; Wales | 1988 |
A retrospective comparison of two drug regimens RHE2/RH10 and RHZ2/RH10 in the treatment of tuberculous mediastinal lymphadenopathy.
Topics: Adolescent; Adult; Aged; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Mediastinal Diseases; Middle Aged; Pyrazinamide; Radiography; Rifampin; Time Factors; Tuberculosis, Lymph Node | 1988 |
Drugs for tuberculosis.
Topics: Adult; Aged; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Child; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis | 1988 |
American Thoracic Society. Medical Section of the American Lung Association: Treatment of tuberculosis and tuberculosis infection in adults and children.
Topics: Adult; Age Factors; Blood Cell Count; Blood Urea Nitrogen; Child; Creatinine; Drug Administration Schedule; Drug Resistance, Microbial; Ethambutol; Female; Humans; Isoniazid; Lactation; Liver; Mycobacterium bovis; Pregnancy; Pyrazinamide; Rifampin; Sputum; Streptomycin; Time Factors; Tuberculin; Tuberculosis | 1986 |
[Observations on the effect of PZA, EB and RFP on uric acid metabolism].
Topics: Adolescent; Adult; Arthritis; Drug Therapy, Combination; Ethambutol; Female; Gout; Humans; Male; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary; Uric Acid | 1986 |
New approach to treatment of pulmonary and extrapulmonary tuberculosis. Possible ramifications of cutaneous mycobacterial infections.
Topics: Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Cutaneous; Tuberculosis, Pulmonary | 1987 |
Fulminant hepatitis during treatment with rifampicin, pyrazinamid and ethambutol.
Topics: Cervical Vertebrae; Chemical and Drug Induced Liver Injury; Child; Drug Therapy, Combination; Ethambutol; Female; Humans; Pyrazinamide; Rifampin; Tuberculosis, Spinal | 1987 |
Short-course antituberculous chemotherapy for pulmonary and pleural disease: 5 years' experience in clinical practice.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Drug Administration Schedule; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Pyridoxine; Rifampin; Streptomycin; Tuberculosis, Pleural; Tuberculosis, Pulmonary | 1987 |
Antituberculous agents.
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis | 1987 |
[Results of a therapeutic trial comparing a 6-month regimen to a 12-month regimen in the treatment of pulmonary tuberculosis in the Algerian Sahara. Final report: results 3 years after the onset of treatment].
Topics: Adult; Algeria; Antitubercular Agents; Drug Administration Schedule; Drug Resistance, Microbial; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Male; Pyrazinamide; Recurrence; Rifampin; Streptomycin; Transients and Migrants; Tuberculosis, Pulmonary | 1986 |
[Tuberculostatics-induced systemic lupus erythematosus].
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Lupus Erythematosus, Systemic; Middle Aged; Prothionamide; Pyrazinamide; Streptomycin; Tuberculosis, Pulmonary | 1986 |
Safety of thrice-weekly rifampicin for tuberculosis in South-East Asian refugees.
Topics: Adolescent; Adult; Aged; Asia, Southeastern; Australia; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Middle Aged; Prospective Studies; Pyrazinamide; Refugees; Rifampin; Tuberculosis, Pulmonary | 1985 |
The action of antituberculosis drugs in short-course chemotherapy.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Models, Biological; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Sterilization; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1985 |
[Chemotherapeutic treatment of pulmonary tuberculosis].
Topics: Antitubercular Agents; Ethambutol; Humans; Hydrazines; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1985 |
Dosage of antituberculous drugs in obese patients.
Topics: Adult; Antitubercular Agents; Ethambutol; Humans; Male; Obesity; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Meningeal; Tuberculosis, Miliary | 1985 |
Successful treatment of tuberculous brain abscess.
Topics: Brain Abscess; Ethambutol; Humans; Male; Middle Aged; Pyrazinamide; Tomography, X-Ray Computed; Tuberculosis | 1985 |
Ultrashort-course chemotherapy for culture-negative pulmonary tuberculosis--a qualified success.
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Follow-Up Studies; Humans; Isoniazid; Male; Pyrazinamide; Random Allocation; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1985 |
Adult tuberculous meningitis: comparative study of different chemotherapeutic regimens.
Topics: Adolescent; Adult; Aminosalicylic Acid; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Prospective Studies; Pyrazinamide; Random Allocation; Rifampin; Streptomycin; Tuberculosis, Meningeal | 1985 |
Results after retreatment of advanced pulmonary tuberculosis with rifampin and other drugs.
Topics: Adult; Aged; Anti-Bacterial Agents; Antitubercular Agents; Cycloserine; Drug Resistance, Microbial; Ethambutol; Ethionamide; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pyrazinamide; Recurrence; Rifampin; Thioacetazone; Tuberculosis, Pulmonary | 1971 |
The first clinical experiences with ethambutol in chronic pulmonary tuberculosis and basilar meningitis.
Topics: Adult; Aminosalicylic Acids; Capreomycin; Chronic Disease; Cycloserine; Drug Combinations; Drug Resistance, Microbial; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Kanamycin; Male; Meningitis; Middle Aged; Pyrazinamide; Radiography; Streptomycin; Tuberculosis, Pulmonary; Viomycin | 1970 |
Clinical experience with ethambutol.
Topics: Aminosalicylic Acids; Blood Chemical Analysis; Capreomycin; Drug Combinations; Drug Hypersensitivity; Drug Resistance, Microbial; Ethambutol; Ethionamide; Gentamicins; Humans; Isoniazid; Kanamycin; Pyrazinamide; Streptomycin; Tuberculosis, Pulmonary; Viomycin | 1970 |
Clinical results of rifampicin treatment.
Topics: Administration, Oral; Adult; Aged; Capreomycin; Chronic Disease; Drug Combinations; Ethambutol; Female; Humans; Kanamycin; Lung; Male; Middle Aged; Mycobacterium tuberculosis; Oxytetracycline; Pyrazinamide; Radiography; Rifampin; Sputum; Time Factors; Tuberculosis, Pulmonary | 1970 |
[Allergy to antitubercular agents; with special reference to new drugs].
Topics: Adult; Aged; Agranulocytosis; Anaphylaxis; Antitubercular Agents; Capreomycin; Cycloserine; Drug Hypersensitivity; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Kanamycin; Pyrazinamide; Rifampin; Thrombocytopenia; Viomycin | 1973 |
[Proceedings: Ambulatory chemotherapy of tuberculosis in Finland (organization)].
Topics: Ambulatory Care; Aminosalicylic Acids; Antitubercular Agents; Capreomycin; Ethambutol; Ethionamide; Finland; Humans; Isoniazid; Patient Dropouts; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary | 1973 |
[Drug therapy of tuberculosis].
Topics: Amides; Aminosalicylic Acids; Antitubercular Agents; Capreomycin; Drug Therapy, Combination; Ethambutol; Ethionamide; Humans; Isoniazid; Isonicotinic Acids; Kanamycin; Phenylthiourea; Pyrazinamide; Rifampin; Streptomycin; Tetracycline; Thiosemicarbazones; Tuberculosis; Viomycin | 1974 |
Primary cutaneous inoculation drug-resistant tuberculosis.
Topics: Capreomycin; Drug Resistance, Microbial; Ethambutol; Female; Humans; Isoniazid; Laboratory Infection; Middle Aged; Mycobacterium tuberculosis; Needles; Punctures; Pyrazinamide; Streptomycin; Thumb; Tuberculin Test; Tuberculosis, Cutaneous | 1974 |
Management of drug failure cases.
Topics: Adult; Aged; Aminosalicylic Acids; Antitubercular Agents; Collapse Therapy; Congresses as Topic; Cycloserine; Drug Resistance, Microbial; Ethambutol; Ethionamide; Female; Humans; India; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Prognosis; Pyrazinamide; Tuberculosis, Pulmonary | 1972 |
In vitro and in vivo studies to assess the suitability of antituberculous drugs for use in intermittent chemotherapy regimens.
Topics: Animals; Antitubercular Agents; Cycloserine; Ethambutol; Ethionamide; Guinea Pigs; In Vitro Techniques; Isoniazid; Mycobacterium tuberculosis; Phenylthiourea; Pyrazinamide; Streptomycin; Thioacetazone; Time Factors; Tuberculosis | 1968 |
Drugs for tuberculosis.
Topics: Aminosalicylic Acids; Costs and Cost Analysis; Cycloserine; Drug Synergism; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Pyrazinamide; Streptomycin; Thioacetazone; Tuberculosis; Viomycin | 1968 |
In vitro and in vivo studies to assess the suitability of anti-tuberculous drugs for use in intermittent chemotherapy regimens.
Topics: Animals; Antitubercular Agents; Cycloserine; Ethambutol; Ethionamide; Guinea Pigs; In Vitro Techniques; Isoniazid; Methods; Phenylthiourea; Pyrazinamide; Streptomycin; Thioacetazone; Tuberculosis | 1968 |
The effect of radiation on microbiologic characteristics of M tuberculosis.
Topics: Aminosalicylic Acids; Antitubercular Agents; Cell Survival; Chromosomes, Bacterial; Cycloserine; Dose-Response Relationship, Radiation; Drug Resistance, Microbial; Ethambutol; Ethionamide; Freezing; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Preservation, Biological; Pyrazinamide; Radiation Genetics; Rifampin; Streptomycin | 1974 |
[Algodystrophy associated with antitubercular chemotherapy: 22 cases].
Topics: Adult; Antitubercular Agents; Cycloserine; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Male; Niacinamide; Pyrazinamide; Reflex Sympathetic Dystrophy; Rifampin; Tuberculosis; Vitamin B Deficiency | 1969 |
[Treatment with secondary antitubercular agents].
Topics: Antitubercular Agents; Cycloserine; Ethambutol; Ethionamide; Humans; Kanamycin; Pyrazinamide; Time Factors; Viomycin | 1968 |
[Minor tuberculostatic drugs].
Topics: Antitubercular Agents; Cycloserine; Ethambutol; Ethionamide; Humans; Kanamycin; Pyrazinamide; Viomycin | 1967 |
[Treatment with new antitubercular agents].
Topics: Antitubercular Agents; Cycloserine; Drug Resistance, Microbial; Drug Synergism; Ethambutol; Ethionamide; Humans; Mycobacterium tuberculosis; Phenylthiourea; Pyrazinamide; Rifampin; Thiosemicarbazones; Tuberculosis; Viomycin | 1968 |
Ethambytol in the retreatment of pulmonary tuberculosis. United States Public Health Service cooperative trial.
Topics: Cycloserine; Drug Resistance, Microbial; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Pyrazinamide; Thiosemicarbazones; Tuberculosis, Pulmonary; United States; United States Public Health Service; Viomycin | 1968 |
[Treatment of drug resistant chronic pulmonary tuberculosis with a number of tuberculostatics].
Topics: Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Drug Resistance, Microbial; Ethambutol; Ethionamide; Humans; Kanamycin; Pyrazinamide; Tuberculosis, Pulmonary; Viomycin | 1968 |
The treatment of drug resistant chronic pulmonary tuberculosis with new tuberculostatics.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Cycloserine; Drug Resistance, Microbial; Ethambutol; Ethionamide; Humans; Kanamycin; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary; Viomycin | 1968 |
[Drug sensitivity of the so-called atypical mycobacteria].
Topics: Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Drug Resistance, Microbial; Ethambutol; Ethionamide; In Vitro Techniques; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Morpholines; Mycobacterium; Pyrazinamide; Pyrazines; Rifampin; Streptomycin; Viomycin | 1968 |
Ethambutol in the treatment of 26 patients with chronic active pulmonary tuberculosis.
Topics: Chronic Disease; Cycloserine; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Kanamycin; Pyrazinamide; Tuberculosis, Pulmonary; Viomycin | 1969 |
Treatment of patients with drug-resistance in economically developed countries.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Costs and Cost Analysis; Cycloserine; Drug Resistance, Microbial; Ethambutol; Ethionamide; Humans; Microbial Sensitivity Tests; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary; Viomycin | 1969 |
Chemotherapy of tuberculosis.
Topics: Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Pyrazinamide; Streptomycin; Tuberculosis, Pulmonary; Viomycin | 1970 |
[Experimental studies on intermittent use of rifampicin alone or combined with other secondary antituberculous drugs].
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Antitubercular Agents; Body Weight; Ethambutol; Ethionamide; Injections, Intramuscular; Kanamycin; Lung; Mice; Organ Size; Pyrazinamide; Rifampin; Spleen; Tuberculosis; Viomycin | 1971 |
Treatment of drug-resistant tuberculosis.
Topics: Aminosalicylic Acids; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Cycloserine; Drug Eruptions; Drug Hypersensitivity; Drug Resistance, Microbial; Drug Synergism; Ethambutol; Ethionamide; Female; Gastrointestinal Diseases; Humans; Hypothyroidism; Isoniazid; Kanamycin; Male; Microbial Sensitivity Tests; Pyrazinamide; Recurrence; Rifampin; Streptomycin; Tuberculosis, Pulmonary; Viomycin | 1971 |
[Advances and principles in tuberculostatic therapy].
Topics: Adult; Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Drug Resistance, Microbial; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Kanamycin; Male; Microbial Sensitivity Tests; Middle Aged; Phenylthiourea; Pyrazinamide; Rifampin; Streptomycin; Thiosemicarbazones; Tuberculosis; Viomycin | 1971 |
[Studies on the effect of antituberculosis agents against tubercle bacilli in the resting state, using streptomycin-dependent strain (18-b). I. Studies in vitro].
Topics: Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Drug Resistance, Microbial; Ethambutol; Ethionamide; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Streptomycin; Sulfisoxazole; Tetracycline; Viomycin | 1971 |
[Duration of the after-control of the tuberculous patients following the termination of the treatment].
Topics: Adolescent; Adult; Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Recurrence; Rifampin; Streptomycin; Thiosemicarbazones; Time Factors; Tuberculosis, Pulmonary; Viomycin | 1972 |
Treatment of tuberculosis today in Nebraska.
Topics: Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Drug Hypersensitivity; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Pyrazinamide; Pyridoxine; Rifampin; Sputum; Streptomycin; Tuberculosis; Viomycin | 1973 |
New antituberculosis drugs and concepts of prophylaxis.
Topics: Aminosalicylic Acids; Antitubercular Agents; Arthritis; Chemical and Drug Induced Liver Injury; Child; Cycloserine; Drug Hypersensitivity; Drug Resistance, Microbial; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Liver; Lupus Vulgaris; Male; Middle Aged; Pyrazinamide; Rifampin; Streptomycin; Tuberculin Test; Tuberculosis; Viomycin | 1974 |
[Experience in treatment of patients with chronic destructive pulmonary tuberculosis in a suburban tuberculosis hospital].
Topics: Adult; Antitubercular Agents; Chronic Disease; Cycloserine; Drug Evaluation; Ethambutol; Ethionamide; Female; Hospitals, Special; Humans; Kanamycin; Male; Middle Aged; Pyrazinamide; Rifampin; Thiosemicarbazones; Tuberculosis, Pulmonary; Viomycin | 1974 |
Intermittent chemotherapy for adults with tuberculosis.
Topics: Administration, Oral; Adult; Drug Resistance, Microbial; Ethambutol; Humans; Injections, Intramuscular; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis | 1974 |
Hong Kong Treatment Services-Royal Postgraduate Medical School-British Medical Research Council Co-operative study of rifampicin plus ethambutol in daily and intermittent regimens. Clinical observations on adverse reactions.
Topics: Acute Kidney Injury; Adolescent; Cycloserine; Drug Therapy, Combination; Dyspnea; Ethambutol; Ethionamide; Fever; Follow-Up Studies; Headache; Humans; Purpura, Thrombocytopenic; Pyrazinamide; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1973 |
Therapeutic effects and side effects of rifampicin administered daily or twice-weekly.
Topics: Adult; Body Weight; Drug Therapy, Combination; Ethambutol; Exanthema; Female; Fever; Follow-Up Studies; Gastrointestinal Diseases; Hemorrhage; Humans; Male; Middle Aged; Pain; Pyrazinamide; Recurrence; Rifampin; Shock; Sputum; Time Factors; Tuberculosis, Pulmonary | 1973 |
[Therapeutic effect of rifampicin on re-treatment cases of pulmonary tuberculosis. The second study: a study on the combined therapy of rifampicin with ethambutol and pyrazinamide, especially on intermittent therapy].
Topics: Adult; Ethambutol; Female; Humans; Male; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1972 |
[Toxicity of antitubercular agents for the liver].
Topics: Aminosalicylic Acids; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Cycloserine; Ethambutol; Ethionamide; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin | 1973 |
Transfer factor therapy in a patient with progressive primary tuberculosis.
Topics: Adult; Aminosalicylic Acids; Anemia, Aplastic; Cell Migration Inhibition; Ethambutol; Female; Humans; Immunity, Cellular; Immunity, Maternally-Acquired; Isoniazid; Lectins; Lymphocytes; Macrophages; Pyrazinamide; Radiography; Rifampin; Splenectomy; Streptodornase and Streptokinase; Streptomycin; Thymidine; Tritium; Tuberculin Test; Tuberculosis, Pulmonary | 1973 |
[Statement on tuberculosis treatment].
Topics: Aminosalicylic Acids; Antitubercular Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Dyspepsia; Ethambutol; Ethionamide; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Thiosemicarbazones | 1973 |
Hyperuricemia induced by ethambutol.
Topics: Allopurinol; Creatinine; Diuretics; Ethambutol; Ethanol; Gout; Humans; Isoniazid; Lactates; Pyrazinamide; Pyridoxine; Salicylates; Stimulation, Chemical; Streptomycin; Time Factors; Tuberculosis; Uric Acid | 1974 |
Three patients with intracranial tuberculomas with unusual features.
Topics: Adolescent; Aminosalicylic Acids; Brain Diseases; Dexamethasone; Diabetic Coma; Electroencephalography; Emigration and Immigration; Ethambutol; Female; Headache; Humans; Hydrocephalus; India; Isoniazid; Male; Papilledema; Pyrazinamide; Radionuclide Imaging; Rifampin; Streptomycin; Technetium; Tuberculoma; United Kingdom | 1974 |
A ten-year clinical experience with Mycobacterium kansasii.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Antitubercular Agents; Child; Cycloserine; Ethambutol; Ethionamide; Female; Follow-Up Studies; Humans; Isoniazid; Lung Diseases; Male; Middle Aged; Mycobacterium; Mycobacterium Infections; Pneumonectomy; Pyrazinamide; Rifampin; Sputum; Streptomycin | 1974 |
[Chronic tuberculous meningitis in a case of known Mycobacterium kansasii infection].
Topics: Adult; Burns; Cell Count; Cerebrospinal Fluid; Cerebrospinal Fluid Proteins; Drug Therapy, Combination; Ethambutol; Humans; Kanamycin; Lymphocytes; Male; Mycobacterium; Prednisolone; Pyrazinamide; Rifampin; Tuberculosis, Meningeal; Tuberculosis, Pulmonary; Uveitis | 1974 |
[Internal medicine treatment of pulmonary tuberculosis].
Topics: Ambulatory Care; Aminosalicylic Acids; Anti-Bacterial Agents; Antitubercular Agents; Cycloserine; Drug Resistance, Microbial; Drug Synergism; Ethambutol; Ethionamide; Humans; Isoniazid; Long-Term Care; Prednisolone; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1970 |
[Refractory tuberculosis: concept and clinical cases].
Topics: Adult; Aged; Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Drug Resistance, Microbial; Ethambutol; Female; Humans; Kanamycin; Male; Mycobacterium tuberculosis; Pneumothorax, Artificial; Pyrazinamide; Streptomycin; Sulfisoxazole; Tuberculosis, Pulmonary | 1971 |
[Studies on the effects of antituberculosis agents against tubercle bacilli in the resting state, using streptomycin-dependent strain (18-b). II. Studies in vivo].
Topics: Animals; Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Isoniazid; Kanamycin; Male; Mice; Mice, Inbred Strains; Mycobacterium tuberculosis; Pyrazinamide; Streptomycin; Tuberculosis | 1971 |
Recent developments in the treatment of infectious diseases. V. Management of tuberculosis in the community hospital.
Topics: Aminosalicylic Acids; Cross Infection; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Sanitation; Streptomycin; Tuberculosis, Pulmonary | 1971 |
Drug resistant pulmonary tuberculosis treated with ethambutol and rifampicin in North East England.
Topics: Aminosalicylic Acids; Chronic Disease; Cycloserine; Drug Resistance, Microbial; Ethambutol; Ethionamide; Humans; Isoniazid; Microbial Sensitivity Tests; Pyrazinamide; Rifampin; Sputum; Streptomycin; Tuberculosis, Pulmonary | 1971 |
[Tuberculostatic activity of the 2d line drugs].
Topics: Animals; Antitubercular Agents; Ethambutol; Ethionamide; Humans; Kanamycin; Mice; Pyrazinamide; Time Factors | 1971 |
Clinical activity of cycloserine in the treatment of tuberculosis.
Topics: Adult; Aged; Chronic Disease; Cycloserine; Drug Resistance, Microbial; Ethambutol; Female; Humans; Male; Middle Aged; Pyrazinamide; Tuberculosis | 1970 |
Experimental studies on therapeutic effects of various combinations of antituberculosis drugs. I. Comparison of various regimens in treatment of experimental mouse tuberculosis infected with drug-susceptible mycobacteria.
Topics: Aminosalicylic Acids; Animals; Antitubercular Agents; Cycloserine; Ethambutol; Ethionamide; Isoniazid; Kanamycin; Male; Mice; Mycobacterium; Pyrazinamide; Streptomycin; Tuberculosis | 1967 |
Comparative studies of various antituberculosis drug regimens by means of serum antimycobacterial activity tests in man.
Topics: Adolescent; Adult; Aminoisobutyric Acids; Antitubercular Agents; Cycloserine; Drug Resistance, Microbial; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Kanamycin; Male; Middle Aged; Phenylthiourea; Pyrazinamide; Streptomycin; Tuberculosis, Pulmonary | 1967 |
[Improved therapy of tuberculosis with a well tolerated INH derivative (INHG)].
Topics: Cycloserine; Ethambutol; Ethionamide; Glucuronates; Humans; Isoniazid; Middle Aged; Pyrazinamide; Streptomycin; Tuberculosis, Pulmonary | 1969 |
Ethambutol in the retreatment of chronic pulmonary tuberculosis.
Topics: Aminosalicylic Acids; Chronic Disease; Cycloserine; Depression, Chemical; Drug Synergism; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Pyrazinamide; Sputum; Streptomycin; Tuberculosis, Pulmonary | 1970 |
[Drug therapy of urogenital tuberculosis].
Topics: Aminosalicylic Acids; Cycloserine; Drug Synergism; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Phenylthiourea; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Urogenital | 1970 |
Report on the therapeutic results obtained with rifampicin.
Topics: Aminosalicylic Acids; Chronic Disease; Drug Combinations; Ethambutol; Humans; Pyrazinamide; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1970 |
Clinical experience with Myambutol in the treatment of polyresistant chronic tuberculosis.
Topics: Adult; Cycloserine; Drug Combinations; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Kanamycin; Male; Middle Aged; Phenylthiourea; Pyrazinamide; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1970 |
Report on experiences with ethambutol.
Topics: Chronic Disease; Cycloserine; Drug Combinations; Ethambutol; Ethionamide; Humans; Phenylthiourea; Pyrazinamide; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1970 |
[Cheotherapy of chronic pulmonary tuberculosis with resistant mycobacteria].
Topics: Aminosalicylic Acids; Antitubercular Agents; Chronic Disease; Cycloserine; Drug Resistance, Microbial; Ethambutol; Ethionamide; Humans; Kanamycin; Phenylthiourea; Pyrazinamide; Tuberculosis, Pulmonary | 1967 |
Multiple drugs in retreatment of chronic pulmonary tuberculosis. Results with capreomycin and ethambutol.
Topics: Adult; Aged; Anti-Bacterial Agents; Antitubercular Agents; Chronic Disease; Drug Resistance, Microbial; Drug Synergism; Ethambutol; Ethionamide; Female; Follow-Up Studies; Humans; Kanamycin; Male; Middle Aged; Pyrazinamide; Tuberculosis, Pulmonary | 1968 |
[Combination of ethambutol with ethionamide, cycloserine and-or pyrazynamide in retreatment of pulmonary tuberculosis].
Topics: Cycloserine; Ethambutol; Ethionamide; Humans; Pyrazinamide; Tuberculosis, Pulmonary | 1968 |
Results of the second chemotherapy trial of the IUAT. Bacteriological part.
Topics: Antitubercular Agents; Cycloserine; Drug Resistance, Microbial; Ethambutol; Humans; Pyrazinamide; Tuberculosis, Pulmonary | 1968 |
[Colloquium on class II antitubercular agents].
Topics: Antitubercular Agents; Ethambutol; Ethionamide; Humans; Kanamycin; Pyrazinamide; Rifampin | 1969 |
[Experimental therapy with so-called "minor" tuberculostatics].
Topics: Aminosalicylic Acids; Animals; Antitubercular Agents; Cycloserine; Ethambutol; Ethionamide; Guinea Pigs; Kanamycin; Mice; Phenylthiourea; Pyrazinamide; Rabbits; Tuberculosis; Tuberculosis, Avian | 1966 |
Addendum on serum levels.
Topics: Aminosalicylic Acids; Anti-Bacterial Agents; Antitubercular Agents; Cycloserine; Drug Resistance, Microbial; Ethambutol; Ethionamide; Humans; Isoniazid; Phenazines; Pyrazinamide; Rifampin; Streptomycin | 1967 |
Drug-resistant Mycobacterium tuberculosis in Korean isolates.
Topics: Adult; Capreomycin; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Korea; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1982 |
[Current treatment of pulmonary tuberculosis].
Topics: Adult; Aged; Antitubercular Agents; Child; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1984 |
[Effectiveness of pyrazinamide combined with rifampicin and ethambutol in animal experiments].
Topics: Animals; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Ethambutol; Mice; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1984 |
[Tuberculosis treatment today].
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1984 |
The management of urinary tuberculosis--a logical approach.
Topics: Adult; Aged; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis, Urogenital | 1984 |
[Comparison of 3 6-month chemotherapy regimes in pulmonary tuberculosis in routine practice in Algiers. 18th-month results].
Topics: Adolescent; Adult; Antitubercular Agents; Drug Evaluation; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1983 |
The treatment of urinary tuberculosis.
Topics: Adult; Aged; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Kidney; Male; Methods; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis, Urogenital; Ureter; Urinary Bladder; Urinary Tract; Urography | 1984 |
Present chemotherapy for tuberculosis.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis | 1982 |
Antituberculous agents. Isoniazid, rifampin, streptomycin, ethambutol, and pyrazinamide.
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis | 1983 |
Current concept of short-term chemotherapy of tuberculosis.
Topics: Drug Combinations; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Time Factors; Tuberculosis | 1981 |
Tuberculosis in patients with end-stage renal disease.
Topics: Adult; Aged; Ethambutol; Female; Humans; Immunity, Cellular; Isoniazid; Kidney Failure, Chronic; Male; Middle Aged; Pyrazinamide; Renal Dialysis; Rifampin; Risk; Tuberculosis | 1980 |
A service program of antituberculosis chemotherapy with five drugs for four months in the treatment of drug addicts and prisoners with pulmonary tuberculosis in Hong Kong. Hong Kong Chest Service/British Medical Research Council.
Topics: Antitubercular Agents; Drug Administration Schedule; Drug Resistance, Microbial; Ethambutol; Heroin Dependence; Hong Kong; Humans; Isoniazid; Male; Opioid-Related Disorders; Opium; Prisoners; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary | 1980 |
[Side effects of various combinations of rifampin and isoniazid with ethambutol or streptomycin and pyrazinamide in short-term chemotherapy of newly-detected pulmonary tuberculosis].
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Drug Administration Schedule; Drug Hypersensitivity; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Middle Aged; Pyrazinamide; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1980 |
Hepatotoxicity associated with acetaminophen usage in patients receiving multiple drug therapy for tuberculosis.
Topics: Acetaminophen; Adult; Capreomycin; Ciprofloxacin; Drug Combinations; Drug Overdose; Ethambutol; Female; Humans; Isoniazid; Liver; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis; Tuberculosis, Lymph Node; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1994 |
Relapse rates in tuberculosis patients.
Topics: Antitubercular Agents; Drug Combinations; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Male; Patient Compliance; Pyrazinamide; Recurrence; Rifampin; Tuberculosis, Pulmonary | 1995 |
Drugs for tuberculosis.
Topics: Adult; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Combinations; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1995 |
Ethambutol-induced pulmonary infiltrates with eosinophilia and skin involvement.
Topics: Aged; Drug Eruptions; Drug Therapy, Combination; Eosinophilia; Ethambutol; Female; Humans; Isoniazid; Pulmonary Eosinophilia; Pyrazinamide; Radiography; Rifampin; Streptomycin; Thrombocytopenia; Tuberculosis, Miliary | 1995 |
Drug resistance of Mycobacterium tuberculosis strains isolated from HIV-infected Italian patients: preliminary report from a multicentric study. The Italian Tuberculosis Drug Resistance Study Group.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; HIV Infections; Humans; Isoniazid; Italy; Mycobacterium tuberculosis; Prospective Studies; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant | 1995 |
[Therapy of tuberculosis in the adult].
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1995 |
Transient exacerbation of tuberculous lymphadenitis during chemotherapy in patients with AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Ethambutol; Humans; Isoniazid; Leukocyte Count; Male; Pyrazinamide; Rifampin; Tuberculosis, Lymph Node; Tuberculosis, Multidrug-Resistant | 1994 |
Treating tuberculosis with one combination drug.
Topics: Antitubercular Agents; Drug Combinations; Ethambutol; Humans; Isoniazid; Patient Compliance; Pyrazinamide; Rifampin; Tuberculosis | 1994 |
Empiric antituberculosis treatment: benefits for earlier diagnosis and treatment of tuberculosis.
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Body Weight; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Fever; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Time Factors; Treatment Outcome; Tuberculosis | 1994 |
[Pulmonary tuberculosis in infants. Apropos of 6 cases].
Topics: BCG Vaccine; Drug Therapy, Combination; Ethambutol; Female; Humans; Infant; Isoniazid; Male; Pyrazinamide; Radiography; Rifampin; Tuberculosis, Pulmonary | 1994 |
Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Child; Clinical Protocols; Drug Monitoring; Ethambutol; Humans; Infant; Isoniazid; Patient Compliance; Pyrazinamide; Recurrence; Rifampin; Streptomycin; Tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1994 |
Rifampin-resistant Mycobacterium kansasii.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Antitubercular Agents; Ciprofloxacin; Clinical Protocols; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Pyrazinamide; Pyridoxine; Rifampin; Streptomycin; Texas; Treatment Outcome; Tuberculosis | 1994 |
[Hepatic toxicity of antitubercular agents. Role of different drugs. 199 cases].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ethambutol; Female; Humans; Infant; Isoniazid; Male; Middle Aged; Pyrazinamide; Retrospective Studies; Rifampin; Streptomycin; Tuberculosis | 1993 |
Turning intermittent regimens into daily regimens using blister-packs. An exploration in murine tuberculosis.
Topics: Animals; Antitubercular Agents; Drug Administration Schedule; Drug Packaging; Drug Therapy, Combination; Ethambutol; Isoniazid; Mice; Mice, Inbred BALB C; Pyrazinamide; Rifampin; Tuberculosis | 1993 |
Chemotherapy of tuberculosis for patients with renal impairment.
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Kidney Failure, Chronic; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1993 |
From the Centers for Disease Control and Prevention. Initial therapy for tuberculosis in the era of multidrug resistance: recommendations of the Advisory Council for the Elimination of Tuberculosis.
Topics: Adult; Antitubercular Agents; Child; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Humans; Immunocompromised Host; Infant; Isoniazid; Mycobacterium tuberculosis; Pregnancy; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis | 1993 |
CDC recommends four-drug treatment of tuberculosis in multidrug-resistant era.
Topics: Adult; Centers for Disease Control and Prevention, U.S.; Child; Drug Therapy; Drug Therapy, Combination; Ethambutol; Female; Humans; Immunocompromised Host; Infant; Isoniazid; Pregnancy; Pregnancy Complications, Infectious; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary; United States | 1993 |
Bactericidal action of pulsed exposure to rifampicin, ethambutol, isoniazid & pyrazinamide on Mycobacterium tuberculosis in vitro.
Topics: Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Time Factors | 1993 |
Initial therapy for tuberculosis in the era of multidrug resistance. Recommendations of the Advisory Council for the Elimination of Tuberculosis.
Topics: Adult; Antitubercular Agents; Child; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Humans; Immunocompromised Host; Infant; Isoniazid; Mycobacterium tuberculosis; Pregnancy; Pregnancy Complications, Infectious; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis | 1993 |
Antibiotic-resistant tuberculous choroiditis.
Topics: Aged; Anti-Bacterial Agents; Choroiditis; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Mycobacterium tuberculosis; Prednisone; Pyrazinamide; Rifampin; Sputum; Tuberculosis, Ocular; Uveitis; Visual Acuity | 1993 |
Pelvic-peritoneal tuberculosis with elevated serum and peritoneal fluid Ca-125 levels. A report of two cases.
Topics: Adnexal Diseases; Adult; Antigens, Tumor-Associated, Carbohydrate; Ascitic Fluid; Diagnosis, Differential; Ethambutol; Female; Humans; Infertility, Female; Isoniazid; Menopause; Middle Aged; Peritonitis, Tuberculous; Pyrazinamide; Rifampin; Tuberculosis, Female Genital; Uterine Diseases | 1993 |
Mycobacterial infections in renal allograft recipients.
Topics: Drug Therapy, Combination; Ethambutol; HIV Seropositivity; Humans; Immunosuppressive Agents; Isoniazid; Kidney Transplantation; Mycobacterium Infections; New York; Postoperative Complications; Pyrazinamide; Rifampin; Transplantation, Homologous | 1993 |
The high incidence of tuberculosis among renal transplant recipients in India.
Topics: Adult; Antitubercular Agents; Ethambutol; Female; Follow-Up Studies; Humans; Incidence; India; Isoniazid; Kidney Transplantation; Male; Pyrazinamide; Tuberculosis | 1996 |
Management of primary chest wall tuberculosis.
Topics: Abscess; Adult; Antibiotics, Antitubercular; Antitubercular Agents; Combined Modality Therapy; Debridement; Diagnosis, Differential; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Retrospective Studies; Rifampin; Suppuration; Thoracic Diseases; Thoracic Neoplasms; Treatment Outcome; Tuberculosis | 1995 |
Total hip arthroplasty complicated by tuberculous infection.
Topics: Aged; Anti-Bacterial Agents; Drug Therapy, Combination; Ethambutol; Female; Hip Joint; Hip Prosthesis; Humans; Isoniazid; Mycobacterium tuberculosis; Prosthesis Failure; Prosthesis-Related Infections; Pyrazinamide; Radiography; Range of Motion, Articular; Reoperation; Rifampin; Tuberculosis, Osteoarticular | 1996 |
Tuberculosis Control Programme Practical Guidelines, 1996--treatment regimens.
Topics: Antitubercular Agents; Ethambutol; Humans; Practice Guidelines as Topic; Pyrazinamide; Tuberculosis | 1996 |
Clinical manifestation and outcome of tuberculosis in children with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; AIDS-Related Opportunistic Infections; Antibiotics, Antitubercular; Antitubercular Agents; Capreomycin; Child; Child, Preschool; Ethambutol; Female; Humans; Infant; Isoniazid; Male; Microbial Sensitivity Tests; Pyrazinamide; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1996 |
The duration of excretion of viable bacilli in elderly patients on treatment for cavitating pulmonary tuberculosis.
Topics: Aged; Antitubercular Agents; Black People; Ethambutol; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Sputum; Time Factors; Tuberculosis, Pulmonary | 1996 |
Focal tuberculosis of the liver with local hemorrhage in a patient with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Ethambutol; Granuloma; Histocytochemistry; Homosexuality, Male; Humans; Isoniazid; Liver; Male; Mycobacterium; Pyrazinamide; Rifampin; Tuberculosis | 1996 |
The management of mycobacterial infections in HIV seropositive individuals. Jefferiss Wing Therapeutics and Protocols Group.
Topics: Adrenal Cortex Hormones; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Clofazimine; Drug Therapy, Combination; Ethambutol; HIV Infections; Humans; Isoniazid; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections; Nontuberculous Mycobacteria; Practice Guidelines as Topic; Pyrazinamide; Pyridoxine; Radiography; Rifabutin; Rifampin; Tuberculosis, Meningeal; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1996 |
Gout secondary to pyrazinamide and ethambutol.
Topics: Diuretics; Ethambutol; Gout; Humans; Male; Middle Aged; Pyrazinamide | 1996 |
Disseminated infection due to multidrug-resistant Mycobacterium bovis in a patient who was seropositive for human immunodeficiency virus.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; DNA Fingerprinting; DNA, Bacterial; Drug Resistance, Multiple; Ethambutol; HIV Infections; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium bovis; Mycobacterium Infections; Pyrazinamide; Rifampin | 1996 |
Unusual presentation of intra-abdominal tuberculosis.
Topics: Antitubercular Agents; Child; Diagnosis, Differential; Ethambutol; Female; Humans; Isoniazid; Mycobacterium tuberculosis; Peritonitis, Tuberculous; Pyrazinamide; Rifampin; Tuberculosis, Gastrointestinal | 1996 |
Tuberculosis control programme guidelines--treatment regimens.
Topics: Antitubercular Agents; Body Weight; Dose-Response Relationship, Drug; Drug Combinations; Ethambutol; Humans; Isoniazid; Optic Neuritis; Practice Guidelines as Topic; Pyrazinamide; Rifampin; South Africa; Streptomycin; Tuberculosis | 1996 |
Tuberculosis and renal transplantation.
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Follow-Up Studies; Humans; Isoniazid; Kidney Transplantation; Male; Postoperative Complications; Pyrazinamide; Retrospective Studies; Rifampin; Time Factors; Tuberculosis | 1996 |
Tuberculous perianal ulcers.
Topics: Adult; Antibiotics, Antitubercular; Antitubercular Agents; Ethambutol; Fissure in Ano; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Tuberculosis, Gastrointestinal | 1996 |
Effects of uricosuric and antiuricosuric agents on urate transport in human brush-border membrane vesicles.
Topics: Aged; Benzbromarone; Biological Transport; Biphenyl Compounds; Carbon Radioisotopes; Diuretics; Ethambutol; Humans; Imidazoles; Kidney Cortex; Kidney Neoplasms; Kinetics; Losartan; Microvilli; Middle Aged; Probenecid; Pyrazinamide; Salicylates; Salicylic Acid; Sulfinpyrazone; Tetrazoles; Ticrynafen; Uric Acid; Uricosuric Agents | 1997 |
Esophagomediastinal fistula as a complication of tuberculous mediastinal lymphadenitis.
Topics: Adult; Antibiotics, Antitubercular; Esophageal Fistula; Ethambutol; Female; Fistula; Humans; Isoniazid; Mediastinal Diseases; Pyrazinamide; Radiography, Thoracic; Rifampin; Tomography, X-Ray Computed; Tuberculosis, Lymph Node | 1996 |
Vulvovaginal tuberculosis: a case report.
Topics: Aged; Anti-Bacterial Agents; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; HIV Seronegativity; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis, Female Genital; Vulvovaginitis | 1997 |
[Hematologic abnormalities in pulmonary tuberculosiss].
Topics: Anemia; Antitubercular Agents; Ethambutol; Hematologic Diseases; Humans; Leukopenia; Pancytopenia; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1997 |
Pancreatic insufficiency due to antituberculous therapy.
Topics: Antitubercular Agents; Chronic Disease; Drug Hypersensitivity; Drug Therapy, Combination; Ethambutol; Exocrine Pancreatic Insufficiency; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin | 1997 |
Reduced plasma concentrations of antituberculosis drugs in patients with HIV infection.
Topics: Adult; Aged; Antitubercular Agents; Case-Control Studies; Diarrhea; Ethambutol; Female; HIV Infections; HIV Seropositivity; Humans; Intestinal Absorption; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin | 1997 |
Autoimmune haemolytic anaemia responding to anti-tuberculous treatment.
Topics: Adult; Anemia, Hemolytic; Antitubercular Agents; Autoimmune Diseases; Biopsy; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Tuberculosis, Lymph Node | 1997 |
Problems of diagnosis and treatment of tuberculosis following renal transplantation.
Topics: Adolescent; Adult; Antitubercular Agents; Bronchoalveolar Lavage Fluid; Drug Therapy, Combination; Ethambutol; Female; Humans; Immunosuppressive Agents; Isoniazid; Kidney Transplantation; Male; Middle Aged; Pakistan; Postoperative Complications; Pyrazinamide; Retrospective Studies; Sputum; Time Factors; Tuberculosis, Pulmonary | 1997 |
[Effects of intermittent short-course chemotherapy under full-course supervision on the treatment of smear positive pulmonary tuberculosis].
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Follow-Up Studies; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1996 |
[CT scanning and treatment of intracranial tuberculoma].
Topics: Adolescent; Animals; Antitubercular Agents; Child; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Parietal Lobe; Pyrazinamide; Rabbits; Retrospective Studies; Rifampin; Streptomycin; Tomography, X-Ray Computed; Tuberculoma, Intracranial | 1996 |
Unusual miliary tuberculosis presenting with generalized lymphadenopathy and abdominal involvement.
Topics: Adult; Antitubercular Agents; Biopsy; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Follow-Up Studies; Humans; Isoniazid; Lymph Nodes; Lymphatic Diseases; Male; Neck; Pleural Effusion; Prednisolone; Pyrazinamide; Rifampin; Sputum; Tomography, X-Ray Computed; Tuberculosis, Gastrointestinal; Tuberculosis, Miliary | 1997 |
[Reasons for chronic expectoration--case reports].
Topics: Adult; Aged; Antitubercular Agents; Capreomycin; Cycloserine; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Patient Compliance; Pyrazinamide; Rifampin; Secondary Prevention; Sputum; Streptomycin; Treatment Failure; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1997 |
[Surgical treatment of patients with multi-resistant pulmonary tuberculosis--case reports].
Topics: Adult; Antitubercular Agents; Bronchial Fistula; Drug Therapy, Combination; Ethambutol; Fatal Outcome; Humans; Isoniazid; Male; Middle Aged; Pleural Diseases; Pneumonectomy; Pyrazinamide; Rifampin; Sputum; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1997 |
[A case of multiple intracranial tuberculoma diagnosed by open brain biopsy].
Topics: Antitubercular Agents; Biopsy; Brain; Ethambutol; Humans; Immunocompromised Host; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Streptomycin; Tuberculoma, Intracranial | 1997 |
Risk factors for hepatotoxicity induced by antituberculosis drugs.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Child; Ethambutol; Female; Humans; Isoniazid; Logistic Models; Male; Middle Aged; Pyrazinamide; Retrospective Studies; Rifampin; Risk Factors; Streptomycin | 1997 |
[Thrombocytopenia following a re-introduction of rifampicin in a daily treatment. Apropos of a case].
Topics: Adult; Antibiotics, Antitubercular; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Drug Administration Schedule; Drug Hypersensitivity; Ethambutol; Humans; Isoniazid; Male; Middle Aged; Purpura; Pyrazinamide; Rifampin; Streptomycin; Thrombocytopenia; Tuberculosis, Pulmonary | 1995 |
Two excellent management tools for national tuberculosis programmes: history of prior treatment and sputum status at two months.
Topics: Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Medical Records; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Sputum; Streptomycin; Tuberculosis, Pulmonary | 1998 |
Physician compliance with national tuberculosis treatment guidelines: a university hospital study.
Topics: Antitubercular Agents; Cerebrospinal Fluid; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Hospitals, University; Humans; Isoniazid; Mycobacterium tuberculosis; Pakistan; Physicians; Practice Guidelines as Topic; Pyrazinamide; Rifampin; Sputum; Surveys and Questionnaires; Tuberculosis; World Health Organization | 1998 |
[Complications of polychemotherapy for renal tuberculosis].
Topics: Adult; Antitubercular Agents; Drug Administration Routes; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pyrazinamide; Retrospective Studies; Streptomycin; Tuberculosis, Renal | 1998 |
How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis.
Topics: AIDS-Related Opportunistic Infections; Antibiotics, Antitubercular; Antitubercular Agents; Drug Administration Schedule; Drug Resistance, Microbial; Ethambutol; HIV Seropositivity; Humans; Isoniazid; Mutation; Mycobacterium tuberculosis; Patient Compliance; Pyrazinamide; Recurrence; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1998 |
Epidemiology of drug-resistant tuberculosis in New Jersey from 1991 to 1995.
Topics: Adult; Age Distribution; Aged; Antitubercular Agents; Confidence Intervals; Ethambutol; Female; Humans; Incidence; Isoniazid; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; New Jersey; Odds Ratio; Population Surveillance; Pyrazinamide; Rifampin; Risk Factors; Sex Distribution; Streptomycin; Tuberculosis, Multidrug-Resistant | 1998 |
Short-course chemotherapy for isoniazid-resistant pulmonary tuberculosis.
Topics: Antitubercular Agents; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Retrospective Studies; Rifampin; Tuberculosis, Pulmonary | 1998 |
Drug-resistant tuberculosis of the brain in a two-year-old child.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Brain Diseases; Child, Preschool; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Hip Joint; Humans; Magnetic Resonance Imaging; Pyrazinamide; Rifampin; Time Factors; Tuberculosis, Multidrug-Resistant; Tuberculosis, Osteoarticular; Tuberculosis, Pulmonary | 1998 |
[Eruption after the 1st dose of standard antitubercular chemotherapy. Thoughts on pyrazinamide].
Topics: Aged; Antitubercular Agents; Child; Drug Combinations; Drug Eruptions; Ethambutol; Exanthema; Female; Humans; Isoniazid; Male; Middle Aged; Pruritus; Pyrazinamide; Recurrence; Rifampin; Tuberculosis, Pulmonary | 1998 |
[Resistance and multiresistance to antitubercular drugs in Argentina and in other Latin American countries].
Topics: Acquired Immunodeficiency Syndrome; Antitubercular Agents; Argentina; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Latin America; Mycobacterium tuberculosis; Pyrazinamide; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1998 |
Peptide-specific T cell response to Mycobacterium tuberculosis: clinical spectrum, compartmentalization, and effect of chemotherapy.
Topics: Adolescent; Adult; Antigens, Bacterial; Antitubercular Agents; Bacterial Proteins; BCG Vaccine; Cell Division; Cells, Cultured; Epitopes, T-Lymphocyte; Ethambutol; Female; Humans; Interferon-gamma; Interleukin-10; Isoniazid; Leukocytes, Mononuclear; Lipoproteins; Male; Middle Aged; Mycobacterium tuberculosis; Peptides; Pleural Effusion; Pyrazinamide; Rifampin; T-Lymphocytes; Tuberculin; Tuberculosis | 1998 |
Primary tuberculous tracheitis.
Topics: Antitubercular Agents; Cough; Ethambutol; Female; Humans; Isoniazid; Middle Aged; Pyrazinamide; Respiratory Sounds; Rifampin; Tracheal Stenosis; Tracheitis; Tuberculosis, Pulmonary | 1998 |
Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998. Joint Tuberculosis Committee of the British Thoracic Society.
Topics: Adult; Antitubercular Agents; Child; Child, Preschool; Disease Notification; Drug Administration Schedule; Ethambutol; Female; Humans; Infant; Isoniazid; Male; Pregnancy; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1998 |
Longitudinal trends in serum levels of mycobacterial secretory (30 kD) and cytoplasmic (65 kD) antigens during chemotherapy of pulmonary tuberculosis patients.
Topics: Antibodies, Bacterial; Antigens, Bacterial; Antitubercular Agents; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Time Factors; Treatment Outcome; Tuberculosis, Pulmonary | 1998 |
[Fulminant hepatitis in the course of antitubercular treatment (apropos of 2 cases)].
Topics: Adult; Anti-Bacterial Agents; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Ethambutol; Fatal Outcome; Female; HIV Infections; Humans; Isoniazid; Liver Function Tests; Pyrazinamide; Rifampin; Tuberculosis, Miliary; Tuberculosis, Pulmonary | 1995 |
Tuberculosis of the pyriform fossa--a rare entity.
Topics: Adult; Antitubercular Agents; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Laryngoscopy; Male; Pharyngeal Diseases; Pharyngeal Neoplasms; Pyrazinamide; Radiography; Rifampin; Tuberculosis; Tuberculosis, Laryngeal; Tuberculosis, Pulmonary | 1998 |
[Hepatic tuberculosis: a case with pseudotumours form].
Topics: Adult; Antibiotics, Antitubercular; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Pyrazinamide; Rifampin; Time Factors; Tomography, X-Ray Computed; Tuberculosis, Hepatic | 1998 |
The effect of hemodialysis on isoniazid, rifampin, pyrazinamide, and ethambutol.
Topics: Adult; Antibiotics, Antitubercular; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Renal Dialysis; Rifampin | 1999 |
Mycobacterium bovis BCG causing vertebral osteomyelitis (Pott's disease) following intravesical BCG therapy.
Topics: Administration, Intravesical; Aged; Antitubercular Agents; BCG Vaccine; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Male; Mycobacterium bovis; Osteomyelitis; Pyrazinamide; Rifampin; Tuberculosis, Spinal; Urinary Bladder Neoplasms | 1999 |
-Skin eruption after the first dose of antitubercular quadri-therapy: consideration of pyrazinamide-.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Child; Drug Combinations; Drug Eruptions; Ethambutol; Exanthema; Humans; Isoniazid; Male; Pyrazinamide; Recurrence; Rifampin; Tuberculosis, Pulmonary | 1998 |
[Six-months chemotherapy (2HRZS or E/4HRE) of new cases of pulmonary tuberculosis--six year experiences on its effectiveness, toxicity, and acceptability].
Topics: Adult; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Diabetes Complications; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Patient Acceptance of Health Care; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1999 |
Twice-weekly, directly observed treatment for HIV-infected and uninfected tuberculosis patients: cohort study in rural South Africa.
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Cohort Studies; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Predictive Value of Tests; Prospective Studies; Pyrazinamide; Rifampin; South Africa; Sputum; Treatment Outcome; Tuberculosis | 1999 |
Drug-resistant tuberculosis in the Philippines.
Topics: Antitubercular Agents; Drug Resistance, Multiple; Ethambutol; Female; Humans; Incidence; Isoniazid; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Philippines; Pyrazinamide; Rifampin; Tuberculosis, Multidrug-Resistant | 1999 |
Four-month, four-drug preventive therapy for inactive pulmonary tuberculosis.
Topics: Adult; Aged; Antitubercular Agents; Cost-Benefit Analysis; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Emigration and Immigration; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Patient Compliance; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary | 1999 |
Cutaneous tuberculosis: efficient therapeutic response in a case with multiple lesions.
Topics: Adult; Antibiotics, Antitubercular; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Foot Dermatoses; Hand Dermatoses; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis, Cutaneous | 1999 |
Is the treatment of WHO category I tuberculosis with 2HRZE/6HE a defensible practice?
Topics: Antitubercular Agents; Developing Countries; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; World Health Organization | 1999 |
Relapse rates after short-course (6-month) treatment of tuberculosis in HIV-infected and uninfected persons.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; AIDS-Related Opportunistic Infections; Antitubercular Agents; Child; Child, Preschool; Cohort Studies; Ethambutol; Female; Follow-Up Studies; Humans; Infant; Isoniazid; Male; Middle Aged; Pyrazinamide; Recurrence; Rifampin; Time Factors; Tuberculosis | 1999 |
Pulmonary nodule mimicking lung cancer in a human immunodeficiency virus type-1 infected patient.
Topics: Acquired Immunodeficiency Syndrome; Adenocarcinoma; Adult; Antitubercular Agents; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; HIV-1; Humans; Isoniazid; Lung Neoplasms; Male; Pyrazinamide; Rifampin; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 1999 |
Evaluation of a bacteriophage-based assay (phage amplified biologically assay) as a rapid screen for resistance to isoniazid, ethambutol, streptomycin, pyrazinamide, and ciprofloxacin among clinical isolates of Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Ciprofloxacin; Drug Resistance, Microbial; Ethambutol; Evaluation Studies as Topic; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacteriophages; Mycobacterium tuberculosis; Phenotype; Pyrazinamide; Streptomycin; Tuberculosis | 1999 |
[Current aspects of spinal tuberculosis: apropos of 16 case reports].
Topics: Adult; Aged; Antibiotics, Antitubercular; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Magnetic Resonance Imaging; Male; Middle Aged; Pyrazinamide; Retrospective Studies; Rifampin; Tomography, X-Ray Computed; Tuberculosis, Spinal | 1999 |
The colorimetric analysis of anti-tuberculosis fixed-dose combination tablets and capsules.
Topics: Antitubercular Agents; Capsules; Chemistry, Pharmaceutical; Colorimetry; Drug Combinations; Ethambutol; Isoniazid; Pyrazinamide; Rifampin; Tablets | 1999 |
[Breast abscess and pregnancy toxemia revealing multidrug resistant tuberculosis].
Topics: Abscess; Adult; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Antitubercular Agents; Breast Diseases; Bronchoscopy; Cesarean Section; Ciprofloxacin; Drug Therapy, Combination; Eclampsia; Ethambutol; Female; Follow-Up Studies; Humans; Infant, Newborn; Pregnancy; Pregnancy Complications, Infectious; Pyrazinamide; Radiography, Thoracic; Time Factors; Tomography, X-Ray Computed; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1999 |
Mycobacterial infections in solid organ transplant recipients.
Topics: Adolescent; Adult; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Male; Mycobacterium Infections; Organ Transplantation; Postoperative Complications; Pyrazinamide; Retrospective Studies; Rifampin; Rural Population; Socioeconomic Factors; Time Factors; Turkey | 1999 |
Unusual clinical manifestation of tuberculosis in a renal transplant recipient.
Topics: Adult; Antitubercular Agents; Ethambutol; Fatal Outcome; Female; Humans; Isoniazid; Kidney Transplantation; Liver; Liver Function Tests; Postoperative Complications; Pyrazinamide; Rifampin; Tuberculin Test; Tuberculosis | 1999 |
Reply to Davis and colleagues: Twice weekly, directly observed treatment for HIV-infected and uninfected tuberculosis patients: cohort study in rural South Africa.
Topics: Antitubercular Agents; Drug Administration Schedule; Drug Resistance, Microbial; Drug Resistance, Multiple; Ethambutol; HIV Infections; Humans; Isoniazid; Pyrazinamide; Rifampin; South Africa; Tuberculosis, Pulmonary | 1999 |
Diagnosis and treatment of cervical tuberculous lymphadenitis.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antitubercular Agents; Biopsy, Needle; Child; Child, Preschool; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium; Neck Dissection; Pyrazinamide; Retrospective Studies; Rifampin; Treatment Outcome; Tuberculosis, Lymph Node | 2000 |
Antituberculosis activity of once-weekly rifapentine-containing regimens in mice. Long-term effectiveness with 6- and 8-month treatment regimens.
Topics: Animals; Antibiotics, Antitubercular; Antitubercular Agents; Colony Count, Microbial; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Isoniazid; Lung; Mice; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Spleen; Streptomycin; Tuberculosis | 2000 |
Kinetics of circulating antibodies, immune complex and specific antibody-secreting cells in tuberculosis patients during 6 months of antimicrobial therapy.
Topics: Adult; Aged; Anti-Bacterial Agents; Antibodies, Bacterial; Antibody-Producing Cells; Antigen-Antibody Complex; Antitubercular Agents; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Predictive Value of Tests; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary | 2000 |
Relation of leptin and tumor necrosis factor alpha to body weight changes in patients with pulmonary tuberculosis.
Topics: Adult; Antibiotics, Antitubercular; Antitubercular Agents; Body Mass Index; Body Weight; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Leptin; Male; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary; Tumor Necrosis Factor-alpha | 1999 |
The comparison of tuberculosis treatments: a short course therapy and the directly observed short course treatment (DOTS), East Java Province, Indonesia.
Topics: Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Humans; Indonesia; Isoniazid; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary | 2000 |
Comparison of Mycobacterium tuberculosis susceptibility testing performed with BACTEC 460TB (Becton Dickinson) and MB/BacT (Organon Teknika) systems.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Carbon Dioxide; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Reagent Kits, Diagnostic; Rifampin; Sensitivity and Specificity; Streptomycin; Time Factors | 2000 |
Evaluation of rifalazil in a combination treatment regimen as an alternative to isoniazid-rifampin therapy in a mouse tuberculosis model.
Topics: Animals; Antitubercular Agents; Colony-Forming Units Assay; Disease Models, Animal; Drug Therapy, Combination; Ethambutol; Female; Isoniazid; Mice; Pyrazinamide; Rifampin; Rifamycins; Tuberculosis | 2000 |
Treatment of tuberculosis: a well-standardised protocol.
Topics: Adult; Child; Clinical Protocols; Ethambutol; France; Humans; Isoniazid; Pyrazinamide; Rifampin; Time Factors; Tuberculosis; United Kingdom; United States; World Health Organization | 2000 |
Chromosomal aberrations and micronuclei in lymphocytes of patients before and after exposure to anti-tuberculosis drugs.
Topics: Adolescent; Adult; Age Factors; Aged; Antibiotics, Antitubercular; Antitubercular Agents; Case-Control Studies; Cell Nucleus; Chromosome Aberrations; Ethambutol; Female; Humans; Isoniazid; Lymphocytes; Male; Micronuclei, Chromosome-Defective; Middle Aged; Pyrazinamide; Rifampin; Streptomycin | 2000 |
Hypercalcemia in renal transplant patients with tuberculosis.
Topics: Adult; Antitubercular Agents; Blood Urea Nitrogen; Calcitriol; Calcium; Ethambutol; Humans; Hypercalcemia; Kidney Transplantation; Male; Parathyroid Hormone; Postoperative Complications; Pyrazinamide; Time Factors; Tuberculosis, Pulmonary | 2000 |
Tuberculous abscess of the graft in a renal transplant recipient after chronic rejection: case report.
Topics: Abscess; Adult; Antitubercular Agents; Chronic Disease; Drug Therapy, Combination; Ethambutol; Female; Graft Rejection; Humans; Isoniazid; Kidney Transplantation; Nephrectomy; Pyrazinamide; Reoperation; Rifampin; Tuberculosis | 2000 |
Tuberculosis after renal transplantation.
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Incidence; India; Isoniazid; Kidney Transplantation; Living Donors; Male; Postoperative Complications; Pyrazinamide; Pyridoxine; Retrospective Studies; Rifampin; Time Factors; Tuberculosis; Tuberculosis, Pulmonary | 2000 |
Paradoxical worsening of tuberculosis after anti-TB therapy in a kidney transplant recipient.
Topics: Adult; Antitubercular Agents; Disease Progression; Drug Therapy, Combination; Ethambutol; Female; Humans; Immunosuppressive Agents; Isoniazid; Kidney Transplantation; Living Donors; Mycobacterium tuberculosis; Postoperative Complications; Pyrazinamide; Rifampin; Tomography, X-Ray Computed; Tuberculosis, Pulmonary | 2000 |
Normouricemia in the syndrome of inappropriate antidiuretic hormone secretion.
Topics: Acquired Immunodeficiency Syndrome; Ethambutol; Humans; Hyponatremia; Inappropriate ADH Syndrome; Lung Neoplasms; Male; Middle Aged; Pneumonia, Pneumocystis; Pyrazinamide; Tuberculosis, Pulmonary; Uric Acid | 2001 |
[Early anterolateral surgery for tuberculosis of the lower cervical spine with neurological complications in adult. Our experience in Gabon].
Topics: Adult; Antitubercular Agents; Cervical Vertebrae; Combined Modality Therapy; Debridement; Emergencies; Ethambutol; Follow-Up Studies; Gabon; Humans; Isoniazid; Kyphosis; Paraplegia; Physical Therapy Modalities; Pyrazinamide; Quadriplegia; Retrospective Studies; Rifampin; Treatment Outcome; Tuberculosis, Spinal | 2000 |
A whole blood bactericidal assay for tuberculosis.
Topics: Anti-Infective Agents; Antitubercular Agents; Aza Compounds; Blood; Blood Bactericidal Activity; Culture Media; Ethambutol; Fluoroquinolones; Humans; Isoniazid; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Pyrazinamide; Quinolines; Rifampin | 2001 |
Tuberculosis treatment: dangerous regimens?
Topics: Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Thioacetazone; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; World Health Organization | 2001 |
Osteoarticular tuberculosis: current diagnosis and treatment.
Topics: Adult; Antitubercular Agents; Ethambutol; Humans; Isoniazid; Male; Mycobacterium; Osteoarthritis, Knee; Pyrazinamide; Rifampin; Streptomycin; Synovial Fluid; Tuberculosis, Osteoarticular | 2000 |
Increasing resistance of M. tuberculosis to anti-TB drugs in Saudi Arabia.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Prevalence; Pyrazinamide; Rifampin; Saudi Arabia; Streptomycin; Tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2001 |
Multifocal extensive spinal tuberculosis (Pott's disease) involving cervical, thoracic and lumbar vertebrae.
Topics: Antitubercular Agents; Cervical Vertebrae; Ethambutol; Female; Humans; Isoniazid; Lumbar Vertebrae; Middle Aged; Pyrazinamide; Quadriplegia; Rifampin; Thoracic Vertebrae; Tomography, X-Ray Computed; Treatment Outcome; Tuberculosis, Spinal | 2001 |
CPCRA researchers present OI studies at Vancouver.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Antitubercular Agents; Candidiasis; Child; Clarithromycin; Clinical Trials as Topic; DNA, Viral; Drug Therapy, Combination; Ethambutol; Female; Fluconazole; Humans; Isoniazid; Molluscum Contagiosum; Molluscum contagiosum virus; Multicenter Studies as Topic; Mycobacterium avium-intracellulare Infection; Ofloxacin; Patient Compliance; Pyrazinamide; Rifampin; Sequence Analysis, DNA; Tuberculosis | 1996 |
Rifampicin allergy confirmed by an intradermal test, but with a negative patch test.
Topics: Antitubercular Agents; Diagnosis, Differential; Drug Eruptions; Ethambutol; False Negative Reactions; Female; Humans; Intradermal Tests; Isoniazid; Middle Aged; Patch Tests; Peritonitis, Tuberculous; Pyrazinamide; Pyridoxine; Rifampin | 2001 |
Treatment of tuberculosis in Haiti.
Topics: Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Haiti; Health Services Research; Humans; Isoniazid; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis | 2001 |
Isonicotinic acid hydrazide induced anagen effluvium and associated lichenoid eruption.
Topics: Adult; Alopecia; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Lichenoid Eruptions; Pyrazinamide; Rifampin; Scalp Dermatoses; Tuberculosis, Gastrointestinal | 2001 |
Tuberculosis presenting as immune thrombocytopenic purpura.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Autoimmune Diseases; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Lymph Nodes; Middle Aged; Mycobacterium tuberculosis; Purpura, Thrombocytopenic, Idiopathic; Pyrazinamide; Pyridoxine; Rifampin; Tuberculosis | 2002 |
Can serial qualitative polymerase chain reaction monitoring predict outcome of pulmonary tuberculosis treatment?
Topics: Antitubercular Agents; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Sputum; Time Factors; Tuberculosis, Pulmonary | 2001 |
Tuberculous meningoencephalitis in HIV-seronegative patients: variety of clinical presentation and impact on diagnostics and treatment.
Topics: Adult; Aged; Antitubercular Agents; Brain; Drug Therapy, Combination; Ethambutol; Female; HIV Seronegativity; Humans; Isoniazid; Lumbar Vertebrae; Magnetic Resonance Imaging; Male; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis, Meningeal | 2001 |
Erythema nodosum associated with reactivation tuberculous lymphadenitis (scrofula).
Topics: Aged; Antitubercular Agents; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Leg; Mycobacterium tuberculosis; Neck; Pyrazinamide; Rifampin; Tomography, X-Ray Computed; Tuberculosis, Lymph Node | 2002 |
Use of molecular techniques to distinguish between treatment failure and exogenous reinfection with Mycobacterium tuberculosis.
Topics: Adult; Aged; Antibiotics, Antitubercular; Antitubercular Agents; Bacterial Typing Techniques; DNA Fingerprinting; Drug Administration Schedule; Drug Resistance, Bacterial; Ethambutol; Female; Genetics, Microbial; Humans; Isoniazid; Kanamycin; Male; Middle Aged; Mycobacterium tuberculosis; Polymorphism, Restriction Fragment Length; Pyrazinamide; Recurrence; Retrospective Studies; Rifampin; Streptomycin; Treatment Failure; Tuberculosis, Pulmonary | 2002 |
Antitubercular therapy decreases nitric oxide production in HIV/TB coinfected patients.
Topics: Adult; Antibiotics, Antitubercular; Antitubercular Agents; Biomarkers; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Citrulline; Drug Administration Schedule; Enzyme Inhibitors; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Male; Middle Aged; Mycobacterium; Nitric Oxide; Nitrites; Pyrazinamide; Rifampin; T-Lymphocyte Subsets; Tuberculosis | 2002 |
Behavior of uptake of moisture by drugs and excipients under accelerated conditions of temperature and humidity in the absence and the presence of light. 1. Pure anti-tuberculosis drugs and their combinations.
Topics: Adsorption; Antitubercular Agents; Darkness; Drug Combinations; Drug Stability; Ethambutol; Excipients; Isoniazid; Light; Pyrazinamide; Rifampin; Temperature; Water | 2002 |
Frequency of recurrence among MDR-tB cases 'successfully' treated with standardised short-course chemotherapy.
Topics: Adult; Antibiotics, Antitubercular; Antitubercular Agents; Drug Administration Schedule; Drug Combinations; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Recurrence; Rifampin; Russia; Streptomycin; Time Factors; Treatment Failure; Tuberculosis, Multidrug-Resistant | 2002 |
[Myrin P in the combined treatment of tuberculosis].
Topics: Adolescent; Adult; Antitubercular Agents; Drug Combinations; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Isoniazid; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 2002 |
Population pharmacokinetics of antituberculous drugs and treatment of Mycobacterium bovis infection in bongo antelope (Tragelaphus eurycerus isaaci).
Topics: Amikacin; Animals; Antelopes; Antitubercular Agents; Area Under Curve; Ethambutol; Female; Isoniazid; Levofloxacin; Male; Mycobacterium bovis; Ofloxacin; Pyrazinamide; Rifampin; Tuberculosis | 2002 |
Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antibiotics, Antitubercular; Child; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Retrospective Studies; Rifampin; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2002 |
Bactericidal and sterilizing activities of antituberculosis drugs during the first 14 days.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Colony Count, Microbial; Confidence Intervals; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Probability; Pyrazinamide; Rifampin; Sensitivity and Specificity; Sputum; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 2003 |
Prognosis of tuberculous meningitis in adults in the era of modern antituberculous chemotherapy.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Immunocompromised Host; Isoniazid; Leukocyte Count; Male; Mycobacterium tuberculosis; Prognosis; Pyrazinamide; Rifampin; Streptomycin; Treatment Outcome; Tuberculosis, Meningeal | 2002 |
Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Drug Eruptions; Ethambutol; Female; HIV Seropositivity; Humans; Incidence; Isoniazid; Male; Middle Aged; Proportional Hazards Models; Pyrazinamide; Rifampin; Risk Factors; Tuberculosis, Pulmonary | 2003 |
Perianal tuberculosis: a rare case of skin ulceration?
Topics: Adult; Antitubercular Agents; Anus Diseases; Ethambutol; Humans; Male; Pyrazinamide; Skin Ulcer; Treatment Outcome; Tuberculosis, Cutaneous; Tuberculosis, Pulmonary | 2002 |
Drug-resistant Mycobacterium tuberculosis among new tuberculosis patients, Yangon, Myanmar.
Topics: AIDS-Related Opportunistic Infections; Drug Resistance, Bacterial; Ethambutol; Humans; Isoniazid; Myanmar; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Treatment Failure; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2003 |
Evaluation of the recently reported USP gradient HPLC method for analysis of anti-tuberculosis drugs for its ability to resolve degradation products of rifampicin.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Chromatography, High Pressure Liquid; Drug Combinations; Ethambutol; Isoniazid; Pharmacopoeias as Topic; Pyrazinamide; Reference Standards; Rifampin; Tablets; United States | 2003 |
The decline of high drug resistance rate of pulmonary Mycobacterium tuberculosis isolates from a southern Taiwan medical centre, 1996-2000.
Topics: Antitubercular Agents; Cycloserine; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; In Vitro Techniques; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Retrospective Studies; Rifampin; Streptomycin; Taiwan; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2003 |
Choroidal tuberculoma in miliary tuberculosis.
Topics: Adult; Anti-Bacterial Agents; Antitubercular Agents; Choroid Diseases; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Ethambutol; Fluorescein Angiography; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Sputum; Tomography, X-Ray Computed; Tuberculoma; Tuberculosis, Miliary; Tuberculosis, Ocular; Ultrasonography | 2003 |
Anti-tuberculosis 4FDC tablets--mystery to chemistry.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Drug Combinations; Drug Stability; Drug Storage; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Tablets; Tuberculosis | 2003 |
Pharmaceutical formulation of a fixed-dose anti-tuberculosis combination.
Topics: Administration, Oral; Antibiotics, Antitubercular; Antitubercular Agents; Chemistry, Pharmaceutical; Dose-Response Relationship, Drug; Drug Combinations; Drug Compounding; Ethambutol; Excipients; Feasibility Studies; Humans; Isoniazid; Powders; Pyrazinamide; Rifampin; Tuberculosis | 2003 |
A pilot stability study on four-drug fixed-dose combination anti-tuberculosis products.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Biological Availability; Drug Combinations; Drug Labeling; Drug Packaging; Drug Stability; Drug Storage; Ethambutol; Humans; Isoniazid; Pilot Projects; Pyrazinamide; Rifampin; Tablets; Time Factors; Tuberculosis | 2003 |
Bilateral bone loss of the maxilla.
Topics: Adult; Alveolar Bone Loss; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Maxillary Diseases; Pyrazinamide; Rifampin; Tuberculosis, Oral | 2003 |
PULMONARY TUBERCULOSIS.
Topics: Adrenal Cortex Hormones; Aminosalicylic Acid; Aminosalicylic Acids; Child; Cycloserine; Drug Resistance; Drug Resistance, Microbial; Ethambutol; Ethionamide; Isoniazid; Kanamycin; Mycobacterium Infections; Pharmacology; Prognosis; Pyrazinamide; Streptomycin; Surgical Procedures, Operative; Thiosemicarbazones; Toxicology; Tuberculosis; Tuberculosis, Miliary; Tuberculosis, Pulmonary; Viomycin | 1964 |
[DRUG TREATMENT OF RENAL TUBERCULOSIS].
Topics: Adrenal Cortex Hormones; Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Dihydrostreptomycin Sulfate; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Oxytetracycline; Phenylthiourea; Pyrazinamide; Streptomycin; Thiosemicarbazones; Tuberculosis; Tuberculosis, Renal; Viomycin | 1964 |
RE-TREATMENT OF DRUG-RESISTANT PULMONARY TUBERCULOSIS AT BATTEY STATE HOSPITAL.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Cycloserine; Drug Resistance; Drug Resistance, Microbial; Drug Therapy; Ethambutol; Ethionamide; Geriatrics; Hospitals, State; Isoniazid; Kanamycin; Pyrazinamide; Streptomycin; Toxicology; Tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Viomycin | 1964 |
CHEMOTHERAPY REGIMENS USED IN RETREATMENT OF PULMONARY TUBERCULOSIS. II. OBSERVATIONS ON THE EFFICACY OF COMBINATIONS OF ETHAMBUTOL, CAPREOMYCIN AND COMPANION DRUGS, INCLUDING 4-4 DIISOAMYLOXYTHIOSEMICARBANILIDE.
Topics: Antitubercular Agents; Capreomycin; Cycloserine; Drug Resistance; Drug Resistance, Microbial; Drug Therapy; Ethambutol; Ethionamide; Kanamycin; Phenylthiourea; Pyrazinamide; Retreatment; Toxicology; Tuberculosis; Tuberculosis, Pulmonary; Viomycin | 1965 |
[Severe course and contingent risk factors in optic neuropathy and myelopathy after tuberculostatics].
Topics: Adult; Antitubercular Agents; Disease Progression; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Male; Optic Nerve Diseases; Photophobia; Pyrazinamide; Rifampin; Risk Factors; Risk Management; Spinal Cord Diseases; Treatment Outcome; Tuberculosis, Lymph Node | 2003 |
Bioavailability of rifampicin following concomitant administration of ethambutol or isoniazid or pyrazinamide or a combination of the three drugs.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Area Under Curve; Body Weight; Ethambutol; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Staphylococcus aureus; Time Factors | 2003 |
Multidrug-resistant Mycobacterium tuberculosis in HIV-infected persons, Peru.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Ethambutol; Female; HIV Infections; Humans; Interviews as Topic; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Peru; Prevalence; Pyrazinamide; Rifampin; Tuberculosis, Multidrug-Resistant | 2003 |
[Septic loosening of a Wagner revision stem provoked by Mycobacterium tuberculosis].
Topics: Acetabulum; Aged; Antibiotics, Antitubercular; Antitubercular Agents; Arthroplasty, Replacement, Hip; Ethambutol; Follow-Up Studies; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Prosthesis Failure; Prosthesis-Related Infections; Pyrazinamide; Radioimmunoassay; Reoperation; Rifampin; Synovial Fluid; Time Factors; Titanium; Tuberculosis | 2003 |
Retrovesical tuberculosis.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Biopsy, Fine-Needle; Child; Combined Modality Therapy; Drug Therapy, Combination; Ethambutol; Fever; Humans; Isoniazid; Laparotomy; Male; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tomography, X-Ray Computed; Tuberculoma; Tuberculosis, Urogenital; Ultrasonography, Interventional; Urination Disorders | 2004 |
Cranial-epidural tuberculosis presenting as a scalp swelling.
Topics: Adult; Antitubercular Agents; Biopsy; Diagnosis, Differential; Drug Therapy, Combination; Edema; Epidural Space; Ethambutol; Frontal Bone; Humans; Isoniazid; Magnetic Resonance Imaging; Male; Parietal Bone; Pyrazinamide; Rifampin; Scalp; Tomography, X-Ray Computed; Tuberculosis, Osteoarticular | 2004 |
Characteristics and outcome of tuberculosis patients whose sputum smears are positive at or after 5 months of treatment.
Topics: Adult; Antitubercular Agents; Ethambutol; Female; Follow-Up Studies; Health Surveys; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Sputum; Time Factors; Treatment Outcome; Tuberculosis, Pulmonary | 2004 |
Drug resistance trends among previously treated tuberculosis patients in a national registry in Peru, 1994-2001.
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Isoniazid; Peru; Pyrazinamide; Registries; Retrospective Studies; Rifampin; Streptomycin; Treatment Outcome; Tuberculosis | 2004 |
Prescriptions and dosages of anti-tuberculosis drugs in the National Tuberculosis Control Programme of Malawi.
Topics: Administration, Oral; Adult; Antibiotics, Antitubercular; Antitubercular Agents; Body Weight; Communicable Disease Control; Drug Therapy, Combination; Drug Utilization Review; Ethambutol; Female; Guideline Adherence; Hospital Records; Hospitals, Public; Humans; Isoniazid; Malawi; Male; Middle Aged; Pyrazinamide; Registries; Rifampin; Tuberculosis, Pulmonary | 2004 |
A 32-year-old man with tuberculosis, fever, and rash.
Topics: Adult; Antitubercular Agents; Diagnosis, Differential; Drug Hypersensitivity; Ethambutol; Exanthema; Fever; Humans; Isoniazid; Liver; Liver Failure; Male; Pyrazinamide; Pyridoxine; Rifampin; Skin; Tuberculosis, Pulmonary | 2004 |
Lack of activity of orally administered clofazimine against intracellular Mycobacterium tuberculosis in whole-blood culture.
Topics: Anti-Infective Agents; Antitubercular Agents; Area Under Curve; Blood; Cells, Cultured; Clofazimine; Colony Count, Microbial; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Mycobacterium tuberculosis; Ofloxacin; Pyrazinamide; Serum Bactericidal Test | 2004 |
Standardization of the method for estimation of ethambutol in pharmaceutical preparations and biological fluid.
Topics: Antitubercular Agents; Chemistry, Clinical; Chromatography; Dose-Response Relationship, Drug; Ethambutol; HIV Seropositivity; Humans; Isoniazid; Pharmaceutical Preparations; Pyrazinamide; Reference Standards; Reproducibility of Results; Resins, Synthetic; Sensitivity and Specificity; Time Factors | 2004 |
Cervical spine tuberculosis.
Topics: Adolescent; Antitubercular Agents; Cervical Vertebrae; Ethambutol; Humans; Isoniazid; Male; Pyrazinamide; Radiography; Rifampin; Treatment Outcome; Tuberculosis, Spinal | 2004 |
[Efficiency of an intensive stage of chemotherapy for tuberculosis in elderly and senile patients].
Topics: Age Factors; Aged; Aged, 80 and over; Antibiotics, Antitubercular; Antitubercular Agents; Diabetes Complications; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Risk Factors; Sex Factors; Sputum; Tuberculosis, Pulmonary; World Health Organization | 2004 |
Tuberculosis: medical management update.
Topics: Adult; Antitubercular Agents; Child; Dental Staff; Ethambutol; Humans; Infectious Disease Transmission, Patient-to-Professional; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis, Oral; Tuberculosis, Pulmonary | 2004 |
Multifocal osteoarticular tuberculosis: a case report.
Topics: Adult; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Joints; Magnetic Resonance Imaging; Pyrazinamide; Rifampin; Tomography, X-Ray Computed; Treatment Outcome; Tuberculosis, Osteoarticular | 2005 |
Rapid, automated, nonradiometric susceptibility testing of Mycobacterium tuberculosis complex to four first-line antituberculous drugs used in standard short-course chemotherapy.
Topics: Antitubercular Agents; Colony Count, Microbial; Culture Media; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Sampling Studies; Sensitivity and Specificity; Tuberculosis, Multidrug-Resistant | 2004 |
The effect of initial drug resistance on treatment response and acquired drug resistance during standardized short-course chemotherapy for tuberculosis.
Topics: Antitubercular Agents; Directly Observed Therapy; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Pyrazinamide; Retrospective Studies; Rifampin; Siberia; Tuberculosis, Pulmonary | 2004 |
The transpedicular approach in the management of thoracic spine tuberculosis: a short-term follow up study.
Topics: Abscess; Adolescent; Adult; Aged; Antitubercular Agents; Braces; Combined Modality Therapy; Curettage; Debridement; Decompression, Surgical; Disease Progression; Drainage; Ethambutol; Female; Follow-Up Studies; Humans; Immobilization; Isoniazid; Kyphosis; Male; Middle Aged; Movement Disorders; Pyrazinamide; Radiography; Recovery of Function; Retrospective Studies; Rifampin; Severity of Illness Index; Spinal Cord Compression; Thoracic Vertebrae; Treatment Outcome; Tuberculosis, Spinal | 2004 |
Successful kidney re-transplantation in a patient with previous allograft kidney tuberculosis.
Topics: Adult; Antitubercular Agents; Ethambutol; Humans; Immunosuppression Therapy; Isoniazid; Kidney Transplantation; Male; Opportunistic Infections; Pyrazinamide; Reoperation; Rifampin; Tuberculosis, Renal | 2004 |
Tuberculosis control and the private health sector in Bolivia: a survey of pharmacies.
Topics: Antitubercular Agents; Bolivia; Communicable Disease Control; Community Pharmacy Services; Cooperative Behavior; Drug Prescriptions; Ethambutol; Humans; Isoniazid; Pharmacies; Prescription Fees; Private Sector; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 2004 |
[Case of pulmonary tuberculosis in late stage of pregnancy].
Topics: Adult; Antitubercular Agents; Cesarean Section; Cross Infection; Drug Therapy, Combination; Ethambutol; Female; Hospitals, General; Humans; Infant, Newborn; Infection Control; Isoniazid; Patient Isolation; Pregnancy; Pregnancy Complications, Infectious; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 2004 |
Treatment outcome of new culture positive pulmonary tuberculosis in Norway.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Child; Child, Preschool; Cohort Studies; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Humans; Infant; Infant, Newborn; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Norway; Patient Compliance; Pyrazinamide; Registries; Rifampin; Treatment Failure; Treatment Outcome; Tuberculosis, Pulmonary | 2005 |
A woman with a long history of abdominal pain.
Topics: Abdominal Pain; Adult; Antitubercular Agents; Cecal Diseases; Crohn Disease; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Female; Humans; Ileal Diseases; Intestinal Obstruction; Isoniazid; Pyrazinamide; Radiography; Time Factors; Treatment Outcome; Tuberculosis, Gastrointestinal | 2004 |
Treatment outcome of multidrug-resistant tuberculosis among Vietnamese immigrants.
Topics: Capreomycin; Cycloserine; Drug Therapy, Combination; Emigration and Immigration; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Male; Middle Aged; Ofloxacin; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Vietnam | 2005 |
Multifocal osteoarticular tuberculosis.
Topics: Adult; Antitubercular Agents; Bone and Bones; Combined Modality Therapy; Drug Therapy, Combination; Ethambutol; Fever; Humans; Isoniazid; Knee; Male; Pain; Pyrazinamide; Radiography; Radius; Rifampin; Treatment Outcome; Tuberculosis, Osteoarticular; Weight Loss; Wrist | 2005 |
Inactive hepatitis B surface antigen carrier state and hepatotoxicity during antituberculosis chemotherapy.
Topics: Adult; Antitubercular Agents; Carrier State; Case-Control Studies; Chemical and Drug Induced Liver Injury; Ethambutol; Female; Hepatitis B; Hepatitis B Surface Antigens; Humans; Incidence; Isoniazid; Male; Pyrazinamide; Retrospective Studies; Rifampin; Risk Factors | 2005 |
Mechanistic explanation to the catalysis by pyrazinamide and ethambutol of reaction between rifampicin and isoniazid in anti-TB FDCs.
Topics: Amides; Antibiotics, Antitubercular; Antitubercular Agents; Catalysis; Chromatography, High Pressure Liquid; Drug Combinations; Ethambutol; Isoniazid; Picolinic Acids; Pyrazinamide; Rifampin; Spectrophotometry, Ultraviolet | 2005 |
Multidrug-resistant tuberculous spondylodiscitis: need for aggressive management and drug susceptibility testing of Mycobacterium tuberculosis isolates.
Topics: Anti-Bacterial Agents; Biopsy, Fine-Needle; Bone Transplantation; Cycloserine; Discitis; Drug Therapy, Combination; Ethambutol; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Pyrazinamide; Streptomycin; Thoracic Vertebrae; Tomography, X-Ray Computed; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Osteoarticular; Vitamin B 6; Vitamin B Complex | 2006 |
Serum concentrations of antimycobacterial drugs in patients with pulmonary tuberculosis in Botswana.
Topics: Adult; Antitubercular Agents; Botswana; Comorbidity; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 2005 |
High hepatotoxicity of pyrazinamide and ethambutol for treatment of latent tuberculosis.
Topics: Adult; Antitubercular Agents; Carrier State; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Drug Administration Schedule; Ethambutol; Female; Follow-Up Studies; Humans; Liver Function Tests; Male; Middle Aged; Pyrazinamide; Tuberculosis, Multidrug-Resistant | 2005 |
[Two pregnant immigrant women with tuberculous peritonitis].
Topics: Adult; Antitubercular Agents; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Female; Fetal Death; Humans; Isoniazid; Peritonitis, Tuberculous; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Pyrazinamide; Rifampin | 2005 |
[Tuberculoma complicating tuberculous meningitis: description of one paediatric case].
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Antibiotics, Antitubercular; Antitubercular Agents; Child; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Magnetic Resonance Imaging; Prednisone; Pyrazinamide; Rifampin; Streptomycin; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Tuberculoma, Intracranial; Tuberculosis, Meningeal | 2005 |
Concurrence of granular cell tumor and Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Bronchoscopy; Ethambutol; Granular Cell Tumor; Humans; Isoniazid; Lung; Male; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis | 2005 |
[Cervical spondylodiscitis: one pathogen may hide another].
Topics: Anti-Bacterial Agents; Antitubercular Agents; Aza Compounds; Cervical Vertebrae; Cholecystitis; Discitis; Disease Progression; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Ethambutol; Fluoroquinolones; France; Humans; Immobilization; Isoniazid; Male; Middle Aged; Morocco; Moxifloxacin; Mycobacterium tuberculosis; Pyrazinamide; Quinolines; Radiography; Rifampin; Tuberculosis, Spinal | 2006 |
Usefulness of E-test strips for testing susceptibility of Mycobacterium tuberculosis complex strains.
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Reagent Strips; Rifampin; Streptomycin | 2005 |
Reactivation of tuberculosis after apparently adequate chemoprophylaxis.
Topics: Adolescent; Antitubercular Agents; Chemoprevention; Contact Tracing; Disease Transmission, Infectious; Ethambutol; Female; Humans; Isoniazid; Molecular Diagnostic Techniques; Mycobacterium tuberculosis; Pyrazinamide; Recurrence; Rifampin; Tuberculosis, Pulmonary | 2005 |
A 2-year-old girl with an abnormal gait.
Topics: Antitubercular Agents; Child, Preschool; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Female; Gait Ataxia; Humans; Isoniazid; Osteomyelitis; Physical Examination; Pyrazinamide; Rifampin; Tuberculosis, Spinal | 2005 |
Drug-drug interaction studies on first-line anti-tuberculosis drugs.
Topics: Antitubercular Agents; Chromatography, Liquid; Drug Combinations; Drug Compounding; Drug Incompatibility; Drug Stability; Drug Storage; Ethambutol; Hot Temperature; Humidity; Isoniazid; Mass Spectrometry; Pyrazinamide; Rifampin | 2005 |
Low levels of pyrazinamide and ethambutol in children with tuberculosis and impact of age, nutritional status, and human immunodeficiency virus infection.
Topics: Adolescent; Adult; Age Factors; Child; Child, Preschool; Ethambutol; HIV Infections; Humans; Infant; Malnutrition; Pyrazinamide; Tuberculosis | 2006 |
Role of latent genital tuberculosis in repeated IVF failure in the Indian clinical setting.
Topics: Adult; Antitubercular Agents; Endometrium; Ethambutol; Female; Fertilization; Fertilization in Vitro; Humans; India; Infertility, Female; Polymerase Chain Reaction; Pregnancy; Pregnancy Rate; Pyrazinamide; Rifampin; Tuberculosis, Female Genital | 2006 |
Adverse drug reactions observed during DOTS.
Topics: Adolescent; Adult; Antitubercular Agents; Directly Observed Therapy; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; India; Isoniazid; Male; Middle Aged; National Health Programs; Patient Compliance; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis | 2004 |
Determinants of rifampin, isoniazid, pyrazinamide, and ethambutol pharmacokinetics in a cohort of tuberculosis patients.
Topics: Adult; Antitubercular Agents; Area Under Curve; Cohort Studies; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Pyrazinamide; Rifampin; Tuberculosis | 2006 |
Pharmacokinetic and pharmacodynamic behaviour of antitubercular drugs encapsulated in alginate nanoparticles at two doses.
Topics: Alginates; Animals; Antitubercular Agents; Area Under Curve; Chemistry, Pharmaceutical; Dose-Response Relationship, Drug; Ethambutol; Female; Glucuronic Acid; Hexuronic Acids; Isoniazid; Male; Mice; Nanostructures; Pyrazinamide; Rifampin; Tissue Distribution | 2006 |
[Tuberculosis of the submandibular gland: a case report].
Topics: Antitubercular Agents; Combined Modality Therapy; Diagnosis, Differential; Ethambutol; Female; Humans; Isoniazid; Middle Aged; Pyrazinamide; Rifampin; Submandibular Gland Diseases; Tuberculosis, Oral | 2006 |
Anti-tuberculous therapy-induced crystal arthropathy.
Topics: Aged; Antitubercular Agents; Crystallization; Ethambutol; Female; Humans; Joint Diseases; Pyrazinamide; Tuberculosis, Osteoarticular | 2006 |
The use of real-time polymerase chain reaction for rapid diagnosis of skeletal tuberculosis.
Topics: Antitubercular Agents; Bacterial Typing Techniques; DNA, Bacterial; Drug Therapy, Combination; Ethambutol; Female; Femur; Humans; Isoniazid; Middle Aged; Mycobacterium tuberculosis; Osteolysis; Pyrazinamide; Reverse Transcriptase Polymerase Chain Reaction; Rifampin; Tuberculosis, Osteoarticular | 2006 |
[Treatment outcome of patients with multidrug-resistant pulmonary tuberculosis during pregnancy].
Topics: Adult; Aminosalicylic Acid; Amoxicillin-Potassium Clavulanate Combination; Antitubercular Agents; Cycloserine; Drug Resistance, Multiple; Ethambutol; Female; Humans; Mutation; Mycobacterium tuberculosis; Parturition; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Pyrazinamide; Retrospective Studies; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2006 |
Combination chemotherapy with the nitroimidazopyran PA-824 and first-line drugs in a murine model of tuberculosis.
Topics: Animals; Antibiotics, Antitubercular; Antitubercular Agents; Disease Models, Animal; Drug Therapy, Combination; Ethambutol; Female; Isoniazid; Mice; Mice, Inbred BALB C; Mycobacterium tuberculosis; Nitroimidazoles; Pyrazinamide; Rifampin; Secondary Prevention; Time Factors; Tuberculosis, Pulmonary | 2006 |
Impact of country of origin on drug-resistant tuberculosis among foreign-born persons in British Columbia.
Topics: Adolescent; Adult; Age Factors; Aged; Analysis of Variance; Anti-Bacterial Agents; Antibiotics, Antitubercular; British Columbia; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Emigration and Immigration; Ethambutol; Female; Humans; Infant; Infant, Newborn; Isoniazid; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Odds Ratio; Pyrazinamide; Rifampin; Risk Factors; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2006 |
Impact of DOTS expansion on tuberculosis related outcomes and costs in Haiti.
Topics: Antitubercular Agents; Cost of Illness; Directly Observed Therapy; Drug Therapy, Combination; Ethambutol; Haiti; Health Care Costs; Humans; Isoniazid; Program Evaluation; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary; World Health Organization | 2006 |
Multidrug-resistant tuberculosis of the ankle: case report.
Topics: Antitubercular Agents; Child, Preschool; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Hospitalization; Humans; Magnetic Resonance Imaging; Pyrazinamide; Talus; Time Factors; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Osteoarticular | 2006 |
Ocular tuberculosis in acquired immunodeficiency syndrome.
Topics: Abscess; Adolescent; Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; CD4 Lymphocyte Count; Child; Conjunctival Diseases; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Panophthalmitis; Pyrazinamide; Retinal Diseases; Retrospective Studies; Rifampin; Tuberculosis, Central Nervous System; Tuberculosis, Ocular; Tuberculosis, Pulmonary | 2006 |
Penile tuberculosis associated with monoclonal gammopathy of undetermined significance.
Topics: Aged; Antitubercular Agents; Ethambutol; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Paraproteinemias; Penile Diseases; Pyrazinamide; Rifampin; Tuberculosis, Cutaneous; Tuberculosis, Male Genital | 2006 |
Sir, I turned much darker!
Topics: Addison Disease; Adult; Antitubercular Agents; Ethambutol; Germany; Humans; Hydrocortisone; Hyperpigmentation; Isoniazid; Male; Pyrazinamide; Rifampin; Tuberculosis, Endocrine | 2006 |
Mycobacterium tuberculosis presenting as chronic red eye.
Topics: Adolescent; Antitubercular Agents; Chronic Disease; Conjunctivitis, Bacterial; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Tuberculosis, Ocular | 2006 |
Modification to improve efficiency of sampling schedules for BA/BE testing of FDC anti-tuberculosis drugs.
Topics: Antitubercular Agents; Area Under Curve; Biological Availability; Blood Specimen Collection; Ethambutol; Humans; Isoniazid; Pyrazinamide; Quality Assurance, Health Care; Rifampin; South Africa; Therapeutic Equivalency | 2007 |
[A case of tuberculosis showing immune reconstitution syndrome after the initiation of antiretroviral therapy for HIV infection].
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; HIV-1; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary; Zidovudine | 2007 |
[Case report: tuberculosis of parotid gland].
Topics: Adult; Antitubercular Agents; Biopsy; Diagnosis, Differential; Ethambutol; Humans; Isoniazid; Lymph Node Excision; Male; Parotid Diseases; Parotid Gland; Pyrazinamide; Radiography; Rifampin; Tuberculosis | 2007 |
Trend of anti-tuberculosis drug resistance in Korea, 1994-2004.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Child; Ethambutol; Humans; Isoniazid; Korea; Middle Aged; Prevalence; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2007 |
[Case of liver tuberculosis requiring differentiation from liver metastasis of cancer].
Topics: Aged; Antitubercular Agents; Diagnosis, Differential; Ethambutol; Female; Humans; Isoniazid; Liver Neoplasms; Lymphatic Metastasis; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Hepatic; Tuberculosis, Lymph Node | 2007 |
[Centrofacial granulomatous inflammation].
Topics: Aged; Aged, 80 and over; Antibiotics, Antitubercular; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Lupus Vulgaris; Male; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Skin; Time Factors; Treatment Outcome; Tuberculin Test | 2007 |
Tuberculous sacro-ileitis: two cases and radiological findings.
Topics: Abscess; Adult; Antitubercular Agents; Arthritis, Infectious; Brucellosis; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Pyrazinamide; Radiography; Rifampin; Sacroiliac Joint; Tuberculosis, Osteoarticular; Tuberculosis, Pulmonary; Ultrasonography | 2007 |
Liver and pancreatic injury induced by antituberculous therapy.
Topics: Adult; Antitubercular Agents; Biopsy; Chemical and Drug Induced Liver Injury; Cholangiopancreatography, Endoscopic Retrograde; Ethambutol; Female; Follow-Up Studies; Humans; Pancreatitis; Pyrazinamide; Rifampin; Tomography, X-Ray Computed; Tuberculosis | 2007 |
[Case of fatal liver failure due to anti-tuberculous therapy].
Topics: Aged; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Fatal Outcome; Female; Humans; Isoniazid; Liver Failure; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 2007 |
[Mycobacterium ulcerans infection treated by Rifater, pyrazynamide, Myambutol, and surgery: a case report with a 6-year follow-up].
Topics: Anti-Bacterial Agents; Buruli Ulcer; Child; Chloramines; Combined Modality Therapy; Drug Combinations; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Mastectomy; Metronidazole; Mycobacterium ulcerans; Nitrofurantoin; Pleurisy; Prednisolone; Pyrazinamide; Recurrence; Rifampin; Skin Transplantation | 2008 |
[A surgically treated case of ileus caused by small intestinal tuberculosis during treatment for pulmonary tuberculosis].
Topics: Adult; Antitubercular Agents; Ethambutol; Humans; Ileal Diseases; Ileus; Isoniazid; Male; Pyrazinamide; Rifampin; Tuberculosis, Gastrointestinal; Tuberculosis, Pulmonary | 2007 |
Treatment of isoniazid-resistant pulmonary tuberculosis.
Topics: Adult; Aged; Antitubercular Agents; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Medical Audit; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Retrospective Studies; Rifampin; Treatment Failure; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2008 |
[Tuberculosis dactylis: a case report].
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Biopsy; Child; Drug Therapy, Combination; Ethambutol; Female; Fingers; Humans; Isoniazid; Pyrazinamide; Radiography; Rifampin; Time Factors; Treatment Outcome; Tuberculin Test; Tuberculosis, Osteoarticular | 2008 |
Outcome of multi-drug resistant tuberculosis cases treated by individualized regimens at a tertiary level clinic.
Topics: Adolescent; Adult; Aminoglycosides; Aminosalicylic Acid; Antitubercular Agents; Child; Cycloserine; Ethambutol; Female; Fluoroquinolones; Follow-Up Studies; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pyrazinamide; Radiography; Severity of Illness Index; Thioamides; Time Factors; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2008 |
Isolated tuberculous thyroiditis as solitary thyroid nodule.
Topics: Adult; Antitubercular Agents; Ethambutol; Humans; Male; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Thyroid Nodule; Thyroiditis, Suppurative | 2008 |
Papulonecrotic tuberculids associated with uveitis.
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Glucocorticoids; Humans; Isoniazid; Male; Ophthalmic Solutions; Pyrazinamide; Rifampin; Tuberculin Test; Tuberculosis, Cutaneous; Tuberculosis, Ocular; Uveitis | 2008 |
Psoriasiform lupus vulgaris.
Topics: Adolescent; Antitubercular Agents; Biopsy; Buttocks; Child; Disease Progression; Ethambutol; Female; Humans; Isoniazid; Lupus Vulgaris; Pyrazinamide; Pyridoxine; Rifampin; Tuberculin Test; Vitamin B Complex | 2008 |
Primary drug resistance against Mycobacterium tuberculosis in Karachi.
Topics: Adolescent; Adult; Antitubercular Agents; Bronchoscopy; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Pakistan; Pilot Projects; Pyrazinamide; Sputum; Streptomycin; Tuberculosis, Pulmonary | 2008 |
Diagnostic challenges of intestinal tuberculosis in a patient with chronic diarrhoea: case report.
Topics: Adult; Antitubercular Agents; Chronic Disease; Diarrhea; Ethambutol; Humans; Isoniazid; Laparotomy; Male; Pyrazinamide; Rifampin; Tuberculosis, Gastrointestinal | 2008 |
One to make the diagnosis. A case of non tuberculous mycobacterial mastoiditis in a nine year old female.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Child; Ethambutol; Female; Humans; Ireland; Isoniazid; Mastoiditis; Nontuberculous Mycobacteria; Pyrazinamide; Rifampin | 2008 |
Drug lymphocyte stimulation test in the diagnosis of adverse reactions to antituberculosis drugs.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Lymphocyte Activation; Male; Middle Aged; Prospective Studies; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis | 2008 |
Update on the treatment of tuberculosis.
Topics: Antitubercular Agents; Comorbidity; Directly Observed Therapy; Disease Progression; Drug Therapy, Combination; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Male; Mass Screening; Mycobacterium tuberculosis; Patient Compliance; Pregnancy; Pregnancy Complications, Infectious; Pyrazinamide; Rifampin; Risk Factors; Tuberculin Test; Tuberculosis | 2008 |
A case of oculomotor nerve palsy and choroidal tuberculous granuloma associated with tuberculous meningoencephalitis.
Topics: Adolescent; Antitubercular Agents; Blepharoptosis; Choroid Diseases; Dexamethasone; Drug Therapy, Combination; Ethambutol; Glucocorticoids; Humans; Magnetic Resonance Imaging; Male; Meningoencephalitis; Mycobacterium tuberculosis; Oculomotor Nerve Diseases; Pyrazinamide; Radiography, Thoracic; Tuberculoma; Tuberculosis, Meningeal; Tuberculosis, Ocular; Visual Field Tests; Visual Fields | 2008 |
Rifampicin, ethambutol and pyrazinamide-induced thrombocytopenia.
Topics: Aged; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Humans; Male; Pyrazinamide; Rifampin; Thrombocytopenia | 2008 |
Scapholunate dissociation: a rare presentation of TB wrist in a case of multi-focal skeletal tuberculosis.
Topics: Adolescent; Antitubercular Agents; Arthritis, Infectious; Arthrodesis; Carpal Joints; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Lunate Bone; Pyrazinamide; Radiography; Range of Motion, Articular; Rifampin; Scaphoid Bone; Tuberculosis, Osteoarticular | 2008 |
An unusual case of a pleural effusion with an abdominal mass.
Topics: Adult; Antitubercular Agents; Drainage; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Male; Pleural Effusion; Pyrazinamide; Rifampin; Tomography, X-Ray Computed; Tuberculosis, Pulmonary; Tuberculosis, Renal | 2008 |
[Sternal tuberculosis].
Topics: Antitubercular Agents; Biopsy, Fine-Needle; Debridement; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Middle Aged; Pyrazinamide; Rifampin; Sternum; Tuberculosis, Osteoarticular | 2008 |
Postoperative Mycobacterium tuberculosis infection after total knee arthroplasty.
Topics: Aged; Antitubercular Agents; Arthroplasty, Replacement, Knee; Drug Combinations; Ethambutol; Female; Humans; Isoniazid; Pyrazinamide; Rifampin; Taiwan; Tuberculosis, Osteoarticular | 2009 |
Tuberculous liver abscess.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Ethambutol; Humans; Isoniazid; Liver Abscess; Male; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis, Hepatic | 2008 |
Tuberculous meningitis in HIV-infected and non-infected patients: comparison of cerebrospinal fluid findings.
Topics: Adult; Antitubercular Agents; Cerebrospinal Fluid; Cerebrospinal Fluid Proteins; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Ethambutol; Female; Glucose; HIV Infections; Hospital Mortality; Humans; Isoniazid; Leukocyte Count; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Retrospective Studies; Treatment Outcome; Tuberculosis, Meningeal; Young Adult | 2009 |
[Ex juvantibus diagnosis in suspected skin tuberculosis].
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Time Factors; Tuberculosis, Cutaneous | 2008 |
[Cerebellar soap bubble lesions and mediastinal lymph nodes].
Topics: Adult; Antitubercular Agents; Brain Abscess; Cerebellar Diseases; Combined Modality Therapy; Craniotomy; Ethambutol; Female; Humans; Isoniazid; Magnetic Resonance Imaging; Mediastinum; Pyrazinamide; Rifampin; Tuberculosis, Central Nervous System; Tuberculosis, Lymph Node | 2009 |
[Renal mass in an HIV-positive elderly patient].
Topics: Aged; AIDS-Related Opportunistic Infections; Antitubercular Agents; Combined Modality Therapy; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Nephrectomy; Ofloxacin; Pyrazinamide; Tomography, X-Ray Computed; Tuberculosis, Renal | 2009 |
[Optimization of chemotherapy regimens in children with primary pulmonary tuberculosis].
Topics: Adolescent; Age Factors; Antibiotics, Antitubercular; Antitubercular Agents; Child; Child, Preschool; Cycloserine; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Prothionamide; Pyrazinamide; Radiography, Thoracic; Rifampin; Streptomycin; Time Factors; Tuberculosis, Lymph Node; Tuberculosis, Pulmonary | 2009 |
Coccidioides immitis and Mycobacterium tuberculosis diagnosed by endoscopic ultrasound.
Topics: Adult; Antibiotics, Antitubercular; Antifungal Agents; Antitubercular Agents; Coccidioides; Coccidioidomycosis; Endosonography; Ethambutol; Follow-Up Studies; Humans; Isoniazid; Itraconazole; Lymph Nodes; Male; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Time Factors; Treatment Outcome; Tuberculosis, Pulmonary | 2009 |
Isoniazid induced gynaecomastia: a case report.
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Gynecomastia; Humans; Isoniazid; Male; Mammography; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 2009 |
[Fever and thin-walled cavitary lung lesions].
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Fever; Humans; Isoniazid; Male; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Pyrazinamide; Radiography; Rifampin; Sputum; Tuberculosis, Pulmonary | 2009 |
A rapid and robust liquid chromatography/tandem mass spectrometry method for simultaneous analysis of anti-tuberculosis drugs--ethambutol and pyrazinamide in human plasma.
Topics: Antitubercular Agents; Chromatography, Liquid; Ethambutol; Humans; Pyrazinamide; Tandem Mass Spectrometry; Tuberculosis | 2009 |
Isoniazid, rifampin, ethambutol, and pyrazinamide pharmacokinetics and treatment outcomes among a predominantly HIV-infected cohort of adults with tuberculosis from Botswana.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Botswana; CD4 Lymphocyte Count; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Serum; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult | 2009 |
A tumor-like manifestation of extrapulmonary tuberculosis in a hemodialysis patient.
Topics: Diabetic Nephropathies; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Renal Dialysis; Rifampin; Tomography, X-Ray Computed; Tuberculosis, Hepatic | 2009 |
In vitro synergistic effects of antituberculous drugs plus antifungals against Coccidioides posadasii.
Topics: Amphotericin B; Antifungal Agents; Antitubercular Agents; Caspofungin; Coccidioides; Coccidioidomycosis; Drug Synergism; Echinocandins; Ethambutol; Fluconazole; Humans; Isoniazid; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrazinamide; Pyrimidines; Triazoles; Voriconazole | 2009 |
Pulmonary tuberculosis presenting as fever without source in a pediatric patient with acute lymphoblastic leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antitubercular Agents; Azithromycin; Child, Preschool; Combined Modality Therapy; Contact Tracing; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Drug Therapy, Combination; Ethambutol; Fever of Unknown Origin; Humans; Immunocompromised Host; Isoniazid; Lymphopenia; Male; Mycobacterium tuberculosis; Pneumonectomy; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary; Vincristine | 2009 |
British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children.
Topics: Adenosine Deaminase; Adult; Antibiotics, Antitubercular; Antitubercular Agents; Cerebrospinal Fluid; Child; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Spinal Puncture; Tuberculin Test; Tuberculoma, Intracranial; Tuberculosis, Meningeal; Tuberculosis, Spinal | 2009 |
Factors influencing time to smear conversion in patients with smear-positive pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Child; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium; Proportional Hazards Models; Pyrazinamide; Retrospective Studies; Rifampin; Sputum; Time Factors; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult | 2009 |
Incomplete immunological recovery following anti-tuberculosis treatment in HIV-infected individuals with active tuberculosis.
Topics: Acquired Immunodeficiency Syndrome; Analysis of Variance; beta 2-Microglobulin; Biomarkers; CD4-Positive T-Lymphocytes; Cell Count; Enzyme-Linked Immunosorbent Assay; Ethambutol; Humans; India; Isoniazid; Neopterin; Pyrazinamide; Receptors, Tumor Necrosis Factor, Type I; Rifampin; Tuberculosis | 2009 |
Non conversion of sputum smears in new smear positive pulmonary tuberculosis patients in Yaoundé, Cameroon.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotics, Antitubercular; Antitubercular Agents; Cameroon; Child; Confidence Intervals; Ethambutol; Female; Humans; Isoniazid; Logistic Models; Male; Middle Aged; Mycobacterium tuberculosis; Odds Ratio; Prospective Studies; Pyrazinamide; Rifampin; Sputum; Time Factors; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult | 2009 |
New susceptibility breakpoints for first-line antituberculosis drugs based on antimicrobial pharmacokinetic/pharmacodynamic science and population pharmacokinetic variability.
Topics: Antitubercular Agents; Aza Compounds; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; Fluoroquinolones; Humans; In Vitro Techniques; Isoniazid; Microbial Sensitivity Tests; Models, Biological; Monte Carlo Method; Moxifloxacin; Mycobacterium tuberculosis; Pyrazinamide; Quinolines; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2010 |
Resistance to pyrazinamide and ethambutol compromises MDR/XDR-TB treatment.
Topics: Antitubercular Agents; Directly Observed Therapy; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Extensively Drug-Resistant Tuberculosis; Humans; Microbial Sensitivity Tests; Pyrazinamide | 2009 |
Incision infection with Mycobacterium tuberculosis after total hip arthroplasty without any primary tuberculosis focus.
Topics: Arthroplasty, Replacement, Hip; Drug Therapy, Combination; Ethambutol; Female; Hip Dislocation, Congenital; Hip Prosthesis; Humans; Isoniazid; Middle Aged; Mycobacterium tuberculosis; Prosthesis-Related Infections; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis | 2011 |
Determination of antituberculosis drug concentration in human plasma by MALDI-TOF/TOF.
Topics: Antitubercular Agents; Drug Monitoring; Ethambutol; Humans; Pyrazinamide; Reproducibility of Results; Rifampin; Sensitivity and Specificity; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Streptomycin | 2010 |
Dysuria: don't take it lightly.
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Dysuria; Ethambutol; Female; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis, Female Genital; Tuberculosis, Renal; Urine | 2011 |
Drug resistance pattern in multidrug resistance pulmonary tuberculosis patients.
Topics: Adult; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Ethambutol; Ethionamide; Female; Humans; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pakistan; Pyrazinamide; Retrospective Studies; Risk Factors; Sputum; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2010 |
Nasolacrimal tuberculosis: case report highlighting the need for imaging in identifying and managing it effectively.
Topics: Adult; Antitubercular Agents; Drug Combinations; Drug Therapy, Combination; Endoscopy; Ethambutol; Female; Humans; Isoniazid; Lacrimal Apparatus Diseases; Nasolacrimal Duct; Pyrazinamide; Pyridoxine; Rifampin; Tomography, X-Ray Computed; Tuberculosis, Ocular | 2010 |
A facile synthesis and discovery of highly functionalized tetrahydro-pyridines and pyridines as antimycobacterial agents.
Topics: Anti-Bacterial Agents; Ethambutol; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Pyridines | 2010 |
A survey of prescribing pattern for osteoarticular tuberculosis: orthopaedic surgeons' and infectious disease experts' perspective.
Topics: Antitubercular Agents; Congresses as Topic; Ethambutol; Humans; Infectious Disease Medicine; Isoniazid; Ofloxacin; Orthopedics; Practice Patterns, Physicians'; Pyrazinamide; Rifampin; Streptomycin; Surveys and Questionnaires; Tuberculosis, Osteoarticular | 2009 |
Role of 2-month sputum smears in predicting culture conversion in pulmonary tuberculosis.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Radiography; Rifampin; Sensitivity and Specificity; Sputum; Treatment Outcome; Tuberculosis, Pulmonary | 2011 |
Pott's disease with scrofuloderma and psoas abscess misdiagnosed and treated as hidradenitis suppurativa.
Topics: Adult; Antibiotics, Antitubercular; Antitubercular Agents; Diagnosis, Differential; Diagnostic Errors; Ethambutol; Hidradenitis Suppurativa; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Psoas Abscess; Pyrazinamide; Rifampin; Tuberculosis, Cutaneous; Tuberculosis, Spinal | 2011 |
[Onset of neurological symptoms during tuberculosis treatment: description of two cases].
Topics: Adult; Aged, 80 and over; Antitubercular Agents; Aphasia; Child, Preschool; Drug Therapy, Combination; Dystonia; Ethambutol; Facial Pain; Female; Humans; Isoniazid; Magnetic Resonance Imaging; Male; Nigeria; Prednisone; Pyrazinamide; Reflex, Abnormal; Rifampin; Tremor; Tuberculoma; Tuberculosis, Meningeal; Tuberculosis, Miliary | 2010 |
Impact of adverse drug reaction and predictivity of quality of life status in tuberculosis.
Topics: Antitubercular Agents; British Columbia; Ethambutol; Female; Humans; Isoniazid; Longitudinal Studies; Male; Middle Aged; Pyrazinamide; Quality of Life; Retrospective Studies; Rifampin; Sickness Impact Profile; Tuberculosis, Pulmonary | 2010 |
Mediastina Tuberculosis mass in a three-month-old boy.
Topics: Adrenal Cortex Hormones; Antibiotics, Antitubercular; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Follow-Up Studies; Humans; Infant; Isoniazid; Magnetic Resonance Imaging; Male; Mediastinal Diseases; Pyrazinamide; Rifampin; Time Factors; Treatment Outcome; Tuberculosis | 2010 |
A nodulo-ulcerative lesion on the nose.
Topics: Aged, 80 and over; Antitubercular Agents; Chronic Disease; Ethambutol; Female; Humans; Isoniazid; Lupus Vulgaris; Mycobacterium tuberculosis; Nose Diseases; Pyrazinamide; Rifampin; Skin Ulcer; Treatment Outcome; Tuberculosis, Pulmonary | 2010 |
Scrofula.
Topics: Adult; Antibiotics, Antitubercular; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Pyrazinamide; Rifampin; Sentinel Lymph Node Biopsy; Tuberculosis, Lymph Node | 2010 |
[A case of tuberculous pleurisy with transient new intra-pulmonary lesions during anti-tuberculosis therapy].
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Lung; Male; Pyrazinamide; Rifampin; Tuberculosis, Pleural; Young Adult | 2010 |
[Culture and susceptibility testing of mycobacteria with VersaTREK].
Topics: Algorithms; Antitubercular Agents; Automation; Bacteriological Techniques; Culture Media; Ethambutol; Humans; Isoniazid; Manometry; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium Infections; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Staining and Labeling; Streptomycin; Time Factors | 2011 |
Granulomatous lesion on the face successfully treated with antitubercular therapy.
Topics: Aged, 80 and over; Antibiotics, Antitubercular; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Facial Dermatoses; Female; Granuloma; Humans; Isoniazid; Mycobacterium Infections; Pyrazinamide; Rifampin; Skin Diseases, Bacterial | 2010 |
The use of the QuantiFERON-tuberculosis gold test in the diagnosis of ocular tuberculosis.
Topics: Adolescent; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Fluorescein Angiography; Humans; Interferon-gamma Release Tests; Isoniazid; Pyrazinamide; Rifampin; Tuberculin Test; Tuberculosis, Ocular; Vision Disorders | 2010 |
[A case of tuberculous lateral great adductor muscle abscess during treatment of miliary tuberculosis].
Topics: Abscess; Aged; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Thigh; Tuberculosis, Miliary | 2010 |
Effectiveness and safety of the schedules of short and long term treatment for tuberculous meningoencephalitis at two hospitals of Lima--Peru.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Hospitals; Humans; Isoniazid; Male; Meningoencephalitis; Middle Aged; Peru; Pyrazinamide; Retrospective Studies; Rifampin; Treatment Outcome; Tuberculosis, Meningeal; Young Adult | 2011 |
A case of isoniazid-induced liver injury diagnosed by use of the DLST, and successful reintroduction of isoniazid for pleural tuberculosis.
Topics: Antitubercular Agents; Chemical and Drug Induced Liver Injury; Desensitization, Immunologic; Ethambutol; Female; Humans; Isoniazid; Lymphocyte Activation; Middle Aged; Pyrazinamide; Radiography; Retreatment; Rifampin; Tuberculosis, Pleural | 2011 |
[Sputum smear conversion during intensive TB treatment phase according to HIV status, in hospitalised patients in Togo].
Topics: Adult; Antitubercular Agents; CD4 Lymphocyte Count; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Inpatients; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Prospective Studies; Pyrazinamide; Sampling Studies; Sputum; Togo; Tuberculosis, Pulmonary; Young Adult | 2011 |
Cutaneous tuberculosis mimicking erysipelas of the lower leg in a heart transplant recipient.
Topics: Antitubercular Agents; Erysipelas; Ethambutol; Heart Transplantation; Humans; Isoniazid; Leg; Opportunistic Infections; Pyrazinamide; Tuberculosis, Cutaneous | 2011 |
Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis.
Topics: Amikacin; Antitubercular Agents; Bacterial Proteins; Capreomycin; Ciprofloxacin; Ethambutol; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Ofloxacin; Pyrazinamide; Rifampin | 2011 |
An apparently healthy young man with a peculiar-looking chest radiograph.
Topics: Adult; Antibiotics, Antitubercular; Drug Therapy, Combination; Ethambutol; Fever; HIV Seropositivity; Humans; Isoniazid; Male; Pleural Effusion; Pyrazinamide; Radiography; Rifampin; Tuberculosis, Pulmonary; Young Adult | 2011 |
[Pulmonary paragonimiasis].
Topics: Adult; Animals; Anthelmintics; Antitubercular Agents; Caulobacteraceae; Delayed Diagnosis; Ecuador; Ethambutol; Food Parasitology; Gram-Negative Bacterial Infections; Granuloma; Hemoptysis; Humans; Isoniazid; Lung Diseases, Parasitic; Male; Paragonimiasis; Pneumonia, Bacterial; Praziquantel; Pyrazinamide; Radiography; Rifampin; Spain; Tuberculosis, Pulmonary | 2011 |
BCG-induced lupus vulgaris complicated by squamous cell carcinoma in a 7-year-old child.
Topics: Antitubercular Agents; BCG Vaccine; Carcinoma, Squamous Cell; Child; Ethambutol; Humans; Isoniazid; Lupus Vulgaris; Lymphatic Metastasis; Male; Pyrazinamide; Rifampin; Skin Neoplasms; Treatment Outcome | 2011 |
Verrucous plaque on the thigh.
Topics: Adult; Antitubercular Agents; Ethambutol; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Thigh; Treatment Outcome; Tuberculosis, Cutaneous | 2011 |
The variable clinical presentation of tuberculosis otitis media and the importance of early detection.
Topics: Adolescent; Adult; Audiometry, Pure-Tone; Early Diagnosis; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Otitis Media, Suppurative; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis | 2011 |
Clinical response of newly diagnosed HIV seropositive & seronegative pulmonary tuberculosis patients with the RNTCP Short Course regimen in Pune, India.
Topics: Adult; Antitubercular Agents; Communicable Disease Control; Directly Observed Therapy; Enzyme-Linked Immunosorbent Assay; Ethambutol; HIV Seronegativity; HIV Seropositivity; Humans; India; Isoniazid; Middle Aged; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary | 2011 |
Metabolic regulation of mycobacterial growth and antibiotic sensitivity.
Topics: Acetyl Coenzyme A; Anaerobiosis; Animals; Antitubercular Agents; Bacterial Load; Bacterial Proteins; Biosynthetic Pathways; Citric Acid Cycle; Drug Resistance, Bacterial; Ethambutol; Isoniazid; Lung; Mice; Mice, Inbred C57BL; Mutation; Mycobacterium tuberculosis; Pyrazinamide; Spleen; Stress, Physiological; Triglycerides; Tuberculosis, Pulmonary | 2011 |
Tuberculosis-associated chronic kidney disease.
Topics: Antitubercular Agents; Ethambutol; Fever; Humans; Isoniazid; Kidney Failure, Chronic; Male; Pyrazinamide; Renal Dialysis; Rifampin; Tuberculosis; Young Adult | 2011 |
Multifocal tuberculosis revealed by multiple cutaneous gummas in the immunocompetent.
Topics: Antitubercular Agents; Clavicle; Drug Therapy, Combination; Ethambutol; Humans; Immunocompetence; Isoniazid; Male; Morocco; Pyrazinamide; Rifampin; Skin Ulcer; Tuberculosis, Cutaneous; Tuberculosis, Osteoarticular; Tuberculosis, Pulmonary; Young Adult | 2011 |
Isoniazid-resistant intracranial tuberculoma treated with a combination of moxifloxacin and first-line anti-tuberculosis medication.
Topics: Antitubercular Agents; Aza Compounds; Biopsy; Brain; Cerebrospinal Fluid; Drug Resistance, Bacterial; Ethambutol; Female; Fluoroquinolones; Histocytochemistry; Humans; Isoniazid; Magnetic Resonance Imaging; Moxifloxacin; Mycobacterium tuberculosis; Pyrazinamide; Quinolines; Rifampin; Tomography, X-Ray Computed; Treatment Outcome; Tuberculoma, Intracranial; Tuberculosis, Multidrug-Resistant; Young Adult | 2011 |
Synergistic effect of antituberculosis drugs and azoles in vitro against Histoplasma capsulatum var. capsulatum.
Topics: Antitubercular Agents; Drug Combinations; Drug Interactions; Ethambutol; Fluconazole; Histoplasma; Isoniazid; Itraconazole; Pyrazinamide; Pyrimidines; Triazoles; Voriconazole | 2011 |
[A case of tuberculous peritonitis developed during chemotherapy for tuberculous pleurisy as paradoxical response].
Topics: Adenosine Deaminase; Adult; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Peritonitis, Tuberculous; Pleural Effusion; Pyrazinamide; Rifampin; Tomography, X-Ray Computed; Tuberculosis, Pleural | 2011 |
Acute liver failure in a pediatric patient with disseminated tuberculosis.
Topics: Antifungal Agents; Antitubercular Agents; Child; Coccidioidomycosis; Drug Therapy, Combination; Ethambutol; Fluconazole; Humans; Isoniazid; Liver Failure, Acute; Male; Pyrazinamide; Recovery of Function; Rifampin; Tuberculosis, Multidrug-Resistant | 2011 |
Tuberculous damaged lung in a child.
Topics: Antitubercular Agents; Child; Drug Therapy, Combination; Ethambutol; Female; Granuloma; Humans; Isoniazid; Lung; Lung Neoplasms; Mycobacterium tuberculosis; Pyrazinamide; Radiography; Rifampin; Treatment Outcome; Tuberculosis, Hepatic; Tuberculosis, Pulmonary | 2011 |
Pyrazinamide-induced sideroblastic anemia.
Topics: 5-Aminolevulinate Synthetase; alpha-Thalassemia; Anemia, Sideroblastic; Antitubercular Agents; Aza Compounds; Bone Marrow; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Ethambutol; Female; Fluoroquinolones; Hemolysis; Humans; Isoniazid; Middle Aged; Moxifloxacin; Peritonitis, Tuberculous; Pyrazinamide; Pyridoxine; Quinolines; Rifampin | 2012 |
[Anti-tuberculosis chemotherapy and management of adverse reactions].
Topics: Aged, 80 and over; Antitubercular Agents; Child; Drug Administration Schedule; Drug Hypersensitivity; Ethambutol; Female; Humans; Isoniazid; Liver; Pregnancy; Pyrazinamide; Rifampin; Tuberculosis | 2011 |
[Immune reconstitution syndrome related to a Mycobacterium avium complex infection, revealed by a mono-adenitis].
Topics: Abscess; Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antitubercular Agents; Axilla; Clarithromycin; Darunavir; Dideoxynucleosides; Enfuvirtide; Ethambutol; HIV Envelope Protein gp41; HIV-1; Humans; Immune Reconstitution Inflammatory Syndrome; Isoniazid; Lamivudine; Lymph Node Excision; Lymphadenitis; Male; Mycobacterium avium-intracellulare Infection; Peptide Fragments; Pyrazinamide; Rifampin; Ritonavir; Streptomycin; Sulfonamides | 2011 |
Clinical presentations and therapeutic effect of presumed choroidal tuberculosis.
Topics: Adolescent; Adult; Antitubercular Agents; Child; Choroid Diseases; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Retrospective Studies; Rifampin; Tuberculosis, Ocular; Young Adult | 2012 |
Dissolution testing of isoniazid, rifampicin, pyrazinamide and ethambutol tablets using near-infrared spectroscopy (NIRS) and multivariate calibration.
Topics: Antitubercular Agents; Calibration; Chromatography, High Pressure Liquid; Ethambutol; Isoniazid; Pyrazinamide; Rifampin; Solubility; Spectroscopy, Near-Infrared | 2012 |
Anti-tuberculosis drugs and human polymorphonuclear leukocyte functions.
Topics: Antitubercular Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ethambutol; Flow Cytometry; Humans; Isoniazid; Neutrophils; Phagocytosis; Pyrazinamide; Respiratory Burst; Rifampin; Staphylococcus aureus; Tuberculosis | 2011 |
How useful is the Mantoux test in the diagnosis of doubtful cases of cutaneous tuberculosis?
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Biopsy; Child; Child, Preschool; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Predictive Value of Tests; Pyrazinamide; Rifampin; ROC Curve; Tuberculin Test; Tuberculosis, Cutaneous; Young Adult | 2011 |
Systemic exposure to rifampicin in patients with tuberculosis and advanced HIV disease during highly active antiretroviral therapy in Burkina Faso.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antitubercular Agents; Burkina Faso; Chromatography, High Pressure Liquid; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Male; Middle Aged; Plasma; Pyrazinamide; Rifampin; Tuberculosis | 2012 |
Cutaneous polyarteritis nodosa induced by Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Lung; Male; Middle Aged; Mycobacterium tuberculosis; Phenylpropionates; Polyarteritis Nodosa; Pyrazinamide; Radiography; Rifampin; Treatment Outcome; Tuberculosis, Cutaneous | 2012 |
[Sudden decrease in visual acuity and pulmonary infiltrates].
Topics: Adrenal Cortex Hormones; Antitubercular Agents; Ethambutol; Humans; Isoniazid; Laser Coagulation; Male; Neovascularization, Pathologic; Pyrazinamide; Radiography; Recurrence; Retinal Hemorrhage; Retinal Vasculitis; Rifampin; Tuberculosis, Pulmonary; Visual Acuity; Young Adult | 2012 |
Therapeutic drug monitoring in the treatment of tuberculosis patients.
Topics: Adult; Aged; Alcoholism; Antibiotics, Antitubercular; Antitubercular Agents; Chromatography, High Pressure Liquid; Diabetes Complications; Diabetes Mellitus, Type 2; Drug Monitoring; Ethambutol; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Precision Medicine; Pyrazinamide; Recurrence; Rifampin; Schizophrenia; Sputum; Treatment Failure; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2012 |
A case of isolated pancreatic tuberculosis mimicking pancreatic carcinoma.
Topics: Aged; Antitubercular Agents; Biopsy, Fine-Needle; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Pancreatic Diseases; Pancreatic Neoplasms; Pyrazinamide; Rifampin; Tomography, X-Ray Computed; Tuberculosis | 2011 |
Minimally invasive posterior stabilization for treating spinal tuberculosis.
Topics: Adult; Antitubercular Agents; Bed Rest; Casts, Surgical; Combined Modality Therapy; Ethambutol; Humans; Isoniazid; Magnetic Resonance Imaging; Male; Minimally Invasive Surgical Procedures; Orthopedic Procedures; Pyrazinamide; Rifampin; Tomography, X-Ray Computed; Tuberculosis, Spinal | 2013 |
[Sternal tumour in a 46-year-old woman].
Topics: Antitubercular Agents; Biopsy; Carcinoma; Combined Modality Therapy; Diagnosis, Differential; Ethambutol; Female; Humans; Isoniazid; Lymphatic Diseases; Middle Aged; Mycobacterium tuberculosis; Osteolysis; Osteomyelitis; Pleural Effusion; Pleural Neoplasms; Pyrazinamide; Rifampin; Sputum; Sternum; Tomography, X-Ray Computed; Tuberculosis, Osteoarticular | 2012 |
Tuberculosis.
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Humans; Male; Pyrazinamide; Rifampin; Tuberculosis, Ocular; Uveitis; Young Adult | 2012 |
Outcomes among tuberculosis patients with isoniazid resistance in Georgia, 2007-2009.
Topics: Adult; Antitubercular Agents; Chi-Square Distribution; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Female; Georgia (Republic); Humans; Isoniazid; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Mycobacterium tuberculosis; Predictive Value of Tests; Pyrazinamide; Retrospective Studies; Rifampin; Risk Assessment; Risk Factors; Sputum; Time Factors; Treatment Outcome; Tuberculosis | 2012 |
Potential use of nitrate reductase as a biomarker for the identification of active and dormant inhibitors of Mycobacterium tuberculosis in a THP1 infection model.
Topics: Antitubercular Agents; Biomarkers; Cell Line, Tumor; Drug Discovery; Ethambutol; High-Throughput Screening Assays; Humans; Isoniazid; Leukemia, Monocytic, Acute; Macrophages; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitrate Reductase; Pentachlorophenol; Pyrazinamide; Rifampin; Streptomycin | 2012 |
Extra-pulmonary primary multidrug-resistant tubercular lymphadenitis in an HIV negative patient.
Topics: Adult; Antitubercular Agents; Clarithromycin; Clofazimine; Cycloserine; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Ethionamide; Female; HIV Seronegativity; Humans; Isoniazid; Kanamycin; Ofloxacin; Pyrazinamide; Rifampin; Tuberculosis, Lymph Node; Tuberculosis, Multidrug-Resistant | 2012 |
[Paradoxical radiologic progression despite appropriate anti-tuberculous therapy].
Topics: Aged; Antitubercular Agents; Bronchoalveolar Lavage Fluid; Bronchoscopy; Ethambutol; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Tomography, X-Ray Computed; Treatment Outcome; Tuberculosis, Pulmonary | 2012 |
Dose-ranging comparison of rifampin and rifapentine in two pathologically distinct murine models of tuberculosis.
Topics: Animals; Antibiotics, Antitubercular; Antitubercular Agents; Disease Models, Animal; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Isoniazid; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Random Allocation; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary | 2012 |
[Bilateral tuberculous mastitis nulliparous patient, initially treated as idiopathic granulomatous mastitis].
Topics: Adult; Antitubercular Agents; Diagnostic Errors; Drug Therapy, Combination; Ethambutol; Female; Granulomatous Mastitis; Humans; Isoniazid; Mastitis; Methotrexate; Mycobacterium tuberculosis; Polymerase Chain Reaction; Prednisone; Pyrazinamide; Recurrence; Rifampin; Tuberculosis | 2012 |
Lupus vulgaris in an immunocompromised patient.
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Immunocompromised Host; Isoniazid; Kidney Transplantation; Lupus Vulgaris; Pyrazinamide; Rifampin | 2014 |
[Treatment of intractable tuberculous meningitis using intrathecal isoniazid administration and steroid pulse therapy; a report of two cases].
Topics: Adult; Antitubercular Agents; Dexamethasone; Drug Therapy, Combination; Ethambutol; Female; Humans; Injections, Spinal; Isoniazid; Male; Methylprednisolone; Middle Aged; Pulse Therapy, Drug; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Meningeal | 2012 |
Optimization of a reversed-phase-high-performance thin-layer chromatography method for the separation of isoniazid, ethambutol, rifampicin and pyrazinamide in fixed-dose combination antituberculosis tablets.
Topics: Antitubercular Agents; Chromatography, Reverse-Phase; Chromatography, Thin Layer; Ethambutol; Ethanol; Isoniazid; Pyrazinamide; Reproducibility of Results; Rifampin; Tablets | 2012 |
Intraretinal tuberculosis.
Topics: Administration, Oral; Adult; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Granuloma; Humans; Isoniazid; Male; Prednisolone; Pyrazinamide; Retinal Vasculitis; Rifampin; Tuberculosis, Ocular; Visual Acuity; Vitreous Hemorrhage | 2012 |
Indirect supportive evidence for diagnosis of tuberculosis-related uveitis: from the tuberculin skin test to the new interferon gamma release assays.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Child; Drug Therapy, Combination; Ethambutol; Female; Glucocorticoids; Humans; Interferon-gamma Release Tests; Isoniazid; Male; Middle Aged; Prednisone; Prospective Studies; Pyrazinamide; Racial Groups; Radiography, Thoracic; Rifampin; Risk Factors; Sensitivity and Specificity; Spain; Surveys and Questionnaires; Tuberculin Test; Tuberculosis, Ocular; Urban Population; Uveitis; Young Adult | 2013 |
Paucibacillary tubercular vulval ulcer in a sexually inactive pubertal girl: role of therapeutic trial.
Topics: Adolescent; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Pyrazinamide; Rifampin; Skin Ulcer; Tuberculin Test; Tuberculosis, Female Genital; Vulvar Diseases | 2012 |
[Directly observed treatment for tuberculosis in a Buenos Aires City hospital].
Topics: Adult; Antitubercular Agents; Argentina; Directly Observed Therapy; Drug Therapy, Combination; Ethambutol; Female; HIV Seronegativity; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Self Administration; Streptomycin; Treatment Outcome; Tuberculosis, Pulmonary | 2012 |
Pharmacokinetics of anti-tuberculosis drugs in Venezuelan children younger than 16 years of age: supportive evidence for the implementation of revised WHO dosing recommendations.
Topics: Acetyltransferases; Adolescent; Age Factors; Antitubercular Agents; Area Under Curve; Biological Availability; Child; Child, Preschool; Dose-Response Relationship, Drug; Ethambutol; Female; Humans; Infant; Isoniazid; Least-Squares Analysis; Male; Malnutrition; Polymorphism, Genetic; Practice Guidelines as Topic; Pyrazinamide; Rifampin; Tuberculosis; Venezuela; World Health Organization | 2012 |
Nosocomial transmission of extensively drug-resistant tuberculosis in a rural hospital in South Africa.
Topics: Adult; Antitubercular Agents; Cluster Analysis; Cross Infection; Drug Therapy, Combination; Ethambutol; Extensively Drug-Resistant Tuberculosis; Female; Genotype; HIV Infections; Hospitals, Rural; Humans; Isoniazid; Male; Mutation; Mycobacterium tuberculosis; Polymorphism, Restriction Fragment Length; Prevalence; Pyrazinamide; Retrospective Studies; Rifampin; Sequence Analysis, DNA; South Africa | 2013 |
Evaluation of tuberculosis underreporting in Greece through comparison with anti-tuberculosis drug consumption.
Topics: Antitubercular Agents; Epidemiological Monitoring; Ethambutol; Greece; Humans; Isoniazid; Latent Tuberculosis; Prescription Drugs; Pyrazinamide; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2012 |
[Epidural abscess due to a Mycobacterium tuberculosis strain with primary resistance to isoniazid and ethambutol].
Topics: Antitubercular Agents; Cervical Vertebrae; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Epidural Abscess; Ethambutol; Humans; Isoniazid; Levofloxacin; Magnetic Resonance Imaging; Male; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Thoracic Vertebrae; Tuberculosis, Central Nervous System | 2012 |
Impact of pharmacogenetic markers of CYP2B6, clinical factors, and drug-drug interaction on efavirenz concentrations in HIV/tuberculosis-coinfected patients.
Topics: Adenine; Adolescent; Adult; Alkynes; Anti-HIV Agents; Antitubercular Agents; Aryl Hydrocarbon Hydroxylases; Benzoxazines; Cyclopropanes; Cytochrome P-450 CYP2B6; Drug Interactions; Ethambutol; Female; Genotype; HIV Infections; Humans; Isoniazid; Lamivudine; Male; Middle Aged; Organophosphonates; Oxidoreductases, N-Demethylating; Pharmacogenetics; Polymorphism, Single Nucleotide; Pyrazinamide; Reverse Transcriptase Inhibitors; Rifampin; Tenofovir; Tuberculosis; Young Adult | 2013 |
[Anti-mycobacteria drugs therapy for periductal mastitis with fistula].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Drug Therapy, Combination; Ethambutol; Female; Fistula; Humans; Isoniazid; Mastitis; Nontuberculous Mycobacteria; Pyrazinamide; Retrospective Studies; Rifampin; Young Adult | 2012 |
A pregnant woman with dyspnoea, fever & decreased vision.
Topics: Adult; Antitubercular Agents; Choroid Diseases; Ethambutol; Female; Humans; Isoniazid; Pregnancy; Pregnancy Outcome; Pyrazinamide; Radiography; Rifampin; Treatment Outcome; Tuberculosis, Miliary | 2012 |
[Thyroid tuberculosis; a rare cause of compressive goiter].
Topics: Antitubercular Agents; Biopsy; Combined Modality Therapy; Deglutition Disorders; Drainage; Ethambutol; Goiter; Hormone Replacement Therapy; Humans; Hypothyroidism; Isoniazid; Lymphatic Diseases; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Pyrazinamide; Rifampin; Thyroiditis; Thyroxine; Tuberculosis, Endocrine | 2013 |
[A case of tuberculous peritonitis in a hemodialysis patient revealed by severe diarrhea and stomachache].
Topics: Abdominal Pain; Antitubercular Agents; Biomarkers; CA-125 Antigen; Diagnosis, Differential; Diarrhea; Drug Combinations; Ethambutol; Female; Humans; Isoniazid; Middle Aged; Peritonitis, Tuberculous; Pyrazinamide; Receptors, Interleukin-2; Renal Dialysis; Rifampin; Treatment Outcome | 2013 |
Isoniazid- and streptomycin-resistant miliary tuberculosis complicated by intracranial tuberculoma in a Japanese infant.
Topics: Antitubercular Agents; Drug Substitution; Drug Therapy, Combination; Ethambutol; Ethionamide; Female; Humans; Infant; Isoniazid; Microbial Sensitivity Tests; Pyrazinamide; Radiography, Thoracic; Rifampin; Streptomycin; Treatment Outcome; Tuberculoma, Intracranial; Tuberculosis, Miliary; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2013 |
[Primary sinonasal tuberculosis: apropos of a case].
Topics: Aged; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Maxillary Sinusitis; Mycobacterium tuberculosis; Nasal Obstruction; Nasal Polyps; Pyrazinamide; Rifampin; Tuberculosis | 2013 |
Characterization of mutations in multi- and extensive drug resistance among strains of Mycobacterium tuberculosis clinical isolates in Republic of Korea.
Topics: Acetyltransferases; Amidohydrolases; Amikacin; Antigens, Bacterial; Bacterial Proteins; Capreomycin; Catalase; DNA Gyrase; DNA Primers; DNA-Directed RNA Polymerases; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; Fluoroquinolones; Genetic Loci; Humans; Isoniazid; Kanamycin; Mutation; Mycobacterium tuberculosis; Ofloxacin; Oxidoreductases; Pentosyltransferases; Polymerase Chain Reaction; Promoter Regions, Genetic; Pyrazinamide; Republic of Korea; Rifampin; Sequence Analysis, DNA; Streptomycin; Tuberculosis, Multidrug-Resistant | 2013 |
Factors associated with the rapid implementation process of the fixed-dose combination RHZE tuberculosis regimen in Brazil: an ecological study.
Topics: Antitubercular Agents; Brazil; Drug Combinations; Ethambutol; Health Plan Implementation; Humans; Incidence; Isoniazid; Population Density; Practice Guidelines as Topic; Pyrazinamide; Rifampin; Time Factors; Tuberculosis | 2013 |
Treatment outcomes for extensively drug-resistant tuberculosis and HIV co-infection.
Topics: Adolescent; Adult; Antitubercular Agents; Coinfection; Cycloserine; Drug Therapy, Combination; Ethambutol; Ethionamide; Extensively Drug-Resistant Tuberculosis; Female; HIV Infections; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Pyrazinamide; Retrospective Studies; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult | 2013 |
Pharmacokinetics of first-line tuberculosis drugs in Tanzanian patients.
Topics: Adult; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Tanzania; Treatment Outcome; Tuberculosis, Pulmonary | 2013 |
Development and validation of a hydrophilic interaction liquid chromatography-tandem mass spectrometry method for the simultaneous determination of five first-line antituberculosis drugs in plasma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Child; Chromatography, Liquid; Drug Monitoring; Ethambutol; Female; Humans; Hydrophobic and Hydrophilic Interactions; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Streptomycin; Tandem Mass Spectrometry; Tuberculosis; Young Adult | 2013 |
Severe hyponatremia and MRI point to diagnosis of tuberculous meningitis in the Southwest USA.
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Hyponatremia; Isoniazid; Magnetic Resonance Imaging; Pyrazinamide; Rifampin; Southwestern United States; Tuberculosis, Meningeal; Young Adult | 2013 |
A breathtaking response to tuberculosis therapy.
Topics: Adult; Antitubercular Agents; Disease Progression; Dyspnea; Ethambutol; Female; Humans; Isoniazid; Mediastinum; Pericarditis, Tuberculous; Pyrazinamide; Radiography; Rifampin; Tuberculosis, Lymph Node | 2013 |
Estimation of content of anti-TB drugs supplied at centres of the Revised National TB Control Programme in Tamil Nadu, India.
Topics: Antitubercular Agents; Cycloserine; Drug Stability; Drug Storage; Drug Therapy, Combination; Ethambutol; Ethionamide; Humans; India; Isoniazid; Levofloxacin; Ofloxacin; Pyrazinamide; Rifampin; Spectrophotometry; Tuberculosis | 2013 |
Therapeutic potential of thymoquinone against anti-tuberculosis drugs induced liver damage.
Topics: Analysis of Variance; Animals; Antitubercular Agents; Benzoquinones; Blood Chemical Analysis; Chemical and Drug Induced Liver Injury; Ethambutol; Female; Isoniazid; Kidney; Lipid Peroxidation; Lipids; Liver; Liver Function Tests; Pyrazinamide; Rats; Rats, Sprague-Dawley; Rifampin; Superoxide Dismutase | 2013 |
Plasma concentrations of isoniazid and rifampin are decreased in adult pulmonary tuberculosis patients with diabetes mellitus.
Topics: Adult; Antitubercular Agents; Biological Availability; Diabetes Mellitus, Type 2; Drug Administration Schedule; Drug Dosage Calculations; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 2013 |
A case of skin and lung tuberculosis: diagnostic difficulties.
Topics: Antitubercular Agents; Bronchitis; Bronchoalveolar Lavage Fluid; Bronchoscopy; CD4-CD8 Ratio; Diagnosis, Differential; Diagnostic Errors; Drug Therapy, Combination; Ethambutol; Facial Dermatoses; Female; Humans; Isoniazid; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Sarcoidosis; Sputum; Tuberculosis, Cutaneous; Tuberculosis, Pulmonary | 2013 |
[Primary penile tuberculosis].
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Humans; Immunocompromised Host; Isoniazid; Male; Middle Aged; Penile Diseases; Pyrazinamide; Rifampin; Skin Ulcer; Tuberculosis, Male Genital; Vitiligo | 2013 |
Pharmacokinetics and serum concentrations of antimycobacterial drugs in adult Turkish patients.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antitubercular Agents; Area Under Curve; Directly Observed Therapy; Drug Monitoring; Ethambutol; Female; Half-Life; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary; Turkey; Young Adult | 2013 |
Comparison of time to positive and colony counting in an early bactericidal activity study of anti-tuberculosis treatment.
Topics: Adult; Antitubercular Agents; Automation, Laboratory; Colony Count, Microbial; Drug Monitoring; Drug Therapy, Combination; Ethambutol; Feasibility Studies; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Predictive Value of Tests; Prospective Studies; Pyrazinamide; Rifampin; Sputum; Time Factors; Treatment Outcome; Tuberculosis, Pulmonary; Uganda; Young Adult | 2013 |
Anti‑tuberculosis drugs decrease viability and stimulate the expression of chondrocyte marker genes in human nucleus pulposus cells.
Topics: Adolescent; Aggrecans; Antitubercular Agents; Cell Survival; Cells, Cultured; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type II; Ethambutol; Glycosaminoglycans; Humans; Intervertebral Disc; Isoniazid; Pyrazinamide; Rifampin; RNA, Messenger; SOX9 Transcription Factor; Transforming Growth Factor beta1; Young Adult | 2014 |
Clonal expansion of Mycobacterium tuberculosis isolates and coexisting drug resistance in patients newly diagnosed with pulmonary tuberculosis in Hanoi, Vietnam.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Clone Cells; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Mycobacterium tuberculosis; Operon; Phylogeny; Polymorphism, Restriction Fragment Length; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Vietnam | 2013 |
[Thrombocytopenia induced by rifampicin not previously sensitized: a case presentation].
Topics: Adult; Antibiotics, Antitubercular; Ethambutol; Female; Humans; Immunization; Isoniazid; Purpura, Thrombocytopenic, Idiopathic; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 2013 |
[Antimicrobial resistance in tuberculosis].
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Spain; Streptomycin; Tuberculosis, Pulmonary | 2013 |
The incidence of liver injury in Uyghur patients treated for TB in Xinjiang Uyghur autonomous region, China, and its association with hepatic enzyme polymorphisms nat2, cyp2e1, gstm1 and gstt1.
Topics: Adult; Antitubercular Agents; Arylamine N-Acetyltransferase; Chemical and Drug Induced Liver Injury; China; Cross-Sectional Studies; Cytochrome P-450 CYP2E1; Drug Therapy, Combination; Ethambutol; Female; Gene Frequency; Genetic Association Studies; Glutathione Transferase; Humans; Incidence; Isoniazid; Male; Middle Aged; Polymorphism, Single Nucleotide; Prevalence; Pyrazinamide; Rifampin; Sex Distribution; Tuberculosis, Pulmonary; Young Adult | 2014 |
Esophageal anthracosis with tuberculous lymphadenitis confirmed on transesophageal endoscopic ultrasound-guided fine-needle aspiration.
Topics: Aged; Anthracosis; Antitubercular Agents; Chest Pain; Drug Therapy, Combination; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Esophagus; Ethambutol; Female; Humans; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Lymph Node; Weight Loss | 2014 |
[Hypothermia due to anti-tuberculosis drugs: first case].
Topics: Aged; Antitubercular Agents; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Ethambutol; Female; Humans; Hypothermia; Isoniazid; Pyrazinamide; Tuberculosis, Pulmonary; Vomiting | 2014 |
Multidrug-resistant tuberculosis in Western Australia, 1998-2012.
Topics: Adolescent; Adult; Antitubercular Agents; Aza Compounds; Case-Control Studies; Child; Drug Therapy, Combination; Ethambutol; Female; Fluoroquinolones; Hospitalization; Humans; Isoniazid; Male; Middle Aged; Moxifloxacin; Mycobacterium tuberculosis; Pyrazinamide; Quinolines; Retrospective Studies; Risk Factors; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Western Australia; Young Adult | 2014 |
An unusual cause of breast lump: isolated tuberculosis of the breast.
Topics: Antitubercular Agents; Biopsy, Fine-Needle; Breast Diseases; Ethambutol; Female; Humans; Isoniazid; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis | 2014 |
Isoniazid mediates the CYP2B6*6 genotype-dependent interaction between efavirenz and antituberculosis drug therapy through mechanism-based inactivation of CYP2A6.
Topics: Alkynes; Antitubercular Agents; Benzoxazines; Cyclopropanes; Cytochrome P-450 CYP2A6; Cytochrome P-450 CYP2B6; Drug Interactions; Enzyme Activation; Ethambutol; Humans; Hydroxylation; Isoniazid; Microsomes, Liver; Pyrazinamide; Rifampin | 2014 |
Cervical lymphadenopathy--pitfalls of blind antitubercular treatment.
Topics: Adolescent; Adult; Antitubercular Agents; Biopsy; Diagnostic Errors; Ethambutol; Female; Histiocytic Necrotizing Lymphadenitis; Hodgkin Disease; Humans; India; Isoniazid; Lymphoma, Non-Hodgkin; Male; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant; Young Adult | 2014 |
Prevalence of extended treatment in pulmonary tuberculosis patients receiving first-line therapy and its association with recurrent tuberculosis in Beijing, China.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; China; Cohort Studies; Cost of Illness; Drug Combinations; Ethambutol; Female; Health Care Costs; Humans; Isoniazid; Male; Middle Aged; Prevalence; Pyrazinamide; Recurrence; Retrospective Studies; Rifampin; Tuberculosis, Pulmonary; Young Adult | 2014 |
Association of serum levels of iron, copper, and zinc, and inflammatory markers with bacteriological sputum conversion during tuberculosis treatment.
Topics: Adult; Antitubercular Agents; Biomarkers; C-Reactive Protein; Copper; Ethambutol; Hemoglobins; Host-Pathogen Interactions; Humans; Inflammation; Iron; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Serum Albumin; Serum Globulins; Sputum; Time Factors; Treatment Outcome; Tuberculosis, Pulmonary; Zinc | 2014 |
Novel bronchoscopic balloon dilation for patients with bronchostenosis caused by bronchial tuberculosis: a case report.
Topics: Antitubercular Agents; Bronchial Diseases; Bronchoscopy; Constriction, Pathologic; Dilatation; Ethambutol; Female; Humans; Isoniazid; Lung; Pyrazinamide; Radiography; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult | 2014 |
Genotoxic effects of some antituberculosis drugs and mixtures in rats.
Topics: Animals; Antitubercular Agents; DNA Damage; Drug Combinations; Ethambutol; Isoniazid; Kidney; Liver; Male; Pyrazinamide; Rats; Rifampin | 2015 |
Disseminated Mycobacterium celatum disease with prolonged pulmonary involvement.
Topics: Aged; Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Lung; Lung Diseases; Mycobacterium; Mycobacterium Infections; Pyrazinamide; Radiography | 2014 |
High cure rate with standardised short-course multidrug-resistant tuberculosis treatment in Niger: no relapses.
Topics: Adolescent; Adult; Aged; Body Mass Index; Body Weight; Clofazimine; Dose-Response Relationship, Drug; Drug Combinations; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Fluoroquinolones; Follow-Up Studies; Gatifloxacin; HIV Infections; Humans; Kanamycin; Male; Middle Aged; Niger; Prospective Studies; Pyrazinamide; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Young Adult | 2014 |
False-positive rifampicin resistance on Xpert® MTB/RIF caused by a silent mutation in the rpoB gene.
Topics: Aged; Amikacin; Amino Acid Sequence; Antibiotics, Antitubercular; Bacterial Proteins; DNA-Directed RNA Polymerases; Drug Resistance, Multiple, Bacterial; Ethambutol; Ethionamide; Fluoroquinolones; Genotype; Humans; Isoniazid; Male; Molecular Sequence Data; Moxifloxacin; Mutation; Mycobacterium tuberculosis; Phenotype; Pyrazinamide; Rifampin; Sensitivity and Specificity; Sputum; Tuberculosis, Pulmonary | 2014 |
Drug resistance of Mycobacterium tuberculosis isolates from tuberculosis lymphadenitis patients in Ethiopia.
Topics: Antitubercular Agents; Biopsy, Fine-Needle; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Ethambutol; Ethiopia; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Prospective Studies; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Lymph Node | 2014 |
Investigating gender disparities in the profile and treatment outcomes of tuberculosis in Ebonyi state, Nigeria.
Topics: Adult; Antitubercular Agents; Cohort Studies; Coinfection; Ethambutol; Female; Health Status Disparities; HIV Infections; Humans; Isoniazid; Male; Middle Aged; Nigeria; Pyrazinamide; Retrospective Studies; Rifampin; Rural Population; Sex Factors; Streptomycin; Time Factors; Treatment Outcome; Tuberculosis; Tuberculosis, Pulmonary; Urban Population; Young Adult | 2015 |
Re-emphasizing Thygeson's warning: conjunctival phlyctenulosis as presenting sign of impending clinical tuberculosis.
Topics: Antitubercular Agents; Blood Sedimentation; Child; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Keratoconjunctivitis; Pyrazinamide; Rifampin; Tuberculosis, Lymph Node; Tuberculosis, Ocular | 2014 |
Severe meningoencephalitis co-infection due to Cryptococcus neoformans and Mycobacterium tuberculosis in a child with systemic lupus erythematosus.
Topics: Amphotericin B; Antitubercular Agents; Child; Coinfection; Cryptococcosis; Cryptococcus neoformans; Ethambutol; Female; Humans; Immunocompromised Host; Isoniazid; Lupus Erythematosus, Systemic; Meningoencephalitis; Mycobacterium tuberculosis; Pyrazinamide; Rifampin | 2015 |
Treatment options and outcomes of hospitalised tuberculosis patients: a nationwide study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Child; Child, Preschool; Ethambutol; Female; Hospital Mortality; Hospitalization; Humans; Infant; Infant, Newborn; Isoniazid; Japan; Logistic Models; Male; Middle Aged; Multivariate Analysis; Patient Discharge; Pyrazinamide; Retrospective Studies; Rifampin; Risk Factors; Sputum; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2015 |
Diseases at the crossroads: chronic myelogenous leukemia and tuberculosis.
Topics: Adult; Antitubercular Agents; Dasatinib; Ethambutol; Female; Fluoroquinolones; Humans; Isoniazid; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Moxifloxacin; Peritonitis, Tuberculous; Protein Kinase Inhibitors; Pyrazinamide; Pyrimidines; Thiazoles | 2015 |
Tuberculosis of the cervix mimicking cervical cancer.
Topics: Antitubercular Agents; Cervix Uteri; Diagnosis, Differential; Ethambutol; Female; Gynecological Examination; Humans; Middle Aged; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Female Genital; Ultrasonography; Uterine Cervical Neoplasms | 2014 |
Drug-induced hepatotoxicity of anti-tuberculosis drugs and their serum levels.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alanine Transaminase; Antitubercular Agents; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Ethambutol; Female; Humans; Isoniazid; Liver; Liver Function Tests; Male; Middle Aged; Pyrazinamide; Retrospective Studies; Rifampin; Tuberculosis, Pulmonary; Young Adult | 2015 |
Infliximab therapy in two cases of severe neurotuberculosis paradoxical reaction.
Topics: Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antitubercular Agents; Dexamethasone; Ethambutol; Female; Humans; Infliximab; Isoniazid; Middle Aged; Prednisolone; Pyrazinamide; Rifampin; Tuberculoma, Intracranial; Tuberculosis, Meningeal; Tumor Necrosis Factor-alpha | 2015 |
Profile of adverse drug reactions in drug resistant tuberculosis from Punjab.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Arthralgia; Ataxia; Chemical and Drug Induced Liver Injury; Child; Cycloserine; Drug Eruptions; Drug Therapy, Combination; Ethambutol; Ethionamide; Female; Gastrointestinal Diseases; Hearing Loss; Humans; Hypothyroidism; India; Kanamycin; Levofloxacin; Male; Middle Aged; Peripheral Nervous System Diseases; Psychoses, Substance-Induced; Pyrazinamide; Severity of Illness Index; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Vision Disorders; Young Adult | 2014 |
Six- vs. eight-month anti-tuberculosis regimen for pulmonary tuberculosis under programme conditions.
Topics: Adult; Antitubercular Agents; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Logistic Models; Male; Middle Aged; Multivariate Analysis; Nigeria; Pyrazinamide; Retrospective Studies; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult | 2015 |
Effective anti-tuberculosis therapy correlates with plasma small RNA.
Topics: Adult; Antitubercular Agents; Biomarkers; Coinfection; Ethambutol; Female; Gene Expression Profiling; HIV Infections; Humans; Isoniazid; Male; MicroRNAs; Prospective Studies; Pyrazinamide; Rifampin; RNA; Treatment Outcome; Tuberculosis, Pulmonary | 2015 |
[A case of tuberculous meningitis complicated with multiple drug hypersensitivity to antituberculosis agents].
Topics: Antitubercular Agents; Drug Hypersensitivity; Drug Therapy, Combination; Ethambutol; Ethionamide; Humans; Immunologic Tests; Isoniazid; Levofloxacin; Lymphocyte Activation; Male; Middle Aged; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Meningeal | 2015 |
Tuberculosis cutis orificialis in an immunocompetent patient.
Topics: Antibiotics, Antitubercular; Diagnosis, Differential; Drug Combinations; Ethambutol; Female; Humans; Middle Aged; Mycobacterium tuberculosis; Oral Ulcer; Pyrazinamide; Rifampin; Tuberculosis, Oral | 2015 |
Pharmacokinetics of anti-TB drugs in Malawian children: reconsidering the role of ethambutol.
Topics: Adolescent; Antitubercular Agents; Child; Child, Preschool; Ethambutol; Female; Humans; Infant; Isoniazid; Malawi; Male; Plasma; Pyrazinamide; Rifampin | 2015 |
[The interest of addiction to first line anti-TB drugs].
Topics: Antitubercular Agents; Drug Eruptions; Drug Hypersensitivity; Ethambutol; Female; Humans; Isoniazid; Middle Aged; Pyrazinamide | 2014 |
Safe and effective treatment for patients with isoniazid drug resistance.
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Ethambutol; Female; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Tuberculosis | 2015 |
In reply.
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Ethambutol; Female; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Tuberculosis | 2015 |
High effectiveness of a 12-month regimen for MDR-TB patients in Cameroon.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Cameroon; Clofazimine; Cohort Studies; Confidence Intervals; Developing Countries; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Ethambutol; Female; Fluoroquinolones; Gatifloxacin; Humans; Isoniazid; Kanamycin; Male; Medication Adherence; Middle Aged; Odds Ratio; Prospective Studies; Prothionamide; Pyrazinamide; Risk Assessment; Time Factors; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Young Adult | 2015 |
Effectiveness of RHZE-FDC (fixed-dose combination) compared to RH-FDC + Z for tuberculosis treatment in Brazil: a cohort study.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Brazil; Cohort Studies; Drug Combinations; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary | 2015 |
Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in Indian children.
Topics: Adolescent; Antitubercular Agents; Area Under Curve; Child; Child, Preschool; Ethambutol; Ethnicity; Female; Humans; India; Infant; Isoniazid; Male; Prospective Studies; Pyrazinamide; Regression Analysis; Rifampin; Tandem Mass Spectrometry; Treatment Outcome; Tuberculosis, Pulmonary | 2015 |
High mortality associated with retreatment of tuberculosis in a clinic in Kampala, Uganda: a retrospective study.
Topics: Adult; Antitubercular Agents; Coinfection; Ethambutol; Female; Follow-Up Studies; HIV Infections; Humans; Isoniazid; Male; Middle Aged; Proportional Hazards Models; Pyrazinamide; Recurrence; Retreatment; Retrospective Studies; Rifampin; Streptomycin; Survival Rate; Treatment Failure; Treatment Outcome; Tuberculosis; Uganda | 2015 |
Is Europe ready to reach tuberculosis elimination? An outbreak report from Southern Italy.
Topics: Adult; Child, Preschool; Communicable Disease Control; Contact Tracing; Disease Outbreaks; Ethambutol; Europe; Female; Humans; Incidence; Interferon-gamma Release Tests; Isoniazid; Italy; Male; Pyrazinamide; Rifampin; Tomography, X-Ray Computed; Tuberculosis | 2015 |
Advanced stage of chronic kidney disease is risk of poor treatment outcome for smear-positive pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Cardiovascular Diseases; Child; Drug Therapy, Combination; Ethambutol; Female; Glomerular Filtration Rate; Humans; Isoniazid; Japan; Male; Middle Aged; Pyrazinamide; Renal Insufficiency, Chronic; Retrospective Studies; Rifampin; Risk Factors; Serum Albumin; Sputum; Steroids; Streptomycin; Survival Rate; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult | 2015 |
IL-37 Expression is Upregulated in Patients with Tuberculosis and Induces Macrophages Towards an M2-like Phenotype.
Topics: Antitubercular Agents; Arginase; B7-2 Antigen; Cell Differentiation; Cells, Cultured; Ethambutol; Female; Humans; Interferon-gamma; Interleukin-1; Interleukin-10; Interleukin-12 Subunit p35; Isoniazid; Lectins, C-Type; Macrophages; Male; Mannose Receptor; Mannose-Binding Lectins; Middle Aged; Mycobacterium tuberculosis; Nitric Oxide; Phagocytosis; Phenotype; Pyrazinamide; Receptors, Cell Surface; Rifampin; RNA Interference; RNA, Messenger; RNA, Small Interfering; Transcriptional Activation; Transforming Growth Factor beta; Tuberculosis, Pulmonary; Up-Regulation | 2015 |
Isolated hepatosplenic tuberculosis: a rare presentation.
Topics: Abdominal Pain; Antitubercular Agents; Diagnosis, Differential; Ethambutol; Female; Humans; Isoniazid; Middle Aged; Pyrazinamide; Rifampin; Tomography, X-Ray Computed; Treatment Outcome; Tuberculosis, Hepatic; Tuberculosis, Splenic; Weight Loss | 2015 |
A Clinical Study of Miliary Brain Tuberculomas in China.
Topics: Adult; Aged; Antitubercular Agents; Brain; Contrast Media; Drug Therapy, Combination; Ethambutol; Female; Gadolinium; Humans; Isoniazid; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculoma, Intracranial | 2016 |
Therapeutic drug monitoring and the conservative management of chronic tuberculous empyema: case report and review of the literature.
Topics: Aged, 80 and over; Antitubercular Agents; Bronchial Fistula; Canada; Croatia; Diagnosis, Differential; Drainage; Drug Monitoring; Drug Therapy, Combination; Emigrants and Immigrants; Empyema, Tuberculous; Ethambutol; Humans; Isoniazid; Male; Pleural Diseases; Pyrazinamide; Radiography | 2015 |
Isolated tuberculosis of tunica albuginea and tunica vaginalis presenting as acute hydrocoele: a diagnostic dilemma.
Topics: Adult; Antitubercular Agents; Ethambutol; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Scrotum; Testicular Hydrocele; Testis; Treatment Outcome; Tuberculosis, Male Genital | 2015 |
The relationship between chitotriosidase activity and tuberculosis.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Biomarkers; Case-Control Studies; China; Ethambutol; Female; Hexosaminidases; Humans; Isoniazid; Lung; Male; Middle Aged; Pyrazinamide; Radiography; Rifampin; Streptomycin; Thioacetazone; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult | 2015 |
Pleural tuberculosis in a patient with untreated type 1 Gaucher disease.
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Gaucher Disease; Humans; Isoniazid; Male; Pulmonary Fibrosis; Pyrazinamide; Rifampin; Tuberculosis, Pleural; Turkey | 2016 |
Serum Levels of Antituberculosis Drugs and Their Effect on Tuberculosis Treatment Outcome.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Chromatography, Liquid; Drug Monitoring; Ethambutol; Female; Humans; Isoniazid; Male; Mass Spectrometry; Middle Aged; Multivariate Analysis; Mycobacterium tuberculosis; Pyrazinamide; Recurrence; Retrospective Studies; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary | 2016 |
Primary Gingival Tuberculosis Diagnosed Based on Genetic Identification.
Topics: Aged; Antitubercular Agents; Biopsy; Diagnosis, Differential; DNA, Bacterial; Ethambutol; Female; Gingival Diseases; Humans; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Oral | 2015 |
The background and rationale for a new fixed-dose combination for first-line treatment of tuberculosis in children.
Topics: Antitubercular Agents; Body Weight; Child; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Practice Guidelines as Topic; Pyrazinamide; Rifampin; Tuberculosis; World Health Organization | 2015 |
Beyond multidrug-resistant tuberculosis in Europe: a TBNET study.
Topics: Adult; Antitubercular Agents; Ethambutol; Ethionamide; Europe; Extensively Drug-Resistant Tuberculosis; Female; Fluoroquinolones; Humans; Logistic Models; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide | 2015 |
Thanks to Trauma: A Delayed Diagnosis of Pott Disease.
Topics: Accidental Falls; Antitubercular Agents; Child, Preschool; Delayed Diagnosis; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Fractures, Comminuted; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Spinal Injuries; Tomography, X-Ray Computed; Tuberculin Test; Tuberculosis, Spinal | 2015 |
Sterilizing Activity of Pyrazinamide in Combination with First-Line Drugs in a C3HeB/FeJ Mouse Model of Tuberculosis.
Topics: Animals; Antitubercular Agents; Disease Models, Animal; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Female; Isoniazid; Mice, Inbred BALB C; Mice, Inbred C3H; Mutation; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary | 2016 |
Painful Red Eye in a Woman in Her 70s.
Topics: Aged; Antitubercular Agents; Choroid Diseases; Drug Therapy, Combination; Ethambutol; Eye Infections, Bacterial; Eye Pain; Female; Humans; Interferon-gamma Release Tests; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Radiography, Thoracic; Rifampin; Scleritis; Skin Tests; Tuberculoma; Tuberculosis, Ocular | 2016 |
Repeat exposure to active tuberculosis and risk of re-infection.
Topics: Adult; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Emergency Service, Hospital; Ethambutol; Female; Humans; Isoniazid; Mycobacterium tuberculosis; Parents; Pyrazinamide; Recurrence; Rifampin; Risk Assessment; Risk Factors; Siblings; Sputum; Time Factors; Treatment Outcome; Tuberculosis, Pulmonary | 2016 |
[CLINICAL EFFECTS OF TREATMENT FOR MYCOBACTERIUM TUBERCULOSIS INFECTION IN PATIENTS AT A SPECIALIZED HOSPITAL IN 2011].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Child; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Hospitals, Special; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Retrospective Studies; Rifampin; Streptomycin; Time Factors; Treatment Outcome; Tuberculosis; Young Adult | 2015 |
Global Urine Metabolomics in Patients Treated with First-Line Tuberculosis Drugs and Identification of a Novel Metabolite of Ethambutol.
Topics: Adult; Aged; Aged, 80 and over; Aminobutyrates; Antitubercular Agents; Biotransformation; Case-Control Studies; Chromatography, Gas; Ethambutol; Female; Humans; India; Isoniazid; Male; Metabolomics; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tuberculosis, Pulmonary | 2016 |
Later emergence of acquired drug resistance and its effect on treatment outcome in patients treated with Standard Short-Course Chemotherapy for tuberculosis.
Topics: Adolescent; Adult; Antitubercular Agents; China; Cohort Studies; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Prospective Studies; Pyrazinamide; Rifampin; Streptomycin; Treatment Failure; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2016 |
Clofazimine Contributes Sustained Antimicrobial Activity after Treatment Cessation in a Mouse Model of Tuberculosis Chemotherapy.
Topics: Animals; Antitubercular Agents; Clofazimine; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Ethambutol; Female; Isoniazid; Mice; Mice, Inbred BALB C; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis; Withholding Treatment | 2016 |
Leukapheresis in the management of drug rash with eosinophilia and systemic symptoms syndrome.
Topics: Antitubercular Agents; Combined Modality Therapy; Drug Combinations; Drug Hypersensitivity Syndrome; Ethambutol; Glucocorticoids; Herpesvirus 6, Human; Humans; Isoniazid; Leukapheresis; Male; Multiple Organ Failure; Plasmapheresis; Pyrazinamide; Rifampin; Roseolovirus Infections; Tuberculosis, Pleural; Young Adult | 2017 |
Ameliorative Effects of Kolaviron, a Biflavonoid Fraction from Garcinia Kola Seed, on Hepato-renal Toxicity of Anti-tuberculosis Drugs in Wistar Rats.
Topics: Alanine Transaminase; Animals; Antioxidants; Antitubercular Agents; Aspartate Aminotransferases; Ethambutol; Flavonoids; Garcinia kola; Glutathione; Glutathione Peroxidase; Isoniazid; Kidney; Liver; Male; Malondialdehyde; Oxidative Stress; Pyrazinamide; Rats, Wistar; Rifampin; Seeds | 2016 |
Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in HIV-infected Indian children.
Topics: Adolescent; Age Factors; Antitubercular Agents; Child; Child, Preschool; Chromatography, Liquid; Coinfection; Drug Dosage Calculations; Drug Monitoring; Ethambutol; Female; HIV Infections; Humans; India; Infant; Isoniazid; Male; Prospective Studies; Pyrazinamide; Rifampin; Spectrometry, Mass, Electrospray Ionization; Treatment Outcome; Tuberculosis | 2016 |
The outcomes of chemotherapy only treatment on mild spinal tuberculosis.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Kyphosis; Male; Middle Aged; Pyrazinamide; Treatment Outcome; Tuberculosis, Spinal; Young Adult | 2016 |
Anterior debridement may not be necessary in the treatment of tuberculous spondylitis of the thoracic and lumbar spine in adults: a retrospective study.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Decompression, Surgical; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Kyphosis; Laminectomy; Lumbar Vertebrae; Middle Aged; Pyrazinamide; Retrospective Studies; Rifampin; Spinal Fusion; Spondylitis; Thoracic Vertebrae; Tuberculosis, Spinal | 2016 |
Frequency of adverse events observed with second-line drugs among patients treated for multidrug-resistant tuberculosis.
Topics: Adult; Antitubercular Agents; Cohort Studies; Cycloserine; Drug Therapy, Combination; Ethambutol; Ethionamide; Female; Humans; Kanamycin; Male; Ofloxacin; Pyrazinamide; Tuberculosis, Multidrug-Resistant; Young Adult | 2016 |
Population pharmacokinetics, optimised design and sample size determination for rifampicin, isoniazid, ethambutol and pyrazinamide in the mouse.
Topics: Animals; Antibiotics, Antitubercular; Disease Models, Animal; Ethambutol; Isoniazid; Mice, Inbred C57BL; Models, Biological; Pyrazinamide; Rifampin; Sample Size | 2016 |
Bacterial Loads Measured by the Xpert MTB/RIF Assay as Markers of Culture Conversion and Bacteriological Cure in Pulmonary TB.
Topics: Antitubercular Agents; Area Under Curve; Bacterial Load; Bacteriological Techniques; Biomarkers; Ethambutol; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Pyrazinamide; ROC Curve; Sensitivity and Specificity; Treatment Failure; Tuberculosis, Pulmonary | 2016 |
[EVALUATION OF THE EFFICIENCY OF TREATMENT AND THE CHOICE OF CONTROL COMPUTED TOMOGRAPHY TIME IN CHILDREN WITH MINOR FORMS OF INTRATHORACIC TUBERCULOSIS].
Topics: Antitubercular Agents; Child; Child, Preschool; Comparative Effectiveness Research; Drug Monitoring; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Lymph Nodes; Male; Outcome Assessment, Health Care; Pyrazinamide; Rifampin; Thorax; Tomography, X-Ray Computed; Tuberculosis, Lymph Node; Tuberculosis, Pulmonary | 2010 |
Simultaneous quantification of isoniazid, rifampicin, ethambutol and pyrazinamide by liquid chromatography/tandem mass spectrometry.
Topics: Antitubercular Agents; Chromatography, Liquid; Drug Monitoring; Ethambutol; Humans; Isoniazid; Plasma; Pyrazinamide; Rifampin; Tandem Mass Spectrometry | 2016 |
Cutaneous Tuberculosis Occurring After a Skin Cut in a Child.
Topics: Abattoirs; Adolescent; Animals; Antitubercular Agents; Axilla; Ethambutol; Finger Injuries; Humans; Isoniazid; Lupus Vulgaris; Lymphadenopathy; Male; Mycobacterium tuberculosis; Occupational Diseases; Pyrazinamide; Rifampin; Sheep; Treatment Outcome; Turkey; Wound Healing | 2016 |
Pyrazinamide Resistance Assays and Two-Month Sputum Culture Status in Patients with Multidrug-Resistant Tuberculosis.
Topics: Adolescent; Adult; Age Factors; Alcohol Drinking; Amidohydrolases; Antitubercular Agents; Biological Assay; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Gene Expression; Humans; Longitudinal Studies; Male; Middle Aged; Mutation; Mycobacterium tuberculosis; Pyrazinamide; Risk Factors; Sensitivity and Specificity; Sequence Analysis, DNA; Sex Factors; Sputum; Tuberculosis, Multidrug-Resistant | 2016 |
Comprehensive cost of treating one patient with MDR/pre-XDR-TB in Wellington, New Zealand.
Topics: Adult; Amikacin; Aminosalicylic Acid; Anti-Bacterial Agents; Antitubercular Agents; Bronchoscopy; Clofazimine; Depression; Drug Costs; Emigrants and Immigrants; Ethambutol; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Health Care Costs; Humans; India; Isoniazid; Linezolid; Male; Mediastinum; Microbial Sensitivity Tests; Moxifloxacin; New Zealand; Pyrazinamide; Radiography, Thoracic; Rifampin; Schizophrenia, Paranoid; Tuberculosis, Lymph Node; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pleural; Tuberculosis, Pulmonary | 2016 |
Association between TXNRD1 polymorphisms and anti-tuberculosis drug-induced hepatotoxicity in a prospective study.
Topics: Adult; Age Factors; Alleles; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Ethambutol; Female; Gene Expression; Gene Frequency; Haplotypes; Humans; Isoniazid; Liver; Lung; Male; Middle Aged; Mycobacterium tuberculosis; Polymorphism, Single Nucleotide; Prospective Studies; Pyrazinamide; Rifampin; Risk Factors; Sex Factors; Thioredoxin Reductase 1; Tuberculosis, Pulmonary | 2016 |
Mechanisms of first-line antimicrobial resistance in multi-drug and extensively drug resistant strains of Mycobacterium tuberculosis in KwaZulu-Natal, South Africa.
Topics: Amidohydrolases; Antitubercular Agents; Bacterial Proteins; Catalase; Drug Resistance, Multiple, Bacterial; Ethambutol; Extensively Drug-Resistant Tuberculosis; Humans; Isoniazid; Mutation; Mycobacterium tuberculosis; Oxidoreductases; Pentosyltransferases; Polymorphism, Restriction Fragment Length; Pyrazinamide; Rifampin; South Africa; Tuberculosis, Multidrug-Resistant | 2016 |
Role of Risorine in the Treatment of Drug - Susceptible Pulmonary Tuberculosis: A Pilot Study.
Topics: Adult; Alkaloids; Antitubercular Agents; Benzodioxoles; Cytochrome P-450 Enzyme Inhibitors; Drug Combinations; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pilot Projects; Piperidines; Polyunsaturated Alkamides; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary; Young Adult | 2016 |
Applicability of the shorter 'Bangladesh regimen' in high multidrug-resistant tuberculosis settings.
Topics: Antitubercular Agents; Clinical Protocols; Diarylquinolines; Drug Therapy, Combination; Ethambutol; Fluoroquinolones; Humans; Isoniazid; Moxifloxacin; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Pyrazinamide; Tuberculosis, Multidrug-Resistant; World Health Organization | 2017 |
Drug-related hepatitis in patients treated with standard anti-tuberculosis chemotherapy over a 30-year period.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Ethambutol; Female; Follow-Up Studies; Hepatitis; Humans; Incidence; Infant; Infant, Newborn; Isoniazid; Longitudinal Studies; Male; Middle Aged; Prospective Studies; Pyrazinamide; Rifampin; Tuberculosis; Young Adult | 2016 |
Resistance to First-Line Antituberculosis Drugs in Washington State by Region of Birth and Implications for Latent Tuberculosis Treatment Among Foreign-Born Individuals.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Child; Child, Preschool; Drug Resistance, Bacterial; Ethambutol; Female; Humans; Infant; Infant, Newborn; Isoniazid; Latent Tuberculosis; Logistic Models; Male; Mexico; Middle Aged; Multivariate Analysis; Philippines; Pyrazinamide; Rifampin; Risk Factors; Vietnam; Washington; Young Adult | 2017 |
Tuberculous pericarditis: a case report.
Topics: Aged; Antitubercular Agents; Ethambutol; Humans; Isoniazid; Male; Pericarditis, Tuberculous; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculin Test | 2016 |
Applicability of the World Health Organization recommended new shorter regimen in a multidrug-resistant tuberculosis high burden country.
Topics: Adult; Antitubercular Agents; Communicable Disease Control; Drug Administration Schedule; Ethambutol; Female; Humans; Infectious Disease Medicine; Male; Mycobacterium tuberculosis; Ofloxacin; Pakistan; Pyrazinamide; Streptomycin; Tuberculosis, Multidrug-Resistant; World Health Organization; Young Adult | 2017 |
Treatment outcomes of fixed-dose combination versus separate tablet regimens in pulmonary tuberculosis patients with or without diabetes in Qatar.
Topics: Adult; Antitubercular Agents; Diabetes Complications; Dose-Response Relationship, Drug; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Ethambutol; Female; Hospitals, General; Humans; Isoniazid; Male; Pyrazinamide; Qatar; Retrospective Studies; Rifampin; Sputum; Tablets; Treatment Outcome; Tuberculosis, Pulmonary | 2017 |
TB Alliance regimen development for multidrug-resistant tuberculosis.
Topics: Antitubercular Agents; Clinical Protocols; Diarylquinolines; Dose-Response Relationship, Drug; Ethambutol; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Humans; Isoniazid; Linezolid; Moxifloxacin; Nitroimidazoles; Pyrazinamide; Randomized Controlled Trials as Topic; Research Design; Rifampin; Tuberculosis, Multidrug-Resistant | 2016 |
Concomitant metastatic cutaneous tuberculous abscesses and Pott disease in an immunocompetent patient.
Topics: Abscess; Adult; Antitubercular Agents; Arthrodesis; Debridement; Ethambutol; Humans; Immunocompetence; Isoniazid; Magnetic Resonance Imaging; Male; Pyrazinamide; Rifampin; Tuberculosis, Cutaneous; Tuberculosis, Spinal | 2016 |
Association of CYP2B6 gene polymorphisms and anti-tuberculosis drug-induced hepatotoxicity in a Chinese population.
Topics: Adult; Alleles; Antitubercular Agents; Asian People; Chemical and Drug Induced Liver Injury; Cytochrome P-450 CYP2B6; Ethambutol; Female; Gene Expression; Gene Frequency; Genetic Predisposition to Disease; Haplotypes; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Polymorphism, Single Nucleotide; Prospective Studies; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 2017 |
The Rate of Drug-Resistant Tuberculosis in Korean Children and Adolescents Since 2007.
Topics: Adolescent; Antitubercular Agents; Asian People; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Humans; Incidence; Infant; Isoniazid; Male; Mycobacterium tuberculosis; Pyrazinamide; Republic of Korea; Rifampin; Tuberculosis, Multidrug-Resistant; Young Adult | 2017 |
Poncet's disease in human immunodeficiency virus: a case report.
Topics: Adult; Antibiotics, Antitubercular; Antiretroviral Therapy, Highly Active; Arthritis, Reactive; Ethambutol; HIV Infections; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Tomography, X-Ray Computed; Tuberculosis, Pulmonary | 2017 |
Pharmacokinetics of Pyrazinamide and Optimal Dosing Regimens for Drug-Sensitive and -Resistant Tuberculosis.
Topics: Adolescent; Adult; Antitubercular Agents; Coinfection; Drug Combinations; Ethambutol; HIV Infections; Humans; Isoniazid; Male; Metabolic Clearance Rate; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2017 |
Assessment of treatment response by colony forming units, time to culture positivity and the molecular bacterial load assay compared in a mouse tuberculosis model.
Topics: Animals; Antitubercular Agents; Bacterial Load; Colony Count, Microbial; Disease Models, Animal; DNA, Bacterial; Ethambutol; Female; Isoniazid; Lung; Mice, Inbred BALB C; Mycobacterium tuberculosis; Nonlinear Dynamics; Predictive Value of Tests; Pyrazinamide; Ribotyping; Rifampin; RNA, Ribosomal, 16S; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 2017 |
Inhibitory Effects of Selected Antituberculosis Drugs on Common Human Hepatic Cytochrome P450 and UDP-glucuronosyltransferase Enzymes.
Topics: Acetaminophen; Antitubercular Agents; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Diarylquinolines; Enzyme Inhibitors; Ethambutol; Glucuronosyltransferase; Humans; Inhibitory Concentration 50; Isoenzymes; Isoniazid; Kinetics; Liver; Pyrazinamide; Rifabutin | 2017 |
Resistance to first- and second-line antituberculosis drugs in Southern Taiwan: Implications for empirical treatment.
Topics: Aminosalicylic Acid; Antitubercular Agents; Ethambutol; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Pyrazinamide; Streptomycin; Taiwan | 2018 |
Massive choroidal granuloma as the presenting feature of disseminated tuberculosis in immunocompetent patients.
Topics: Adolescent; Adult; Antitubercular Agents; Choroid Diseases; Drug Combinations; Ethambutol; Female; Granuloma; Humans; Immunocompetence; Isoniazid; Magnetic Resonance Imaging; Male; Pyrazinamide; Rifampin; Tomography, X-Ray Computed; Tuberculosis, Ocular; Tuberculosis, Pulmonary; Ultrasonography | 2018 |
Serum levels of soluble urokinase plasminogen activator receptor (suPAR) as a marker of tuberculosis treatment efficacy.
Topics: Adult; Aged; Antitubercular Agents; Biomarkers; Drug Monitoring; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Receptors, Urokinase Plasminogen Activator; Rifampin; Tuberculosis, Pulmonary; Young Adult | 2017 |
Simultaneous Determination of First-Line 4-FDC Antituberculosis Drugs by UHPLC-UV and HPLC-UV: A Comparative Study.
Topics: Antitubercular Agents; Chromatography, High Pressure Liquid; Ethambutol; Isoniazid; Pyrazinamide; Rifampin | 2017 |
A 25-Year-Old Woman With a Deceptive Pancreas Cyst: All Is Not as It Appears!
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Ethambutol; Female; Humans; Isoniazid; Mycobacterium tuberculosis; Pancreatic Cyst; Pyrazinamide; Rifampin; Tomography, X-Ray Computed; Treatment Outcome; Tuberculosis | 2018 |
Assessment of Bactericidal Drug Activity and Treatment Outcome in a Mouse Tuberculosis Model Using a Clinical Beijing Strain.
Topics: Animals; Antitubercular Agents; Disease Models, Animal; Drug Therapy, Combination; Ethambutol; Female; Isoniazid; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Treatment Outcome; Tuberculosis, Pulmonary | 2017 |
Urine trouble: genitourinary tuberculosis and subsequent DRESS syndrome.
Topics: Adult; Antibiotics, Antitubercular; Drug Hypersensitivity Syndrome; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Pyrazinamide; Rifabutin; Tuberculosis, Urogenital | 2017 |
An unusual pain in the gut.
Topics: Abdominal Pain; Africa; Anti-Bacterial Agents; Colon, Transverse; Colonoscopy; Diagnosis, Differential; Ethambutol; Female; Humans; Isoniazid; Middle Aged; Mycobacterium bovis; Pyrazinamide; Rifampin; Thailand; Travel; Treatment Outcome; Tuberculosis, Gastrointestinal | 2017 |
The clinical recovery of tuberculosis patients undergoing specific treatment is associated with changes in the immune and neuroendocrine responses.
Topics: Adult; Antitubercular Agents; C-Reactive Protein; Case-Control Studies; Dehydroepiandrosterone; Ethambutol; Female; Gene Expression Regulation; Humans; Hydrocortisone; Interferon-gamma; Interleukin-6; Isoniazid; Leukocytes, Mononuclear; Male; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Receptors, Glucocorticoid; Rifampin; Transforming Growth Factor beta; Treatment Outcome; Tuberculosis, Pulmonary | 2017 |
Cohort profile of a study on outcomes related to tuberculosis and antiretroviral drug concentrations in Uganda: design, methods and patient characteristics of the SOUTH study.
Topics: Adult; Anti-Retroviral Agents; Antitubercular Agents; Biomedical Research; CD4 Lymphocyte Count; Cohort Studies; Coinfection; Drug Combinations; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Male; Pyrazinamide; Research Design; Rifampin; Tuberculosis, Pulmonary; Uganda | 2017 |
Treatment outcomes of rifampin-sparing treatment in patients with pulmonary tuberculosis with rifampin-mono-resistance or rifampin adverse events: A retrospective cohort analysis.
Topics: Adult; Age Distribution; Aged; Alcohol Drinking; Aminosalicylic Acid; Antitubercular Agents; Cohort Studies; Comorbidity; Cycloserine; Ethambutol; Female; Fluoroquinolones; HIV Infections; Humans; Isoniazid; Male; Middle Aged; Prothionamide; Pyrazinamide; Republic of Korea; Retrospective Studies; Rifampin; Severity of Illness Index; Treatment Outcome; Tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2017 |
Achieving High
Topics: Antitubercular Agents; Deuterium; Ethambutol; Isoniazid; Magnetic Resonance Spectroscopy; Pyrazinamide; Rifampin | 2017 |
'A most malignant malady': a rare case of laryngeal tuberculosis in epidermal growth factor receptor mutant lung adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Antibiotics, Antitubercular; Drug Therapy, Combination; Dysphonia; ErbB Receptors; Ethambutol; Female; Gene Expression Regulation, Neoplastic; Humans; Isoniazid; Lung Neoplasms; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Laryngeal | 2017 |
Prescription practice of anti-tuberculosis drugs in Yunnan, China: A clinical audit.
Topics: Adult; Aged; Antitubercular Agents; Asian People; China; Clinical Audit; Ethambutol; Female; Fluoroquinolones; Humans; Isoniazid; Male; Middle Aged; Outcome Assessment, Health Care; Prescriptions; Pyrazinamide; Retreatment; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2017 |
Secretome profile analysis of multidrug-resistant, monodrug-resistant and drug-susceptible Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Ethambutol; Gene Expression Profiling; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Proteomics; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant | 2018 |
Pharmacokinetics and Drug-Drug Interactions of Lopinavir-Ritonavir Administered with First- and Second-Line Antituberculosis Drugs in HIV-Infected Children Treated for Multidrug-Resistant Tuberculosis.
Topics: Anti-HIV Agents; Antitubercular Agents; Child; Drug Administration Schedule; Drug Combinations; Drug Interactions; Ethambutol; Female; HIV; HIV Infections; Humans; Isoniazid; Lopinavir; Male; Models, Statistical; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Ritonavir; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2018 |
Outcomes of pulmonary tuberculosis in patients with discordant phenotypic isoniazid resistance testing.
Topics: Aged; Antitubercular Agents; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Female; Fluoroquinolones; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Nucleic Acid Synthesis Inhibitors; Pyrazinamide; Republic of Korea; Retrospective Studies; Rifampin; Treatment Failure; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2017 |
Tuberculosis of the tonsil simulating a cancer.
Topics: Adenoids; Adult; Antitubercular Agents; Diagnosis, Differential; Ethambutol; Female; Humans; Isoniazid; Mycobacterium tuberculosis; Pharyngeal Neoplasms; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis | 2017 |
A retrospective study on tuberculosis treatment outcomes at Jinka General Hospital, southern Ethiopia.
Topics: Adolescent; Adult; Antitubercular Agents; Coinfection; Drug Combinations; Ethambutol; Ethiopia; Female; HIV Infections; Hospitals, General; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Retrospective Studies; Rifampin; Sex Factors; Streptomycin; Survival Analysis; Treatment Outcome; Tuberculosis, Pulmonary | 2017 |
Machine learning for classifying tuberculosis drug-resistance from DNA sequencing data.
Topics: Antitubercular Agents; Ciprofloxacin; Ethambutol; Humans; Isoniazid; Machine Learning; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Pyrazinamide; Rifampin; Sequence Analysis, DNA; Streptomycin; Tuberculosis, Multidrug-Resistant | 2018 |
A Painful Red Eye.
Topics: Alcoholism; Antitubercular Agents; Conjunctival Diseases; Ethambutol; Eye Pain; Glucocorticoids; Humans; Hyperemia; Interferon-gamma; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Scleritis; Tobacco Use Disorder; Tuberculosis, Pulmonary | 2018 |
Molecular Screening Versus Phenotypic Susceptibility Testing of Multidrug-Resistant Mycobacterium tuberculosis Isolates for Streptomycin and Ethambutol.
Topics: Antitubercular Agents; Ethambutol; Genes, Bacterial; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Pyrazinamide; Streptomycin; Tuberculosis, Multidrug-Resistant | 2018 |
Drug resistant tuberculosis in Saudi Arabia: an analysis of surveillance data 2014-2015.
Topics: Adult; Age Factors; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Regression Analysis; Retrospective Studies; Rifampin; Saudi Arabia; Sex Factors; Streptomycin; Tuberculosis, Multidrug-Resistant; World Health Organization; Young Adult | 2018 |
Antituberculosis Treatment in a Patient with Celiac Disease.
Topics: Aged; Antitubercular Agents; Celiac Disease; Diarrhea; Diet, Gluten-Free; Drug Compounding; Drug Substitution; Drug Therapy, Combination; Ethambutol; Glutens; Hemoptysis; Humans; Isoniazid; Male; Metronidazole; Moxifloxacin; Pyrazinamide; Rifampin; Smoking; Tomography, X-Ray Computed; Tuberculosis, Pulmonary | 2018 |
First-line anti-tuberculosis drugs induce hepatotoxicity: A novel mechanism based on a urinary metabolomics platform.
Topics: Adult; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Chromatography, High Pressure Liquid; Ethambutol; Female; Humans; Isoniazid; Liver; Male; Mass Spectrometry; Metabolic Networks and Pathways; Metabolomics; Middle Aged; Purines; Pyrazinamide; Rifampin; Tuberculosis; Young Adult | 2018 |
Improved Stability of Tuberculosis Drug Fixed-Dose Combination Using Isoniazid-Caffeic Acid and Vanillic Acid Cocrystal.
Topics: Antitubercular Agents; Caffeic Acids; Crystallization; Drug Combinations; Drug Stability; Drug Storage; Ethambutol; Humans; Isoniazid; Models, Molecular; Pyrazinamide; Rifampin; Tuberculosis; Vanillic Acid | 2018 |
Tuberculosis treatment outcome and predictors in northern Ethiopian prisons: a five-year retrospective analysis.
Topics: Adolescent; Adult; Aftercare; Anti-Retroviral Agents; Antitubercular Agents; Coinfection; Directly Observed Therapy; Drug Therapy, Combination; Ethambutol; Ethiopia; Female; HIV Infections; Humans; Isoniazid; Logistic Models; Lost to Follow-Up; Male; Multivariate Analysis; Patient Discharge; Patient Transfer; Prisoners; Prisons; Pyrazinamide; Retreatment; Retrospective Studies; Rifampin; Risk Factors; Sputum; Streptomycin; Treatment Failure; Treatment Outcome; Tuberculosis; Tuberculosis, Pulmonary; Young Adult | 2018 |
Sex differences and factors influencing the duration of the QT interval in patients on anti-tuberculosis therapy.
Topics: Antitubercular Agents; Clinical Trials as Topic; Electrocardiography; Ethambutol; Female; Gatifloxacin; Heart Rate; Humans; Isoniazid; Male; Models, Theoretical; Multivariate Analysis; Pyrazinamide; Rifampin; Sex Factors; Tuberculosis | 2018 |
Rapid and sensitive method for simultaneous determination of first-line anti-tuberculosis drugs in human plasma by HPLC-MS/MS: Application to therapeutic drug monitoring.
Topics: Antitubercular Agents; Chromatography, High Pressure Liquid; Drug Monitoring; Ethambutol; Humans; Isoniazid; Predictive Value of Tests; Pyrazinamide; Reproducibility of Results; Rifampin; Spectrometry, Mass, Electrospray Ionization; Streptomycin; Tandem Mass Spectrometry; Tuberculosis | 2018 |
Effect of Antituberculous Therapy on Uveitis Associated With Latent Tuberculosis.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Child; Child, Preschool; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Interferon-gamma Release Tests; Isoniazid; Latent Tuberculosis; Male; Middle Aged; Pyrazinamide; Recurrence; Retrospective Studies; Rifampin; Treatment Outcome; Tuberculosis, Ocular; Uveitis; Visual Acuity | 2018 |
Improving treatment outcome assessment in a mouse tuberculosis model.
Topics: Administration, Oral; Animals; Antitubercular Agents; Disease Models, Animal; Drug Therapy, Combination; Ethambutol; Female; Genotype; Humans; Mice; Mice, Inbred BALB C; Models, Theoretical; Moxifloxacin; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis | 2018 |
[Optochiasmatic tuberculomas as a paradoxical reaction to treatment for meningeal tuberculosis].
Topics: Adult; Antitubercular Agents; Brain Infarction; Diagnostic Errors; Disease Progression; Drug Resistance, Microbial; Drug Substitution; Ethambutol; Female; Host-Pathogen Interactions; Humans; Isoniazid; Magnetic Resonance Imaging; Meningitis, Viral; Moxifloxacin; Mycobacterium tuberculosis; Neuroimaging; Optic Chiasm; Paresis; Prednisone; Pyrazinamide; Rifampin; Thalamus; Tuberculoma; Tuberculosis, Meningeal; Vision Disorders | 2018 |
Protein Binding of First-Line Antituberculosis Drugs.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Protein Binding; Pyrazinamide; Rifampin; Tuberculosis | 2018 |
Evaluation of dried blood spot sampling for pharmacokinetic research and therapeutic drug monitoring of anti-tuberculosis drugs in children.
Topics: Adolescent; Antitubercular Agents; Child; Child, Preschool; Dried Blood Spot Testing; Drug Monitoring; Ethambutol; Female; Humans; Infant; Male; Pyrazinamide; Rifampin; Tuberculosis | 2018 |
A Breast Lump in an Elderly Lady - Carcinoma or else ?.
Topics: Aged; Antitubercular Agents; Biopsy, Fine-Needle; Breast; Breast Neoplasms; Ethambutol; Female; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis | 2016 |
Perianal ulcerative skin tuberculosis: A case report.
Topics: Aged; Antitubercular Agents; Ethambutol; Fissure in Ano; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Sputum; Tomography, X-Ray Computed; Treatment Outcome; Tuberculosis, Cutaneous; Tuberculosis, Pulmonary | 2018 |
Drug-resistance patterns of Mycobacterium tuberculosis strains and associated risk factors among multi drug-resistant tuberculosis suspected patients from Ethiopia.
Topics: Antitubercular Agents; Ethambutol; Ethiopia; Female; HIV Infections; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Risk Factors; Sputum; Streptomycin; Tuberculosis, Multidrug-Resistant | 2018 |
Characterizing the Effects of Glutathione as an Immunoadjuvant in the Treatment of Tuberculosis.
Topics: Adjuvants, Immunologic; Anti-Bacterial Agents; Antitubercular Agents; Cell Line; Drug Therapy, Combination; Ethambutol; Glutathione; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; THP-1 Cells; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2018 |
Improved Treatment Outcomes With Bedaquiline When Substituted for Second-line Injectable Agents in Multidrug-resistant Tuberculosis: A Retrospective Cohort Study.
Topics: Adult; Antitubercular Agents; Coinfection; Diarylquinolines; Drug Resistance, Multiple, Bacterial; Ethambutol; Ethionamide; Female; HIV; HIV Infections; Humans; Isoniazid; Isoxazoles; Levofloxacin; Male; Mycobacterium tuberculosis; Oxazolidinones; Pyrazinamide; Retrospective Studies; South Africa; Survival Analysis; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2019 |
Predicting the Outcomes of New Short-Course Regimens for Multidrug-Resistant Tuberculosis Using Intrahost and Pharmacokinetic-Pharmacodynamic Modeling.
Topics: Antitubercular Agents; Clofazimine; Colony Count, Microbial; Computer Simulation; Diarylquinolines; Dose-Response Relationship, Drug; Drug Dosage Calculations; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Host-Pathogen Interactions; Humans; Immunity, Innate; Isoniazid; Kanamycin; Macrophages; Microbial Sensitivity Tests; Models, Statistical; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Prothionamide; Pyrazinamide; Time Factors; Tuberculosis, Multidrug-Resistant | 2018 |
Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing.
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Ethambutol; Genome, Bacterial; Genotype; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Phenotype; Pyrazinamide; Rifampin; Tuberculosis; Whole Genome Sequencing | 2018 |
Pharmacokinetics of First-Line Drugs Among Children With Tuberculosis in Rural Tanzania.
Topics: Adolescent; Antitubercular Agents; Child; Child, Preschool; Drug Therapy, Combination; Ethambutol; Female; HIV Seronegativity; Humans; Infant; Isoniazid; Longitudinal Studies; Male; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Rural Population; Tanzania; Tuberculosis | 2020 |
A Diagnostic Algorithm To Investigate Pyrazinamide and Ethambutol Resistance in Rifampin-Resistant Mycobacterium tuberculosis Isolates in a Low-Incidence Setting.
Topics: Algorithms; Antitubercular Agents; Ethambutol; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Phenotype; Pyrazinamide; Rifampin; Whole Genome Sequencing | 2019 |
Scrofuloderma with disseminated tuberculosis in an Ethiopian child: a case report.
Topics: Anti-Inflammatory Agents; Antitubercular Agents; Child; Ethambutol; Female; Humans; Isoniazid; Mycobacterium tuberculosis; Neck; Prednisolone; Pyrazinamide; Rifampin; Skin; Treatment Outcome; Tuberculosis, Cutaneous | 2018 |
Potentially High Number of Ineffective Drugs with the Standard Shorter Course Regimen for Multidrug-Resistant Tuberculosis Treatment in Haiti.
Topics: Adult; Antitubercular Agents; Coinfection; Drug Resistance, Multiple, Bacterial; Ethambutol; Ethionamide; Female; Fluoroquinolones; Haiti; HIV; HIV Infections; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Retrospective Studies; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2019 |
Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis.
Topics: Antitubercular Agents; Bacterial Proteins; DNA-Directed RNA Polymerases; Drug Resistance, Multiple, Bacterial; Ethambutol; Genotype; Humans; Incidence; Isoniazid; Kuwait; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Polymerase Chain Reaction; Pyrazinamide; Rifampin; Tuberculosis, Multidrug-Resistant | 2019 |
Isoniazid-Resistant Rifampicin-Susceptible Tuberculosis in Children.
Topics: Antitubercular Agents; Child; Child, Preschool; Contact Tracing; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Prospective Studies; Pyrazinamide; Rifampin; Spain; Tuberculosis, Multidrug-Resistant | 2019 |
Efficacy and tolerability of desensitization in the treatment of delayed drug hypersensitivities to anti-tuberculosis medications.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Desensitization, Immunologic; Drug Hypersensitivity; Ethambutol; Female; Humans; Incidence; Isoniazid; Male; Middle Aged; Prospective Studies; Pyrazinamide; Rifampin; Tuberculosis | 2019 |
Conventional and molecular determination of drug resistance in Mycobacterium tuberculosis and Mycobacterium bovis isolates in cattle.
Topics: Animals; Antitubercular Agents; Cattle; Drug Resistance, Bacterial; Ethambutol; Genes, Bacterial; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium bovis; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis, Bovine | 2019 |
Simultaneous determination of the potent anti-tuberculosis regimen-Pyrazinamide, ethambutol, protionamide, clofazimine in beagle dog plasma using LC-MS/MS method coupled with 96-well format plate.
Topics: Animals; Antitubercular Agents; Calibration; Chromatography, Liquid; Clofazimine; Dogs; Ethambutol; Prothionamide; Pyrazinamide; Reproducibility of Results; Tandem Mass Spectrometry | 2019 |
Metformin induced autophagy in diabetes mellitus - Tuberculosis co-infection patients: A case study.
Topics: Adult; Antitubercular Agents; Autophagy; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Ethambutol; Humans; Hypoglycemic Agents; Insulin; Interferon-gamma; Interleukin-10; Isoniazid; Leukocytes, Mononuclear; Metformin; Microtubule-Associated Proteins; Middle Aged; Pyrazinamide; Rifampin; Sputum; Superoxide Dismutase; Tuberculosis | 2019 |
The Combination Rifampin-Nitazoxanide, but Not Rifampin-Isoniazid-Pyrazinamide-Ethambutol, Kills Dormant Mycobacterium tuberculosis in Hypoxia at Neutral pH.
Topics: Antitubercular Agents; Drug Combinations; Drug Therapy, Combination; Ethambutol; Humans; Hydrogen-Ion Concentration; Hypoxia; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitroimidazoles; Oxazolidinones; Pyrazinamide; Rifampin; Tuberculosis | 2019 |
Prevailing practices in the treatment of tuberculous meningitis (TBM): a cross-sectional study.
Topics: Anticonvulsants; Antitubercular Agents; Cross-Sectional Studies; Disease Management; Drug Therapy, Combination; Duration of Therapy; Ethambutol; Humans; India; Isoniazid; Levetiracetam; Neurologists; Practice Patterns, Physicians'; Pyrazinamide; Rifampin; Streptomycin; Surveys and Questionnaires; Tuberculosis, Meningeal | 2019 |
Compatibility Between Four Anti-TB Drugs and Tablet Excipients Determined By Microcalorimetry.
Topics: Antitubercular Agents; Calorimetry; Ethambutol; Excipients; Isoniazid; Pyrazinamide; Rifampin | 2019 |
Tuberculosis Meningitis in a 10-Month-Old Living in an Immigrant Township.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Brain; Diagnosis, Differential; Electroencephalography; Emigrants and Immigrants; Ethambutol; Female; Glucocorticoids; Humans; Infant; Isoniazid; Magnetic Resonance Imaging; Prednisone; Pyrazinamide; Rifampin; Romania; Texas; Tuberculosis, Meningeal | 2019 |
First-line tuberculosis drug resistance patterns and associated risk factors in Germany, 2008-2017.
Topics: Adolescent; Adult; Antitubercular Agents; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Emigrants and Immigrants; Ethambutol; Female; Germany; Humans; Infant; Isoniazid; Logistic Models; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Prevalence; Public Health Surveillance; Pyrazinamide; Rifampin; Risk Factors; Streptomycin; Tuberculosis, Multidrug-Resistant | 2019 |
A Rare Case of a Tuberculosis Patient with Sarcoidosis.
Topics: Adult; Antitubercular Agents; Deprescriptions; Ethambutol; Female; Glucocorticoids; Humans; Isoniazid; Prednisolone; Pyrazinamide; Radiography, Thoracic; Rifampin; Romania; Sarcoidosis, Pulmonary; Tomography, X-Ray Computed; Tuberculosis, Pulmonary; Vitamin B 6; Vitamin B Complex | 2019 |
Treatment outcomes of drug-resistant tuberculosis in the Netherlands, 2005-2015.
Topics: Adult; Aged; Antitubercular Agents; Ethambutol; Humans; Incidence; Isoniazid; Logistic Models; Middle Aged; Netherlands; Pyrazinamide; Registries; Retrospective Studies; Rifampin; Risk Factors; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Young Adult | 2019 |
Model-Based Relationship between the Molecular Bacterial Load Assay and Time to Positivity in Liquid Culture.
Topics: Antitubercular Agents; Bacterial Load; Biological Assay; Biomarkers, Pharmacological; Computer Simulation; DNA, Bacterial; Drug Dosage Calculations; Drug Monitoring; Ethambutol; Female; Humans; Isoniazid; Malawi; Male; Models, Statistical; Mozambique; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Sputum; Tanzania; Time Factors; Tuberculosis, Pulmonary | 2019 |
Fluoroquinolones and isoniazid-resistant tuberculosis: implications for the 2018 WHO guidance.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Drug Therapy, Combination; Duration of Therapy; Ethambutol; Female; Fluoroquinolones; Humans; Isoniazid; Levofloxacin; Logistic Models; London; Male; Middle Aged; Practice Guidelines as Topic; Pyrazinamide; Recurrence; Retrospective Studies; Rifampin; Treatment Failure; Tuberculosis, Multidrug-Resistant; World Health Organization; Young Adult | 2019 |
Individualising therapy for drug-sensitive tuberculosis.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Precision Medicine; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 2019 |
Determinants of serum concentration of first-line anti-tuberculosis drugs from China.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Case-Control Studies; China; Chromatography, Liquid; Creatinine; Dose-Response Relationship, Drug; Drug Monitoring; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Retrospective Studies; Rifampin; Sex Factors; Smoking; Tuberculosis; Young Adult | 2019 |
[Tuberculosis].
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2019 |
Association of ABCC Gene Polymorphism With Susceptibility to Antituberculosis Drug-Induced Hepatotoxicity in Western Han Patients With Tuberculosis.
Topics: Adult; Alanine Transaminase; Antitubercular Agents; Asian People; ATP-Binding Cassette Transporters; Chemical and Drug Induced Liver Injury; China; Drug Therapy, Combination; Ethambutol; Female; Genetic Predisposition to Disease; Genotype; Humans; Isoniazid; Male; Middle Aged; Multidrug Resistance-Associated Protein 2; Polymorphism, Single Nucleotide; Pyrazinamide; Rifampin; Risk Factors; Sex Factors; Tuberculosis; Young Adult | 2020 |
Lack of Weight Gain During the First 2 Months of Treatment and Human Immunodeficiency Virus Independently Predict Unsuccessful Treatment Outcomes in Tuberculosis.
Topics: Adult; Antitubercular Agents; Brazil; Ethambutol; Female; HIV Seropositivity; Humans; Isoniazid; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Pyrazinamide; Rifampin; Time Factors; Treatment Outcome; Tuberculosis, Pulmonary; Weight Gain | 2020 |
Exposure to first line anti-tuberculosis drugs in prepubertal age reduces the quality and functional competence of spermatozoa and oocytes in Swiss albino mice.
Topics: Animals; Antitubercular Agents; Cell Nucleus; Ethambutol; Female; Isoniazid; Male; Metaphase; Mice; Oocytes; Pharmaceutical Preparations; Pregnancy; Pyrazinamide; Rifampin; Spermatozoa; Streptomycin | 2020 |
Miliary tuberculosis and choroidal tuberculoma in a three-month old baby girl: Diagnosis and follow-up of a case.
Topics: Adrenal Cortex Hormones; Amikacin; Antitubercular Agents; Choroid Diseases; Drug Therapy, Combination; Ethambutol; Female; Humans; Infant; Isoniazid; Ophthalmoscopy; Pyrazinamide; Rifampin; Tuberculoma; Tuberculosis, Miliary; Tuberculosis, Ocular; Uveitis, Posterior | 2020 |
Rapid and highly sensitive quantification of the anti-tuberculosis agents isoniazid, ethambutol, pyrazinamide, rifampicin and rifabutin in human plasma by UPLC-MS/MS.
Topics: AIDS-Related Opportunistic Infections; Antitubercular Agents; Calibration; Chromatography, High Pressure Liquid; Drug Monitoring; Ethambutol; Humans; Isoniazid; Pyrazinamide; Reference Standards; Reproducibility of Results; Rifabutin; Rifampin; Sensitivity and Specificity; Tandem Mass Spectrometry; Tuberculosis | 2020 |
Presumed Intraocular Tuberculosis Manifesting as Unilateral Iris Granuloma.
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Granuloma; Humans; Iris Diseases; Isoniazid; Male; Microscopy, Acoustic; Pyrazinamide; Rifampin; Tuberculin Test; Tuberculosis, Ocular | 2020 |
Whole-genome sequencing in drug susceptibility testing of Mycobacterium tuberculosis in routine practice in Lyon, France.
Topics: Antitubercular Agents; Bacterial Proteins; DNA-Directed RNA Polymerases; Drug Resistance, Multiple, Bacterial; Ethambutol; France; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pentosyltransferases; Pyrazinamide; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Whole Genome Sequencing | 2020 |
LC-QToF-MS method for quantification of ethambutol, isoniazid, pyrazinamide and rifampicin in human plasma and its application.
Topics: Antitubercular Agents; Chromatography, High Pressure Liquid; Ethambutol; Humans; Isoniazid; Mass Spectrometry; Plasma; Pyrazinamide; Rifampin | 2020 |
Cytochemical Evaluation of the Toxic Effects of Combined Antituberculosis Substances on Metabolic State of Blood Lymphocytes.
Topics: Acid Phosphatase; Administration, Oral; Animals; Animals, Outbred Strains; Antitubercular Agents; Drug Combinations; Esterases; Ethambutol; Fluoroquinolones; Gene Expression; Glycerolphosphate Dehydrogenase; Isoniazid; L-Lactate Dehydrogenase; Lymphocytes; Male; Primary Cell Culture; Prothionamide; Pyrazinamide; Rats; Rifampin; Succinate Dehydrogenase | 2020 |
Tuberculous meningitis manifesting with neuroregression in a eleven month child.
Topics: Acetazolamide; Antitubercular Agents; Carbonic Anhydrase Inhibitors; Cerebrospinal Fluid; Early Medical Intervention; Ethambutol; Female; Glucocorticoids; Humans; Hydrocephalus; Infant; Isoniazid; Magnetic Resonance Imaging; Neurodevelopmental Disorders; Nucleic Acid Amplification Techniques; Prednisolone; Pyrazinamide; Rifampin; Stomach; Treatment Outcome; Tuberculosis, Meningeal | 2020 |
Treatment outcome of tuberculosis treatment regimens in Kandahar, Afghanistan.
Topics: Adolescent; Adult; Afghanistan; Antitubercular Agents; Cohort Studies; Cough; Drug Therapy, Combination; Duration of Therapy; Ethambutol; Female; Fever; Humans; Isoniazid; Male; Middle Aged; Mortality; Prognosis; Pyrazinamide; Retreatment; Retrospective Studies; Rifampin; Sex Distribution; Sputum; Treatment Failure; Treatment Outcome; Tuberculosis, Pulmonary; Weight Loss; Young Adult | 2020 |
Primary tuberculosis of the glans penis in an immunocompetent male.
Topics: Adult; Antitubercular Agents; Ethambutol; Humans; Isoniazid; Male; Penile Diseases; Pyrazinamide; Rifampin; Tuberculosis, Male Genital | 2020 |
Gene expression responses to anti-tuberculous drugs in a whole blood model.
Topics: Antitubercular Agents; Bacterial Proteins; Blood; Drug Combinations; Drug Repositioning; Ethambutol; Gene Expression Profiling; Gene Expression Regulation, Bacterial; Humans; Isoniazid; Models, Biological; Mycobacterium tuberculosis; Oligonucleotide Array Sequence Analysis; Pyrazinamide; Rifampin; Sputum | 2020 |
Esophageal Tuberculosis - A Mass of Confusion.
Topics: Aged; Antitubercular Agents; Deglutition Disorders; Delayed Diagnosis; Diagnosis, Differential; Directly Observed Therapy; Endoscopy, Digestive System; Esophageal Neoplasms; Esophagitis; Ethambutol; Fever; Humans; Isoniazid; Lymph Nodes; Lymphadenopathy; Male; Mexican Americans; Pyrazinamide; Rifampin; Substance-Related Disorders; Tomography, X-Ray Computed; Tuberculosis, Gastrointestinal; Ultrasonography | 2020 |
A Complete Triad: Horner's Syndrome in Tuberculous Meningitis.
Topics: Antitubercular Agents; Brain; Ethambutol; Horner Syndrome; Humans; Immunocompetence; Isoniazid; Male; Nucleic Acid Amplification Techniques; Pyrazinamide; Pyridoxine; Rifampin; Tomography, X-Ray Computed; Tuberculosis, Meningeal; Uganda; Young Adult | 2020 |
Inclusion of Mechanical Ventilation in Severity Staging of Tuberculous Meningitis Improves Outcome Prediction.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Antitubercular Agents; Child; Child, Preschool; Consciousness Disorders; Ethambutol; Female; Humans; Hydrocephalus; India; Isoniazid; Magnetic Resonance Imaging; Male; Middle Aged; Prognosis; Pyrazinamide; Registries; Respiration, Artificial; Rifampin; Seizures; Severity of Illness Index; Tomography, X-Ray Computed; Tuberculosis, Meningeal; Ventriculoperitoneal Shunt; Young Adult | 2020 |
Tuberculosis sepsis after tocilizumab treatment.
Topics: Antibodies, Monoclonal, Humanized; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Middle Aged; Multiple Organ Failure; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Sepsis; Treatment Outcome; Tuberculosis | 2020 |
Ocular adverse events in drug sensitive TB patients on daily fixed dose combination anti-TB drugs: A record review study from Kerala, India.
Topics: Adult; Aged; Antitubercular Agents; Dose-Response Relationship, Drug; Drug Combinations; Ethambutol; Eye Diseases; Female; Humans; India; Isoniazid; Male; Middle Aged; Pyrazinamide; Retrospective Studies; Rifampin; Tuberculosis; Vision Disorders | 2020 |
An Unexpected Cause of Conjunctivitis in an Adolescent.
Topics: Adolescent; Antitubercular Agents; Conjunctivitis; Diagnosis, Differential; Ethambutol; Glucocorticoids; Humans; Isoniazid; Male; Prednisolone; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 2020 |
Primary breast tuberculosis in an HIV-infected patient.
Topics: Adult; Antitubercular Agents; Biopsy; Breast; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis | 2020 |
Intestinal tuberculosis in a patient with end-stage renal disease on hemodialysis: A case report.
Topics: Anorexia; Antitubercular Agents; Drug Combinations; Ethambutol; Humans; Isoniazid; Kidney Failure, Chronic; Male; Middle Aged; Muscle Weakness; Pyrazinamide; Renal Dialysis; Republic of Korea; Rifampin; Tomography, X-Ray Computed; Tuberculosis, Gastrointestinal | 2020 |
Initial resistance to companion drugs should not be considered an exclusion criterion for the shorter multidrug-resistant tuberculosis treatment regimen.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Bangladesh; Child; Child, Preschool; Clinical Protocols; Ethambutol; Female; Fluoroquinolones; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Time Factors; Tuberculosis, Multidrug-Resistant; Young Adult | 2020 |
Intrapulmonary Pharmacokinetics of First-line Anti-tuberculosis Drugs in Malawian Patients With Tuberculosis.
Topics: Antitubercular Agents; Bayes Theorem; Ethambutol; Humans; Isoniazid; Pyrazinamide; Tuberculosis | 2021 |
Management of isoniazid-monoresistant tuberculosis (Hr-TB) in Queensland, Australia: a retrospective case series.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Australia; Child; Child, Preschool; Drug Therapy, Combination; Ethambutol; Ethinyl Estradiol-Norgestrel Combination; Female; Fluoroquinolones; Humans; Isoniazid; Levofloxacin; Male; Middle Aged; Pyrazinamide; Retrospective Studies; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Young Adult | 2020 |
Development and validation of a simple LC-MS/MS method for simultaneous determination of moxifloxacin, levofloxacin, prothionamide, pyrazinamide and ethambutol in human plasma.
Topics: Adult; Chromatography, Liquid; Drug Monitoring; Ethambutol; Female; Fluoroquinolones; Humans; Limit of Detection; Linear Models; Male; Prothionamide; Pyrazinamide; Reproducibility of Results; Tandem Mass Spectrometry | 2020 |
Effect of interval between food intake and drug administration at fasting condition on the plasma concentrations of first-line anti-tuberculosis drugs in Chinese population.
Topics: Administration, Oral; Adult; Antitubercular Agents; China; Drug Administration Schedule; Eating; Ethambutol; Fasting; Female; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Time Factors; Treatment Outcome; Tuberculosis, Pulmonary | 2020 |
Population Pharmacokinetic Properties of Antituberculosis Drugs in Vietnamese Children with Tuberculous Meningitis.
Topics: Adult; Antitubercular Agents; Asian People; Child; Ethambutol; Humans; Isoniazid; Pyrazinamide; Tuberculosis, Meningeal | 2020 |
Tuberculosis in the intensive care unit: alternative treatment regimens and association with mortality.
Topics: Adult; Amikacin; Antibiotics, Antitubercular; APACHE; Brazil; Drug Administration Routes; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; Intensive Care Units; Isoniazid; Logistic Models; Male; Middle Aged; Multivariate Analysis; Pyrazinamide; Retrospective Studies; Rifampin; Streptomycin; Tuberculosis | 2021 |
Point-of-Care Ultrasound Image of Intra-Abdominal Lymphadenopathy in Tuberculosis.
Topics: Abdomen; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Lymph Nodes; Lymphadenopathy; Mycobacterium tuberculosis; Point-of-Care Systems; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis; Ultrasonography; Young Adult | 2020 |
Tackling quantitative polymorphic analysis through fixed-dose combination tablets production. Pyrazinamide polymorphic assessment.
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Least-Squares Analysis; Pyrazinamide; Tablets | 2021 |
Successful Use of Rifamycin-Sparing Regimens for the Treatment of Active Tuberculosis in Lung Transplant Recipients.
Topics: Ethambutol; Humans; Isoniazid; Lung; Lung Transplantation; Moxifloxacin; Pyrazinamide; Rifamycins; Transplant Recipients; Treatment Outcome; Tuberculosis | 2021 |
Effectiveness of Shorter Treatment Regimen in Multidrug-Resistant Tuberculosis Patients in Pakistan: A Multicenter Retrospective Record Review.
Topics: Adult; Amikacin; Antitubercular Agents; Clofazimine; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Lost to Follow-Up; Male; Middle Aged; Moxifloxacin; Mycobacterium tuberculosis; Pakistan; Pyrazinamide; Retrospective Studies; Survival Analysis; Treatment Failure; Tuberculosis, Multidrug-Resistant | 2021 |
Pharmacokinetics of First-Line Drugs in Children With Tuberculosis, Using World Health Organization-Recommended Weight Band Doses and Formulations.
Topics: Adult; Antitubercular Agents; Child; Child, Preschool; Ethambutol; Female; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Tuberculosis; World Health Organization | 2022 |
A hydrogel-based implantable multidrug antitubercular formulation outperforms oral delivery.
Topics: Animals; Antitubercular Agents; Ethambutol; Hydrogels; Isoniazid; Mice; Pyrazinamide | 2021 |
Early phase of effective treatment induces distinct transcriptional changes in Mycobacterium tuberculosis expelled by pulmonary tuberculosis patients.
Topics: Adult; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Transcriptome; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult | 2021 |
Images in Clinical Tropical Medicine.
Topics: Adolescent; Antitubercular Agents; Ethambutol; Humans; Isoniazid; Knee; Lupus Vulgaris; Male; Pyrazinamide; Rifampin | 2021 |
Optimizing Dosing and Fixed-Dose Combinations of Rifampicin, Isoniazid, and Pyrazinamide in Pediatric Patients With Tuberculosis: A Prospective Population Pharmacokinetic Study.
Topics: Adult; Antitubercular Agents; Child; Drug Combinations; Ethambutol; Female; Humans; Infant; Isoniazid; Male; Prospective Studies; Pyrazinamide; Rifampin; Tablets; Tuberculosis | 2022 |
No implication of HIV coinfection on the plasma exposure to rifampicin, pyrazinamide, and ethambutol in tuberculosis patients.
Topics: Adult; Antitubercular Agents; Ethambutol; HIV Infections; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis | 2022 |
LC-MS/MS method for simultaneous quantification of the first-line anti-tuberculosis drugs and six primary metabolites in patient plasma: Implications for therapeutic drug monitoring.
Topics: Antitubercular Agents; Chromatography, High Pressure Liquid; Drug Monitoring; Ethambutol; Humans; Isoniazid; Plasma; Pyrazinamide; Rifampin; Tandem Mass Spectrometry; Tuberculosis | 2021 |
Prediction of lung exposure to anti-tubercular drugs using plasma pharmacokinetic data: Implications for dose selection.
Topics: Animals; Antitubercular Agents; Ethambutol; Humans; Isoniazid; Lung; Mice; Pyrazinamide; Tuberculosis | 2022 |
High Intrapulmonary Rifampicin and Isoniazid Concentrations Are Associated With Rapid Sputum Bacillary Clearance in Patients With Pulmonary Tuberculosis.
Topics: Adult; Antitubercular Agents; Bacillus; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Sputum; Tuberculosis, Pulmonary | 2022 |
Assessment of the efficacy of clofazimine alone and in combination with primary agents against Mycobacterium tuberculosis in vitro.
Topics: Animals; Antitubercular Agents; Clofazimine; Ethambutol; Humans; Isoniazid; Mice; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis | 2022 |
Drug concentration at the site of disease in children with pulmonary tuberculosis.
Topics: Adult; Antitubercular Agents; Child; Ethambutol; Humans; Infant; Isoniazid; Pyrazinamide; South Africa; Tuberculosis, Pulmonary | 2022 |
Analysis of Adverse Drug Reactions to First-Line Anti-Tuberculosis Drugs Using the Korea Adverse Event Reporting System.
Topics: Antitubercular Agents; Drug-Related Side Effects and Adverse Reactions; Ethambutol; Humans; Isoniazid; Pyrazinamide; Republic of Korea; Rifampin | 2022 |
Intracellular Activity of Poly (DL-Lactide-co-Glycolide) Nanoparticles Encapsulated with Prothionamide, Pyrazinamide, Levofloxacin, Linezolid, or Ethambutol on Multidrug-Resistant
Topics: Anti-Bacterial Agents; Antitubercular Agents; Ethambutol; Humans; Levofloxacin; Linezolid; Mycobacterium tuberculosis; Nanoparticles; Polylactic Acid-Polyglycolic Acid Copolymer; Prothionamide; Pyrazinamide; Reactive Oxygen Species; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2023 |
Diagnostic Accuracy of Therapeutic Drug Monitoring During Tuberculosis Treatment.
Topics: Antitubercular Agents; Drug Monitoring; Ethambutol; HIV Infections; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis | 2022 |
Enteropathogen spectrum and effect on antimycobacterial pharmacokinetics among children with tuberculosis in rural Tanzania: a prospective cohort study.
Topics: Antitubercular Agents; Child; Cohort Studies; Ethambutol; Female; Humans; Isoniazid; Male; Prospective Studies; Pyrazinamide; Rifampin; Tanzania; Tuberculosis; United States | 2022 |
IFN-γ ELISpot in Severe Cutaneous Adverse Reactions to First-Line Antituberculosis Drugs in an HIV Endemic Setting.
Topics: Antitubercular Agents; Ethambutol; HIV Infections; Humans; Interferon-gamma; Isoniazid; Pyrazinamide; Rifampin; Stevens-Johnson Syndrome | 2022 |
The role of the farnesoid X receptor in quadruple anti-tuberculosis drug-induced liver injury.
Topics: Animals; Antitubercular Agents; Bile Acids and Salts; Chemical and Drug Induced Liver Injury; Chemical and Drug Induced Liver Injury, Chronic; Ethambutol; Isoniazid; Liver; Pyrazinamide; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; Rifampin | 2022 |
Prediction of drug resistance by Sanger sequencing of Mycobacterium tuberculosis complex strains isolated from multidrug resistant tuberculosis suspect patients in Ethiopia.
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Ethambutol; Ethiopia; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant | 2022 |
A national, multicentre web-based point prevalence survey of antimicrobial use in community healthcare centres across South Africa and the implications.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Community Health Services; Ethambutol; Humans; Internet; Isoniazid; Prevalence; Pyrazinamide; Rifampin; South Africa | 2022 |
Comparison of different regimens with or without fluoroquinolone in isoniazid-resistant tuberculosis: A multicenter cohort study.
Topics: Antitubercular Agents; Cohort Studies; Drug Therapy, Combination; Ethambutol; Fluoroquinolones; Humans; Isoniazid; Pyrazinamide; Retrospective Studies; Rifampin; Tuberculosis, Multidrug-Resistant | 2022 |
Tuberculosis: Common Questions and Answers.
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Latent Tuberculosis; Pyrazinamide; Rifampin; Tuberculin; Tuberculosis; United States | 2022 |
Chronic purulent pericarditis: case report.
Topics: Adult; COVID-19; Ethambutol; Humans; Isoniazid; Male; Mediastinitis; Pericarditis; Pericardium; Pyrazinamide; Rifampin; Sclerosis; Suppuration | 2022 |
Pyrazinamide related prolonged drug-induced liver injury: A case report.
Topics: Antitubercular Agents; Arylamine N-Acetyltransferase; Chemical and Drug Induced Liver Injury; Ethambutol; Humans; Levofloxacin; Pyrazinamide; Transaminases; Tuberculosis, Lymph Node | 2022 |
A Mycobacterium tuberculosis-Infected Patient Who Could Not Tolerate Oral Intake Successfully Treated Using an Intravenous Tedizolid-Containing Regimen.
Topics: Aged; Anti-Bacterial Agents; Antitubercular Agents; Cutaneous Fistula; Ethambutol; Humans; Isoniazid; Levofloxacin; Linezolid; Male; Meropenem; Micafungin; Mycobacterium tuberculosis; Oxazolidinones; Pyrazinamide; Rifampin; Streptomycin; Teicoplanin; Tetrazoles; Tuberculosis | 2022 |
Validation and application of a quantitative LC-MS/MS assay for the analysis of first-line anti-tuberculosis drugs, rifabutin and their metabolites in human breast milk.
Topics: Antitubercular Agents; Chromatography, Liquid; Ethambutol; Female; Humans; Isoniazid; Milk, Human; Pyrazinamide; Rifabutin; Rifampin; Tandem Mass Spectrometry | 2022 |
Topics: Ethambutol; Genotype; Humans; Isoniazid; Mycobacterium tuberculosis; Pilot Projects; Pyrazinamide; Rifampin; Timor-Leste | 2022 |
Development and Optimization of a New UPLC-UV/MS Method through DoE and MLR for Detecting Substandard Drug Products to Treat Tuberculosis.
Topics: Antitubercular Agents; Chromatography, Liquid; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Substandard Drugs; Tablets; Tuberculosis | 2022 |
A high-throughput LC-MS/MS method for simultaneous determination of isoniazid, ethambutol and pyrazinamide in human plasma.
Topics: Antitubercular Agents; Chromatography, High Pressure Liquid; Chromatography, Liquid; Ethambutol; Humans; Isoniazid; Pyrazinamide; Tandem Mass Spectrometry; Tuberculosis | 2023 |
Naringenin protects hepato-renal tissues against antituberculosis drugs induced toxic manifestations by modulating interleukin-6, insulin like growth factor-1, biochemical and ultra-structural integrity.
Topics: Animals; Antioxidants; Antitubercular Agents; Cytochrome P-450 CYP2E1; Ethambutol; Insulin-Like Growth Factor I; Interleukin-6; Isoniazid; Liver; Oxidative Stress; Pyrazinamide; Rats; Rats, Wistar; Rifampin | 2023 |
A physiologically-based pharmacokinetic model for tuberculosis drug disposition at extrapulmonary sites.
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis | 2023 |
Protein binding investigation of first-line and second-line antituberculosis drugs.
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Levofloxacin; Linezolid; Moxifloxacin; Protein Binding; Pyrazinamide; Rifampin; Tuberculosis | 2023 |
Atypical Morphology of a Typical Mycobacterial Infection.
Topics: Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Pyrazinamide; Skin Neoplasms | 2023 |